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Abstract 
Vulvar Yestibulitis Syndrome (VVS) is a chronic inflammatory condition affecting the vestibular 
epithelium of the vulva, which has been estimated to affect 15% of the female population (Goetsch, 
1991 ). Many studies have attempted unsuccessfully, to elucidate the cause of this condition, and few 
advances have been made towards the understanding of the associated inflammatory response. The initial, 
and principal aim of this investigation was to characterise normal vestibular epithelium using electron 
microscopy. The ultrastructural characteristics of normal vestibular epithelium were compared with 
closely related epithelia, and with vestibular epithelia from VVS patients. Other aims included an 
investigation of the epidemiological characteristics of VVS; an assessment of vulvar sensitivity over 
several months, and an evaluation of ketoconazole as a non-invasive treatment for VVS. 
Transmission electron microscopy, confirmed that vestibular epithelium was non-keratinised, 
and closely resembled oral and vaginal mucosae. Intermediate cells were predominant, characterised by 
pale staining cytokeratin filaments and glycogen deposits. Leukocytes were present in small numbers. 
Using SEM, superficial cells were characterised by an interlacing network of rounded microridges. 
By comparison, vestibular epithelium from VVS patients demonstrated the presence of 
numerous, intensely staining, apoptotic-like cells.These cells were associated with membrane bound 
cytoplasmic lobules and leukocytes of varying types. A similar ultrastructural appearance was observed 
in post-treatment biopsies. However, apoptotic-like cells appeared heavily vacuolated, and the number 
of cytoplasmic bodies present was increased. Mature plasma cells, NK-Iike cells and macrophages were 
common in the dermis. Leukocyte counts, demonstrated a significantly greater number of leukocytes in 
the VVS biopsies compared with the controls, however, there was no statistical difference in the number 
of leukocytes in pre and post-treatment samples. The presence of apoptotic-like cells accompanied by 
a significant inflammatory cell infiltrate, may suggest a cell signalling defect, resulting in the pain 
associated with VVS. Treatment with ketoconazole cream was found to have very little effect on either 
the number of leukocytes or the frequency of apoptotic-like cells as quantified using image analysis. 
The epidemiological characteristics of YVS patients were investigated using a structured 
questionnaire interview. All of the VVS patients interviewed fulfilled the diagnostic criteria established 
by Fried rich ( 1987), and epidemiological findings were generally consistent with previous 
epidemiological reports. Unique to this study, HPY infections were rare, however recurrent Candida 
infections and cystitis were commonly reported. The 'Yulvar Algesiometer', was designed and developed 
in Plymouth, to assist diagnosis and assessment ofYVS patients. Using this equipment, VVS patients 
demonstrate heightened vestibular sensitivity when compared with control patients. 
The utilisation of a pain measuring device the 'Vulvar Algesiometer', in accordance with the 
questionnaire and ultrastructural investigation has formed a novel and balanced approach to the study 
ofVVS. This study has demonstrated several distinct features ofVVS which have not previously been 
described, features which may be important in elucidating the cause of this condition. These features 
centre around the presence of apoptotic-like cells and associated cytoplasmic bodies which have not 
previously been described in association with YVS. 
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Glossary 
• Acantholysis:loosening of spines, loss of cohesion between cells that leads to the fonnation 
of intra epithelial clefts, vesicles or blisters. 
• Atrophy: a decrease in the overall skin thickness usually due to decreased thickness of the 
dennis and less commonly of the subcutaneous fat. Atrophy may occur due to the thinning of 
the collagen bundles due to ageing. Skin appears thin, shiny, whitened, with the loss of surface 
markings. 
• Dyskeratosis: premature, and abnonnally cornified cells which have eosinophillic cytoplasm 
and small darkly staining nuclei. Difficult to distinguish from necrotic keratinocytes. 
Dyskeratotic cells occur in inflammatory and neoplastic processes. 
• Dyspareunia: difficult or painful coitus in women. 
• Dysplasia: an abnormality of development in size, shape, and in organisation of adult cells. 
• Erythema: redness of the skin around caused by congestion of the capillaries in the lower 
layers of the skin, which may occur with any skin injury, infection or inflammation. 
• Hyperkeratosis: increased thickness of the cornified layer. Hyperkeratosis may be absolute 
in that the is an actual increase in the cornified layer, or the change may be relative, an 
apparent increase in comparison with the spinous cell layer. 
• Hyperplasia: increased number of cells that results in a thick epidennis. The degree of 
thickening may vary, there are four main fonns of hyperplasia; psoriasifonn, irregular, 
papillated and pseudocarcinomatous 
• Hypertrophy:increase in size of the spiny cells which results in a thickened epidennis. This 
may be due to hyperplasia (an increased number of cells) or hypertrophy (an increase in the 
size of the cells). 
• Hypoplasia: decreased number of cells which results in a thin epidennis. 
• Koilocytosis: characterised by C)1oplasmic vacuolation and nuclear pynknosis within 
squamous epithelium. 
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• Lichenfication: a papular thickening of the skin associated with accentuation of the normal 
skin markings. Usually results from chronic rubbing of the skin. 
• Necrosis: local death of cells or tissue that occurs within a living organism. Characterised 
histologically by nuclear fragmentation, nuclear shrinkage, and swollen eosinophilic 
cytoplasm. 
• Papilloma: finger-like projections above the skin surface due to upward extensions of the 
dermal papillae which are usually covered by hyperplastic epidermis. 
• Papillomatosis: projections of dermal papillae above the skin surface. 
• Papillomaviruses: any of a group ofpapoviruses causing papillomata in humans and various 
other animals. Double stranded DNA viruses that cause epithelial proliferations of skin and 
mucosa. Human papillomaviruses cause warts, particularly planar and genital warts on the skin 
and mucous membranes. These viruses may be transmitted by direct and indirect contact. 
• Parakeratosis: departure from the normal cornification. Hyperkeratosis where in which 
pyknotic nuclei are retained in cells or squames of the cornified layer. Often occurs in 
inflammatory processes such as psoriasis, and in necrotic conditions. 
• Priuitus vulvae: condition associated with chronic itching. 
• Scleroses: a circumscribed area of hardened skin only detectable by touch. Sclerosis signifies 
hyalinization of collagen bundles with decreased fibroblasts. 
• Vestibule: space or cavity at the entrance to another structure. The vulvar vestibule is the 
space between the labia minora into which the urethra and vagina open. 
• Vestibulitis: chronic inflammation of the mucous glands of the vulvar vestibule. Persistent 
vulvar burning and discomfort especially during intercourse are characteristic symptoms. 
• Vulva: two pairs of skin folds protect the vaginal opening. The larger folds are the labia 
majora, and the inner smaller folds are the labia minor. The upper or forward ends of the labia 
join around the clitoris. The opening of the urethra, which empties from the bladder, lies 
between the clitoris and the vagina. 
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• Vulvectomy: excision of the vulva. 
• Vulvitis: inflammation of the vulva. Erosive vulvitis may be due to a variety of microbial 
infections, in this case gangrenous ulcerations similar to the lesions seen in the oral tissues 
affect the labia majora. 
• Vulvodynia: chronic vulvar discomfort, especially that characterised by the patients complaint 
of burning and sometimes rawness, irritation, and stinging. Vulvodynia should be 
differentiated from pruritus vulvae. Vulvodynia is a symptom which is agreed to have a variety 
of causes. 
• Vulvovaginitis: inflammation of the vulva and vagina. 
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CHAPTER ONE 
Genera/Introduction 
Vulvar discomfort with dyspareunia was first recognised over a century ago by Skene (1889), 
and was described a few years later by Thomas and Munde as excessive sensitiveness or 
hypersensitivity of the vulva (1891). In 1928, Kelly described a reddening of the vestibule 
which made intercourse difficult, but it was not until 1976 that Pelisse and Hewitt associated 
the pain experienced during intercourse with erythemous vulvitis. The history and potential 
causes of these symptoms have been reviewed by many researchers who have given the 
syndrome a variety of names including, focal vulvitis, burning vulva syndrome, vestibular 
adenitis, and the minor vestibular gland syndrome (Young, 1984; Peckham et al., 1986; 
Friedrich, 1987; McKay, 1991; Me Kay et al., 1989; Marinoff & Turner, 1991, 1992).This 
distinct clinical condition has received very little attention in the literature in the last 20 years. 
However, renewed interest in vulvar conditions, and in particular unidentified vulvar pain, has 
coincided with an apparent increase in prevalence ofVVS (Friedrich, 1987; Reid et al., 1988). 
Vulvar Vestibulitis Syndrome is a chronic inflammatory condition, which affects the vestibule 
of the vulva (Friedrich, 1987; Marinoff & Turner, 1991, 1992). The vestibule is that part of 
the vulva which extends from the hymenal ring outwards, blending with the more keratinised 
skin of the labia minora, upward to the frenulum of the clitoris and downward to include the 
posterior fourchette. Embryonically the vestibule represents the only part of the female 
genitalia which is endodermal in origin, originating from the urogenital sinus of the embryo 
(Woodruff & Friedrich, 1985; Wilkinson, 1992). The vestibule contains a number of glands 
termed minor vestibular glands, which are believed to secrete mucus. These glands are small 
and shallow, are variable in number, being numerous, or completely absent in some 
individuals. Generally however, 2-10 identifiable glands are present. The epithelium of this 
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area is not characterised by true mucus secreting glands, but is bathed in mucous from the 
vagina and cervix. The epithelium of the vestibule has been described as non-keratinised 
having a similar appearance as mucosal-like surfaces, however, some reports suggest that the 
whole of the vulva is keratinised (Friedrich, 1983; Woodruff & Friedrich, 1985; Friedrich, 
1987; Wilkinson, 1992). 
The term VVS was suggested by Friedrich (1987), and was incorporated into the current 
terminology at the 1987 meeting of the International Society for the Study ofVulvar Disease 
(ISSVD), to replace inaccurate terms such as focal vulvitis, vestibular adenitis and the burning 
vulva syndrome (Ridley, 1989). Friedrich, suggested that the term VVS should be applied 
only to those women who present with the following constellation of symptoms: a) sensitivity 
to pressure located on the vestibule, b) erythema of the periductal tissue of varying degrees, 
and c) pain during sexual intercourse or on attempted vaginal entry (Friedrich, 1987). These 
diagnostic criteria have been widely accepted and are now commonly used for the assessment 
of patients with unidentified vulvar discomfort. McKay (1985, 1988, 1989), suggested that 
a distinction between pruritus and the pain associated with VVS should be made. Patients who 
complain of itching, but do not have a burning sensation should not be diagnosed as having 
VVS. 
The etiology of the syndrome remains unknown. Associations have been made with: recurrent 
Candida infection; hypersensitivity to Candida antigens (Marinoff & T umer, 1986); sub-
clinical HPV infection, auto immunity (Ashmann & Ott, 1989); lgA deficiency (Scrimin et al., 
1991), allergic and, or irritant reactions to topical therapies (Friedrich, 1987); psychosexual 
problems (Koblenzer, 1983; Lynch, 1986; Schover et al., 1992, Abramov et al., 1994, Kehoe 
& Luesley, 1995); and interstitial cystitis or urinogenital sinus syndromes (Fitzpatrick er 
al., 1993; Kozios et al., 1993; Foster er al., 1993). Histopathological investigations have been 
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of limited help in elucidating the pathogenic cause of the syndrome. Several authors have 
completed basic histological examination of biopsies from VVS patients (Turner & Marinoff, 
!988; Furlonge et al., 1991 ), however, the most comprehensive investigation was completed 
by Pyka et al.(J988). A similar investigation was completed recently by Prayson et al. (1995), 
this investigation involved the study of 36 VVS samples from vestibulectomies, using 
microbiological and immunological tests to characterise the type of inflammatory reaction or 
to detect the presence of an etiological agent. In common with a majority of work published 
on VVS, Prayson et al. ( 1995) concentrated on the role of HPV in the development of 
vestibulitis syndrome. Despite numerous reports ofHPV associated VVS very little work has 
been completed on the histology ofVVS since the landmark paper by Pyka et al.(l988). 
Research has concentrated on treating the symptoms ofvulvar vestibulitis syndrome, usually 
with interferon, rather than investigating the source of the problem (Hatch, 1988, 1991, 1992; 
Horowitz, 1989; Kent, 1990; Bomstein et al., 1991, 1993; Umpierre et al., 1991; Waltzman 
& Wade, 1991; Larsen et al., 1993). Associations with HPV were originally founded on the 
presence of koilocytes in the epithelium ofVVS samples, which are considered indicative of 
HPV infection. Despite only a small percentage of cases being proven to contain HPV using 
the polymerase chain reaction (PCR), Southern blotting or in situ hybridisation, research has 
continued in this area (Wilkinson et al., 1993; Bergeron et al., 1994). Although interferon has 
been used for the treatment of VVS in numerous studies, the results are inconsistent 
(Wilkinson et al., 1993; Bergeron et al., 1994). Surgical removal of the affected area remains 
the most successful method for the treatment ofVVS, however vestibulectomy is invasive and 
also the most expensive means of treatment (Woodruff & Parmley, 1983; Marinoff et al., 
1993; Bomstein et al., 1995). Other treatments for VVS have included: carbon dioxide laser 
(Davis, 1989), local alcohol injection (Clowser & Friedrich, 1986), steroid and anti-candida 
therapies (Friedrich, 1988), pelvic floor musculature development (Glazer et al., 1995) and 
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calciwn citrate (Solomons et al., 1991 ). 
One of the initial aims of this study was to investigate any possible link between HPV and 
Vulvar Vestibulitis Syndrome using transmission electron microscopy and associated 
immuno-gold labelling techniques. However, when reviewing the literature on the VVS it 
became apparent that a large volwne of research had already been completed on HPV 
associated VVS, and that very little advance had been made towards understanding or even 
proving this association. In comparison, there was a large area which had not received any 
attention. The vestibule of the vulva had been neglected histologically for many years, with 
a majority of work concentrating on cervical and vaginal disease. The normal histology, and 
the ultrastructural appearance of the vagina and cervix had already been characterised, 
however, the vulva, and in particular the unique epithelia of the vestibule had been overlooked 
(Ferenczy & Richart, 1974 ). The ultrastructural characteristics of normal vulvar tissue were 
thus considered essential to any investigation of VVS. A detailed investigation of the 
vestibular epithelium was required in order to establish a baseline for the ultrastructural 
investigation ofVVS. Very little information was available on the normal appearance of this 
tissue, and consequently, normal skin and keratinised areas of the vulva were the only similar 
tissues available for comparison. Electron microscopy was chosen to investigate the 
ultrastructural characteristics of the vestibule, and the pathology ofvestibulitis syndrome. The 
project then followed three main avenues: firstly, an ultrastructural investigation of normal, 
and VVS affected vestibular epitheliwn, followed by the assessment ofketoconazole as a non-
invasive treatment for VVS (A); secondly, the assessment, diagnosis and monitoring of vulvar 
sensitivity in VVS patients (B); and finally an investigation of the epidemiological 
characteristics of the study cohort (C). The channels of research are perhaps best exemplified 
in Figure 1.0. 
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Figure 1.0 Proposed channels of research 
- .. -------------- ----------------
Proposed Channels ofResearch (C) 
(A) 
1. Ultrastrucutral 
Evaluation & 
Characterisation of 
the Normal Vulva 
2. Ultrastructural 
Investigation ofVVS 
Affected Biopsies 
3. Treatment with 
Ketoconazole -An 
Ultrastructural 
Assessment 
--------- --------
(B) 
Epidemiology 
--of Vestibulitis I 
Assessment of 
Vulvar 
Sensitivity-
Vulvar 
Algesiometer 
Patients ~ 
Studies investigating both the basic histology ofVVS, and the presence of HPV using DNA 
probes often lacked controls. As very little information was available on the normal 
appearance of the vestibule, an investigation of the normal vestibular tissue using EM was 
considered essential as a control for the study of VVS affected epithelium. However, 
obtaining suitable control samples for the ultrastructural investigation proved to be one of the 
greatest challenges of the project. Samples from cadavers and vulvectomy operations were 
considered inappropriate controls for the EM investigation, as changes in ultrastructure due 
to autolysis or tumours would significantly complicate the ultrastructural investigation. 
Biopsies of vestibular epithelium are not removed routinely during any gynaecological 
procedure, and therefore obtaining samples from women between the ages of 20-50 years, 
who had not suffered with vulvar pain proved problematic. After several months, a group of 
women in this age range, scheduled for gynaecological repair surgery were identified. Ethical 
committee approval was required, and was obtained in February, 1994. 
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Initially the Genitourinary Medicine (G.U.M.) clinic at Freedom fields Hospital, Plymouth, 
was the sole centre for the study of VVS patients. In the years 1990-1993 forty patients had 
been diagnosed as having VVS, and were now being treated at this centre. Patients already 
being treated for VVS were not suitable for this study, as it was intended that the ultrastructure 
of the vestibular epithelium would be investigated pre and post treatment. However, in true 
scientific fashion, soon after ethical committee approval was received, no new patients 
became available to participate in the study. Other sources of VVS patients were explored, 
and Addenbrookes G.U.M. clinic (Cambridge) agreed to provide vestibular samples from 
women with VVS. Dudley Road Hospital (Birmingham), is one of the only hospitals in the 
country carrying out vestibulectomies for VVS. Permission was given to use archival material 
from VVS patients, embedded in paraffin wax for the light microscopy part of the 
investigation. Contacts made at both Birmingham and Cambridge proved invaluable to the 
success of the study, both centres providing additional biopsies for the EM investigation. 
Biopsies of periductal tissue from VVS patients, were taken from beside the right Skenes' 
gland and processed for TEM. Vestibulitis patients were then treated for four months with 
ketoconazole, after which a second biopsy was removed from the lateral border of the left 
Skenes' gland. The objectives of the ultrastructural investigations were to a) describe the 
overall structure of the epithelium, b) characterise the different cell types present, c) 
investigate the inter-relationships of the epidermal and non-epidermal cells present, d) 
describe differences in ultrastructural appearance in VVS samples, and e) indicate any change 
in the ultrastructural appearance ofVVS affected epithelia after treatment \.Vith ketoconazole. 
As an addition to the ultrastructural investigation, low temperature (LT) processing for TEM 
was expected to be completed on several control and VVS samples. Low temperature freeze 
substitution (L TFS), maintains the antigenicity of the tissues and provides good ultrastructural 
30 
preservation. This was essential, as immunocytochemical labelling of VVS tissues was 
planned if sufficient samples became available. It was expected that differences in 
ultrastructure would be evident using this LT method of processing, giving a more accurate 
picture of both the control and the VVS samples. However, due to limited sample numbers, 
only a small number of control samples were processed using this technique. Scanning 
electron microscopy (SEM) was completed on several samples of vestibular tissue from 
control and VVS patients, the surface characteristics were compared with keratinised perineal 
epithelium, and vaginal epithelium. Finally, it was expected that the results obtained from 
both the TEM and SEM investigations would be quantified using image analysis. Various 
parameters would be compared in control, VVS and post treatment samples, as well as 
differences between vestibular and perineal samples. 
Measurement ofvulvar sensitivity in VVS patients is notoriously problematic. A number of 
studies have used a cotton tipped swab to assess the sensitivity of the vestibular epithelium. 
However, this means of assessment is highly subjective, not reproducible, and does not 
provide a measurement of the degree of sensitivity. Vulvar discomfort was monitored in VVS 
patients throughout the study using a pain measuring device, the 'Vulva! Algesiometer', which 
was designed specifically for the investigation. Measurements were taken at monthly intervals 
from the time of initial diagnosis, and for four months whilst the patients were treated with 
ketoconazole. 
Women with VVS have been studied on several occaswns usmg self administered 
questionaries. One large investigation of 210 women in the USA has dominated the literature 
(Goetsch, 1991 ). Several characteristics of the syndrome were established during this 
investigation, and have since been confirmed by other authors (Furlonge et al., 1991 ). The 
study by Goetsch ( 1991 ), although large, involved the assessment of vulvar pain in a group 
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of women attending a vulvar clinic, and consequently, the proposed incidence ofVVS in the 
population studied may be inaccurate. In the present pilot investigation, epidemiological data 
was obtained from 19 women with VVS attending the G.U.M. clinic in Plymouth. A similar 
group of women without VVS were used as controls for the epidemiological investigation. 
The aim of the epidemiological study was to test several of the hypotheses reported in 
previous studies (Friedrich, 1987; Goetsch, 1991; Furlonge et al., 1991; Marinoff & Turner, 
1992), and to establish whether our study group of VVS patients met the criteria suggested 
by Friedrich (1987). Areas of interest included; biographical details, gynaecological history, 
self treatment by patients, treatment by their GP, patients perception and description of pain, 
and their assessment of the treatment received at the G.U.M. clinic. 
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CHAPTER TWO 
Vulvodynia : A review of the current literature 
2.0 The anatomy of the vulva 
The female vulva is defined as that area of the genitalia bounded laterally by the genitocrural 
folds, anteriorly by the mons pubis, and posteriorly by the perineal body (Fig.2.0). The 
components of the vulva are the labia minora, labia majora, urethra, clitoris, mons pubis, the 
vestibule, the vaginal orifice and the openings of Bartholins' and Skenes' glands. 
The labia majora and labia minora 
The labia majora, which are composed of adipose and fibrous tissue, form the lateral extent 
of the vulva. These fuse with the labia minora where, posteriorly, they flatten and become 
narrower towards the fourchette, where they are seen to terminate. The labia majora develop 
as a secondary sexual characteristic to completely cover and protect the labia minora, and are 
consequently different in appearance. The skin of the labia majora is notably pigmented, 
giving this area a darker appearance than the remainder of the vulvar epithelium. The structure 
of the epithelium covering the labia majora is the same stratified, squamous epithelium as that 
found covering other parts of the body. This epithelium has all of the characteristics of normal 
skin; the underlying dermis, is characterised by sebaceous, apocrine and sweat glands. 
The labia minora consist of flat folds of connective tissue with a small amount of adipose 
tissue. The labia minora are partially covered with skin, but on the medial aspect the 
epithelium is mucosal-like. Hart ( 1893) described this junction of keratinised and mucosal 
epithelium, now termed Harts' Line; "if the genitals can be looked at carefully, we can trace 
a line of demarcation between the skin and mucous membrane as running along the base of 
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the inner aspect of each labia minora." Anteriorly the labia minora form the prepuce and 
frenulum of the clitoris, and posteriorly, they blend with the labia majora to form the posterior 
fourchette (Friedrich, 1983) (Fig.2.0). The cleft between the two labia minora is termed the 
vestibule, into which, open the vagina, urethra, and vestibular glands. The epithelium of this 
area is not characterised by mucus secreting glands, but is bathed in mucous from the vagina 
and cervix. However, the epithelium is mainly non-keratinised having a similar appearance 
as mucosal-like surfaces. In comparison with the epithelium covering the labia majora, the 
labia minora is covered by a lightly pigmented, non-keratinised epithelium, with a thin or 
absent granular cell layer and few of the appendages seen in skin. There are no hair follicles 
on the medial aspect of the labia minora, but sebaceous glands are abundant. The dermis is 
highly vascular, with loose connective tissue rich in elastic fibres. Enlargement of the labia 
minora has been reported as a congenital disease, or as a secondary response to trauma or 
infection. Post menopausal women frequently show shrinkage of the labia minora due to 
hormonal changes which affects the storage of fat in the labia, giving a similar appearance to 
that seen in pre-pubescent girls (Wilkinson, 1992). 
The vestibule and vestibular glands 
The vestibule, along with the urethra and the trigone of the bladder, represent the remains of 
the urogenital sinus of the embryo, and is analogous with the penile urethra of the male. The 
vestibule contains a number of mucous secreting glands termed minor vestibular glands. 
These glands are small and shallow, are variable in number, being numerous or completely 
absent in some individuals, however, generally 2-1 0 identifiable glands are present (Woodruff 
& Friedrich, 1985). The orifices of these glands, which drain via ducts, are visible as pits in 
the vestibular surface. The columnar epithelium lining these ducts often undergoes metaplasia, 
squamous epithelium replacing columnar cells. Metaplasia of the glands often occurs due to 
a condition termed vulvar vestibulitis syndrome. As a result of this condition, the columnar 
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cells are largely replaced by squamous cells, however, in the base of the vestibular cleft some 
columnar cells are visible (Friedrich, 1987) . 
Figure 2.0 The anatomv of the vulva 
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Other glands which open onto the vestibular surface of the vulva are Brutholins' and Skenes' 
glands. Bartholins' glands lie beneath the fascia on each side of the vestibule, these glands are 
homologous to Cowpers' glands in the male. Lobulate, racemose, glandular structures, these 
glands contain multiple acini grouped around the termination of each of their many branching 
ducts. Lining these ducts are cuboidal epithelial cells. which contain mucin to be secreted 
during sexual activity. The main ducts ofBartholins' glands reach the vestibular surface at 5 
and 7 o'clock outside the hymenal ring (Figure 2.0). On each side of the vaginal opening are 
bulbocavernosus muscles situated beneath the floor of the vestibule. Within these muscles are 
the bulbi vestibuli which are homologous to the bulbi penis in the male. Bartholins ' glands 
and the associated structures are rarely involved in vulvar disease. The Skenes' ducts or 
paraurethral ducts open into the urethral canal external to the uretlu·al meatus. Paraurethral 
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glands are branched tubular structures which empty into paraurethral ducts. These ducts are 
inconsistent in number and location, they form an extensive network throughout the tissues 
of the distal urethra, extending close to the bladder. These ducts terminate in tubular glands 
which are lined mainly with columnar epithelium, and have a limited secretory activity 
(Huffman, 1948). 
Using light microscopy, the vestibule of the vulva has a similar appearance to that of vaginal 
epithelium, and oral epithelium. At electron microscopy level, vestibular epithelium has 
features in common with both of these epithelia, but also the epithelia of the cornea and the 
bladder (Sargeant et al., 1996). Vaginal, bladder, oral and vestibular epithelia store glycogen 
in intermediate and surface cells, and often appear non-keratinised (Kurman, 1987). The 
surface of the oral cavity and the esophagus is particularly interesting, and has many features 
in common with vestibular epithelium (Rhodin, 1974, Landay & Shroeder, 1977, 1979). Oral 
epithelia may be non keratinised, para-keratinised or fully keratinised; a similar range of 
keratinisation may occur in the vulva. Moving from the vestibule towards Harts' line the 
epithelium appears to change from non-keratinised to keratinised epithelium (see Chapter 5). 
Other similarities with oral epithelium include the presence of pale staining cytokeratin 
filaments, interdigitating cytoplasmic processes, and leukocytes in all cell layers. Both oral, 
vaginal and vestibular epithelium are stratified, squamous epithelia, however these mucosal-
like epithelial surfaces share some characteristics with other epithelia. The bladder is 
composed of transitional epithelium, which is a modification of cuboidal type epithelium. In 
common with bladder epithelium, cells of vestibular epithelium are glycogenated, have few 
desmosomes and numerous cytoplasmic processes (Richter & Moize, 1963 as cited by 
Rhodin, 1974). Surface cells of bladder, soft palate, cornea and esophagus are characterised 
by the presence of microvillous-like processes, which are believed to maintain a layer of 
mucus or moisture on the surface of these epithelia, and which are evident on surface cells of 
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vestibular epithelium (Sargeant et al., 1996). 
2.1 Non-neoplastic and neoplastic epithelial disorders of the vulva 
The earliest reports of 'itching, white lesions' of the vulva were written by Wier in 1875 (as 
cited by Friedrich, 1985). Since this observation, many authors have concentrated on these 
lesions which appeared to be pre-cancerous. Progress was hampered for many years by the 
lack of uniform nomenclature (Table 2.0), until the landmark paper by Jeffcoate and 
Woodcock in 1961 (as cited by Lmvrence, 1993), which suggested the replacement of non-
specific terminology. They suggested that "all skin changes for which a specific cause is not 
clear are best given clinically an all embracing and non committal title such as 'chronic 
epithelial dystrophy"'. Since this major change in terminology, the nomenclature of vulvar 
disease has been modified extensively, especially over the last twenty years. Current 
terminology classifies conditions of the vulva into neoplastic and non-neoplastic, a 
classification which has been widely accepted (Lawrence, 1993; Laverly, 1994). 
The incidence of non-neoplastic epithelial disorders (NNEDs) is unknown. Generally, it is 
believed that disorders of this type are under diagnosed, as the primary characteristic of the 
condition is either minor or non existent pruritus, which is difficult to demonstrate and to 
assess. The local environment of the vulvar epithelium effects the appearance of non-
neoplastic epithelial disorders. It has been reported that vulvar skin sweats more than any 
other epithelial surface of the body except the axilla (Lawrence, 1993). The moist, warm 
environment, frequently results in the modification of lesions so that they are often 
indistinguishable from the same dermatological lesion on another areas of the body, and 
similar dermatological lesions on other parts of the vulva. The presence of an infectious agent 
as well as dermatological vulvar lesions, is a further complicating factor in the accurate 
diagnosis ofvulvar dermatoses, as the infectious agent may further modify the epithelium. It 
37 
is these factors which have lead to complicated and often conflicting terminology over the last 
century. This may now have been resolved due to the introduction of less ambiguous and 
universal terms by the International Society for the Study ofVulvar Disease (ISSVD). 
Table 2.0 Historv of nomenclature associated with vulvar disease 
Author I Date 
Weir 1875 
Breiski 1885 
Berkeley & Bonney 1909 
Taussig 1929 
McAdams & Kismer 
J effcoate 1961 
Jeffcoate & Woodcock 1961 
Jeffcoate 1966 
(Adapted from Lawrence, 1993) 
Description I Nomenclature 
Persistent, pruritic, benign vulvar lesion in association with leukoplakia 
of the tongue- Greek "leukos" white and "plax" plate. 
White lesion of the vulva designated as leukoplakia - probably 
represented lichen sclerosus. 
Leukoplakia vulvitis added to literature to describe white lesions of the 
labia, perineum, thigh and perianal regions, thought to be premalignant. 
Leukoplakic vulvitis described as involving any part of the vulva( or 
perianal skin. Leukoplakia implied a precancerous lesion. 
Leukoplakia used to describe any lesion with histological atypia 
regardless of gross appearance. 
General white lesions of the vulva are benign. Excessive use of the term 
leukoplakia to describe atypia of the vulva. 
Introduced term 'chronic epithelial dystrophy' to include intractable 
vulva( diseases of unknown etiology previously termed leukoplakia, or 
leukoplakic vulvitis. 
Altered terminology to 'chronic vulva( dystrophy', included any vulvar 
skin change of uncertain etiology, including red and white lesions 
During the next decade, the ISSVD adopted its first classification of vulvar dystrophies using 
microscopic criteria (Ridley, 1989). The first challenge put to the ISSVD was to form a system 
of nomenclature for vulvar disease which would be accepted by gynaecologists, doctors, GU 
physicians, pathologists and dermatologists alike. The term dystrophy was not popular, as it 
suggested abnormal, or defective nutrition and is commonly used to describe musculoskeletal 
disorders. Other arguments against the term dystrophy have suggested that the term is non-
specific, non-diagnostic and imprecise. Despite this, the term dystrophy is still widely used 
for the description of vulvovaginal disorders (Friedrich, 1983a, 1985; Carcio, 1992; Mahmud 
et al., 1992; Laverly, 1994). In 1982, Sanchez and Mihm (as cited by Lav:rence, 1993) 
suggested the term hyperplasia to replace dystrophy; vulvar epithelial hyperplasia would 
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include categories with and without atypia. Hyperplasia is defined as an abnormal increase in 
volume of a tissue or organ caused by the formation and growth of new normal cells. Another 
classification was also included, that of benign dermatoses, which included all dermatoses 
commonly affecting the vulva. In 1987 the ISSVD suggested that the term squan10us cell 
hyperplasia should only be used for conditions where hyperplasia can not be attributed to 
particular tissue processes, specific lesions, infections or dermatoses, e.g., lichen planus, 
psoriasis, candidiasis, or condylomata. The subgroups of squamous atypia have been removed 
from the non-neoplastic epithelial disorders to be covered by the umbrella term 'vulvar intra 
epithelial neoplasia' (VIN) (Table 2.1). If non-neoplastic and neoplastic disorders are present 
together, they should be reported individually (Carcio, 1992; Mahmud et al., 1992). 
Itch vs. Bum 
Vulvar pain may manifest itself in many different ways, and may be associated with infectious 
agents such as Human Papillomavirus (HPV), Candida; or with other factors, for example 
cosmetic initants, therapeutic agents, psychological factors, or nerve damage. It is important 
that itching and burning, two symptoms common in the study of vulvar disease, can be 
differentiated by both the physician and also by the patient as these symptoms suggest very 
different causes and therefore require different treatments. It is essential that the patient is 
encouraged to describe her symptoms fully and accurately, to enable a complete assessment 
by the physician, who should be prepared to believe the patient. Patients with itching generally 
show skin changes associated with such conditions, such as excoriation, lichenfication, 
erythema and oedema. In comparison, the patient with vulvodynia complaining of burning 
rarely exhibits such changes (McKay, 1985, 1992). The perception of burning and itching 
often causes confusion, as treatments prescribed for infections which cause itching, may in 
fact result in contact dermatitis and burning. However, if burning and itching are reported 
together an infectious agent such as Candida may be complicating the diagnosis. 
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Table 2.1 Non-neoplastic and neoplastic epithelial disorders 
Non-neoplastic epithelial disorders of skin and mucosa (ISSVD 1990) 
I. Lichen sclerosus 
2. Squamous cell hyperplasia (not otheJWise specified) e.g., Lichen planus, candidiasis, condylomata 
3. Other dermatoses - distinct clinicopathological features or known etiological agent 
Vulvar intraepithelial neoplasia (VIN) 
I. Squamous - VIN I mild dysplasia formerly mild atypia 
- VIN 11 moderate dysplasia; formerly moderate atypia 
- VIN Ill severe dysplasia I carcinoma in siw; formerly severe atypia 
2. Non squamous 
Padgets disease 
Melanoma in situ 
(Adapted from Lawrence, 1993, [ISSVD 1990)) 
The sensations associated with itching and burning are very similar in their initiation 
(Hemdon, 1975). These sensations are perceived by the same nerve endings, receptors for 
which are situated in the dermo-epidermal region of the epidermis. It has been suggested that 
burning and itching sensations are in fact the same entity, one being a continuation of the 
other as the intensity of the stimulation increases. As itching escalates and scratching occurs, 
the sensation of itching is often replaced by burning. The nerve fibres for itching may be 
affected by the phenomenon of sensitisation, which during prolonged stimulation causes 
random background firing of the nerves which persists when the stimulant is removed (e.g., 
the infection causing itching). During the itch response, scratching is initiated, which involves 
larger nerve fibres being stimulated resulting in a negative feedback phenomenon which 
inhibits the itch fibre stimulus. In contrast during burning there is no scratching, which may 
be due to a protective mechanism to help prevent any further tissue damage, and to allow 
damage caused by itching to be repaired (Me Kay, 1985). 
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2.2 Vulvodynia 
The gynaecological problem of vulvae burning with no documentation of a causative agent 
has proved a long term problem for gynaecologists, dermatologists and GU physicians. Many 
clinicians have misdiagnosed such patients as having a psychological problem. It has only 
been in the last 15 years that research has indicated that many of the reported psychological 
cases are in fact due to infective agents such as HPV and Candida infections (Marinoff 
&Turner, 1991, 1993; Ashman & Ott, 1989; McKay, 1991; Sobel, 1992, 1993; Sharp, 1993). 
Vu1vodynia is an umbrella term which covers a variety of NNEDs which cause vulvar 
discomfort, and is defined as a syndrome of unexplained vulvae pain, sexual dysfunction and 
psychological disability (McKay, 1985, 1988, 1991, 1992). The incidence, or prevalence of 
the condition is unknown, however it is understood that there are various subsets of 
vulvodynia, recognition of which is important in the treatment of such conditions (McKay, 
1988; Paavonen, 1995a, 1995b). With the exception of Candida, Herpes simplex, and rarely 
HPV, disorders associated with vulvodynia are not contagious. It is important the patient be 
made aware that their condition is treatable in the long term, as often they harbour fears of 
malignancy and sexually transmitted diseases. 
Tovel and Young (1978, as cited by McKay, 1989) first suggested the term vulvodynia, from 
the Greek "odynia" meaning pain, in replace of the term 'burning vulva syndrome'. Later at 
the ISSVD meeting in 1983, McKay suggested the same term, vulvodynia, which she 
suggested was analogous with glossodynia (painful tongue).The ISSVD accepted this 
terminology, and defined vulvodynia as "chronic vulvae discomfort, especially that 
characterised by the patients complaint of burning, stinging, rawness or irritation" a condition 
which should be differentiated from the itching associated with pruritus vulvae (Young , 1984; 
McKay, 1989; Rid1ey, 1989). Since the introduction of this term, there have been several 
reviews on the subject, particularly describing etiological agents, subsets ofvu1vodynia and 
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vulvovaginal conditions associated with the development of vulvodynia (McKay, 1985; 
Lynch., 1986; McKay, 1985, 1988, 1989, 1991, 1992, 1993 and Sonnendecker et al., 1993; 
Paavonen, 1995a & b; Sonni et al., 1995). As described by McKay ( 1988), and supported by 
other authors (Foster et al., 1993; Sharp 1993) there are five main subgroups ofvulvodynia; 
vulvar dermatoses, essential vu1vodynia, cyclic vulvodynia, vestibulitis syndrome and HPV 
associated vulvodynia. 
The vulva and vagina are embryonically different, the vestibule of the vulva being endodermal 
in origin. However, the closeness of these two tissues often results in inflammatory conditions 
which affect both areas. Vaginitis, caused by infective agents such as Candida, Trichomonas 
or Gardnerella are therefore important in the study of vulvar disease, as these agents may 
initiate the onset of symptoms associated with vulvodynia. Redness and oedema, characteristic 
ofvulvodynia usually occur due to inflammation. A reddened vulva with no infection present 
may suggest the presence of a vaginal infection which is irritating to the vulva. However, 
patients with vulvodynia characterised by vulvar burning, rarely have any physical findings 
associated with disease such as exorcisation, scratching or rubbing (McKay, 1989, 1992). This 
is essentially why the diagnosis of psychological disease is so frequent, especially when 
physical fmdings are subtle and dyspareunia is the major problem. It is essential that all 
possible causes are investigated as often more than one factor may be evident in the 
development of the condition (Table 2.3). 
Remission or exacerbation of symptoms may occur when a treatment for one particular 
problem affects the onset of another, such as spread of HPV infection, or sensitivity to 
medication. Interaction of such factors results in a complicated picture of vulvodynia, for 
example, long term Candida or HPV infection may suggest an auto-immune problem with 
antigen sensitivity causing local inflammation. Thorough diagnosis and patient evaluation are 
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therefore essential, firstly in the recognition of vulvodynia, which frequently manifests as a 
multifactorial problem, and secondly in the treatment of patients with this distressing 
condition. 
Table 2.3 Subsets ofvulvodynia 
Subset of Vulvodynia 
Dermatoses 
Lichen sclerosus 
Inflammatory dermatoses 
Periorifical Dermatitis 
Other Dermatoses 
Infections 
Candida albicans 
Human Papillomavirus 
Herpes simplex virus (HSV) 
Essential Vulvodynia 
Cyclic Vulvovaginitis 
Vulvar Vestibulitis Syndrome 
Characteristics of Subset 
Acute and linked to skin damage due to excoriation. Irritant or allergic 
responses may occur. 
Rarely seen associated with vulvodynia. Flattening of rete pegs, chronic 
inflammatory infiltrate in dermis. 
Examples include Herpes simplex, lupus erythematosus, bullous 
dermatoses, and aphthosis. 
Over use of potent steroid creams causing secondary dermatitis. 
Lichen planus, Lichen simplex, psoriasis, all of which are termed 
papulosquamous disorders. Thickening of the epidermis occurs in 
plaques (Maibach & Mathias, 1985) 
Not associated with vulvar burning but with itching - over use of 
antibiotics may result in super Candida infection and vulvodynia. 
Clinical or subclinical infections rarely itch or burn. Vestibular 
papillomatosis may be seen associated with subclinical and clinical 
infections. Acetowhitening used to detect dysplastic areas. 
Cyclic or recurrent infection common. Papules or vesicles erode to form 
sore patches. Subclinical infection possible. 
No physical fmdings associated with disease. 
Freedom from symptoms between recurrences. Redness and irritation 
are common, skin splits easily due to underlying oedema. Often linked 
to menstrual cycle, some associated with recurrent Candida infection. 
Chronic and continuous pain elicited when pressure is applied to the 
vestibule. HPV and Candida may be of etiological importance. 
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2.21 Diagnosis and treatment ofvulvodynia 
Management, rather than cure of the condition is the goal in the treatment of most 
dermatological conditions, as very few recurring skin infections are easily corrected. McKay 
and others, stress the need for a complete patient history before treatment of any kind (Carcio, 
1992; McKay, 1992; Sharp, 1993 and Sonnendecker et al., 1993). 'Over the counter' (OTC) 
preparations, and doctors prescribing treatments 'over the phone' are other complicating 
factors which should be avoided. OTC preparations frequently contain benzocaine for vulvar 
itching, however, this is a well known sensitizer which commonly initiates contact dermatitis 
(McKay, 1992). Often, by the time the patient sees a clinician she probably will already have 
tried several treatments, which may have altered the original problem, preventing an accurate 
diagnosis. Bland soothing preparations are often required to allow the inflammation to subside 
and the vulvar mucosa to heal before more potent therapeutic chemicals are prescribed. Before 
treatment of any kind, details such as gynaecological history, past surgery, number of children, 
exposure to potential sensitisers and demographic details should be obtained. An account of 
pre-existing dermatoses should be taken, and any current treatment regimes clearly defined. 
This should be followed by a complete and careful physical examination of the vestibule, 
vulva, introitus and finally the vagina. Diagnostic tests for the exclusion of infections should 
include a vaginal smear, culture for Candida, and acetowhitening to detect dysplastic changes 
in the vulvar epithelia which may indicate HPV infection. Acetowhiten.ing, describes the 
reaction of the epithelium to the application of dilute acetic acid to detect thickening of the 
epithelium. Hyperkeratosis, indicated by whitening of the surface on the application of acetic 
acid, may be indicative of HPV infection. If itching is the primary complaint, in addition to 
tests for infectious vaginitis the possibility of dermatoses, general pruritus, carcinoma in situ, 
and cervicitis should be investigated. If burning is also evident, urinary tract infections, post 
inflammatory changes and dysesthesia should be eliminated as diagnoses (McKay, 1985, 
1989, 1991, 1992; Carcio, 1992; Sharp, 1993). 
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The nerve threshold determining the pain experienced may be manipulated using analgesics 
or local anaesthetics, which alter the mediators of the nerve response (McKay, I 985). Other 
means of relieving the pain associated with vulvodynia involves destruction of the nerve 
endings by cryo or laser therapy, alcohol injection or vulvectomy (Woodruff & Parrnley, I 983; 
Clowser & Friedrich, I 986; Davis, I 989). Alcohol injection for pruritus was originally carried 
out by Stone (I 926, as cited by Clowser & Friedrich, I 986). Findings reported by Clowser 
& Friedrich (I 986), were variable with patients reporting remission of symptoms for 6- I 2 
months or more. Other authors have shown similar findings; Wilson (I 949), described 49 
patients, 35% of which achieved complete recovery, and Woodruff & Thompson (I 972), 
reported similar results on 30 women with anogenital pruritus. Woodruff &Babankia (I 979), 
achieved a 90% recovery rate, but emphasised that careful patient selection was particularly 
important as burning was not relieved, and the treatment was unsuitable for patients with 
acute inflammation of the vulva, or diabetic candidiasis. Other drugs with properties useful 
in the treatment ofvulvodynia include tranquillizers and tricyclic anti-depressants, which have 
pain killing properties, and may alter the patients perception of pain. It is essential that the 
physician aims to locate the principal cause of the pain rather than treating the symptoms of 
the condition with topical and systemic drugs, as certain methods of management are more 
successful for vulvodynia than others (McKay, 1989). 
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2.3 Dermatoses 
Dermatoses may occur on all areas of the body, however, factors such as environmental 
conditions for example; vaginal discharge and a moist epithelial surface, complicate the 
diagnosis of vulvar dermatoses. Vulvar dermatoses were originally a subset of a group of 
conditions termed vulvar dystrophies. There are several recognised types ofvulvar dermatoses 
including lichen sclerosus, squamous cell hyperplasia, psoriasis, lichen planus and lichen 
simplex (Maibach & Mathias, 1985; Carcio, 1992; McKay , 1992; Lawrence, 1993) (Table 
2.4). Visualisation of the epithelium using colposcopy is particularly important as the 
condition of the epithelium may improve during treatment despite continued itching and 
burning (McKay, 1989). Several authors have stressed the importance of biopsying affected 
areas of the vulva, as the moist environment may complicate an otherwise straightforward 
diagnosis (McKay, 1989; Carcio, 1992; Lawrence, 1993). 
Table 2.4 Subsets ofVulvar Dermatoses 
Subset of Vulvar 
Dermatitis 
Psoriasis 
Lichen planus 
Lichen Sclerosus 
Tinea 
(after Carcio, 1992) 
Treatment 
Topical hydrocortisone 
or fluorinated steroids. 
Topical steroids 
Topical steroids 
Testosterone 
Antifungal e.g., 
clotrimazole 
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Characteristics of Dermatitis 
Common in areas such as knees and elbows. On the 
vulvar mucosa, moist greyish opaque plaques form 
which may appear glossy and red in skin folds. 
5 P's- purplish, pruritic, polygonal, papules and 
plaques. Generally white patches or erosions on 
mucous membranes. 
Sclerotic dem1is with thin atrophic epidermis, which 
may be finely wrinkled or scaly. Blisters or 
lacerations may develop. Lack of architecture of the 
vulva due to the labia minora resorbing. 
Fungal infection of the skin, many forms, classically 
scaly eruptions due to dermatophyte infection 
Irritant reactions of the vulva are fairly common in comparison with allergic reactions. A 
response such as itching and burning immediately after application of a topical therapy is 
consistent with irritant reactions; however the delayed onset of itching and burning, with a 
longer duration of symptoms suggests a cell mediated allergic reaction. Common irritants 
include soaps, cosmetics, medications and components of topical therapeutic chemicals such 
as alcohol or propylene glycol (McKay, 1992). 
Imidazole derivatives are often reported by patients to induce irritation. The imidazoles are 
probably the widest used of all anti-fungals. Miconazole, econazole, tioconazole and 
isoconazole are commonly reported allergens, however, these are the derivatives which are 
most frequently prescribed. Reports have suggested that there is an increase in the sensitivity 
to certain imidazole derivatives, which may be capable of causing contact allergy. Often 
however, it is the treatment vehicle (base cream) which is causing the allergic reaction and not 
the prescribed drug. In these cases it is important that alternative vehicles are used, or that 
fungal infections are treated with clotrimazole or ketoconazole which do not cause contact 
irritation (Dooms-Goosens et al., 1995). 
Itching, associated with irritant or contact reactions often causes lichenfication, resulting in 
a leathery, thickened epithelial surface with prominent skin markings. The term 'lichen' is 
used to denote several dermatologic conditions seen to affect the vulva e.g., lichen sclerosus, 
lichen planus and lichen simplex (Lawrence, 1993). Lesions are usually pruritic, characterised 
by thickened plaques, and often erosions in lichen planus and lichen sclerosus, however, these 
conditions are all histologically distinct. Topical steroid creams are generally used for the 
treatment of lichenfication to thin the thickened plaques and to reduce the inflammatory 
response to break the scratch I itch cycle. Although topical steroids are essential for the 
treatment of lichenfication their use should be limited as thinning of the skin seen after 
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prolonged use, results in skin fragility and easy bruising (McKay, 1989). 
The use of topical steroids on the vulvar epithelium can result in periorifcal dermatitis. 
Periorifical dermatitis, conunon on the face, generally occurs due to overuse of potent steroid 
creams, resulting in a secondary dermatitis which is easily confused with the original 
condition. This is a conunon problem seen with the overuse of clotrimazole, conunonly found 
in topical anti-fungals such as Canestan (Bayer). Due to repeated and prolonged use, a 
rebound inflammatory reaction, characterised by burning and oedema, may occur which is 
seen to recur each time the cream is withdrawn (Me Kay, 1989). The problem is exacerbated 
by patients continued use of the topical treatment which is in fact causing the dermatitis, in 
these cases the use of potent steroids should be tapered gradually and not withdrawn hastily 
(Britz & Maibach, 1979). 
2.4 Infectious Agents 
Infectious agents have frequently been implicated in the initiation ofvulvodynia. Conunonly 
however, vulvodynia is not associated with the presence of an etiological agent, despite this 
many researchers have studied the relationship between HPV, Herpes simplex virus, and 
Candida species with different subsets of vulvodynia. One of the most frequently investigated 
relationships being that between vulvar vestibulitis syndrome and HPV infection (Hatch, 
1991, 1992; Kent, 1991; Kelly et al., 1992; Marks et al., 1995). 
2. 41 Hemes simplex Associated Vulvodynia 
Ifvulvar discomfort is described as burning, localised or a deep ache, Herpes simplex virus 
(HSV) should be suspected. Generally patients report aching followed by itching and the 
formation of vesicles or papules which erode to form sore patches. Subclinical HSV causes 
the patient to complain of episodic discomfort and pain in the groin and buttocks. HSV 
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infection of this type affecting the lower back and thighs may act as a trigger to pudendal 
neuralgia (Turner & Marinoff, 1991 ). Positive cultures are difficult to obtain, the main 
diagnostic criteria of HSV infection is the pattern of recurrence. Constant or episodic pain 
lasting for two weeks or less is not likely to be associated with HSV infection (McKay, 1992). 
It is possible that HSV infection may be confused with cyclic vulvodynia especially if the pain 
is episodic and, or, linked to the menstrual cycle. However, the pain associated with cyclic 
vulvodynia is generally more diffuse then the site specific pain described with HSV. 
2.42 Papillomatosis- HPV Associated Vulvodynia 
The link between HPV and vulvar pain was initiated by the use of anti viral preparations of 
interferon for the treatment of VVS, a subset of vulvodynia. HPV exists as clinical and 
subclinical infections, the recognition of subclinical infections has fuelled speculation and 
research to establish a link between HPV and vulvodynia, and particularly between vestibulitis 
syndrome and HPV ( Boden et al., 1989; Moyal-Baracco, 1990; Potkul et al., 1990; Cechinni 
et al., 1991; Hatch, 1991; McKay, 1991; Firniani et al., 1993; Welch et al., 1993; Marks et 
al., 1995). Although it is generally agreed that HPV is involved in a small sub group of 
patients with vulvodynia, long term antiviral treatments are generally used only in patients 
who have shown an improvement with use of these treatments in the past (McKay 1988). 
Application of dilute acetic acid to the epithelium is commonly used to detect acetowhitening, 
considered to be evidence of HPV infection. This technique was used originally to detect 
dysplastic changes on the surface of the cervix and is consequently of more use in this area 
than when examining the vulva, where false positive results are common (Brucks & Jacobs, 
1992). Although acetowhitening is effective for the detection of dysplastic changes, it has 
been shown that all acetowhitening is not due to the presence of HPV. DNA hybridisation 
studies have not linked all cases of acetowhitening to HPV suggesting that a multifactorial 
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association is probably present (McKay, 1989; McKay et al., 1991). Papillomatosis is 
characterised by the presence of small cutaneous papillae on the labia minora, vestibule, and 
posterior area of ihe introitus. Epithelia affected by papillomatosis may have a mosaic or 
punctate vascular appearance, with capillaries entering individual papillae which are visible 
using colposcopy. These papillae have been considered to be a natural variant of the 
epithelium (Friedrich, 1987; Bergeron et al., 1994; Welch et al., 1993), however, other 
reports suggest that HPV, particularly subclinical HPV, may be important in the formation of 
these structures (Reid et al., 1987, 1988). Other authors described patients with unidentified 
vulvar burning and superficial dyspareunia who also have vulvar papillomatosis (Growden 
et al., 1985; di Paola and Rueda 1986). A more recent study of295 women estimated the 
natural incidence ofvulvar papillomatosis to be I% of the study group (Welch et al., 1993). 
Other women in this investigation who had been diagnosed as having papillomatosis, showed 
a variety of symptoms; 9 of 18 were asymptomatic, the remaining 9 had intermittent or mild 
symptoms. Of these 18 patients, 94% showed histological evidence ofHPV. Using DNA in-
situ hybridization, 39% were shov.'Il to be HPV positive, and 72% had a history of genital 
warts. In summary this study showed a definite link between papillomatosis and HPV 
infection, contrasting with results from previous investigations which suggested that only 7% 
of patients with papillomatosis harboured HPV using southern Blot analysis (Moyal-Baracco, 
1990). De Deus et al. (1995), have also investigated the incidence of papillomatosis, and 
whether HPV has a role in this condition. Using in situ hybridisation and PCR, these authors 
concluded that papillomatosis of the vestibule is not associated with HPV, and should be 
considered a 'para-physiologic' formation of the vulvar vestibule. They add, that a diagnosis 
of HPV should be avoided in the absence of undisputed histological evidence, as a positive 
report ofHPV commonly leads to unnecessary biopsies and deleterious treatment regimes (De 
Deus et al., 1995). There were several possible differences in these studies which may affect 
the incidence of reported HPV; detection technique, frequency of false positives or negatives, 
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and the use of controls for the detection rate. These factors can not be discussed further as 
insufficient details are available. 
Dennerstein et al. (1994), pose the question of whether HPV vulvitis is a new disease or an 
unfortunate mistake ? They studied 71 women who had been diagnosed as having HPV, to 
determine whether HPV was responsible for the symptoms of burning and irritation associated 
v.rith vulvar pain and pnuitus. The results of the study are consistent with the findings of other 
researchers, in reporting that a diagnosis of HPV is incorrect. Dennerstein et al. (1994), 
suggest that the term HPV vulvitis is not suitable, as it has resulted in often destructive 
treatments for HPV which are unfounded. In particular the authors were not happy with the 
use of histology and colposcopy for the diagnosis ofHPV infection which are commonly used 
in pathology departments, which have frequently been reported to give false positive results. 
They concluded from this study that there was no evidence that HPV caused 'conditions such 
as vulvodynia, VVS, and pruritus, and that destructive treatments aimed at eradicating the 
virus should be abandoned and research concentrated on other more likely causes of these 
difficult clinical problems' (Dennerstein et al., 1994 ). 
Extremely sensitive detection techniques such as Southern Blotting, PCR, and in situ 
hybridization have resulted in a higher detection rate of HPV in specimens than would 
normally occur using routine histology. This is consistent v.rith the findings of McKay ( 1988) 
who suggested that HPV infection of the female genital tract could be much more common 
than first anticipated. These techniques have demonstrated HPV in tissues subsequent to 
treatment and after eradication of condylomata. Several researchers have suggested that these 
detection techniques are too sensitive, and the costs prohibitive, however the use of these 
techniques for the localisation and typing of virus in suspected vulvar carcinomas is 
invaluable. 
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2.43 Dysesthetic or Essential Vulvodynia 
The term dysesthetic vulvodynia was originally used to describe a neurological condition 
which may occur due to damage of the nerve endings. Patients in this category show no 
physical findings on examination, and complain of continuous burning, with a diffuse pattern 
localised to the vulva. When treated with low dose, tricyclic anti-depressants, patients with 
dysesthetic vulvodynia respond in a similar way to patients with glossodynia or neuralgia 
(McKay, 1985, 1992). Neuralgia is defined as pain in the nerve, or along the course of one or 
more nerves. Depicted by a sharp spasm like pain which may recur at intervals, neuralgia is 
caused by inflammation of, or injury to a nerve, or group of nerves. Pudendal neuralgia is 
typified by vulvar pain radiating from the vulva to the perineum, groin and thighs. This is a 
much more specific and defined pain than that described by patients suffering with dysesthetic 
vulvodynia (Turner & Marinoff, 1991 ). 
Me Kay (1992, 1993), described a series of patients with dysesthetic or 'essential' vulvodynia 
who did not describe any radiation of the pain from the vulva to surrounding areas, this study 
also indicated that there was no history of nerve damage in these patients. Me Kay (1989), 
demonstrated that this subset ofvulvodynia is more common in post menopausal women who 
may also complain of rectal and urethral discomfort. Turner & Marinoff (1991), have 
suggested that a majority of patients which are diagnosed as having dysesthetic or essential 
vulvodyn.ia are actually suffering from pudendal neuralgia, the cause of which may be varied 
and the symptoms very similar to essential vulvodynia. Patients with pudendal neuralgia 
'complain of an unprovoked, persistent, superficial, burning sensation that is frequently 
accompanied by a deep aching component' (Turner & Marinoff, 1991 ). Patients which are less 
severely affected complain of an itch-bum sensation or feelings of rawness. These symptoms 
may be reported over various areas of the body which are supplied by branches of the 
pudendal nerve. Patients studied by Turn er and Marinoff ( 1991 ), reported burning on vaginal 
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entry and also prior to, and during sexual intercourse, similar findings to those associated with 
VVS and cyclic vulvodynia. Again, tricyclic anti-depressants arP. beneficial in the treatment 
of these patients, particularly in the older subgroup of patients with this disorder. Tricyclic 
anti-depressants affect cutaneous nerves and are not solely used for treatment of depression. 
However, women with vulvar pain do often show some signs of depression, and often benefit 
from treatment with anti-depressants, especially if pudendal neuralgia is suspected to be 
complicating the diagnosis (Lynch, 1986; McKay, 1989). 
2.44 Cyclic Vulvodynia 
A diagnosis of cyclic vulvodynia may be made on the report of a) symptom free periods and 
b) remission of symptoms with long term anti-candida therapy. Flaring of symptoms 
associated with cyclic vulvodynia can often be related to menses or symptom free weeks 
during the menstrual cycle. Infectious agents such as Candida, HPV, Garderella and 
Trichomonas should be eliminated as diagnoses, and if present, any infection should be 
treated. However, eradication of the infection rarely affects the symptoms associated with 
cyclic vulvodynia. Reports of swelling or episodic erythema of the vulva may be linked with 
Candida vulvitis which presents as itching and burning, and should always be considered a 
possible causative agent of vulvodynia (Carcio, 1992; Secor, 1992; Foster, 1993). Many 
patients with vu1vodynia report being treated for Candida on many occasions. Although 
patients with cyclic vulvodynia do not often prove to be consistently Candida positive, 
treatment of these patients with long term anti-candida! therapies does often improve 
symptoms (Sobel, 1986). Treatment regimes have included the use of oral ketoconazole for 
1-2 months, the dose being reduced after 2 months; the use of ketoconazole 5 days prior to 
menses; and the regular use of topical antifungals such as clotrimazole (McKay, 1985, 1989, 
1991, 1993). Me Kay (1989), treated all of her vulvodynia patients with anti-candida) therapy 
for six months (if they had previously responded to these treatments). A subgroup of these 
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patients, regardless of whether they were Candida positive, showed remission of symptoms 
whilst treatment was maintained, generally these patients had a history of cyclic vulvitis. 
McKay (1989), postulates that low dose anti-candida! therapy is more effective in the 
management of cyclic vulvodynia, as these allow the mucosal surface to recover its natural 
barrier to infection. In summary, although anti-candida! therapies are effective in the treatment 
of cyclic vulvitis, there is no evidence as to whether cyclic vulvitis is related directly to 
Candida allergy, subclinical infection, reinfection, or hypersensitivity to Candida antigens 
(Ashman and Ott, 1989; Witkin, 1987; Sobel, 1986, 1992, 1993). 
2.45 Vulvar Vestibulitis Syndrome 
Sensitivity and pain located within the vestibule of the vulva, have been documented for over 
a century. However, until the 1980s very little research had been completed to elucidate the 
cause and the incidence of this problem. Vulvar vestibulitis syndrome (VVS) was probably 
first recognised over a century ago by Skene (1889), and described a few years later by 
Thomas and Munde (1891) as excessive sensitiveness or hypersensitivity of the vulva. In 
1928, Kelly described a reddening of the vestibule which made intercourse difficult, but it was 
not until 1976 that Pelisse and Hewitt associated the pain experienced during intercourse with 
erythemous vulvitis. The history and potential causes of the syndrome have been reviewed by 
many researchers who have given the syndrome a variety of names including, focal vulvitis, 
vestibular adenitis, and the minor vestibular gland syndrome (Friedrich, 1987; McKay, 1989; 
Oates, 1990; Marinoff & Turner, 1991, 1992; van der Meijen et al., 1994). The term "bwning 
vulva syndrome" was introduced at the 1975 meeting of the International Society for the Study 
ofVulvar Disease, and at the subsequent meeting in 1983 the terms vulvodynia and vulvar 
vestibulitis syndrome (VVS) were added to the existing terminology referring to vulvar 
disease. 
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Since the introduction of new terminology in 1983, VVS has been described on numerous 
occasions (Peckham et al., 1986; Friedrich, 1987; Furlonge et al., 1991; Goetsch, 1991; 
Marinoff & Turner, 1991, 1992 ; Secor & Fertitta, 1992; Monif & Belatti, 1993; Bazin et al., 
1994). Defined by Friedrich (1987), VVS is characterised by a) severe pain on vestibular 
touch or at attempted vaginal entry, accompanied by b) sensitivity to pressure localised within 
the vestibule, and c) erythema of the periductal tissue of varying degrees. This definition of 
the syndrome encompassing the three main diagnostic criteria is now widely accepted, and 
used as a means of diagnosing patients presenting with vulvar discomfort. 
a) Epidemiologv 
The incidence of VVS in the female population is not known, however, one report has 
suggested an incidence of 15% of the gynaecologic population (Goetsch, 1991 ). It is widely 
agreed that reports of the syndrome have been increasing over the past I 0 years, with an 
increasing number of women presenting at their GP's practices with vulvar pain characterised 
by severe entry dyspareunia. It is probable, that a significant number of women suffering with 
VVS do not consult their GP with problems of this nature. In contrast, other women who do 
approach their GP for help, frequently receive treatments which are unsuccessful, and 
alarmingly, these women are often not referred to a GUM clinic. A majority of patients who 
eventually attend a GUM clinic have seen a number of clinicians, and have tried a myriad of 
treatments, mainly antifungal, with no significant improvement in their condition. The 
etiology of this complex and distressing syndrome is yet to be conclusively proven, but it is 
probable that the etiology will be shown to be multifactorial. 
The landmark study by Goetsch (1991) is one of the largest epidemiological studies ofVVS, 
involving 210 women attending a vulvar clinic; however, the proposed incidence of the 
syndrome is higher than suggested by other studies. In contrast a study by Pinsent et al. (1995 
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personal communication) showed the incidence to be much lower, approximately 6%. The 
study cohort in this investigation was a group of 49 women attending their GP for well women 
screening. This difference in the proposed incidence of VVS, may be due to the fact that 
Goetschs' patients were self selected, and not a true representation of the gynaecological 
population, resulting in a higher reported incidence than would normally be seen in the female 
population. 
According to Goetsch (1991 ), the median age for the syndrome was found to be 34 years, with 
a majority of women falling into the 20-40 age range. Goetsch (1991), found that the average 
time length of suffering was I 0 years; many of the women interviewed admitted that they had 
reduced sexual activity as a consequence of pain, and several women attributed marriage 
failures to this problem. Spontaneous remission of the symptoms were found to be very rare 
except in cases where vestibulitis had developed post partum (Lynch, 1986; Goetsch, 1991; 
Schover et al., 1992). A majority of patients had noticed some change over time, but the 
improvement was very gradual usually occurring over several months, and often over several 
years (Goetsch, 1991 ). In contrast, a study by Peck.ham et al. ( 1986), suggested that 50 % of 
VVS patients would show spontaneous remission of symptoms with time. As suggested by 
Goetsch (1991 ), if in fact this was the case, there would be a large number of women recalling 
past dyspareunia which had spontaneously remitted. 
Many of the observations made by Goetsch (1991 ), are supported by Furlonge et al. (1991) 
and Secor & Fertitta (1994), and have previously been described by Marinoff & Turner 
(1988), and Friedrich (1987). In addition, Furlonge (1991) found that a majority of patients 
attending his clinic were Caucasians, mainly in social groups one and two, who were in stable 
monogamous relationships. Symptoms of vulvodynia had occurred for 6 months or more in 
92% of patients, and for 2 years or more in 25% of patients, similar results to those recorded 
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by Marinoff & Turner (1992 ). Very few afro-Caribbeans or asians have been found to suffer 
from the condition, which may indicate a genetic link or a different response to disease 
(Friedrich, 1987; Goetsch, 1991; Marinoff & Turner, 1991, 1992; Secor & Fertitta, 1992). 
Friedrich (1987), who studied 87 patients, concluded that the syndrome was unlikely to be 
related to allergy, menstrual cycle, spinal disorders, Candida, HPV, Herpes simplex, hygiene 
products, sexual abuse or depilatory creams. Marinoff & Turner (1986), also demonstrated 
that patients with VVS seen in their clinic, did not have active infections of gonorrhoea, 
Candida, Gardnerella, Trichomonas or Herpes simplex. 
b) Clinical findings 
Patients presenting with VVS generally have a history of entry dyspareunia and post-coital 
pain often resulting in reduced frequency of sexual intercourse. The pain experienced by these 
patients is not constant but spontaneous, usually elicited by applying pressure, in any form, 
on the vestibule. Pain is usually described as introital or superficial; deep dyspareunia and 
tenderness within the vagina are characteristically absent (Monif & Belatti, 1993; Marinoff 
& Turner, 1991). Other findings may include an intolerance of tampons and tight clothing, and 
the inability to sit for long periods of time, or to ride bicycles or horses. Colposcopic 
examination commonly reveals physical fmdings limited to oedema and small foci of 
erythema surrounding the vestibular gland openings, accompanied by acute tenderness of the 
vestibule. These findings are consistent with the guidelines described by Friedrich for the 
diagnosis ofVVS (Friedrich, 1987). 
Turner and Marinoff (1988), described VVS as being either acute or chronic. If introital 
dyspareunia lasts more than three months and becomes the main problem the syndrome can 
then be considered as being chronic. Borderline vestibulitis (secondary vestibulitis) may be 
diagnosed if a patient has sensitivity to touch with a swab, but has not reduced sexual activity 
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or tampon use as a result of the pain. Patients were divided into subsets of primary and 
secondary VVS by Goetsch (1991). Those having the primary condition had persistent pain 
from the first attempt at vaginal entry, whereas patients with secondary vestibulitis had 
previously been able to have sexual intercourse without discomfort (Marinoff & Turn er, 1991, 
1992). Half of the patients interviewed by Goetsch (1991 ), had noted pain when first using 
tampons rather than during sexual activity, suggesting that the cause of the syndrome is 
probably not sexually transmitted or necessarily linked with sexual intercourse in all cases. 
This is supported by earlier observations by Peckham er al. ( 1986), who reported that 9% of 
their patients reported dyspareunia with first sexual intercourse. In accordance with these 
reports, Bazin et al. (1994) report that dyspareunia was evident at first intercourse in 44% of 
their patients, a much higher incidence than that described by Goetsch ( 1991) or Peckham et 
al. (1986). However, in contrast to these reports, Bazin et al. (1994) add that age at initial 
intercourse, the number of sexual partners and the use of oral contraceptives are all important 
factors in the development ofVVS. 
c) Diagnosis. assessment and counselling ofVVS patients 
A cotton tipped applicator or chlamydia swab has generally been used for assessing the 
sensitivity of the vestibule in cases ofVVS. Despite the common use of this technique, this 
means of assessment may now be challenged by the development of a 'Vulva! Algesiometer' 
(see Chapter 3). The cotton tipped swab is used to palpitate the openings of the vestibular 
glands, to determine whether the patient has vestibular discomfort. In contrast the Vulvar 
Algesiometer, removes the difficulty of keeping pressure constant during an examination, and 
also maintaining a similar pressure from one patient to another. The degree of pressure applied 
can be varied and the patient can indicate when the pressure is uncomfortable, at which point 
the reading can be recorded (see Chapter 3). A measurement of sensitivity, although 
subjective, is helpful for both the patient and clinician, mainly for monitoring improvement 
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or effectiveness of treatment reg1mes (Curnow et a/..1996). Two studies have used a 
measurement of the degree of dyspareunia for assessment of treatment regimes. Michelwitz 
er al. ( 1989), asked women to rate themselves on a scale of 1 to 10 ( 10 representing the most 
functional level) to compare their sexual activity before and after therapy. Authors agree that 
a means of measurement is beneficial to both the clinician and patient (Michelwitz et al., 
1989; Marinoff & Turner, 1991 ). Another means of assessment has involved the use of 
various dilutions of acetic acid, to gauge the sensitivity of the vulva (Sonni et al., 1995). 
Before a diagnosis of VVS can be made, the patient should also be tested for the presence of 
vaginal and vulva! infections. If a patient still complains of VVS after treatment of any 
infection, a full explanation of the problem should be provided by the clinician or health 
counsellor. Suggestions that the problem is wholly psychological should be eliminated, 
information should be provided on current treatments available, and the proposed 
effectiveness and duration of these treatments outlined. Treatment of VVS is notoriously 
problematic, and usually a long term process, however, if symptoms persist for more than six 
months surgery should be considered as an option (Woodruff & Parmley, 1983). 
d) Pathology 
Pyka et al. (1988) completed the most comprehensive study on the histopathology of vulvar 
vestibulitis syndrome. Histologic staining failed to demonstrate fungus, Gram positive 
bacteria, mycobacterium species, spirochetes or Donovan bodies. This study involved 41 
patients who showed a mixed chronic inflammatory infiltrate in the stroma of the vestibular 
epithelium, findings which have been substantiated in other accounts ofVVS (Woodruff & 
Parmley, 1983; Peckham et al., 1986; Friedrich, 1987; Marinoff & Turner, 1988; Michelwitz, 
1989; Furlonge et al., 1991 and Wilkinson et al., 1993; Marks et al., 1995). The predominant 
cell type was the lymphocyte, accounting for 60-70% of the inflammatory cells. Plasma cells 
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were found in approximately 75% of cases although they were never the predominant cell 
type. A small number of granulocytes were found in 25% of cases, but eosinophils were only 
found in one case. In no case was atypia of the inflammatory cells noted (Pyka et al., 1988). 
Immunofluorescence showed no particular pattern of immunoglobulin deposition which may 
be indicative of a specific disease. The intensity of the inflammatory response was graded in 
each case from mild to severe. Consistent with other investigations, most patients (54%) had 
experienced a moderate response, and nearly all (83%) fell into the mild to moderate category, 
with only 17% having a severe inflammatory response (Friedrich, 1987; Michelwitz et al., 
1989; Furlonge et al., 1991; Goetsch, 1991). The infiltrate was diffusely distributed in the 
superficial stroma in all cases, the deep stroma was involved only when very severe 
inflammation had occurred. Minor vestibular glands, when present, were always associated 
with a periglandular distribution of inflammatory cells; when metaplasia of the glands was 
evident, inflammation surrounding vestibular clefts was universally present. However, 
inflammatory cells were never seen to invade the gland lumens, resulting in adenitis; neither 
did the inflammation involve nerves or blood vessels (Pyka et al., 1988). 
e) Etiology ofVu1var Vestibulitis Syndrome 
The etio1ogy of this syndrome is uncertain; the initiating event may be infection or trauma, 
however, what causes the maintenance of the inflammatory response has not yet been 
ascertained. An infective etiology seems probable as the physical and pathological findings 
suggest an inflammatory process. A majority of the work completed on VVS includes routine 
tests for infectious agents, usually with negative results. It is possible that the specialised 
epithelia of the vulvar vestibule and the minor vestibular glands may make this area 
particularly susceptible to infections or morphologic changes which may influence the 
development of vulvar vestibulitis. 
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Vulvar vestibulitis may be defined as an acute or chronic condition. The separation of cases 
into one of these two groups has been shown to be particularly helpful when choosing a 
suitable treatment regime (Marinoff & Turner, 1986, 1991, 1992; Secor, 1992). Any infection 
which causes vulvovaginitis may result in the symptoms associated with vulvodynia and 
vulvar vestibulitis, for example Trichomonas, bacterial vaginosis, and Candida infections. 
Irritants such as soaps, douches and sprays may also have an etiological importance, especially 
if over cleansing with these products occurs. The use of antiseptics and suppositories are also 
possible causes ofVVS, as are destructive therapeutic agents such as short term 5-fluorouracil 
therapy for the treatment of condylomata acuminata, cryotherapy, carbon dioxide lasers and 
treatment vehicles (base cream) (Marinoff et al., 1993; Marinoff & Turner, 1992). Causes of 
chronic vestibulitis include a variety of infections which are the same as those described under 
acute etiologies (as above). However, chronic infections are characterised by recurrence and 
persistence of the etiological agent(s), for example recurrent bacterial vaginosis, HPV and 
chronic candidiasis (Table 2.5) 
Table 2.5 Etiological Agents Associated with VVS. 
Acute Etiologies 
Recurrent Candidiasis 
Recurrent Bacterial Vaginosis 
(BY) 
Persistent HPV 
Symptoms & Association with VVS 
Four documented episodes of infection in 12 months. Associated with 
vaginal soreness and dyspareunia. Hypersensitivity to persistent Candida 
infection may result in VYS (Marinoff & Turner, 1991) 
Alkaline vaginal discharge produced due to BY infection is irritating to 
the vestibular epithelia, which may be sufficient to cause VYS. Symptoms 
often resolve when infection is treated and discharge is removed. 
Several studies have indicated an association of VVS and HPV, which 
may manifest in different forms of the infection. Not conclusive evidence 
as presence of koilocytes is not always indicative of HPV infection. 
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M ann et al. ( 1992), have shown 80% of their I 03 VVS patients to have a history of recurrent 
candidiasis. Other studies have shown this incidence to be slightly lower at 50% (Lynch, 
1986), 67% (Peckham et al., 1986), and 63% (Friedrich, 1988). Although some studies have 
shown a correlation between past Candida infection and VVS, few patients present with acute 
vestibulitis associated with Candida (Bazin et al., 1994 ). The correlation between past 
candida! infection and VVS is particularly interesting, however, the mechanism of 
involvement remains unknown. Ashman and Ott, suggested that some VVS patients who had 
suffered with candidiasis in the past may have developed an autoimmune reaction to the 
organism due to cross reactivity of the candida! and tissue antigens (Ashman & Ott, 1989). 
Others have reported hypersensitivity to Candida due to re-infection (Marinoff & Turner, 
1986), or antichromonal (cross immunity) as an important factor in the development ofVVS 
(Krvavac, 1992). However, bacterial, fungal and viral infections are relatively rare in VVS 
patients, and idiopathic causes form the largest group, with a majority of patients falling into 
this category, showing neither an infection nor an allergic reaction to a particu1ar treatment. 
As described previously, HPV has been well documented as an associated factor in 
vulvodynia and particularly VVS. The fust study linking HPV with vestibulitis was carried 
out by Turner and Marinoff ( 1988). In this investigation, all of the seven women studied with 
VVS were shown by Southern blot and in situ hybridization analysis to harbour HPV (Turner 
& Marinoff, 1988 ). Since this initial investigation, the presence of this ubiquitous virus has 
been identified and typed in VVS samples by routine histological examination, in situ 
hybridisation, Southern Blotting, and PCR. One of the reasons behind this search for HPV 
includes the suggestion that, the inflammatory response in the form of a lymphohistiocytic 
infiltrate around the superficial capillaries, might be the hosts first attempts at eliminating the 
virus (Turner & Marinoff, 1988). Many of the studies investigating the incidence of HPV 
associated with VVS, have indicated the presence of the virus using routine histological 
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examination. Generally, it is considered that there is an over diagnosis ofHPV based solely 
on histological findings (Goetsch, 1991; Bergeron et al., 1992; Schover et al., 1992; 
Dennerstein et al., 1994; Prayson et al., 1995). Although histological examination is essential 
for assessing the inflammatory infiltrate and for eliminating other diagnoses such as VIN, it 
is difficult to identify the presence of koilocytes, using this method. It is probable that many 
studies describing koilocytes in vestibular samples, are actually describing the presence of 
glycogenated superficial cells which have a similar appearance to koilocytes, and are 
commonly seen in the superficial layers of vulvar epithelium (Sargeant et al., 1996). Using 
DNA hybridization techniques, many specimens identified as being koilocyte positive using 
histology, have proven to be HPV negative (Dennerstein et a/_, 1994; Wilkinson et al., 1993; 
Prayson et al., 1995). These findings echo those from an earlier investigation by Turner & 
Marinoff ( 1988), who have recently suggested that one reason for this could be the presence 
of unidentified HPV types in the tissues which were not hybridizing to the DNA probes. 
Bergeron et al. (1994) showed koilocytes in 9% of their VVS specimens, a figure which was 
comparable to negative controls; this study did not isolate HPV DNA in any of the specimens 
showing koilocytes. 
In addition, and contrary to the findings of Turner and Marinoff (1988), Goetsch (1991 ), 
observed that a majority of patients with VVS had no known association with HPV_ However, 
patients who had experienced a HPV infection, were found to suffer vestibulitis as a 
secondary rather than primary condition. Three studies using PCR have also indicated a low 
incidence ofHPV in patients with VVS, estimated to be in the range of approximately 5-10%. 
(Bergeron et af_, 1994; Wilkinson et al., 1993; Bazin et al., 1994) These studies support the 
findings that interferon, an anti-viral treatment, is rarely effective in the treatment of vvs_ 
There is agreement that HPV is probably not the primary cause ofVVS. However, there may 
be a small sub-group of VVS patients which do harbour HPV, and it is this group which 
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respond well to anti-viral therapies (Bergeron et al., 1992, 1994; Wilkinson et al., 1993; Bazin 
et al., 1994; Prayson et al., 1995). 
Other conditions which may be of etiologic importance in the initiation of VVS include 
estrogen deficient states, severe cervicitis, lgA deficiency, reduced numbers of lactobacilli, 
inflammatory bowel disease e.g., Crohns disease and interstitial cystitis (McCormack, 1990; 
Scrimin et al., 1991; Fitzpatrick et al., 1993; Foster et al., 1993). Bazin et al. (1994), have 
shown that hormonal factors such as the early use of oral contraceptives may be a contributing 
factor to VVS. However, the intricacies of these proposed relationships have yet to be 
determined. 
D Treatment & Management ofVestibulitis 
Thomas (1880), in his Diseases of Women, described three women; one was treated with 
nitric acid, and two had removal of the affected mucous membrane, but all three showed no 
improvement. He suggested a holiday away from the patients spouse, with general tonics. 
Todays patient does not fare much better, as in most cases the etiology of VVS is still 
unknown and therefore the treatment of this condition still problematic. Treatment guidelines 
for VVS patients are very vague, and as yet no treatment has been firmly established, and no 
series of results has shown uniformly positive results in all patients treated. In an attempt to 
alleviate suffering the clinician often embarks on a shotgun-type of approach which often 
involves the use of a mixture of therapeutic regimes which may or may not be helpful in the 
relief of symptoms. Often, by using this type of approach the well meaning clinician may 
cause irritant or allergic reactions which subsequently exacerbate the patients condition. As 
described previously there are two categories of VVS, chronic and acute, although the 
duration of the symptoms does not seem immediately important, this factor has been 
suggested to be useful in making therapeutic decisions (Marinoff &Tun1er, 1986, 1991, 1992; 
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Secor & Fertitta, 1992). 
In the case of acute etiologies, any specific infection should receive pharmacologic treatment. 
All therapeutic agents which may contribute to the syndrome should be discontinued. As the 
vestibule is endodermal in origin it is generally less responsive to sex steroid treatment than 
the remainder of the surrounding area consequently very little success has been achieved with 
the use of some steroids (Friedrich, 1988; Peckham et al., 1986; Reid et al., 1988; Marinoff 
& Turner, 1991; McKay, 1992). The rapid relief from symptoms, often seen in acute cases 
when the presumed cause is treated, suggests the presence of an etiological relationship. A 
more complicated treatment approach is required in the chronic cases ofVVS. Some success 
has been achieved where it has been possible to eradicate the causative agent. Frequently 
however, treatment of the causative agent does not result in remission of the symptoms 
associated with vulvar vestibulitis syndrome. Generally, in the chronic form, only an 
association rather than a direct cause and effect relationship can be implied. Many of the 
causes will be identical for both groups, acute VVS becoming chronic, when the cause 
becomes persistent or recurrent. Perinoplasty remains a final option for women with chronic 
VVS of six months or more in duration, who have not responded well to more conservative 
measures. Generally surgery should contemplated only when all conservative therapies have 
failed (Woodruff & Parmley, 1983; Mann et al., 1992; Bornstein et al., 1995). 
Conservative therapies for VVS 
Symptomatic therapy usually consists of the application of topical anaesthetics such as 
Xylocaine (5%) ointment 15 to 30 minutes prior to intercourse. Often the use of some 
protective coating such as petroleum jelly or zinc oxide are useful to minimise the contact of 
any irritating discharges, and add lubrication during intercourse (Marinoff & Turner, 1986; 
1992). 
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Friedrich (1988), completed an investigation of several therapeutic regimes which he used for 
the treatment of VVS, none of which proved particularly successful. Seven women were 
treated with isotretinoin, using doses of between 20 and 60mg/day depending on weight. One 
woman had lasting remission three months after ceasing treatment, however, only three 
women were able to use the drug without serous side effects. Eighteen women were treated 
with Dapsone, commencing at 50mg/day and increasing to 75mg/day if there was no bone 
marrow depression demonstrated. Three women showed subjective and objective 
improvement but only one was permanently cured. Fifteen women were treated with 
Acyclovir, commencing 600mg/day; in five patients, the dose was increased to 1600mg/day. 
Seven patients showed a subjective improvement and in three of these patients there was less 
intense vestibular tenderness, however, only two of these women have shovm long term 
benefit. No correlation between HSV titres and the response to treatment could be shown. 
Eleven women were treated with progesterone cream twice daily; four women were made 
worse, and none of the women became better. Eight patients were treated with 0.025% 
Capsaicin cream 4 hourly. This caused severe burning in the initial two weeks of treatment 
requiring oral analgesia. After four weeks two patients reported complete relief of symptoms 
but had to continue to use the treatment (Friedrich, 1988). 
Glazer et al. ( 1995), treated the symptoms of VVS by assessment and improvement of the 
pelvic floor musculature. In this study 33 women suffering with VVS were treated, the pelvic 
floor musculature was assessed initially and patients were shown how to assess themselves 
at home using a portable system. Biofeedback-assisted pelvic floor exercises were completed 
daily by the patients, and regular evaluations by the consultant were carried out in order to 
monitor progress and ensure correct use of the equipment. After 16 weeks of treatment, pelvic 
floor musculature had improved and reports of pain had decreased in 83% of patients, 22 of 
28 of the patients treated resumed sexual relationships soon after treatment. After six months, 
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patients were found to have maintained therapeutic benefits and were commonly free from 
pain. This study is the first to assess pelvic floor muscle status in relation to VVS and the 
severity of vulvar pain. Unlike other studies, which have concentrated mainly on invasive 
treatment with interferon injections, this study has involved the use of a non-invasive 
treatment which has demonstrated some extremely interesting and promising results. 
Reid et al. (1988) assessed patients 'vith VVS by measuring the degree of acetowhitening on 
application of acetic acid. As described previously, the use of acetic acid for the detection of 
HPV is not suitable, or reliable as other epithelial conditions may result in acetowhite 
changes. Despite this however, Reid and eo-workers treated patients with vulvar pain, who 
demonstrated acetowhitening of the vestibule, with 5% trichloroacetic acid, carbon dioxide 
laser therapy, 5% 5-flurouracil and surgery, depending on the severity of symptoms (Reid et 
al., 1987, 1988). The results of the investigation were described as 'universally disappointing'. 
Patients \vith painful vestibular erythema were described as 'substantially harder to treat', and 
medical and surgical regimes were generally unsuccessful. This study highlighted the 
problems associated with diagnosing patients by assessing the degree of acetowhitening. The 
use of lasers for vulvar conditions was proven to be unsuccessful. This study also 
demonstrated that micro-papillations of the vulva are not always due to HPV and should not 
be treated aggressively. However, the authors' use of 5-fluorouracillater in the investigation 
did successfully control the symptoms in 16 of 24 women with VVS. 
The recurrence rate of vestibular pain in patients treated with lasers is high, and the recovery 
period long (Kaufmann & Friedrich, 1989). Reid et al. (1987, 1988), used carbon dioxide 
laser photo vaporization which they observed to cause exacerbation of the symptoms ofVVS, 
often causing inflammation in previously normal vestibular glands. Davis (1989), 
demonstrated satisfactory results using carbon dioxide laser therapy, In this investigation 63% 
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of his patients experienced pain relief and resumption of sexual intercourse. In conclusion, 
some authors have suggested that laser therapy should no longer be offered as a option for 
treatment ofVVS as the possibility of tissue damage far outweighs any benefits from this type 
of treatment (Mann et al., 1992; Marinoff & Turner, 1992, 1993). 
Inte1jeron 
Until 1990, the only reliable form of treatment for long term VVS was surgery, a procedure 
termed perinoplasty, which was proposed by Woodruff & Parmley in 1983. Approval of the 
Food & Drug Administration (FDA) to use recombinant alpha interferon for the treatment of 
overt clinical warts (Waltz man & Wade, 1991) rapidly lead to the use of this compound for 
the treatment ofVVS, which was proposed to be linked to HPV infection in some cases of 
VVS. Treatment ofVVS with interferon has since received considerable attention, however, 
earlier reports generally showed more success than later studies (Horowitz, 1987; Hatch, 
1988; Umpierre et al., 1991; Mann et al., 1992). 
lnterferons were first identified as having anti-viral properties when it was found that minute 
amounts of alpha interferon are produced in a variety of cells when they are infected by a 
virus. The way in which interferons work is unclear, but it is thought that interferon binds to 
the membrane receptors on the cell surface where it induces enzyme formation, in turn 
preventing viral replication in virus infected cells. Additionally the phagocytic nature of 
macrophages is thought to be enhanced, and the cytotoxicity of lymphocytes for target cells 
augmented by interferon. Kent and Wisniewski (1990), found that a Jag period occurred 
between intralesional injection of alpha interferon and the cellular response. Although patients 
experienced a lapse period of 14-18 days before their condition began to show any 
improvement, the success rate of the treatment was found to be greater than 60% with only 
minimal side effects. The aim ofthe study carried out by Waltzman & Wade (1991), was to 
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evaluate interferon treatment in five patients suffering from VVS and subclinical HPV 
infection, of which none gave a history of overt genital warts, or of having sexual partners 
with genital warts. The degree of acetowhitening indicative ofHPV infection, was estimated 
using a dermogram. After four weeks the size of the aceto-white area was compared to the 
pre-treatment estimate. The results showed that three out of the five patients had experienced 
an improvement of SO% or greater. The presence of aceto-whitening is not a definite 
association with HPV infection, but is seen in many hyperkeratotic states. Ideally, an 
alternative means of detecting HPV infection in such cases should be used in parallel with the 
acetic acid test. The use of a dermogram for the measurement of aceto white areas is also 
fraught with difficulties, as during examination and measurement of the affected area the skin 
is prone to stretching which will give a false representation of the size of the aceto-white area. 
Waltzman and Wade (1991) used 5 million international units (iu) of interferon alpha 2P 
injected intradermally weekly for 3 weeks. Previously, Hatch (1988, 1991) and Horowitz 
(1989), had used a similar technique to that described by Waltzman and Wade (1991), and 
they also indicated that the response was favourable. Horowitz (1989), used alpha 2P 
interferon at a concentration of 1 million iu injected intradermally three times weekly for 4 
weeks. Fifteen out of seventeen patients treated showed complete symptomatic relief, and only 
five out of fifteen patients complained of flu like symptoms during the treatment. 
Hatch ( 1988 ), and later Marinoff & Turner (1991 ), also used alpha 2P for the treatment of 
vestibulitis patients, which they found to be cheaper and more effective than surgery. They 
concluded that interferon treatment seems to be more effective in patents with a short history 
of symptoms. Horowitz ( 1989), did not indicate the length of history of the symptoms in his 
patients, but did say that there was an absence of dyspareunia until shortly before visiting the 
gynaecologist. In agreement 'Nith these findings, Waltzman and Wade (1991 ), found that the 
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two patients who did not show any rei ief of the symptoms after treatment, were in fact long 
sufferers of the condition. One patient had undergone many treatments for VVS including 
laser removal of the surface layers of the vestibule, and the second had shown symptoms of 
the syndrome for 4 years (Waltzman & Wade, 1991). Kent and Wisniewski (1990), also 
observed aceta-whitening in 8 patients, all of whom were shown to fulfil the criteria 
characteristic of VVS. Using the same dose and treatment schedule as Horowitz (1989), the 
results of this study were similar, and were consistent with the findings of Waltzman and 
Wade (1991). Larsen et al. (1993) completed a small study of 10 women with chronic 
vulvodynia. Again, as in the case of Kent & Wisniewski (1990), application of acetic acid 
demonstrated acetowhitening in all patients. Assessment of acetowhitening and histological 
examination for koilocytes was completed prior to treatment, and after I and 3 months of 
treatment. This is the only investigation which has reported histological examination of 
vestibular biopsies subsequent to treatment of any kind. This study involved the intra-lesional 
injection of recombinant alpha 2P interferon, three times a week for eight weeks. All patients 
showed complete (70%) or partial response (30%), however, there was no reported change 
in acetowhitening or the histological appearance of koilocytes post treatment. Again, it seems 
relevant to indicate that acetowhitening is not specific for viral infection, and the presence of 
koilocyte like cells may be a natural variant of the vestibular epithelium. It is likely that both 
acetowhitening and koilocytosis are not related to VVS but that interferon is affecting the 
epithelium in such a way that the symptoms of the syndrome are removed. 
The effectiveness of interferon therapy suggests that in some cases VVS has been caused by 
a subclinical infection by HPV which is eliminated by interferon in some patients. However 
not all VVS patients were found to benefit, again suggesting that several aetiologies may be 
involved (Table 2.6) The rate of detection ofHPV and effectiveness of treatment in cases of 
VVS seems to be dependant upon the method of detection. Studies using only histology for 
70 
the identification ofl-IPV in tissue samples generally showed lower rates of success than those 
using DNA probes or PCR. However, these studies are difficult to compare as there are many 
variables which should be considered such as; inclusion of controls, sample size, selection of 
patients, assessment of dyspareunia, type of interferon, method of injection, the placebo effect 
and the incidence of spontaneous remissions. Despite these factors, it is possible to conclude 
that if sensitive detection techniques are used to select VVS patients with evidence of HPV, 
the chances of success using interferon are greatly increased. 
Table 2.6 Investigations of diagnostic criteria. followed by treatment using interferon 
Author N' of Patients Evaluation Result* 
Hatch 1988 22 Colp, Hist, DNA 72% 
Horowitz 1989 17 Colp, Hist 88% 
Umpierre 1992 13 DNA, PCR 38% 
Larsen et al., 1993 10 Colp, Hist 70% 
Marino If et a/.1993 55 Hist 49% 
Bornstein et al., 1993 7 DNA 71% 
Kent & Wisniewski 1990 8 Hist 62% 
Waltz man & Wade 1991 5 Hist 60% 
M ann et al.. 1992 13 Hist 50% 
• Degree of improvement obtained 
DNA= In situ hybridization with DNA probes for HPV, Colp.=colposcopy, PCR =polymerase chain reaction, 
Hist = General histologic examination 
Surgical Intervenlion 
Surgery has been used by several authors as the last means of treatment ofVVS, very rarely 
is the vestibule removed unless the patient has suffered from extremely intense dyspareunia 
for more than 6 months, and, or, would like to be sexually functional and has been treated 
initially using non invasive methods. Woodruff et al. (1981 ), removed painful foci by local 
excision, but later Woodruff & Parmley (1983), described a more stylised operation which 
they termed perinoplasty. In this operation, a 'Y' shaped strip of tissue is excised beginning 
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just below the Skenes' ducts, and including the lower l-2cm of the labia minora, extending 
to just above the anal orifice. Vaginal mucosa is undermined and advanced to the perineum 
where it is sutured with Vicryl. The rate of success in Woodruff & Parmleys' series was major 
asymptomatic relief in all of the fourteen patients, although two ofthe patients still had some 
tenderness near the Skenes' ducts (Woodruff & Pannely, 1983 ). Since the introduction of this 
operative technique, a success rate of 80% was achieved in 64 patients between 1982 and 
1984 (Woodruff & Parrnely 1983). Peckharn et al. (1986) described a series of eight patients 
who had undergone surgery. On follow up, seven were pain free and sexually active, but the 
authors make the point that post-operative pain disability can last for up to five months. 
Marinoff & Turner (1993) reviewed their series of patients treated using this operation, and 
reported that 71 of 73 patients experienced partial or complete relief of symptoms after an 
average follow up of three years. Others have achieved success in between 60% and 80% of 
VVS patients (Friedrich, 1987; Bomstein et al., 1995). In addition Michelwitz et al. {1989) 
and Marinoff & Turner have modified the operation further to include part of the periurethral 
area, resulting in increased success of this procedure (Marinoff & Turner, 1992). Barbero et 
al. (1994), describe membranous hypertrophy of the posterior fourchette as a cause of 
dyspareunia and vulvodynia. Twenty-one patients, who had erythema and point tenderness of 
the vestibule characteristic ofVVS, were treated surgically for this condition, using a similar 
technique as reported by Woodruff and Parmely (1983), but removing just the posterior part 
of the vestibule. Following excision of the posterior part of the vestibule and vaginal 
advancement, 19 patients showed elimination of symptoms, and the remaining 2 patients were 
much improved. 
Mann et al. ( 1992), evaluated 56 patients six months after perinoplasty using a questionnaire 
to assess vulvar pain and dyspareunia separately. Twenty nine percent reported that they were 
pain free, many patients said they were much improved (37%), and that they were not 
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suffering any dyspareunia (36%), however some patients responded that they do sometimes 
experience dyspareunia ( 42%) (Mann et al., 1992). Michelwitz et al. ( 1989), reported a group 
of 44 women whose symptoms related mainly to the Bartholins' ducts. They assessed 
themselves on an analogue scale using a scale of 1-10 to describe their symptoms. Thirty 
patients whose symptoms were very severe (scale 1-3) were treated using laser therapy to treat 
the periductal tissue to a depth of 5-1 Omm. Thirteen of these patients reported a return to full 
sexual function; eight patients failed to show any improvement and were subsequently treated 
using perinoplasty. In this group the cure rate was 100%. The healing phase post treatment 
was up to 10 weeks for laser therapy, whereas patients treated by perinoplasty generally 
recovered after 4-5 weeks. 
Table 2.7 Vulvar vestibulitis syndrome: success with surgical excision 
Author No. Patients Success* Comments 
No. % 
Baggish et al.(unpublished) 15 13 87 Glands removed + vestibule 
Davis ( 1989) 30 20 67 eo, laser excision + periurethral 
area 
Friedrich (1987) 38 23 60 
M ann et al. ( 1992) 55 37 66 
Marinoff &Turner (1991) 73 60 82 Periurethral area 
Michelwitz et al. ( 1989) 16 16 100 8 failed eo, laser ablation 
Peckham et al. ( 1986) 8 7 88 
Schover et al. (1992) 38 47 Limited excision (Barths) 
32 50 Limited excision + psych 
56 Limited excision+ psych+ sex 
therapy 
Woodruff et al. ( 1983) 14 14 100 
* includes complete cure and much improved, adapted from Baggish et al. (1995) 
Bornstein el al. (1991) have compared perinoplasty with vestibuloplasty. The difference 
between these procedures is that during vestibuloplasty no mucosal epithelium is removed. 
The submucosal glands are removed, the vestibule is undermined, and then the mucosa re-
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sutured into place. Women were allocated to one of the surgical procedures using computer 
randomisation. After I 0 vestibuloplasties had been undertaken the results were found to be 
so unsatisfactory, with no improvement in any patient, that the study was terminated 
(Bomstein e1 al., 1991). 
De Jong et al. ( 1995), comment that surgical intervention for focal vulvitis and VVS is not 
a suitable treatment for the condition, as many patients continued to suffer with focal 
tenderness of the vestibule after the operation, which lead to the authors suggesting that this 
radical treatment should be abandoned. In this study, the authors found all women to exhibit 
'inadequate sexual behaviour', depression, lack of sexual libido, and often sexual aversion, 
all of which added to the problem ofvulvar pain. In conclusion these authors suggested that 
a psychological assessment and treatment would be of more benefit to patients with idiopathic 
vulvar pain. 
2.5 Psychological aspects of vulvodynia and VVS. 
Several investigations have reported psychosexual problems associated with vulvodynia and 
in particular VVS. Many physicians are not willing to accept the concept of non-pathogenic 
vulvodynia, an unwillingness, which may stem from the terminology used to describe 
disorders such as dysesthetic vulvodynia and VVS in the past. Terms such as non-pathogenic 
vaginitis, burning vulva syndrome and psychosomatic vulvovaginitis have been used, 
suggesting that the etiology of the condition is mainly psychosocial (Gardner & Kaufman, 
1981, as cited by Ridley, 1988). 
In a study of 83 women with vulvovaginitis, women were assessed using two psychological 
questionaries. Women with confirmed and unconfirmed vulvovaginitis were found to score 
more highly on depression and emotionally distressed scores than the 32 control women. 
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Patients with unconfirmed vulvovaginitis were often emotionally distressed and suffered pain 
during sexual intercourse. Authors of this report, and others, support psychological inquiry 
as it is important to the clinical assessment and treatment of patients with idiopathic 
vulvovaginitis. Six of the ten women in this study who accepted psychological assessment and 
psychotherapy were found to be suffering from clinical depression, which consequently 
responded to treatment, as did the symptoms of vulvovaginitis (Magni et al., 1984; Stewart 
et al., 1990; de Jong et al., 1995). 
Table 2.8 Classification of psycho-cutaneous disease 
Classification of Psycho Cutaneous Disease 
• Strictly Psychological Origin -Glossodynia 
- Dennatitis artefacta 
• Strong Psychogenic Factors Imputed - Generalised pruritus 
• Genetic or Environmental Factors 
Linked to Emotional Stress 
(adapted from Stewart, 1990) 
- Pruritus of the anogenital region 
- Alopecia areata 
-Psoriasis 
- Atopic Dennatitis 
- Lichen planus 
- Lichen simplex chronicus 
- Recurrent HSV 
Koblenzer (1983), described three main groups of psycho-cutaneous disease (Table 2.8). 
Although there is some overlap between the groups, a classification of this type was 
considered to be useful by the author in the treatment of cutaneous disorders. Koblenzer 
(1983), describes glossodynia, which has since been described as being analogous to 
vulvodyn.ia (McKay, 1988), as rarely having a physical basis. This investigation indicated that 
a continued search for an etiologic agent in cases of glossodynia is often damaging to the 
patient, who is usually extremely anxious and often depressed by their situation. Koblenzer 
( 1983) recommends treatment with antidepressants and short term psychotherapy, similar 
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treatments which have proved useful in the management ofvulvodynia and related conditions. 
VVS is not a psychological problem (Dodson & Friedrich, 1977), however, there are 
psychological factors involved in a syndrome such as VVS which need to be addressed 
(Reaner, 1979; Preti, 1994 ). One investigation has shown a degree of depression in 80-100% 
ofVVS patients, which was demonstrated by questionnaire interviews, and often by patient 
admission (Lynch, 1986). Although the depression was not linked to suicidal tendencies, these 
patients were reported to have histories of obsessive compulsive behaviour, marital problems, 
and commonly showed anger about their condition and previous medical treatment (Lynch, 
1986; Schover et al., 1992). Patients commonly reported anger towards GP's and 
gynaecologists due to their inability to diagnose the problem and relieve the pain, their 
inability to listen, and often their quickness to indicate a psychological origin to the problem. 
Lynch (1986), described a spectrum of VVS patients, ranging from those women with 
demonstrable pathology to those with sexual dysfunction and psychologic disturbance. A 
majority of patients showed some degree of psychologic problem, as they were all 
preoccupied with the pain caused by VVS. These authors concluded that the psychologic 
problems which have caused this preoccupation with VVS associated pain, must be addressed 
regardless of whether there is a pathological cause for the syndrome (Koblenzer, 1983; Lynch, 
1986; Schover et al., 1992). 
A particularly interesting investigation by Abramov et al. ( 1994 ), has indicated yet another 
factor which must be considered in the treatment of patients with VVS. This study describes 
a group of 14 women with VVS, 50% of which also have vaginismus, an involuntary vaginal 
spasm seen on attempted vaginal examination. Similar findings have been reported by Basson 
(1994). Abramov indicated the necessity of treating the vaginismus prior to treatment ofVVS, 
as some patients with VVS and vaginismus improved significantly after treatment of the 
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vaginismus, which was the major cause of dyspareunia. Patients whose vaginismus was 
treated successfully but whom still had dyspareunia due to VVS were referred for perinoplasty 
(Abramov et al., 1994). All patients in this investigation resumed sexual relationships 1 year 
after surgery (if surgery was required), and 71.5% of patients achieved this in 3 months. 
Surgery, although necessary in some cases, does however cause psychological stress often due 
to reluctance to resume sexual relationships after the operation. Therefore, sexual counselling 
and psychological support require careful consideration if surgery is being contemplated. 
Schover et al. (1992), showed that women who were assessed post operatively by a 
psychologist faired much better in terms of complete recovery than patients who refused such 
evaluation. In conclusion, careful selection of patients for surgery, and adequate counselling 
and psychological support were considered important by many researchers ( Lynch, 1986; 
Schover et al., 1992; Abramov et al., 1994). These factors were indicated as essential to 
provide a combined surgical and psychological program to deal with the multiple factors 
which appear to initiate and maintain the symptoms of VVS. 
The relationship of depression and immune function may play an important role in conditions 
such as vulvodynia and VVS. Several authors have reported that immune function is affected 
by bouts of clinical depression, which is commonly seen in women \.Vith these conditions. 
Reports by Cappel et al. (1978) Kronfol et al. (1983) and Murphy et al. (1986), have all shown 
impaired cell mediated immunity during depression, which may result in recurrent infections 
associated with some subsets ofvulvodynia (as cited by Stewart et al., 1990). It is possible 
that depression, often obvious in patients with VVS, may initiate altered immune function. 
The mucosal-like surface of the vulva may be affected by this change in immune function 
resulting in the symptoms associated with VVS. 
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2.6 Summary 
In the overall context of vulvar pain, VVS does not appear to be one of the major causes. 
However, the symptoms of VVS are usually long term, and as described previously, 
notoriously difficult to treat. Researchers have reported an increase in incidence of VVS in 
the past 15 years, and it is proposed that many women suffering with vestibulitis feel unable 
to approach their GP, and are consequently suffering in isolation. Although the incidence of 
the syndrome proposed by Goetsch (1991) was suspected of being slightly high, it may turn 
out that the actual incidence of this syndrome is close to this figure. Research continues into 
the incidence of HPV in cases of VVS, a relationship which appears to be unfounded in a 
majority of studies. An alternative approach to the problem is required, perhaps one which 
aims to identifY the cellular changes involved in this perplexing syndrome. The landmark 
paper by Pyka et al. in 1988, set the ground for immunological advances in the understanding 
of the syndrome. Unfortunately, as this study showed nothing conclusive, this approach seems 
to have been abandoned, as only one further investigation by Prayson et al. ( 1995) has been 
completed in this area. Many questions remain unanswered; are studies aiming to identify an 
etiological agent a waste of resources ? Should research be concentrating on the role of HPV 
in this syndrome despite its' link with only small percentage of cases ? What process is 
resulting in edema of the vestibular tissue? Is a cell signalling mechanism to blame for the 
presence of inflammatory cells in the absence of an etiological agent? Is cell death occurring 
in the epithelium resulting in the symptoms ofVVS? 
It is obvious from the distribution of literature published in the last 15 years that many of the 
avenues of approach to vulvodynia and particularly VVS, were quickly proven unfruitful, 
often leading researchers in the wrong direction. Since 1990, very few papers have been 
published on the syndrome, the ones which have, are characteristically reviews and disputes 
relating to HPV. Consistent with the lack of advancement in understanding, treatments for 
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VVS also remain unaltered with several researchers returning to the use of surgery for the 
treatment of long term cases of VVS. It appears that until new approaches are developed to 
extend the understanding of the cellular mechanism involved in these conditions it is unlikely 
that novel treatments will be generated, resulting in researchers returning to the use of anti-
depressants, interferon, and vestibulectomy to eliminate the symptoms rather than attacking 
the underlying cause of the syndrome. 
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CHAPTER THREE 
Epidemiology and pain assessment of VVS patients 
3.0 Abstract 
Control patients, and women with VVS, were interviewed using a structured questionnaire to obtain 
epidemiological data. Several differences were obvious from the epidemiological data, however, this 
was a pilot investigation, and a larger study would be required in order for any statistically relevant data 
to be obtained. Neither group of patients had a high incidence of HPV infection, however, a large 
proportion of patients reported recurrent Candida infections. Patients with VVS reported a higher 
incidence of'buming' pain, labial and vulvar irritation, and cystitis, than was reported by the control 
group. VVS patients agreed that their GPs could have been more helpful, and that their GPs were often 
unaware ofVVS. Most GPs did not examine their patients either prior to treatment, or on following 
visits. Consequently, VVS patients were commonly misdiagnosed by their GP as having Candida, 
psychosexual or gynaecological problems with no defmite cause. Assessment ofvulvar sensitivity using 
the 'Vulvar Algesiometer' confirmed that patients with the symptoms ofVVS, did have an increased 
sensitivity of the vulvar epithelium compared with control patients. Cumulative algesiometer readings 
from control and VVS patients, taken prior to treatment, were found to be significantly different 
(p<O.OOO I). Readings taken from the Bartholins' glands were significantly lower than those recorded 
on the Skenes' glands (p<0.0034). Over a four month period, VVS patients treated with ketoconazole 
showed a significant decrease in the sensitivity of the vulva! epithelium. Over the first three months, 
readings improved significantly, however, after three months there was no significant change in the 
readings. In order to establish the efficacy of ketoconazole for the treatment of VVS a placebo 
controlled, rnulti-centered trial was considered essential. 
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3.1 Introduction 
Friedrich introduced the term Vulvar Vestibulitis Syndrome at the 1987 meeting of the 
ISSVD, where he suggested three main diagnostic criteria associated with the syndrome, 
which were adopted internationally, and are still widely used for the assessment of patients 
with idiopathic vulvar pain (see Chapter 2). The epidemiological characteristics ofVVS have 
been described on several occasions, and are discussed in detail in Chapter 2 (Woodruff & 
Parrnley, 1983; Peckham et al., 1986; Friedrich, 1987; Pyka et al., 1988; Michelwitz et al., 
1989; Furlonge et al., 1991; Wilk.inson et al., 1993; Bazin et al., 1994 and Marks et al., 1995). 
However, the most comprehensive paper is that by Goetsch, published in 1991. This study, 
involving 210 women attending a private gynaecological clinic in the USA, attempted to 
elucidate the incidence ofVVS, and conflfll1 the main characteristics of the syndrome. Many 
studies of VVS have involved the assessment of patients using the criteria suggested by 
Friedrich (1987); and many authors have subsequently interviewed patients with reference to 
past infections, gynaecological history, and the onset and duration of symptoms. However, 
several deficient areas exist, such as: self treatment, treatment by the GP or specialised clinic, 
the patients perception of the problem, and an assessment of the severity and location of the 
pam. 
Assessing vulvar pain is notoriously problematic. Comparing present, and past pain is 
extremely hard, and may depend not only on the intensity of the pain, but on a myriad of other 
factors. Measuring pain is difficult, as perception of pain varies from patient to patient, and 
over time in an individual patient. Pain is also affected by trauma, stress, illness and 
psychological well being, all of which may alter the intensity and, or, how often the pain is 
felt. Patients presenting at their GP or GUM clinic, are currently assessed for vulvar sensitivity 
by applying pressure to the surface of the vestibule, using a cotton tipped applicator to 
palpitate the minor vestibular glands eliciting a pain response (Goetsch, 1991 ). However, this 
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is an unreliable measurement of sensitivity, as the pressure applied is totally variable from 
patient to patient, variable between different consultants, and is often not reproducible at 
subsequent consultations. Another method of assessing vulvar sensitivity has included the use 
of dilute acetic acid. This investigation used different concentrations of acetic acid to gauge 
vulvar sensitivity in patients attending a vulvar clinic with idiopathic vulvar pain (Sonni et al., 
1995). 
A means of delivering a calibrated, measured amount of pressure for a specified time interval 
was, therefore, required for the continued assessment of such patients. The pressure delivered 
should be totally reproducible in order to provide consistent results, and comparable readings 
for a patient, from one appointment to the next. In order to monitor the progress of patients, 
assess treatments for VVS, and to compare the sensitivity of the vestibule in VVS patients, 
a pain meter or 'Vulvar Algesiometer' was designed as a possible means of measurement 
(Curnow et al., 1996). The 'Vulvar Algesiometer' was designed and developed in the Medical 
Physics Department (Freedom Fields, Plymouth) in collaboration with researchers at the 
G.U.M. clinic and the University of Plymouth. 
Many previous investigations ofVVS have not included a control group for comparison of 
data, or alternatively, included a control group of women attending a vulvar clinic who have 
not suffered with vulvar pain in the past (Goetsch, 1991 ). This self selected group of women 
who were attending a clinic for other gynaecological problems, were not considered suitable 
controls for an epidemiological study, as they did not represent a true cross section of the 
female population. For the present investigation, a suitable control group of patients was 
considered important, as this was a pilot investigation, and the study group was relatively 
small. In order to obtain suitable control samples, two GP's surgeries were identified and 
asked to take part in the investigation. One surgery, was an inner city practice, with patients 
82 
from a wide range of socio-economic groups, the other, was a practice on the outskirts of the 
city centre. It was important that the control group of women were similar biographically to 
the VVS group in order for comparisons to be made. The GP's at both practices were asked 
to recruit patients of 18-40 years for the investigation. Only one of the practices, the rural 
practice, was involved in the trial of the 'Vulvar Algesiometer'. The aim of the 
epidemiological investigation was to address several areas: (a) Have VVS patients been 
diagnosed as having infections ofHPV or Candida, and were these infections documented by 
the GP or the clinic? (b) Have these patients ever treated themselves for vulvar irritation or 
past infection? (c) How were women with VVS treated by their GP I G.U.M. clinic? (d) 
How much do women with VVS understand about the condition and its treatment ? 
The trial of the 'Vulvar Algesiometer' involved the assessment ofvulvar sensitivity in both 
control, and VVS patients, and subsequent statistical analysis of the results obtained over four 
months. The trial of the 'Vulvar Algesiometer' aimed to establish: (a) whether there was any 
difference in the levels of control and VVS readings, (b) whether ketoconazole had any effect 
on the sensitivity of the vulva over a four month period, and (c) whether additional treatment 
with imipramine affected response to treatment with ketoconazole (Nizoral, Janssen 
Pharmaceutical, Belgium). 
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3.2 Methods 
3.21 Questionnaire interview ofVVS patients 
The questionnaire was designed with the assistance ofMs.C. Sutton (Applied Social Science), 
and Dr. J. Chandler (Head of Applied Social Science). After drafting possible questions to be 
included in the questionnaire, assistance with the layout and coding of the questionnaire was 
provided by Ms. Sutton (see Appendix 2). Both the VVS and the control patients were 
interviewed by either Miss Sargeant or Ms. Sutton, who were trained in interview technique 
by Dr. Chandler. Ethical committee approval was obtained for the investigation, allowing 
both control and VVS patients to be interviewed. Confidentiality was of paramount 
importance, and to ensure this, completed questionnaires were only given an identification 
number. Twenty five VVS patients were chosen at random from the Genito-Urinary Medicine 
(G.U.M.) clinic records. These women were invited by letter, to attend a confidential 
interview at the G.U.M. clinic. Not all patients responded to the letter, so in order to maintain 
a suitable sample number for the pilot study, several additional VVS patients were randomly 
selected from the clinic records. In total, nineteen VVS patients completed the questionnaire. 
The control group consisted of twenty nine women, who were of a comparable age to the VVS 
group. Control patients were women attending their GP for Well Woman screening; a 
majority of these patients were recruited from the rural practice, and also participated in the 
trial of the 'Vulvar Algesiometer'. The questionnaire was delivered in the form of a 
confidential, informal interview, a format which was preferred to a self administered 
questionnaire, as the study group was relatively small, and a 100% completion rate was 
required. Interviews lasted for approximately 20-60 minutes; patients were informed that the 
questionnaire was confidential, that they did not have to answer all questions, and that they 
could terminate the interview at any time. Written consent was obtained from each patient 
before the interview commenced in accordance with ethical committee guidelines. Essentially, 
the questionnaire consisted of five sections (Table 3.0), however, not all of the sections were 
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completed by each patient. The number of sections which were completed, was dependent on 
past infections, and on whether the patient was in the control or VVS group (see Appendix 
I & 2). Each of the responses was marked as a variable, and the responses for each patient 
were entered into a statistical package, SPSS for the Apple Macintosh, for analysis. The data 
was entered by Ms. Sutton, the analysis of the data for the present study was completed by 
Miss Sargeant. The raw data is available, but was too unwieldy to be included in an appendix. 
3.22 Development of the 'Vulvar Algesiometer' 
The 'Vulvar Algesiometer' was designed and developed in the Medical Physics Department 
at Freedom Fields, Plymouth. The design of the equipment was completed by Mr. J. Cumow, 
Mr. L Barron in consultation with Dr. G Morrison and Miss P.Sargeant. The system is made 
up of 3 parts, a hand held probe, a control unit incorporating the power supply, and a foot 
switch to increase and decrease the force setting during clinical use (Fig. 3.0). The thrust 
probe is made of stainless steel, and is surrounded by a carbon fibre end sleeve, both of which 
are removable for sterilization purposes. The diameter of the probe tip is 1.5 mm, which is 
connected by a thrust rod to the core of the solenoid which produces the impact force. The 
outer sleeve is supported by a sleeve guide which comprises part of the outer casing. There 
is a boss at the inner end of the outer sleeve which acts as a forward stop and is also used to 
sense when the probe is correctly in contact with the vulva! surface. The control unit provides 
the controlled pulse of current which drives the solenoid. There are eight calibrated levels for 
the drive force ranging from 178 mN (0)- 2046 mN (7). The force level can be selected using 
the foot pedal or the button on the front of the control unit. The force setting, which is 
displayed on the front panel, steps up from one level to the next from 0-7, and then returns to 
0 when it has reached the maximum. The length of the tap pulse was made variable from 
0.005 seconds 0.5 seconds in the pilot model, but was set at 0.5 seconds in all later models. 
(Fig. 3.0) (Cumow et al., 1996) 
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Table 3.0 Format of the Questionnaire 
Section One • Biographical details: age, marital status, children, ethnic 
origin, and occupation. 
• Obstetric Hist01y: details of pregnancies, problems after 
childbirth, use of tampons. 
• Sexual History: current relationship, contraception, age at 
first sexual intercourse. 
• Menstruation: age at start of menses, use of sanitary 
products, problems with the use of these products. 
• Hygiene Regimes: type and usage of toiletries, washing 
powders, and other detergents. Problems associated with 
their usage. 
• Irritations: location, description, diagnosis, and treatment 
of infections I irritations. 
Section Two Only to be completed by women who have suffered with 
Candida (thrush). 
• Symptoms experienced, self management and I or 
treatment of symptoms, medical diagnosis and length of 
treatment if provided. Recurrence of symptoms. 
Section Three Only to be completed by patients who have been diagnosed as 
having HPV. 
• Self assessment, medical diagnosis, treatment and 
management. Recurrence of warts. 
Section Four Only to be completed by women diagnosed as having VVS. 
• Symptoms experienced, self treatment, medical diagnosis 
and treatment prescribed, length of treatment, recurrence 
of symptoms. 
• GP consultation: examination, diagnosis and treatment 
provided, referral to G.U.M., follow up visit to GP. 
Section Five Only to be completed by women attending the G.U.M. clinic for 
treatment ofVVS. 
• Number of visits to the clinic, description of symptoms, 
what factors affect symptoms, duration of symptoms, self 
treatment. 
• Relationship of current symptoms to initial symptoms, 
effectiveness of treatment, problems with daily routines 
and sexual relationships. 
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3.23 Use ofthe 'Vulvar Algesiometer ' 
The use of the ' Vulvar Algesiometer' is very similar to that of the cotton tipped applicator, 
used frequently in gynaecological practice to test sensitivity ofthe vulva (Goetsch, 1991). The 
probe is placed over the minor vestibular glands using a colposcope to position it accurately. 
When lightly placed onto the surface of the vulva the outer sheath moves back into the main 
body of the instrument until the slot in its boss end aligns with the light sensor. This ensures 
that the skin surface is sufficiently flattened, and that the thrust probe is the correct distance 
from the skin. When the control unit receives the sensor signal. it provides a drive pulse to the 
solenoid, that causes the thrust probe to tap the skin at a pre-calibrated level of force. If the 
patient finds this comfortable the force is increased using the foot pedal until slight discomfort 
is felt. This is carried out at all pressure settings and if no discomfort is felt at level 7 a 
reading of 7+ is recorded. On obtaining a result for one duct the clinician moves onto the next 
duct and repeats the procedure. In total, four readings are taken, from the two Skenes' (S 1, 
S2) and the two Bartholins' glands (Bl , B2). 
Figure 3.0 Line drawing illustrating the internal components of the Vulvar Algesiometer 
THRUST ROD SLEEVE GUIDE 
CLAMP SCRE\\ 
(Reproduced from Cumow eT al .. 1996) 
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3.24 Assessment of vulvar sensitivity using the 'Vulvar Algesiometer' 
A pilot study of the 'Vulvar Algesiometer' was carried out in Plymouth and Exeter to test the 
reliability and sensitivity of the device and the reproducibility of results using this means of 
measurement. All women with VVS were asked to participate in the study, so that assessment 
ofvulvar sensitivity and effectiveness of treatment regimes could be established. All women 
who were asked, were pleased to co-operate in the investigation. As a comparison, and in 
order to assess the level of sensitivity in VVS patients, it was important to determine a base 
line reading from control patients with no vulvar discomfort. Twenty nine women, between 
the ages of20-40 years, from a rural GPs surgery were approached by their GP and asked to 
participate in the pilot study. All women were asked several questions about their medical 
histories to determine whether patients had suffered any past vulvar discomfort. After having 
the assessment fully explained, each woman had a brief interview, followed by a short 
examination by their GP, and an assessment of vulvar sensitivity using the 'Vulvar 
Algesiometer'. The assessment of vulvar sensitivity in control patients is an ongoing 
investigation, and to date 4 7 women have been included, the results of which are included 
in this study. 
All patients registered at Plymouth G.U.M. clinic, who were being treated for VVS were 
assessed using the 'Vulvar Algesiometer'. All patients consented to the use of the 'Vulvar 
Algesiometer' prior to being assessed. New VVS patients, who had not received any 
treatment, were assessed prior to treatment, and were asked to participate in the ultrastructural 
investigation (Fig.3 .1 ). These patients were assessed prior to a biopsy being taken, and then 
at monthly intervals for four months. After four months of treatment with ketoconazole a 
second biopsy was removed (see Chapter 6). Some patients required treatment with 
imipramine, a tricyclic anti-depressant, prescribed at a low dose as a pain killer. Additional 
treatment with tricyclic anti-depressants is common in the management of vulvodynia (see 
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Chapter 2). This group ofVVS patients were treated separately in the analysis of the data, as 
it was anticipated that the perception of pain, and therefore the algesiometer readings, may be 
affected by the use of imipramine. All statisitical analysis was completed using Excel 5.0 and 
Statsgraphics for Windows. 
Figure 3.1 Treatment and assessment of patients involved in the investigation ofVVS 
Genitourinary 
/ Medicine Clinic~ 
Current VVS 
Patients 
New VVS Patients 
I 
Assessment using 
Vulvar 
Algesiometer 
I 
Continued* 
treatment with 
ketoconazole 
Randomly 
selected patients 
answered 
questionnaire 
I 
Initial 
assessment with 
Algesiometer 
I st biopsy taken 
Treatment with* 
ketoconazole for 4 
months 
2nd biopsy taken 
Questionnaire 
Ultrastructural 
study 
---Assessed monthly 
with algesiometer 
Ultrastructural study 
* Some VVS patients received additional treatment with imipramine, a low dose anti-
depressant, prescribed for its pain killing properties 
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3.3 Results 
3. 31 Epidemiological characteristics of patients with VVS 
The age distribution of VVS and control patients (Fig. 3.2) illustrates that the majority of 
control patients (88%) were in the age range 25-35 years, whereas VVS patients were mainly 
between the ages of>20-29 years (74%). There were no patients in the 5th or 6th decade in 
the control sample, in comparison, there was a distribution of VVS patients across the age 
range, one of the VVS patients was 54 years old. The average age of control patients was 
30.6±5.0 years, compared with 27.7±7.9 years for the VVS group. The biographical details 
of each group indicated that the control group began menstruating later than the VVS group, 
but became sexually active slightly earlier (Figs. 3.3 & 3.4). The number of children from 
control and VVS patients were very different, 68.2% ofVVS patients had not had children, 
in comparison, only 17.2% of the control group were nulliparous (Fig. 3.5). Patients were 
assigned to a social class by their occupation, using the HMSO guidelines (1980). Generally 
VVS patients were class Ill non-manual, and Jll manual. Class VI included patients who 
described themselves as housewives, or unemployed (Table 3.1). All of the patients in the 
VVS and control groups were white. In the control group 75.9% were married or cohabiting, 
in the VVS group this figure was slightly lower at 63.2%. A majority of patients in both 
groups were involved in a sexual relationship with a man; the duration of the relationship 
ranged from 6 months to 12 years for VVS patients, and 2 -22 years for the control group. Out 
of the control group, 89.7% reported having 'regular' sexual intercourse, compared with 
63.2% of the VVS study group (Table 3.2). 
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Table 3.1 Social class of control and VVS patients 
Social Class vvs (%) Controls 
(%) 
0 0 
li 10 11 
Ill NM 40 52 
Ill M 20 0 
IV 5 0 
V 0 3 
VI 25 34 
n=l9 n=29 
Table 3.2 Relationships and sexual activitv of control and VVS patients 
Group Married /Cohabit Regular sexual Duration of 
intercourse Relationship 
vvs 63.2% 63.2% 6 months - 12 yrs 
Controls 75.9% 89.7% 2 yrs- 22 yrs 
The use of contraception did vary between the two groups, 68% of controls, and 80% ofVVS 
patients reported using some form of contraception. The use of condoms was similar in both 
groups, approximately 20%. However, the use of oral contraceptives was much higher in the 
VVS group than in the control, 60% compared with 38% (Table 3.3). 
Vestibulitis patients showed a higher usage of sanitary towels than tampons when compared 
with the control group. Control patients used tampons only (48.3%), or both towels and 
tampons (82.8%), whereas VVS patients used mainly towels (60%) (Table 3.4). VVS patients 
who did not use tampons, or had used tampons in the past (26.3%), reported that they stopped 
using them due to pain on insertion. 
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Table 3.3 Methods of contraception in VVS and control patients 
Method of Contraception Percentage of Patients 
VVS Controls 
Condoms 20 20 
Pill 60 38 
Cap 0 3 
Coil 0 7 
None 20 32 
n=l9 n-29 
Table 3.4 Types of sanitary products used by both VVS and control patients 
Sanitary Product 
Tampons only & both 
tampons and towels 
Sanitary towels 
vvs 
8 (40%) 
11 (60%) 
n=l9 
Control 
24 (82.8%) 
5 (17.2%) 
n=29 
Despite being advised to use non-biological washing powders and hygiene products, only 40% 
ofVVS patients use non-biological powders. Both groups reported washing their vaginal area 
in addition to bathing or showering (50% VVS, 58% controls). Both groups used soap (75% 
of controls, 52.6% of VVS), however, a smaller percentage of patients in both groups used 
soap to wash their vaginal area ( 15% VVS, 34.5% control). Despite using soap, very few of 
these women had experienced any irritation from cleansing (27 .6% of controls, 31.6% of 
VVS) (Table 3.5). Only one patient in each of the two groups had used any special cleansing 
products for the vaginal area. 
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Table 3.5 Hygiene regimes and cosmetic products used by control and VVS patients 
Action VVS (% Patients) Control (% Patients) 
Biological washing powders 60 62.1 
Fabric softeners 65 69 
Bath products 40 51.7 
Soap 55 75.9 
Wash vaginal area separately 50 58.6 
Use soap for vaginal area 15 34.5 
Irritation after washing 5 13.8 
n=19 n=29 
All of the VVS patients had suffered irritation of some kind in the past due to infe 
allergic reaction (Fig. 3 .6). Irritation of the pubic area, clitoris, urethra, and rectal are 
similar in both groups. However, there was an obvious difference in past irritation 
for the vulva, vagina and labial areas. Amongst VVS patients, 68.4% reported irrit 
the vulva, compared with 41.4% of control patients. Irritation of the labia was reporte 
groups, with 31% of controls and 63.2% of VVS patients reporting past irritation. 
discomfort was noted by 31.6% of VVS patients and only 17.2% of controls (Fig. 3.6 
asked to describe their symptoms in their own words, 62% of controls and 36.8% 
patients described an irritating, itching sensation. Burning was described by 36.8% 
and 10.3% of control patients who had suffered past irritation (Table 3.6). Only the 
who were able to describe their symptoms were included. General unspecified irrita 
described by 14 of 19 VVS patients (73%), a description which was not comm 
control group (6.8%). 
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Table 3.6 Description of symptoms associated with infections 
Symptoms vvs 
Burning 7 
Itching 7 
Discharge 0 
Pain on urination 3 
Pain during sexual intercourse 2 
Swelling 4 
General unspecified 14 
Conlrols 
3 
18 
4 
3 
2 
Amongst VVS patients, 57.9% attempted to treat irritations themselves, whereas 48.3% of 
control patients who had suffered past irritations had tried to treated themselves (Fig. 3.7). On 
average more VVS patients reported their symptoms to their GP, local G.U.M. clinic or 
pharmacist, than control patients. Patients who consulted their GP, had swabs taken in 37.9% 
of control and 68.4% ofVVS cases (Fig. 3.7). Documented infections were reported by both 
groups of patients (Fig. 3.8). Thrush was reported by 89.5% of VVS and 79.3% of control 
patients. Cystitis was more common in the VVS groups as was herpes, HPV, vaginitis and 
VVS. Of patients who had suffered with Candida infections, 36.8% of controls and 41.4% 
ofVVS patients had treated themselves. 
Only patients who had symptoms associated with VVS completed the last two sections of the 
questionnaire. These sections dealt with: self treatment of the symptoms ofVVS; treatment 
by GPs or clinics; effectiveness of the treatment received; and the attitude of the consultant. 
Less than half of the VVS patients had attempted to treat themselves ( 42.1%) for the 
symptoms ofVVS. In addition to self treatment, 78.9% ofVVS patients consulted their GP 
and 21.1% attended a G.U.M. clinic. Of those who reported their symptoms to a GP, only 
52.6% were examined, and only 10.5% were diagnosed as having VVS (Fig. 3.9). Other 
diagnoses by GPs' included: Candida (57.9%); cystitis (5.3%); psychological problems 
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(5.3%); and undetermined cause (31.6%). Only 63% ofGPs' offered any treatment, 37% of 
which was reported to be ineffective. A majority of VVS patients returned to their GP 
(63.2%), and received more treatment which was unsuccessful (47.4%). A small percentage 
of patients reported that their GP was unhelpful (5.3%), or that they changed GP (36.8%), or 
that they were referred to a G.U.M. clinic (15.8%) (Fig. 3.1 0) 
Following treatment with ketoconazole, 13 of 19 patients (68.4%) described their symptoms 
as less intense, and 7 of 19 patients (36.8%) described less frequent discomfort. Only 21% had 
seen no improvement in their symptoms (Table 3.7). Patients were also asked to gauge the 
severity of their symptoms and say whether the pain interfered with their daily routine; in 
order to determine this, patients were asked to respond to one of the five statements provided 
(Tables 3.7 & 3.8). Moderate discomfort was reported by 68.4%, and 31.5% found that the 
pain did not interfere with their daily routine (Table 3.9). Sexual relationships were commonly 
affected by the symptoms of VVS (52.6%), and 36.8% of patients reported that they were 
unable to have sexual intercourse. 
When asked what treatment they had received at the G.U.M. clinic, 10.5% did not know what 
they were using, 63.2% said that they were using Nizoral (Janssen Pharmaceuticals, Belgium), 
and 5.3% referred to the cream as ketoconazole (chemical name). On several occasions 
patients were asked what colour the tube of cream was, in order to determine the treatment. 
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Table 3.7 Initial and current symptoms as described by VVS patients 
Description of symptoms 
More frequent 
Lt:ss frequent 
More intense 
Less intense 
Same 
Number of Responses• 
2 
7 
13 
4 
n=27 responses 
• Patients were allowed to answer 'yes' to one or more statements 
Table 3.8 The severity of discomfort experienced by VVS patients 
Severity of Discomfort 
Severe - I find it difficult to do anything 
Severe - I can only perform some tasks which require little concentration 
Moderate - I always know the pain is there but can perform most tasks 
Slight - I can ignore the pain by not thinking about it 
Slight - I only notice the pain when I think about it 
Table 3.9 Degree of interference with the daily routine 
Degree of interference No. of Patients 
Interferes with daily routine 0 
Some interference with daily routine 6 
No interference with daily routine 13 
Medical attention required 0 
Confinement to bed 0 
n=19 
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No. of Patients 
13 
5 
4 
n=19 
When asked about how they were treated by their GP, only 26.3% ofVVS patients agreed that 
they were completely satisfied with their initial visit to their GP, 26% did not agree with this 
statement, and I 0% were neutral. When asked if aspects of their consultation could have been 
better, 42% of VVS patients agreed with this statement, I 0% disagreed, and 27% were neutral 
(Fig. 3 .1I ). Patients were also asked if the GP was, in their opinion, interested how the 
symptoms were affecting them. More than half(57.9%) of the VVS patients reported that they 
disagreed, or strongly disagreed that the GP was interested, only 10.6% said that their GP 
appeared interested, and I 0% were neutral. After numerous visits to their GPs, 57.9% ofVVS 
patients were referred by their GP to the G.U.M. clinic at Freedom Fields, Plymouth, the 
remaining patients referred themselves. The average number of visits by each patient was 
approximately seven, however the number of visits ranged from I to I2. Only 5.3% ofVVS 
patients suspected that they were suffering from VVS when they attended the G.U.M. clinic. 
Frequently, these patients did not know what was wrong with them (36.8%); 2I.I% believed 
thrush was the cause, IO.S% were convinced that they had a psychosexual problem, and 5.3% 
reported that they thought their symptoms were related to old scar tissue, usually episiotomy 
scars. On average, the duration of the symptoms was reported to be between I and 4 years 
(42.I %), however the duration of symptoms in this group of VVS patients ranged from 6 
months to I 0+ years (Fig. 3.I2). Only 26.3% of patients in this study had ever been free of 
symptoms. 
3.32 Assessment of patients using the 'Vu/var Algesiometer' 
'Vulvar Algesiometer' readings were taken from the Skenes' and Bartholins' ducts. In total 
there were four readings for each patient. Occasionally, one or more ducts were unable to be 
detected. In order to compare readings from different patients, and individual improvement 
over time, cumulative readings (SI +S2+B 1 +B2) were recorded. Control patients generally 
gave readings of7 on all ducts (cumulative reading of28) (Table 3.1 0), however 11 of the 47 
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control patients assessed, produced cumulative readings lower than 28, and several of these 
patients had readings of 1- 4 on one or more ducts (Table 3.11 ). Using analysis of variance, 
it was found that the initial readings from control and VVS groups, were significantly 
different (p<O.OOOl), and that the variation within the groups was less than the variation 
observed between the two groups. The average cumulative reading for the control group was 
26.1 ± 4.81 compared with 6.9 ± 5.8 for the VVS group (Fig. 3.13). Cumulative readings for 
both groups, ranged from 0-28, and in control group 39 of 47 patients (82.9%) scored 25-28, 
only 8 patients scored under 25 (17%). In comparison, VVS patients showed a wide range of 
cumulative readings. The initial assessment of VVS patients showed no patients with 
cumulative readings of25-28, patients commonly scored in the range of0-16 (91.6%), and 
more than halfofthe cumulative readings were in the 0-8 range (68.3%) (Table 3.10). 
After treatment with ketoconazole cumulative readings from VVS patients appeared 
significantly different when compared with the initial reading. Some patients responded 
quickly to treatment with ketoconazole, and several became much improved after 2 months, 
frequently maintaining readings of 7 on all four ducts. However a significant number of VVS 
patients took much longer to respond to treatment, a majority began to see some improvement 
in their condition after four months. In total 29 patients were treated for four months or more 
at the G.U.M. clinic, and had not received any other medication apart from ketoconazole, the 
cumulative readings from these patients were plotted over four months (Figs. 3.13 - 3.17). 
Analysis of variance of the readings from all VVS patients (n=60) over five months showed 
that there was a significant difference between the readings from the first, to the third 
assessment. However, when readings from month 3 and month 4 were compared there was 
no significant improvement in the readings (Table 3.12). Cumulative readings from 
assessments 1-5 exhibited a large intra-group variation when compared to the variation 
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between the different assessments. Cumulative readings were seen to change considerably, 
particularly within a 3 month period. When assessed initially, none of the VVS patients had 
cumulative readings of25-28, and only 3 patients had cumulative readings of 17+ (10%). 
Table 3.10 Initial cumulative 'Algesiometer' readings from control and VVS patients 
Cumulative Algesiometer No of Patients No. of Patients 
Reading Controls vvs 
0- 4* 29 
5-8 0 12 
9- 12 2 7 
13- 16 0 7 
17-20 2 4 
21-24 3 
25-28 39 0 
Average 26.1 6.9 
n=47 n=60 
* 0 representing the most intense vulvar sensitivity, and 28 the least intense. 
Table 3.11 Algesiometer readings from borderline control patients 
Algesiometer Reading 
0 
2 
3 
4 
5 
6 
7 
Number of Readings 
0 
5 
5 
3 
6 
3 
2 
20 
n=44 readings 
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In comparison, after three months of treatment, 17 of the 29 patients had readings of 17+ 
(58.6%), however, the number of patients with cumulative readings of 25-28 remained the 
same as before treatment. After four months treatment the number of patients with readings 
of25-28 decreased to 15 of29 patients (51%), however there was an increase in the frequency 
of readings in the middle of the range, i.e., from 5-24. 
Table 3.12 Comparison of cumulative readings from VVS patients from 1st to 3rd assessment 
Assessment Number of Patients 
2 
3 
4 
5 
60 
60 
59 
42 
27 
(n=60) 
Standard 
Deviation 
6.04 
7.77 
9.33 
8.70 
8.47 
Mean 
6.84 
12.06 
15.29 
15.72 
17.56 
Additional treatment with imipramine was quite common amongst the VVS patients treated 
at the G.U.M. clinic, 17 of the 60 patients had received imipramine at some time during their 
treatment. Of 17 patients, 5 became much improved within three months and did not require 
further treatment, the remaining 12 patients also responded well to treatment with 
ketoconazole, but improvement was slower. On the second assessment, cumulative readings 
from patients treated with imipramine were quite evenly distributed across the range of 
readings, whereas in VVS patients who did not receive imipramine a majority of readings 
were in the range of 0-12. Cumulative readings of 25-28 were seen to increase steadily over 
the four months from 0-17.6%, in addition readings of 0-4 fell dramatically from 41. I% to 
17.6% after just one month of treatment, and to 5.8% after 4 months of treatment. In 
comparison VVS patients not treated with imipramine showed a slower response with only 
17.2% of patients showing readings of25-28 after four months of treatment. Readings of 0-4 
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were not as common on the initial assessment of patients not treated with imipramine (34.4%) 
compared with 41.1% in imipramine patients. Statistical analysis of the data revealed that the 
two groups ofVVS patients, one of which received additional treatment with imipramine, did 
in fact behave as a homogenous group. No statistical differences were observed between the 
two groups in response to treatment over four months (Figs. 3.13 - 3 .17). 
Algesiometer readings also appeared different between the Skenes' and the Bartholins' glands. 
A high percentage of Bartholins' glands gave readings of 0 and I, when compared with the 
Skenes' glands. Of readings taken from the Bartholins' glands 73% were 0 or 1, compared 
with 52% of readings taken from the Skenes' glands in the same patients. Readings from the 
Skenes' glands were generally more evenly distributed over the range of readings when 
compared with the Bartholins' glands (Fig 3.18 & 3.19). Statistical analysis indicated that the 
mean reading from the Bartholins' glands was significantly different from the mean reading 
from the Skenes' glands (p=0.0034); and that the readings from the Skenes' glands were 
significantly higher than those from the Bartholins' glands (p=O.OO 17). 
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Figure 3.2 Age distribution of VVS and control patients (n=29, controls, n=l9 VVS). 
Figure 3.3 Age at first menstruation ( n=29 controls, n=l9 VVS) 
Figure 3.4 Age at fist sexual intercourse (n=29 controls, n= 19 VVS). 
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Figure 3. 7 
Figure 3.8 
Action of control and VVS patients. Patients were asked whether they treated 
themselves for genital irritation. If they did not treat themselves, who did they 
consult? The responses of both groups of patients were very similar. However, 
more VVS patients were reported to have suffered irritation than control 
patients. If patients consulted their GP did he take a swab for microbiological 
identification? 
I = Self treatment of irritation 
2 = Consulted GP 
3 = Consulted a chemist 
4 =Attended a G.U.M. clinic 
5 = Did the GP take a swab? 
Documented past infections. Patients were asked to report past infections which 
were documented by their GP or G.U.M. clinic. 
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Figure 3.9 Action of VVS patients. VVS patients were asked about their course of action 
when they developed the symptoms of VVS. Patients were asked several 
questions regarding their diagnosis: 
Did you anended a G.U.M. clinic? 
Did you consulted your GP? 
Did tour GP examine you? 
Did your GP diagnose VVS? 
Figure 3.10 Treatment ofVVS patients by their GP. VVS patients were asked to comment 
on how they were treated by their GP on their initial, and subsequent visits, and 
on the effectiveness of the treatment prescribed. 
1 = GP treated symptoms 
2 =Treatment ineffective 
3 =Returned to GP 
4 = More ineffective treatment 
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5 = Referral to gynaecologist I G.U.M. 
6 = GP was not helpful 
7 =Consulted other GP's 
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Figure 3.11 Assessment of treatment by the GP. Patients were asked to respond to 3 
statements: 
1. I was completely satisfied with my initial visit to my GP. 
2. Aspects of my consultation could have been better. 
3. The GP was interested in how the symptoms were affecting me. 
Figure 3.12 The duration of the symptoms associated with VVS. 
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Figure 3.13 'Box and whisker' plot of initial cumulative readings from control and VVS 
patients (month =I, initial assessment). Two groups ofVVS patients are included, 
patients who received additional treatment with imipramine (1), and those who 
received only ketoconazole (V). There is a highly significant difference between 
the readings of the control and VVS patients in both groups (Control n=47, VVS 
(I+ V) n=60). Refer to Appendix 6 for an explanation of the Box & Whisker Plot. 
Mean Value V= 6.7 
Standard Deviation V= 5.89 
I =6.9 
I= 6.55 
c = 26.1 
c = 4.81 
Figure 3.14 Cumulative readings taken at month two (2nd assessment). There is no difference 
in the readings in groups I and V. Control patients were not assessed.Refer to 
Appendix 6 for an explanation of the Box & Whisker Plot. 
Mean value V = 11.6 
Standard Deviation V = 7. 78 
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Figure 3.15 Cumulative readings from VVS patients treated with ketoconazole (V), and 
patients receiving imipramine in addition to ketoconazole (1). There is no 
significant difference in the cumulative readings between the two groups at 
month=3 (3rd assessment). Refer to Appendix 6 for an explanation of the Box & 
Whisker Plot. 
Mean l = 14.06 
Standard Deviation I= 10.01 
V= 15.70 
V =9.1 
Figure 3.16 Cumulative readings from VVS patients at month four (4th assessment). Refer 
to Appendix 6 for an explanation of the Box & Whisker Plot. 
Mean I= 17.36 
Standard Deviation I= 9.23 
V= 15.36 
V= 8.28 
Figure 3.17 Cumulative readings after four months of treatment (month=5). There is no 
significant difference in the two groups response to treatment. Refer to Appendix 
6 for an explanation of the Box & Whisker Plot. 
Mean I= 18.2 
Standard Deviation V = 8.5 
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Figure 3.18 A1gesiometer readings taken from the Skenes' and Bartho1ins' glands on the 
initial assessment. There was a significant difference between the two groups, 
generally the readings from the Bartholins' glands were lower than those 
obtained on the Skenes' glands. 
Figure 3.19 'Box and Whisker' plot of the initial readings from the Skenes' and Bartholins' 
glands. 
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3.4 Discussion 
3.41 Epidemiology of VVS and control patients 
Many of the studies completed on VVS have included assessment of pain, and characterisation 
of the symptoms associated with the syndrome (Woodruff & Parrnley, 1983; Peckharn et al., 
1986; Friedrich, 1987; Pyka et al., 1988; Turner & Marinoff, 1988; Furlonge et al., 1991; 
Goetsch, 1991; Wilkinson et al., 1993; Marks et al., 1995). However, very few investigations 
have included a suitable control population as a comparison for epidemiological characteristics 
(Bazin et al., 1994). Our group of VVS patients were of a similar age to those reported in 
previous investigations, with a majority of patients being between the ages of <20-25. The 
distribution of VVS patients over five or six decades was commonly reported in past 
investigations, and this was supported by our results which indicated one women of 54 years. 
Some investigations have reported women with VVS in the 7th decade, however the median 
age of the syndrome is usually quoted to be approximately 36 years which is similar to the 
results obtained in this investigation, where the mean age was 27.7 years (Friedrich, 1987; 
Wilkinson et al., 1993; Marks et al., 1995; Bergeron, et al .. 1994, Baggish et al., 1995). 
The inclusion of a control group of women for comparison of the epidemiological data proved 
difficult, as women between the ages of 17-50 do not usually attend their GP on a regular basis, 
apart from the necessity of contraceptive services. A rural GPs practice was suggested for the 
investigation, as one of the resident GPs had an excellent working relationship with the female 
patients. Patients between the ages of 18-40 were contacted by the GP personally and asked 
whether they would participate in the study, all patients who were approached were pleased to 
co-operate. In comparison, the inner city practice chosen for its location, and range of socio-
economic groups did not prove to be as useful. The GPs at the iilller city practice consented to 
patients being approached by their receptionist when they phoned to book an appointment. 
Although this arrangement worked adequately in the initial stages of the study, the receptionist 
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was obstructive and unreliable, and did not remember to recruit patients for the investigation. 
Consequently, as a suitable number of patients were recruited from the rural practice, this 
became the sole centre for control patients. The age range of the control patients was very 
similar to that of the VVS study group, however, when examining the age distribution, it 
became obvious that the VVS group were on average much younger. Of the control patients, 
88% were between the ages 25-35+, over half were 30+, and there were no patients in their 5th 
or 6th decade (Fig. 3.2). The difference in age between the control and VVS groups was notable 
and it was anticipated that this difference would become apparent in some of the other sections 
of the questionnaire, particularly in the sections regarding pregnancy and contraception. 
Several past investigations have suggested that the incidence ofVVS may be linked to the age 
of the woman at first sexual intercourse (Bazin et al., 1994). Our study showed findings 
confirming that the age of first sexual intercourse is probably not related to the onset, or the 
initiation of the symptoms ofVVS. Results indicated that the control group became sexually 
active slightly earlier than the VVS group, however, this was only a pilot investigation and 
would need to be repeated with a larger sample number in order for a statistical analysis to be 
completed (Fig. 3.4). Bazin et al. (1994) showed that the relative risk of developing VVS was 
increased in women who became sexually active before 15 years. This study showed a 3.3 fold 
increase in relative risk, if women became sexually active at 15 years, compared with 16 years 
or later. Bazin et al. ( 1994) also indicated that women with early menarche also tended to have 
a higher risk of developing VVS. Control patients in the present investigation were found to 
start menstruating later than the VVS patients, 76% ofVVS patients compared with SI% of 
control patients began menstruating before the age of 13 years. 
The number of children from both VVS and control patients were as expected. The control 
group of women being slightly older were considered more likely to have had children than the 
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VVS group. In fact 63.2% ofVVS patients did not have children, compared with 17.2% in the 
control group. Past studies have indicated that a percentage ofVVS cases develop postpartum 
(Goetsch, 1991 ), in the present investigation only 36.8% of patients had given birth, with only 
21 .I% of patients had experienced any lasting discomfort due to childbirth. Problems using 
tampons (5.3%) or having sexual intercourse (1 0.5%) were not common post partum in the 
present investigation. Goetsch (1991 ), refers to a group of patients who developed the 
symptoms of VVS postpartum, this group of women were described as having secondary, 
rather than primary VVS. Goetsch (1991 ), separated patients into 1° and 2° cases, as there were 
obviously two main groups of patients in her study group. Those with primary VVS were often 
nulliparous, with a history of particularly intense pain and a strong familial history. In 
comparison, secondary or 'acquired' VVS was described as having a postpartum onset, and is 
associated \\~th infections or irritant reactions, and does not appear to have a genetic link 
(Goetsch, 1991). Women with secondary VVS, constituted 21% of the VVS population in 
Goetschs' study, and were therefore a significant sub-group of patients. This group of patients 
also reported that the worst period of pain was immediately after giving birth, after which the 
pain had lessened but did not resolve (Goetsch, 1991 ). 
A majority of the women in this investigation, and in past studies, have not had periods of 
vulvar pain followed by spontaneous remission, findings which are contrary to the report by 
Peckhan1 et al. (1985), who reported that there was a remission rate of 50% in their population. 
If this was the case, it is probable that there would be a notable number of women in either the 
control and VVS groups, reporting periods of vulvar pain in the past which spontaneously 
resolved. The large number of women \\~th primary VVS both in our investigation and that of 
other authors (Goetsch, 1991; Bazin et al., 1994 ), suggests that there may be an inherent 
variation in the sensitivity of the vestibule in women; and that many women may suffer with 
varying degrees of VVS, without having had an irritant reaction to a chemical or infection. 
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Consistent with most other studies, all of the patients in this investigation were white. Studies 
in the USA have indicated a prevalence of the syndrome in whites, the syndrome is rarely 
reported in ethnic minorities and Afro-Caribbeans. Goetsch (1991 ), studied a group of 210 
women attending a vulvar clinic, 40 patients were diagnosed as having VVS or borderline VVS; 
of these patients one was Japanese, and another was Chinese. Furlonge et al. (1991), reported 
similar findings in their study group of 24 VVS patients, 22 were Caucasian, one was 
Mediterranean and another was Afro-Caribbean. Similar findings have been reported previously 
by Peckham et al. (1986), and Friedrich (1988). It has been suggested, that the predominance 
of the syndrome in Caucasians, may be due to a predisposition to the cause of the syndrome, 
or alternatively due to socio-cultural differences in response to disease. Alternatively, there may 
be a difference in presentation of the condition linked to social class. Friedrich (1987), 
comments that the "predilection for a single race in a majority of cases, makes an infectious 
agent unlikely as the only cause of the syndrome". 
Other authors have reported that the syndrome is more common in social classes I and II 
(Furlonge et al., 1991; Goetsch, 1991 ). These studies do not say how they classed their patients, 
so it is difficult to compare our data with information from these investigations. Social class 
may be assessed by: the patients occupation; the partners occupation; the area in which you 
live; or your income. The group of women in the present study were classed according to their 
occupation using the 'Classification of Occupations' (HMSO, 1980). Problems were 
encountered as women were classed by job title. For a more accurate assessment the full job 
description would be required. In contrast with previous studies, the present investigation 
showed a prevalence of the syndrome in classes Ill (manual and non- manual) and VI, rather 
than in I & II as reported in other studies. The group of patients classified as group VI included 
women who described themselves as housewives or not in employment. This discrepancy in 
social class, may be related to the class system in the USA where the majority of work on VVS 
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is undertaken. However, as differences in class ascription vary between the USA and the UK, 
this data is extremely difficult to interpret. 
Consistent with the findings of Bazin er al. ( 1994), a significant number of the VVS patients 
in the present study were using oral contraceptives (OCs). Bazin et al. (1994), associated the 
use of OCs at an early age, with a greater risk of developing VVS, when compared with patients 
who have never used OCs. The relative risk of developing VVS was not reported to alter with 
the duration of use, or the strength of the pill. In the present study 60% of the VVS study group 
were using OCs compared with 38%ofthe control group. Despite this significant difference, 
the variation in contraceptive use may be linked to the average age of the patients, which was 
higher in the controls than in the VVS group. Many of the patients in the control group (82.8%) 
had already had children, compared with only 36.8% of the VVS group. Frequently, after 
having a family, control patients reported a change in their contraception from OCs to another 
method. Commonly, control patients used the cap or the coil, or alternatively, they or their 
partners were sterilised, all of which may account for the difference in contraception in the two 
groups. A direct comparison of these two groups of patients is difficult, as the patient numbers 
are limited, and the majority of patients were using OCs. 
All patients attending the G.U.M. clinic in Plymouth were advised to use non-perfumed soaps 
and detergents, and to use non-biological washing powders in order to minimise the chance of 
allergic or irritant reactions. Despite this advice, less than half of the VVS patients ( 40%) used 
non-biological powders. However, only 5% of VVS and 13.8% of controls had ever 
experienced any discomfort or irritation from detergents, soaps, or cosmetic products. In 
comparison, a larger number of patients in both groups had suffered with irritations due to an 
infection. Irritation of the pubic, clitoral, urethra and rectal areas were similar in both groups. 
Differences were however apparent in the number of patients who had suffered v.~th vaginal, 
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vulva! and labial irritation. Vestibulitis patients were expected to report intense vulvar irritation, 
however, only 68.4% described irritation or discomfort in the vulvar area. More commonly 
(73.7%), VVS patients described vaginal irritation, which suggests that either, they are unable 
to pinpoint the source of the problem, or that they have actually had vaginal discomfort due to 
an infection such as Candida. It became apparent whilst interviewing both VVS and control 
patients, that both groups had difficulty describing discomfort, and reporting the location of past 
irritations. Diagrams were provided for this purpose but did not appear to be of much assistance 
in a majority of cases. Notoriously, pain perception is unclear in these patients, which is also 
complicated by the fact that a degree of pain referral may also be occurring. Irritation of the 
labia minora was described in 63.2% of VVS patients, which is probably a more accurate 
description of the location of the pain than those patients who reported vulvar discomfort. The 
labia minora blend with the vestibule of the vulva at Harts' line on the inner aspect of the labia, 
this is the junction of keratinised skin and mucosal-like epithelium. In comparison, control 
patients did not commonly describe irritation in these areas; vaginal irritation was commonly 
reported (5 1.7%), whereas vulvar and labial irritation were less frequently described ( 41.4% and 
31.0%). 
As reported, the patients' description of their symptoms related to irritation also proved 
problematic, many control and VVS patients were unable to describe past symptoms clearly. 
Consistent with the findings of other authors, pain was commonly described as 'burning', and 
was reported by 36.8% of VVS patients, but only 10.3% of control patients. In comparison 
'itching' was reported in 36.8% of VVS cases and 62% of controls. Itching is a different 
physiological process when compared to burning (see Chapter 2).McKay (1988) reported that 
the differentiation between patients who describe itching and those who describe burning is 
important in the treatment of vulvodynia and VVS. Despite this, patients found it difficult to 
describe their symptoms and to differentiate between itching and burning. 
123 
It was interesting that only 21.0% ofVVS patients described post-coital pain, as this is often 
an additional criteria used for the diagnosis ofVVS. This figure was expected to be greater as 
a majority of VVS patients in the present study had described pain during and after sexual 
intercourse when interviewed by their consultant. Frequently, VVS patients appeared to find 
describing their symptoms more difficult than control patients. Many VVS patients described 
their pain as general rather than being located to a particular area (73%). This may be due to the 
structure of the question, or the diagrams used. However, the pain associated with VVS does 
not appear to be as well defined, for example, as the itching reported with Candida infection. 
An investigation into the frequency of self treatment for irritation was included for several 
reasons. The availability of 'over the counter'preparations (OTC) for Candida was expected 
to affect whether patients treat themselves or consult a GP I G.U.M. clinic; alternatively, the 
use of OTC preparations may affect the onset of VVS by initiating an allergic or irritant 
reaction. The true incidence ofVVS may be masked by patients repeatedly treating themselves 
for what they believe to be 'thrush'. Goetsch (1991 ), reported an incidence of VVS of 15% in 
her gynaecological practice population, which is much greater than anticipated by other authors 
(Friedrich, 1987). This is probably due to many patients not consulting their GP regarding 
vulvar discomfort, especially if the condition is not severe, and sexual relationships are not 
adversely affected. The aim of this investigation was to detennine: what patients were using to 
treat themselves; whether the self treatment was successful; and if the treatment was 
unsuccessful did they go to a GP or G.U.M. clinic? It was interesting that approximately 50% 
of both the control and VVS groups had attempted to treat themselves in the past before going 
to their GP. When having symptoms associated with Candida, 36.8% of controls and 41.4% 
of VVS patients attempted self treatment. Recurrence of the symptoms occurred in 6.9% of 
controls and 21% ofVVS patients. These results suggest that the control group were probably 
treating Candida, which is generally able to be treated using OTC preparations. In comparison, 
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a majority of the VVS group may have been trying to treat the symptoms ofVVS thinking they 
had Candida. It is probably true to say, that a small percentage ofVVS patients do have a yeast 
infection when they present at their GP, and therefore, these patients respond well to OTC anti-
fungal preparations. 
VVS patients found it extremely difficult to distinguish between the symptoms they previously 
described as thrush, and their current symptoms, which they now know to be related to VVS. 
Many VVS patients conunented that in hindsight, past diagnoses of thrush were probably not 
in fact thrush but VVS, as on most occasions, infections were not confmned by microbiological 
testing. Less than half of the VVS patients said that they had attempted to treat themselves for 
vulvar burning associated with VVS, however, those patients who did try to treat themselves 
did not have any success in the long term. From this investigation it was evident that nearly half 
of all GPs did not examine patients when they presented \\·ith vulvar pain. This may be due to 
time, they way in which patients described the symptoms, or the routine procedure of the 
practice. However, when patients present at their GP with undiagnosed vulvar discomfort, an 
internal examination should be completed if physically possible, and a swab should be taken 
in order to exclude infections. Although a colposcope is deemed necessary for the visualisation 
of the gland openings, several authors have conunented that it is possible to see erythema of the 
Skenes' and Bartholins' glands with the naked eye. A routine examination will also determine 
whether any abnormal discharge is present which is not indicative of chronic VVS; or whether 
any fissuring of the vulvar skin has occurred, resulting in vulvar discomfort. 
Only 10.5% of the VVS patients in this investigation were diagnosed as having VVS by their 
GP. Generally GPs gave a diagnosis of thrush (57.9%), however, it was interesting that a 
majority of GPs attempted to treat the symptoms of VVS without knowing what etiological 
agent(s) they were treating. Consequently, only 26.3% of treatment had a long term effect on 
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the symptoms ofVVS. This may indicate that there is a subset of acute VVS patients who have 
Candida infections. This suggests the importance of an examination prior to treatment, as long 
term treatment with topical antifungal preparations is both unfounded, and also potentially 
aggravating to the patients condition. Despite unsuccessful treatment by a majority of GPs, 
many VVS patients returned to their GP for further treatment on one, or more occasion. The 
GPs attitude on subsequent visits was described as unhelpful by many patients, very few of 
which showed any improvement in their condition \vith additional treatment. This is a typical 
situation described by VVS patients in other investigations who have often consulted many 
GPs, dermatologists and gynaecologists for an explanation of their condition. Many potential 
VVS patients may be deterred in this way by their GP, and consequently, never receive any 
treatment for their symptoms. These patients, together with borderline cases ofVVS who do 
not consider their problem sufficient to consult a gynaecologist, probably make up a significant 
percentage of women who are never recorded as having VVS. IfGPs routinely asked questions 
regarding sexual relationships, and openly discussed problems related to vulvo-vaginal pain 
during consultations, the true incidence of VVS may be discovered, a point which has been 
demonstrated by Goetsch (1991). The incidence ofVVS is reported to be increasing (Friedrich, 
1987), however, this apparent increase in the number of women reporting vulvar pain, is 
probably not in fact an increase in the incidence of the condition, but more likely, an increase 
in the awareness of women, who now feel more comfortable discussing such issues with their 
GP. 
Despite being a pilot investigation, several conclusions were able to be drawn from the 
questionnaire data. As described by other authors, VVS patients often report a burning 
sensation rather than an itch. Patients with VVS also have a higher usage of OCs and a higher 
incidence of cystitis. The group of patients in this investigation had no evidence of HPV 
infection on colposcopic examination, and did not report any past infections of HPV. One of 
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the most obvious, and disturbing observations from this pilot study, was the number of patients 
receiving unsatisfactory treatment from their GP, whom in a majority of cases, did not perform 
an exan1ination and consequently did not identify VVS. 
3.42 Asse:;sment of control and VVS patients using the 'Vu/var Algesiometer' 
One of the main concerns of vestibulitis patients, which was demonstrated in the 
epidemiological investigation, is that they can not describe their symptoms, or say how much 
pain they are f::eling, or whether the pain they have is more or less intense or more or less 
frequent than at their last consultation. 
Assessment of 47 patients attending their GP for Well Woman screening, using the 'Vulvar 
Algesiometer', resulted in 11 of these patients having slightly low, possibly abnormal readings. 
Two of these patients had readings which were similar to those commonly recorded in cases 
of VVS. Control patients with initial duct readings of 5 and 6 did not report vulvar pain, and 
did not have problems during sexual intercourse or when using tampons. These patients were 
asked if they had ever had any vulvar pain or related problems; one patient recorded an incident 
whilst riding a bike, which she believed was linked to the development ofvulvar pain, another 
patient was considered by her GP to be psychologically unstable, and consequently was unable 
to discuss past events. All of the patients declined a consultation at the G.U.M. clinic at that 
time, and unfortunately, these patients have not been assessed again. It is possible that the 
remaining nine patients with no reported vulvar discomfort but abnormal vulvar sensitivity may 
be borderline VVS cases as described by Goetsch ( 1991 ). 
Vestibulitis patients who were assessed using the 'Algesiometer' had varied responses to the 
device, but generally found that an assessment of their condition was a helpful addition to the 
management and treatment of the syndrome. On several occasions, patients described severe 
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burning, characteristic of VVS, after being assessed using the 'Algesiometer', which was 
attributed to the direct pressure applied to the duct openings during the assessment. This 
discomfort was often parallelled to that experienced during sexual intercourse, and was reported 
to subside over several hours. In comparison with readings from control patients, VVS patients 
demonstrated statistically different readings on initial assessment (p<O.OOOI) (Fig. 3.13) 
On several occasions, imipramine was prescribed for VVS patients, who were in considerable 
pain and complaining of insomnia due to vulvar discomfort. Imipramine is primarily, a tricyclic 
anti-depressant, however, in this study, the drug was used solely for its pain killing ability. All 
patients were informed about the medication they were prescribed; patients taking imipramine 
were told that in higher doses the drug is an anti-depressant, but in low doses it acts only as a 
pain killer. In this study imipramine was prescribed at extremely low levels of I 0-50 mg, and 
was not considered sufficient to act as an anti-depressant. However, whether the use of tricyclic 
anti-depressants has any effect on the psychological well being of the patient has not been 
determined. The use oftricyclics is common in the treatment ofVVS and vulvodynia, and they 
are also used for the treatment of pudendal neuralgia (McKay, 1895; Turner & Marinoff, 1991 ). 
It was interesting to find that there were no differences in response to treatment in patients who 
received imipramine in addition to ketoconazole. Patients who were prescribed imipramine 
appeared to respond more rapidly to treatment than those patients who did not take imipramine 
(Fig 3.13- 3.16). However, statistical analysis ofthe data indicated that these two groups of 
VVS patients responded to treatment as a homogenous group. A larger study group is required 
to investigate the effect of low doses of imipramine on the perception of pain in VVS patients. 
It may be the case that patients treated with imipramine did actually respond better to treatment, 
or alternatively, the knowledge that imipramine is an antidepressant, may have subconsciously 
altered the patients perception of pain. 
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This pilot study primarily aimed to characterise the VVS patients included in the investigation, 
and to compare the gynaecological histories of these patients with a group of control women. 
The use of this pilot questionnaire has been particularly useful for this purpose, and has 
indicated some key areas which would be investigated in more depth in a larger epidemiological 
study of VVS patients. The histories of the VVS patients were particularly useful in the design 
of the electron microscopy investigation, where initially, the incidence of HPV was to be 
investigated. The trial of the algesiometer, also provided some significant results, allowing 
some tentative conclusions to be drawn. 
• It is possible to detect women with VVS from a control population. 
• The 'Algesiometer' is useful for monitoring patient progress and for assessment of 
different treatment regimes. 
• It is possible to differentiate between women with vulva! pain and control 
patients. 
• Borderline or developing cases of VVS may be detectable. 
• There is a difference between the readings ofVVS patients pre- and post-treatment 
Although the 'Vulvar Algesiometer' has proved to be an important part of the assessment of 
VVS patients, it was essential to remember that the readings obtained were subjective, and that 
other factors may also affect the sensitivity of the vestibule when patients are assessed. In 
conclusion, a measuring device is not only useful for the clinician and researcher when 
assessing the benefits, or shortfalls of a treatment, but also an excellent source of progress for 
the patient who often reports that she receives very little information from the consultant. A 
measurement of progress also helps boost L~e patients morale, or provides a reason for why the 
pain has intensified; all information is helpful as recovery may take many months. 
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CHAPTER FOUR 
Ultrastructure of the epithelium of the normal human 
vulva: a comparison with related epithelial surfaces 
4.0 Abstract 
An ultrastructural study of the pathology of Yulvar Yestibulitis Syndrome (Friedrich, 1987) 
necessitated a detailed knowledge of the epithelial surface of the normal vulva. A comparison of 
vulvar, vaginal and keratinised perineal epithelia, confirmed the resemblance of the vulvar epithelium 
to partially thickened mucosal-like epithelia. No conclusive evidence of keratinisation was observed 
and the characteristic granular and spiny cell layers found in skin were absent. The prominent cell type 
was the glycogenated intermediate cell, which formed a structurally homogeneous layer of cells. Other 
cell types present were: superficial flattened cells, many having nuclei, traces of organelles and large 
glycogen deposits; supra basal cells, and basal cells, some of which appeared mitotically active and rich 
in organelles. All cell layers in the vestibular epithelium were characterised by the presence of 
numerous interdigitating C)10plasmic processes, infrequent desmosomal junctions and relatively pale 
staining C)1okeratin filaments. Granules similar to membrane coating granules, were present in close 
contact with the membranes of superficial cells. The granules were commonly electron lucent and found 
in small groups; occasionally granules were found to have electron dense cores. Using SEM, surface 
projections were identified as microridges; raised, rounded projections of the plasma membrane 
forming interlacing ridges covering the surface of the vestibule. When compared with the 
ultrastructural characteristics of perineal and vaginal epithelium, the surface projections evident on 
vestibular epithelium were similar to those covering the vaginal surface, but different from the flattened 
microridges of perineal epithelium. Leukoc)1es were seen in all cell layers, but were particularly 
common immediately below the basement membrane. 
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4.1 Introduction 
As stated in the general introduction, a study of the some what neglected vulvar epithelium 
was considered paramount to the investigation of VVS. When examined using light 
microscopy, vulvar epithelium is found to be composed of four layers as in true skin 
(Wilkinson, 1992). However, the prominence of each of the cell layers is variable depending 
on the location of the epithelium within the vulva. The labia majora are covered by keratinised 
epithelium, characterised by the presence of both a prominent granular and a homy cell layer. 
In comparison the inner aspect of the labia minora which merges with the vestibule, is devoid 
of these characteristic cells, which has resulted in the epithelium being described as mucosal 
or sub-mucosal (Ridley 1988). The labia majora, labia minora and the frenulum and prepuce 
of the clitoris are ectodermal in embryological origin. The inner aspect of the labia major and 
the whole of the labia minora are covered with non hairy epithelium, however, sebaceous 
glands and mucous secreting glands are commonly seen in this epithelium (Ridley, 1988). The 
surface epithelium of the vestibule is particularly interesting as it is the only part of the 
external female genitalia that is endodermal in origin, originating from the same sinus as the 
urethra and the trigone of the bladder (Friedrich, 1983; Woodruff and Friedrich, 1985). The 
vestibule is reported to have similarities to both skin and mucosal surfaces (Lawrence, 1993 ), 
and is described as a collision zone at the junction of two germ layers (Woodruff and 
Friedrich 1985). 
While studying the pathology ofVulvar Vestibulitis Syndrome using electron microscopy, it 
became apparent that it was essential to characterise the normal structure of the vestibular 
epithelium affected by this perplexing condition, before any attempt could be made to describe 
the ultrastructure of tissue from vestibulitis patients. Limited research on the vulva in the last 
few decades has led to the formation of active working groups within the International Society 
for the Study ofYulvar Disease (ISSVD), whose principal aim has been to increase research 
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into vulvar conditions. By looking at the terminology, pathology, dermatology and 
epidemiology ofvulvar diseases, the society aims to make advances in the study of the vulva. 
This is an area which has been merged with vaginal and cervical diseases for many years and 
as a result has consequently received scant attention. Several researchers have described the 
embryology and anatomy of the vulva whilst investigating various conditions affecting it 
(Skene, 1889; Friedrich, 1983, 1987; Woodruff and Friedrich, 1985; Marinoff and Turner, 
1991, 1992), and minimal light microscopy work has outlined the main structural 
characteristics of the tissue (Marks et al., 1986; Pyka et al., 1988; Reid et al, 1988; 
Michelwitz et al., 1989; Furlonge et a!, 1991; Sternberg, 1992; Lawrence, 1993; Prayson et 
al., 1995; Marks et al., 1995). Pyka et al. (1988), made the most comprehensive investigation 
of vulvar vestibulitis at the light microscopy level, exan1ining the structure of the minor 
vestibular glands, the presence of infectious agents, and the composition of the inflanrrnatory 
cell infiltrate using monoclonal antibodies. A comparable study was recently completed by 
Prayson et al., (1995), which produced similar results to the study completed by Pyka et 
a/.(1988). It was therefore surprising that the histology of the normal vestibule has been 
investigated only as part of pathological studies by light microscopy, and tllat an 
ultrastructural survey of the vestibule has not been undertaken. Ferenczy & Richart (1974), 
have commented on tile ultrastructure of keratinised vulvar epithelium, but have failed to 
include details of non-keratinised, mucosal like-epithelium, characteristic of the inner aspect 
of the labia minora and the vestibule. Limited work on the normal vulva may be attributed to 
a persistent bias towards the study of neoplasias being created by the nature of the specimens 
available for study; most being radical vulvectomies as a consequence of tumours or suspected 
tumours of the vulva. In comparison the structure of the vagina and cervix is better 
documented using light and electron microscopy as these tissues are commonly removed 
during repair operations, and for cervical dysplasia. 
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Scanning electron microscopy of epithelial surfaces has been well documented. Ferenczy & 
Richart (1974), completed a comprehensive text 0n scanning and transmission electron 
microscopy of the female genital tract, which described epithelial surfaces ranging from the 
endometrium to the cervix, however, the epithelium of the vestibule has been overlooked. 
Areas of keratinised vulvar epithelium and mucosal vaginal epithelium have been described 
without reference to the vestibular part of the vulva. Apart from investigations of vaginal and 
cervical epithelium, reported descriptions of oral I buccal surfaces appear to be the most 
suitable comparison for vestibular epithelium. Oral epithelium is bounded by keratinised and 
mucosal epithelia, a similar situation to that of vestibular epithelium; consequently oral 
surfaces have much in common with the surface of the vestibule (Squier et al., 1976; Landay 
& Schroeder, 1977, 1979; Schroeder, 1981). 
The influence of ovarian hormones on the epithelium of the vestibule was considered to be 
a possible complicating factor in this investigation. It was expected that hormonal status of 
the control patients would determine the number of patients suitable for inclusion in the 
investigation, as well as affecting the ultrastructural appearance of the vestibular epithelium, 
and ultimately its comparison with biopsies from women with VVS. The epithelia of the 
vulva, vagina and urethra are all reported to be influenced by ovarian hormones. Tozzini et 
al. ( 1971 as cited by Ridley, 1988) report corresponding changes in the epithelia of the 
vagina, and mucosal surfaces of the vulva in response to progesterone and estrogen. The 
influence of these hormones is demonstrated during the first few weeks of life when the 
female infant is under the influence of maternal sex steroids received transplacentally. For 
approximately four weeks after birth the vagina of the infant is lined with glycogenated 
squamous stratified epithelium usually only seen in the adult. As estrogen levels fall, the 
endometrium breaks down and the vaginal epithelium begins to thin and loses its 
stratification. The vaginal epithelium remains thin and unstratified until puberty when ovarian 
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hormones are produced associated with the development of secondary sexual characteristics. 
Increased levels of estrogen has been shown to result in thickening of the epithelium of the 
vagina and vulva, and ultimately, differentiation of these epithelia into well defined cell layers 
(Dickenson, 1949; Eddy, 1969, Burgos & Roig de Vargas-Linares, 1978; Ridley, 1988). The 
percentage of superficial cells present in the epithelium is positively correlated with estrogenic 
activity. In comparison, the presence of progesterone causes a reduction in the numbers of 
superficial cells, and an increase in the intermediate cell population (Friedrich, 1983a). Under 
the influence of estrogens the vaginal epithelium is highly glycogenated. Glycogen is utilised 
by lactobacilli and corynebacterium which produce lactic acid and consequently a low vaginal 
pH to prevent the overgrowth of opportunistic organisms such as Candida. The use of oral 
contraceptives, particularly combined hormone pills, has resulted in an increase in 
progesterone and estrogen levels and consequently a reduction in the superficial cell 
population. Subsequently, a reduced level of glycogen is available to lactobacilli, and 
opportunist infections are more likely to occur (Ridley, 1988). 
Due to the possible influence of ovarian hormones on the epithelium of the vulva, it was 
important that women donating control biopsies were pre-menopausal, consistent with the 
study cohort. Only pre-menopausal women were included in the study in order to exclude any 
physiologic changes in the vestibular epithelia linked with hormonal change. In post-
menopausal women, the decrease in progesterone and estrogen results in a much thinner 
epithelium than is evident during the reproductive years. The period of time involved in the 
thinning of the epithelium, and also the degree of thinning are variable. Similar changes in 
structure have also been reported in oral mucosa, which, in response to alterations in hormone 
levels, becomes thin and atrophic in post-menopausal women (Squier et al., 1976). 
Unfortunately variations in cyclic hormones due to the stage of the menstrual cycle were 
unavoidable in this investigation. Possible differences in ultrastructural appearance, such as 
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thickness of cell layers and glycogen content, due to varying hormone levels, were taken into 
consideration during the TEM investigation. 
The unique nature, and lack of documentation on the ultrastructure of vestibular epithelium, 
form the basis for this study, which principally aimed to describe the ultrastructure of the 
epithelial surface of the vulva using transmission electron microscopy (TEM). Knowledge of 
the normal ultrastructure of the vulva was considered critical to the ultrastructural study of the 
pathological tissue from vestibulitis patients. Particular emphasis was directed towards 
characterising the various cell types present, their inter-relationships, and comparability with 
similar cells found in related epithelia. Perineal and vaginal tissue, obtained during 
gynaecological repair surgery, was processed using the same method as used for vulva! 
epithelia. These tissues were included as controls for the investigation and for comparison of 
the fine structure. 
Routine chemical processing, and low temperature processing techniques were used to 
identify possible artefactual changes in tissues processed by traditional methods, and to 
maintain antigenicity of tissues for immuno-labelling. Routine processing for TEM generally 
involves the use of aldehydes, osmium tetroxide, alcohol dehydration, and heat polymerisation 
of resin; all of which have the ability to alter protein structure and render antigens 
unrecognisable to specific antibodies. Several processing methods have been developed to 
overcome these problems whilst maintaining acceptable ultrastructural detail (Table 4.0) As 
vestibular epithelium had not previously been described using electron microscopy, both 
routine and low temperature processing protocols were considered important to establish an 
accurate description of vestibular epithelium. Low temperature freeze substitution (L IFS) for 
TEM was selected for this study, as antigenicity and ultrastructural preservation are reported 
to be much improved compared with other low temperature processing techniques (Atherton 
135 
et al., 1992; Robertson et al., 1992), LTFS also compares well with other low temperature 
techniques (Table 4,0); freezing is extremely rapid, aldehyde fixation is minimised and heat 
polymerisation of the resin is avoided, If, as anticipated, the study of tissue from VVS patients 
culminated in an immunological study, tissue processed using low temperature methods 
would be essential for immuno-gold marking of specific antigens linked to the condition, Low 
temperature processing was not expected to be completed on all biopsies, 
Table 4.0. Comparison of Low Temperature Processing Techniques for TEM 
Method 
Progressive Lowering of Temperature 
Thawed Cryosections 
Freeze Substitution 
High Pressure Freezing 
Advantages & Disadvantages 
- Low concentration aldehyde fixation 
- Use low temperature resin. 
- UV polymerisation of resin. 
- Low temperature dehydration reduces 
extraction of cellular components. 
- Good morphology. 
- Aldehyde fixation 
- Cryoprotected with glycerol 
- Frozen in LN2 and sectioned at -80°C 
-No resin, no heat polymerization 
- Morphology difficult to interpret 
-No aldehyde fixation 
- Slam frozen onto copper mirror at -80°C 
- Ice removed by methanol at -80°C 
- Ice crystals often form during freezing 
- Good preservation of I 0-ISum 
- Same advantages as freeze substitution 
- High pressure - no ice crystals form 
-Very expensive 
136 
4.2 Materials and Methods 
The structure of perineal, vaginal and vestibular epithelia was investigated using transmission 
electron microscopy (TEM), light microscopy (LM), and scanning electron microscopy 
(SEM). Tissue biopsies were obtained from pre-/ peri-menopausal women attending a local 
hospital for gynaecological repair surgery. Approval from Plymouth Local Ethical Committee 
was obtained (Febmary, 1994 (see Appendix 1)), and women between the ages of20 and 45 
years were approached by their consultant and asked whether they would participate in the 
study. Informed consent was obtained from each patient. Only pre- / pen-menopausal women, 
who had not suffered with vulval pain in the past were included in the investigation. Biopsies 
ofvulvar epithelium were taken under general anaesthetic prior to repair surgery. Biopsies of 
vulvar (San1ple A), perineal (Sample B) and vaginal epithelium were processed for TEM and 
SEM (Fig. 4 .0). Generally, samples were used for one of the four possible routes of 
processing as the biopsies were very small. Occasionally routine TEM and SEM could be 
completed on a single biopsy. Only three vestibular samples were available to be processed 
using both LTFS and cryo SEM (Fig. 4.1). 
Figure 4.0 The anatomy of the vulva. indicating the extent of the vestibule and the position 
of samples 
Urelhra 
Bartholios' ~' 
Gland', -- --'~~" 
~ , ~ , 
- - - ' Harts Line Sample .8 . 
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Figure 4. 1 Route ofProcessing for Control Biopsies 
Control Biopsies 
/ ""-
SEM TEM 
/ \ I \ 
Routine Cryo Routine L TFS 
* * 2.5 % * 
G lut 
4% 0.05 % Glut 
G lut 2 .0% Para. 
*Glut = Glutaraldehyde Para = Parafonnaldehyde 
4.21 Obtaining a Vulvar Punch Biopsy 
Unlike the cervix and endometrium, removing a biopsy from the vulva required some form 
of anaesthetic. Anaesthesia may take the form of a local injection or a pudendal nerve block, 
generally, however, a local injection was considered sufficient. A Keyes cutaneous punch was 
used to remove a small circular plug of skin, working on the same principal as a cork borer. 
Keyes punches range from 2-12mm, however, a 3- 4mm punch was considered suitable for 
biopsying the vulvar area. It was important that the dermis was penetrated as a superficial 
biopsy would not be suitable for pathological diagnosis. Once the incision was made the 
specimen was grasped beneath the epidermis with forceps and the dermal tissue cut with a 
scalpel (Figure 4.2) (Pinkus, 1977). 
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Figure 4.2 Obtaining a punch biopsv 
Epidermis 
Dermis 
Area of skin removed 
4.22 Scanning electron microscopy 
Both routine and cryo processing techniques were used to investigate the surface structure of 
the vestibular epithelium. Samples of vaginal and perineal epithelium were also processed for 
routine SEM to compare their ultrastructure. Tissue samples were briefly rinsed in s-
carboxymethyl-L-cysteine prior to fixation by cryo or routine processing, to remove surface 
mucus. 
a) Chemical Fixation and Critical Point Drying 
Blocks retained for SEM were fixed in the primary fixative for 2 hours, subsequently washed 
in sodium cacodylate buffer (O.l M, pH 7 .2), and post fi xed in 1% osmium tetroxide for 1 
hour. After washing in buffer, tissue blocks were dehydrated in ethanol (30%, 50%, 70%, 
90%, and absolute ethanol) for 10 minutes in each mixture. Samples were subsequently 
critical point dried for SEM. The intermediate fluid was amyl acetate and the transitional fluid 
liquid carbon dioxide. Dry samples were mounted on brass stubs and gold coated in a Polaron 
E 1500 sputter coating unit to a nominal thickness of 5- l Onm, and examined in a J eol JSM 
5300 scanning electron microscope operated at 15kV. 
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b) Cryo SEM 
Only control vestibular samples were investigated using cryo SEM. Tissue samples were 
subdivided into blocks of approximately 3mrn x 3mm and rinsed in s-carboxymethyl-L-
cysteine to remove surface mucus. The tissues were transported in 2.5% glutaraldehyde in 
O.lM sodium cacodylate buffer (pH 7.2). Prior to cryofixation the tissue blocks were rinsed 
in distilled water, and blotted dry on filter paper to remove excess water detrimental to 
visualisation of the fine surface structure. The cryostage was pre-cooled to -170°C. The tissue 
was secured to the specimen arm with silver paste and subsequently rapidly frozen by 
plunging into LN2 slush. The specimen was withdrawn into the vacuum transfer device, and 
under vacuum the specimen arm was inserted into the cryostage. Ice crystals on the surface 
of the epithelium were removed by sublimation and gentle surface etching carried out by 
raising the temperature to -80°C. The specimen was then withdrawn from the cryo chamber, 
sputter coated with gold and viewed under a Jeol 6100 SEM operated at I OkV and at a 
temperature of -170°C. 
4.23 Transmission Electron Microscopy 
a) Chemical fixation 
A 3mm Keyes punch biopsy sample was removed from the lateral border of the right Skene's 
gland (Fig.4.2) and immediately transferred to a vial containing the primary fixative, 4% 
glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2) at 4°C, for two hours. Biopsies of 
perineal and vaginal tissue were obtained from women having posterior repair surgery using 
a 3mm Keyes punch and processed in the same way as the vulvar samples (Fig.4.2). After 30 
minutes the biopsies were subdivided into tissue blocks of approximately lmrn x !mm whilst 
immersed in fixative (4°C). Several blocks of tissue were retained in the primary fixative for 
routine SEM. The tissue blocks for TEM were returned to fresh primary fixative for a further 
90 minutes. Blocks were subsequently washed twice in 0.1 M sodium cacodylate buffer (pH 
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7.2), post fixed in 1% osmium tetroxide for 60 minutes (4"C) and finally washed twice in 0.1 
M sodium cacodylate buffer (pH 7.2). Tissue blocks were block stained in 2% uranyl acetate 
for 20 minutes in the dark, washed in distilled water and dehydrated in a series of graded 
ethanol, 30%, 50%, 70%, 90% and absolute alcohol, for 10 minutes in each mixture. 
Dehydration was completed by two 10 minute washes in propylene oxide. Infiltration of resin 
was carried out over several days to ensure full penetration of the resin into the tissue. A series 
of graded mixtures of propylene oxide and Spurr resin (Spurr, 1969) were used (3: 1, 1:1, 1 :3, 
Pure x 2). Blocks were polymerised at 70°C for 8 hours. Ultrathin sections, cut on a Reichert 
Ultracut ultramicrotome, were collected on copper grids, stained for I 0 minutes in uranyl 
acetate and 20 minutes in lead citrate, and subsequently viewed using a Jeol 1200 
transmission electron microscope. Semi-thin sections, ofO.SJ.lm were cut and stained with 1% 
methylene blue for routine light microscopy. 
b) Low temperature freeze substitution (LTFS) 
To avoid chemical fixation, samples were rapidly frozen and the ice removed at -80°C by 
substitution with methanol i.e., freeze substitution (Robertson et al., 1992). All processing 
was completed using Reichert Automated Freeze Substitution (AFS) equipment and a Leica 
Impact Freezer. Several samples of control vestibular tissue were processed using this 
technique, other epithelial samples were not available for processing using this method. Tissue 
blocks (no larger than 1mm x 1mm) for low temperature processing were fixed in 2% 
paraformaldehyde and 0.05% glutaraldehyde for 60 minutes (Atherton et al., 1992). The 
specimens were cryoprotected by placing in 30% glycerol for 30 minutes. Rapid freezing of 
the tissue was completed using an impact freezer, which brings the tissue in contact with a 
pre-cooled copper mirror at -80°C (Fig.4.3). The pressure, speed and force of impact are 
variable, and were altered depending on the thickness or hardness of the tissue. For vestibular 
epithelium, a moderate force setting suitable for mammalian skin was selected. Tissue blocks 
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were placed on transparent office tape which adhered to the foam disk on the specimen carrier. 
Tape was used on the surface of the foam disks to prevent the tissue blocks adhering to the 
foam during freezing. Prior to rapid freezing the specimen carrier was stored in a humidity 
chamber to prevent dehydration of the specimen. The specimen carrier was held in place on 
the plunger rod by a magnet with the specimen facing downwards (Fig. 4.3). The polished 
metal mirrors were cooled in liquid nitrogen for 1 0 minutes prior to slamming to ensure a 
surface temperature of -190°C . As the plunger rod holding the specimen is released, the pre-
cooled mirrored surface rapidly freezes the tissue block as they make contact. The foam disc 
prevents the tissue from being compressed during the slamming process. After slamming the 
magnet was released leaving the specimen carrier and tissue sample in contact with the copper 
mirror. After 30 seconds the specimen carrier was lifted from the mirrored surface using 
forceps cooled with liquid nitrogen, and the sample gently removed from the surface of the 
tape. The frozen samples were placed in dry plastic capsules and stored in a pre-cooled 
cryotransfer container. This container was used to transfer the samples from the impact freezer 
to the AFS, preventing any increase in temperature and subsequent thawing of the sample. 
Ultra-pure methanol was pre-cooled in the AFS during the slamming process. Samples in the 
cryotransfer container were transferred to a freeze substitution chamber in the AFS. Ice 
crystals were then removed by replacement of ice with an organic solvent (methanol) at -80°C. 
After rinsing the samples with pre-cooled methanol, used methanol was withdrawn via the 
central compartment and replaced with fresh solvent using a dry disposable pipette. 
Substitution with methanol was carried out at -80°C for 36 hours, Tl, (Table 4.1 ), the 
methanol was changed twice during this time. After 36 hours the temperature was increased 
by 4°C/hour up to -50°C, approximately 7.5 hours (S 1 ). Infiltration ofLowicryl resin (HM20) 
took place over 8 hours at -50°C (T2). Resin I methanol mixtures, 1: I, I :2, I :3, Pure x 2, were 
used, two hours in each mixture. The AFS was programmed to 'pause' after the first pure 
resin change, at which point the tissue blocks were left in pure resin overnight. Polymerization 
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was achieved with !l!W 1Jighilor 2idays at· -50?C {Robertson eial., 11992). After polymerisation 
' . 
;of the ,tissue ,IJiocks; the .1\'fs, was warmed to' +259C by stepping ,up,the tempetatliie ,l)y IO' 
0C(hi. All equjpmeht was ~leartec;l in a,cetoheian;d' dried at 50~ C. 
i4:3 
Figure 4.3 Diagrammatic representation of rapid freezing using the Reichert impact freezer 
LN2 evel 
iodic tor 
Foam 
disk 
Table 4.1. Processing Protocol for LTFS 
Stage of Processing Time (hrs) Temp. (0C) 
Tl (Substitution) 36 -80 
SI (Substitution) 7.5 4°C/hr 
---------------------------- ----------------- -----------------
Tl (Infiltration) 1:1 2 -50 
S I (Infiltration) 0 -50 
T2 (Infiltration) 1:2 2 -50 
S2 (Infiltration) 0 -50 
T3 (Infiltration) I :3 2 -50 
Pure 2 -50* 
---------------------------- --------·---------- ------------------
Tl (Polymerisation) 48 -50 
S I (Polymerisation) 7.5 I0°Cihr 
*Pause & maintained at -50°C overnight in pure resin 
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3.3 Results 
4.31 Light microscopy 
The overall appearance ofvulvar, vaginal and perineal epithelia is illustrated diagrammatically 
in Figure 4.4. 
a) General structure of vaginal epithelium 
The differentiation of the epithelium into specific cell layers was not clearly defined. 
Keratinised squames and granular cells were absent, replaced by large, slightly flattened 
polygonal shaped cells (Plate la). Superficial cells were often seen packed with glycogen 
(Plate 1 b). Superficial cells often retained their nuclei, however the intercellular space 
appeared swollen and the cells were often devoid of cytoplasm and organelles. Intermediate 
cells were hexagonal in shape with large nuclei, these cells did not have the characteristic 
spiny appearance associated with epidermal cells at this stage of maturation. Leukocytes were 
present below the basement membrane and occasionally interposed between epidermal cells. 
Melanocytes were not visible using light microscopy (Plate I a). 
b) General structure of vulvar epithelium 
Semi-thin sections (0.3-0.SJ.!m) stained with methylene blue showed an epithelium about 20-
25 cells thick. Differentiation into specific layers was difficult to observe using light 
microscopy, but it was possible to identify some differences in cell type, moving from the 
basement membrane upwards, to the superficial cell layers (Plate le). Notable differences 
included: a significant increase in the size of cells, a decrease in staining intensity, and often 
the loss of nuclei linked with maturation. Cells of the intermediate cell layer are slightly spiny 
in appearance due to the presence of cell junctions which are just visible by light microscopy. 
The surface cells did not stain heavily with methylene blue; in comparison the cells along the 
dermal junction were generally more heavily stained (Plate le). The epithelium was 
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infiltrated by white blood cells, which were seen infrequently in all cell layers. The basement 
membrane is gently undulant in appearance forming wide, shallow projections of the dermis 
into the epidermis. Melanocytes were not visible interposed between basal cells, however, the 
occasional clear cell profile suggestive of a Langerhans cell was present (Plate 1 c). 
c) General structure of perineal epidermis 
Semi-thin sections (0.3-0.SJ.lm) stained with methylene blue showed an epidermis of about 
20 cells thick. Differentiation of the epidermis into four specific cell layers was possible due 
to distinct changes in cell morphology. Staining with methylene blue illustrated a distinct 
granular cell layer, 2-3 cells in thickness, and cornified layer, 5-15 cells in thickness. Nuclei 
were absent in the intensely staining, flattened, cornified cells. Using light microscopy, it was 
possible to identify spiny cells, characterised by distinct. intensely staining cell junctions. 
Basal cells were intensely staining, between which pale staining melanocytes and Langerhans 
cells were visible. Very few leukocytes were visible beneath the basement membrane, or 
penetrating the epidermis. Capillaries were not common close to the basement membrane 
(Plate 1 d). 
4.32 Scanning Electron Microscopy 
a) Surface characteristics of perineal epidermis 
The surface cells of perineal epidermis were flattened in appearance with prominent, raised, 
and thickened cell boundaries. The cells were polygonal in shape, variable in dimension and 
ranging from 5-30 Jlm in diameter (Plate 2 a-c). Some surface cells appear to have a more 
flattened surface topography than neighbouring cells (Plate 2c). Cytoplasmic projections are 
ridge-like, with a flattened, worn appearance. Neighbouring cells \vith more prominent surface 
structures appear to have slightly raised microridges, not flattened as seen on surrounding 
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cells. Microridges formed a dense network on surface cells, the orientation of ridges varied 
between individual cells, some areas being completely flattened. Pore-like structures were 
visible infrequently between surface cells of perineal epidermis (Plate 2a). 
b) Surface characteristics of vaginal epithelium 
Surface cells of vaginal epithelium were relatively large, ranging from 10- 40J.Im in diameter, 
and varied considerably in shape and size. Cell junctions were prominent and raised, but did 
not appear thickened. Microridges characterised the surface of this epithelia. Mucus was 
present covering large areas of the epithelial surface, making it virtually impossible to 
visualise the surface structure. 
c) Surface characteristics of non-keratinised vulvar epithelium 
The surface of vestibular epithelium was undulant in appearance (Plate 3a). Surface cells were 
polygonal, approximately I 0-30J.1m in diameter. Cells of this epithelial surface had 
particularly clear microridges, with a raised, rounded appearance. At high magnification some 
microridges appeared nodular (Plate 3d). Microridges were not straight, but generally curved 
and interlocking. These structures appeared to occur at the same density over individual and 
neighbouring cells, but were variable in length (Plate 3a-e). Orientation of ridges varied from 
cell to cell. Cell boundaries were prominent and raised (Plate 3c). Mucus was common on this 
epithelial surface, however, no bacteria were seen. Occasionally pore-like structures were 
visible interposed between surface epithelial cells, these structures varied in size, and were 
commonly isolated. 
LTSEM was not successful for the study of vaginal and vestibular epithelium. Although tissue 
samples were rinsed in s-carboxymethyi-L-cysteine prior to fixation, visualisation of the 
surface revealed mucus which was evidently masking the ultrastructural detail. Areas which 
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were able to be visualised showed very little morphology, and many of the stmctures seen 
using traditional processing were not visible. The surface appeared flat and structureless, 
possibly due to the presence of ice. Due to poor visualisation of the epithelial surfaces, 
micrographs are not included. 
4.33 Transmission electron microscopy 
a) Ultrastructure of perineal epidermis 
A schematic diagram of the characteristic cell layers is shown in Fig 4.5. The stratum corneum 
was approximately 5-15 cells thick, these cells appeared particularly electron dense, however 
the intensity of staining appeared to decrease as the squames reached the epidemml surface 
(Plate 4a). Surface cells of perineal epidem1is showed thickening of the plasma membrane, 
loss of organelles and the nucleus (Plate 4a & b). The surface of the cornified cells was 
characterised by short, blunt ridges, giving the surface an undulant appearance (Plate 4a). The 
cells of this layer contain closely interwoven, intensely staining, cytokeratin filaments (Plate 
4b & d). The cell layer immediately below this, the stratum granulosum, was only 2-3 cells 
thick (Plate 4c-f). The cells of the granular cell layer are characterised by intracellular, 
irregularly shaped, intensely staining, keratohyalin granules (Plate 4d). Cells in this layer 
sometimes retain their nuclei, but generally the nucleus is absent or flattened, and the 
cytoplasm has few organelles (Plate 4e & f). Melanin granules were often visible in these cells 
(Plate 4f). Cells of the spinous cell layer are polyhedral in shape with numerous dark staining 
cytokeratin filaments forming bundles surrounding the nucleus. The plasma membrane of 
these cells is moderately folded between numerous desmosomal junctions which are studded 
around the periphery of the cell (Plate Sa). It is the numerous desomosomal junctions and 
associated cytokeratin filaments which result in the spiny appearance of these cells, which are 
characteristic of keratinised epithelial surfaces. At the transition from spinous cells to basal 
cells it is evident that basal cells of perineal epithelium have a more diffuse network of 
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individual cytokeratin filaments than seen in the spinous cells. Basal cells were oval in shape, 
and the cytoplasm was rich in mitochondria with occasionally some rough endoplasmic 
reticulum and Golgi present (Plate Sb ). Few desmosomal junctions were evident in the basal 
layer, the majority were observed in the stratum spinosum. When present in the basal layer, 
cytoplasmic junctions were more common adjoining the spiny cells rather than between 
individual basal cells. Folding of the cytoplasmic membrane was more obvious between basal 
cells than in other cell layers. Leukocytes were not common in perineal epithelium. 
Occasionally the profile of a lymphocyte was visible, characterised by few organelles and 
sparse cytoplasm (Plate 6). Other non-epidermal cells included melanocytes and Langerhans 
cells. Other leukocytes were not able to be identified, such as the cell shown in Plate 6, in 
which dense granules, vesicles and numerous organelles are evident. 
b) Ultrastructural characteristics of vestibular epithelia 
Superficial cell layer 
A schematic representation of the ultrastructural characteristics of vestibular epithelium is 
shown in Fig.4.6. Using transmission electron microscopy, the surface of the vulvar 
epithelium was seen to be covered with microridges at intervals of approximately 0.2- 0.7J.lm 
(Plate 7a & d). Irregular in shape and length, and ranging from 200-400nm in height. The 
remains of desmosomal junctions were evident on the surface of superficial cells (Plate 7d). 
Desmosomal disintegration was visible between living surface cells and exfoliating cells. 
Filaments attached to desmosomal junctions in the superficial cell layer were diffuse, and few 
in number. The majority of the surface cells were moderately flattened, containing some 
cytoplasmic filaments but generally few organelles (Plate 7a & d). These cells were 
particularly characterised by the presence of large deposits of glycogen, visible as aggregates 
or rosettes (Plate 7a & b). Surface cells generally had an electron lucent matrix, but 
occasionally an intensely staining cell was present, slightly shrunken; these appeared to be 
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apoptotic (Plate 7a). Microvillous processes were seen to interdigitate between surface cells; 
desmosomal junctions were short and less frequently seen here than in the deeper cell layers 
(Plate 7a & c). Nuclei were not uncommon in the surface layers of vulvar epithelia. Nuclei, 
when present, appeared flattened with a spherical nucleolus, frequently the nuclear matrix was 
partially degenerated (Plate 7a). Displacement of the nucleus, possibly due to the presence of 
large glycogen deposits, was common (Plate 7a & Fig.4.5). The cytoplasmic membrane 
appeared to be slightly thickened, but no prekeratin or keratohyalin granules were visible 
(Plate 7c). Occasionally, vesicles, similar in appearance to membrane coating granules, were 
visible in superficial cells (Plate 7b). Vesicles were not common in the normal tissue; 
however, when they were present, they were seen in close contact with the plasma membrane; 
and were generally electron lucent in appearance, occasionally with an electron dense core 
(Plate 7b&d). 
Upper intermediate eel/layer 
Immediately below the flattened surface cell layer is the upper intermediate cell layer which 
is analogous with the spinous cell layer in keratinised epidermis (Plate Sa). These cells are 
polyhedral in shape, becoming increasingly flattened towards the surface layers. Upper 
intermediate cells have slightly flattened nuclei and contain large deposits of glycogen 
commonly situated in a halo around the nucleus (Plate Sa). The cytoplasm is granular in 
appearance characterised by numerous polyribosomes, however, few organelles were visible 
in these cells. Generally, leukocytes were visible in the basal or lower intermediate cell layers. 
However, occasionally the pale staining profile of a leukocyte was visible interposed between 
upper intermediate cells (Plate Sa). These were usually small lymphocytes with sparse 
cytoplasm and few organelles. Infrequently the lobed nucleus and organelle-rich cytoplasm 
suggestive of a macrophage or neutrophil was evident (Plate Sb ). A definitive identification 
was impossible due to the absence of characteristic granules. 
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Lower intermediate cells layer 
Deeper or lower intermediate cells were rich in mitochondria in the perinuclear region; 
profiles of mitochondria were commonly small and round (Plate 9 & 1 Oa). Some rough 
endoplasmic reticulum and occasionally Golgi regions were seen. The cytoplasm of these 
lower intermediate cells was characterised by the presence of free and poly-ribosomes. As in 
other cell layers, glycogen granules were common, seen here mainly in the form of small 
clusters. Deeper intermediate cells generally have more abundant cytoplasmic organelles than 
cells of the upper intermediate layer, with less glycogen stored in the cytoplasm (Plate 9). 
Glycogen is in the form of rosettes rather than large aggregates. Cytokeratin filaments, which 
are lightly staining in this epithelium, form tonofibril bundles which converge at electron 
dense desmosomal plaques (Plates 9, I Oa & c). Single cytokeratin filaments of low electron-
density form a diffuse network in the cytoplasm leaving a clear zone immediately round the 
nucleus (Plate I Oa). The plasma membrane is highly convoluted; microvillous projections 
extend into the intercellular spaces between neighbouring intermediate cells, between the 
desmosomal junctions (Plates 9 & 1 Oa). Cells which appeared electron-dense using 
transmission electron microscopy also stained intensely with methylene blue for light 
microscopy. These electron dense cells were often slightly shrunken in appearance with few 
organelles and dense cytoplasm (Plate 9). 
Basal eel/layer 
Cells of the basal layer were characteristically round or oval in shape, often slightly elongated 
at the proximal end of the cell where the epithelium meets the dermis (Plate 1 Ob). The nuclei 
were large and oval in the perpendicular direction having one or more nucleoli present (Plate 
I Ob), some mitotic figures were evident. Mitochondria, free ribosomes and endoplasmic 
reticulum are numerous in the proximal perinuclear region; mitochondrial profiles are round 
or oval in shape and usually situated in small clusters close to the basement membrane (Plate 
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I Ob). Cytoplasmic projections, as seen in the spinous and supra basal cells, are present around 
the periphery of basal cells. In this cell layer the cytoplasmic processes are visible forming 
close connections with neighbouring basal cells (Plate I Ob). A to no filament network, as seen 
in the supra basal cells, is also present in basal cells, again leaving a fibre free halo around the 
nucleus. Tonofilament bundles are generally more darkly staining in the proximal region of 
the basal cells than in cells of other layers. Desmosomal junctions are infrequent along the 
lateral borders of the basal cells. Cytoplasmic projections of basal cells form pseudopodia-like 
feet which extend into the dermis following the undulating contours of the basement 
membrane. The projections are smooth in appearance and larger than the villous processes on 
the other faces of the basal cells (Plate lOb). Where the foot-like projections of the basal cells 
meet the basement membrane, hemidesmosomes are formed, characterised by dense patches 
where tonofilaments converge on anchoring plaques (Plate lOb). Some lucent cell profiles, 
characterised by the absence of desmosomal junctions and cytokeratin filaments are also 
apparent (Plate 9). These cells, infiltrating the epidermis from the underlying dermis were 
mainly lymphocytes, with little cytoplasm and few organelles. Occasionally a wall of a 
capillary was visible in close contact with the basement membrane. 
c) Ultrastructural characteristics of vaginal epithelium 
Vaginal epithelium was found to be very similar ultrastructurally to vestibular epithelium. The 
surface cells often appeared flattened, however, in several biopsies surface cells were large 
and swollen. The plasma membrane of surface cells was slightly thickened but non-
keratinised, neither membrane coating granules, or keratohyalin granules were present in the 
superficial cells. The surface structure of vaginal epithelium was commonly masked by the 
presence of electron dense mucus (Plate 11 a) The cytoplasmic matrix of large superficial and 
upper intermediate cells was frequently degraded, organelles were characteristically absent, 
and many cells only had the remains of a nucleus present. A small number of cytokeratin 
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filaments were still present in these cells, mainly associated with desmosomal junctions. As 
in vestibular tissue, desmosomes were short in length in the superficial cell layer. The surface 
and intermediate cells were frequently seen to contain large deposits of glycogen, which, in 
the form of aggregates, formed a halo around the nucleus (Plate !la & b). Glycogen was seen 
to occupy most of the cell space in intermediate, and particularly in superficial cells (Plate 
11 b & c). Basal cells were characterised by dark-staining cytokeratin filaments and numerous 
organelles. Mitochondria were seen in clusters in the proximal cytoplasm. The cytoplasmic 
membrane of these cells was folded to form cytoplasmic processes, particularly numerous at 
the junction of basal and intermediate cells. Cytoplasmic processes were finger-like in 
appearance, and of varying length and dimensions. Leukocytes were visible in small numbers 
in the epidermis, but were more commonly seen in the dermis, immediately below the 
basement membrane. 
d) Ultrastructure of vulvar tissue processed by LTFS 
Vestibular tissue processed by LTFS appeared similar in structure when compared with tissue 
processed by routine chemical fixation for TEM. Semi-thin sections, stained with methylene 
blue, demonstrated an epithelium of similar dimensions, and characteristics as seen in 
chemically fixed tissue. However, when examined using electron microscopy, several 
differences were apparent. Ultrastructural preservation of the surface and upper intermediate 
cells was satisfactory, and all membranes appeared intact and stained well, however, 
organelles when present appeared damaged (Plate 12 a-c). Surface cells were characterised 
by the presence of microvillous projections, nuclei were flattened and often displaced. 
Glycogen was not evident in a halo around the nucleus of these cells, instead a structure less 
area was apparent (Plate 12a). Vesicles were identified in close contact with the plasma 
membrane of superficial cells in all biopsies processed by L TFS (Plate 12b & c). Often, 
vesicles were electron dense with an internal lamella-like structure (Plate 12b & c). Lower 
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intermediate and basal cells appeared extremely shrunken and electron dense, with minimal 
ultrastructural detail (Plate 13a-c ). Organelles were indistinct and it was impossible to 
visualise the cytoplasmic membranes of these cells; the nuclear membrane appeared intact in 
a majority of cases. Collagen in the dermis was well preserved, and banding was clearly 
visible (Plate I 3d). The basement membrane was characterised by hemidesmosomes, and did 
not appear damaged. Vesicles and anchoring fibrils were evident along the basement 
membrane. Cytokeratin filaments were clear, and arranged in bundles in the basal cells, 
however, no mitochondria, endoplasmic reticulum or Golgi were visible. 
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4.4 Discussion 
The epithelium covering the vestibule of the vulva is unlike extra-genital skin because it is 
non-keratinised, with a non-pigmented surface, and consequently has more similarities to 
mucosal surfaces than to skin, at least at the ultrastructural level. Although mucus is not 
secreted by the vulva! epithelial cells, the vestibule is bathed in mucus produced by the cervix, 
and to a lesser extent by the vestibular glands of the vulva (Skene, 1889; Huffman, 1948; 
Dickenson, 1949; Friedrich, 1983b; Woodruff and Friedrich, 1985, Ghadially, 1988; Ekert, 
1989). Like skin, the vestibular surface has an epithelium comprising several layers of closely 
packed cells, which mature and differentiate as they approach the surface (Breathnach, 1971; 
Menton and Eisen, 1971; Toner and Carr, 1982; Sternberg, 1992). However, unlike keratinised 
skin, appendages such as hair follicles and sweat glands, and the characteristic granular and 
cornified cells, are absent from vestibular epithelium. It is in this respect that the epithelium of 
the vestibule resembles vaginal epithelia and oral mucosal surfaces ( Squier et al, 1976; Landay 
and Schroeder, 1977; Schroeder, 1981). 
As evident in vestibular epithelium, the individual cell layers of vaginal epithelium are not 
readily distinguishable, one cell type merging to the next (Plate la & b, I la-c). This is unlike 
highly keratinized epithelia which have 4-5 easily distinguishable cell layers and are particularly 
delineated by the presence of granular and cornified cells or squames (Plates 4 & 5) (Selby, 
1957; Breathnach, 1971; Toner and Carr, 1982; Sternberg, 1992). In vestibular epithelium there 
is a large population of intermediate cells which alter in size, filament distribution, and 
organelle density as they migrate to the surface layers during maturation, a less noticeable 
change than that which occurs in highly keratinized epithelia. It is possible to divide the 
intermediate cell population into two groups; the upper intermediate cells have few organelles 
and large glycogen deposits, and are similar to superficial cells, and lower intermediate cells 
which have numerous mitochondria consistent with the ultrastructure of basal cells (Plates 
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5&7). Changes which occur in vestibular and vaginal epithelium include an increase in 
dimensions of cells and accumulation of glycogen, accompanied by a decrease in the electron-
density of cytoplasmic filaments and the number and diversity of organelles. In comparison, 
keratinised cells undergo a more dramatic transformation with the formation of keratohyalin 
granules, and later squames of keratin, with no nuclei or organelles present in these "dead" cells 
(Plate 4). In comparison with perineal tissue, which is a keratinized surface found in close 
proximity to vulvar epithelium (Plate 4), the overall characteristics of the two epithelial surfaces 
show some similarities, but ultrastructurally the cytoplasmic detail is very different. Basal cells 
of perineal tissue have few microvillous projections and numerous, more electron-dense, 
cytokeratin bundles than observed in vestibular epithelium. Cytokeratin bundles present in the 
intermediate cells of the vestibular epithelium, are pale staining and less numerous, not giving 
the spiny, 'prickle' cell, appearance characteristically seen in true skin. Vaginal epithelium 
showed a similar arrangement and staining intensity of cytokeratin filaments as was evident in 
vestibular epithelium. 
Consistent with changes reported in the vagina, the epithelium of the vulva is affected by 
hormonal status, the thickness of various cell layers being reported to be dependant on estrogen 
and progesterone levels (Friedrich, 1983a). Other similarities to vaginal and oral epithelia 
include: a homogeneous population of cells in the intermediate layer, characterised by 
prominent intercellular bridges; surface cells often with large deposits of glycogen; and no 
obvious thickening of the surface cell membranes (Squier et al., 1976; Friedrich, 1983a & b). 
Women participating in the present investigation were pre- I peri-menopausal consistent with 
vestibulitis patients. However, women in both the control and VVS study groups were at 
various stages of their menstrual cycle. The effect of cyclic hormonal status was taken into 
consideration when assessing samples using EM. Variations in glycogen content and the 
thickness of various cell layers were not investigated, due to this complicating factor. 
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In this investigation vaginal epithelium was often characterised by extremely large surface cells 
which were not evident in normal vestibular tissue. It is possible that these surface cells were 
previously packed with glycogen which had leaked out of the cells prior to desquamation, 
leaving the intercellular space empty. Frequently, there were areas of the epithelium where 
surface cells appeared more flattened, consistent with superficial cells of the vestibule. It is 
possible that at different stages of the hormonal cycle, surface cells of the vagina and, to a lesser 
extent, the vulva, become swollen and contain large aggregates of glycogen. This would 
account for the variation in surface cell size in vaginal epithelium. Although variation in cell 
surface volume was evident in vestibular tissue, this was not as pronounced as the variation 
seen in vaginal tissue. King (I 983), depicts ultrastructural changes in the vagina during the 
menstrual cycle and pregnancy. He describes a keratinised epithelium of varying thickness with 
numerous surface microridges and adherent bacteria. In the present investigation a partially 
thickened epithelium v.rith microridges was evident. However, King (1983), reports the 
presence of electron dense granules, similar in appearance to those found in keratinised 
epithelia, which were not visible in vaginal epithelium. A dramatic transition from intermediate 
to superficial cells was also reported, a much more definite change than was seen in either 
vagina or vestibular epithelium in this study (King, 1983). Consistent with the present 
investigation, King (1983), describes the presence of swollen and electron lucent superficial 
cells. In the luteal phase, large numbers of lymphocytes, often surrounded by a dilated 
cytoplasmic space, were reported in the upper cell layers of vaginal epithelium (King, 1983). 
This is similar to observations of vestibular and vaginal epithelia in the present investigation, 
which often demonstrated leukocytes interposed between superficial cells. 
During the investigation of normal vulvar tissue it became apparent that SEM of the surface 
morphology would be a useful addition to the study. Using TEM it was possible to determine 
that cytoplasmic projections, which were similar in appearance to microvilli, varied in length 
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and distribution in both vestibular and vaginal epithelia. In comparison, the surface of perineal 
tissue appeared undulant using TEM but was not characterised by the same type of cytoplasmic 
projections as were evident on the surface of vaginal and vestibular epithelia. As the SEM 
investigation concentrated on the surface cells of each epithelia, no information was available 
on the surface characteristics of lower cell layers. Keratinised vulvar epithelium is reported to 
be similar in appearance to keratinised skin, having flattened microridges similar to perineal 
epithelium (Ferenczy & Richart, 1974) The epithelia of the vagina and cervix has been 
described on many occasions as mucosal-like, becoming keratinised during the menstrual cycle 
(Hackeman et al., 1969; Parakkal, 1974; Davina et al., 1981; Odor et al., 1989). Despite several 
reports on the vagina and cervix of various species, there is no information on the surface 
ultrastructure of the vestibule of the vulva. 
Vestibular samples processed by routine and L TSEM were perplexing. Variations in the surface 
morphology were expected using an alternative technique, however, the presence of a virtually 
flat feature-less surface was not anticipated. Variations in the number and density of 
microridges have also been described in bladder epithelium processed using LT techniques. 
Very different structures were visualised when LTSEM was used instead of routine CPD to 
study the bladder surface. In bladder epithelium, folds and microridges which were seen using 
traditional methods of processing were absent using L TSEM. Cell surfaces were smooth and 
intracellular spaces were evident where desmosomal junctions would be situated (Hopkins et 
al., 1989). Similar findings were echoed in the present investigation. Despite poor surface 
visualisation due to mucus, the surface of vestibular epithelium appeared almost completely flat 
when processed using L TSEM. Microridges seen covering the surface of vestibular epithelium 
using routine processing, were absent when processed by this method. L TSEM is designed to 
maintain ultrastructural preservation in as natural a state as possible. It would therefore be 
expected that the surface ultrastructure observed using routine processing techniques may be 
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due to shrinkage artifacts. However, as suggested by Hopkins et al. (1989), it is unlikely that 
microridges are produced solely due to redundant membrane from shrinkage, which is 
consistent with the findings of Davina et al. ( 1981 ), who reported no change in the 
ultrastructural appearance due to chemical processing and CPD. During L TSEM factors such 
as surface ice formation and etching of the surface may affect the surface appearance, it is 
possible that factors such as these prevented an accurate visualisation of the surface 
ultrastructure during this investigation. 
Several researchers have described the development of microridges in non-keratinised epithelia. 
Reports include similar structures in the bladder, ectocervix, oral mucosa, oesophagus, corneum 
of skin, cornea and also in fish skin ( Murphy et al., 1975; Sperry & Wassersug, 1976; Odor et 
al., 1989). Rabbit epithelium, according to Saito & Itoh (1993) is covered with 'mesh-like 
microridges'. Barberinni et al. ( 1991 ), completed a study of rabbit vagina, including tissue from 
the cervix to the 'vestibulum'. This study indicated that cyclic changes in the epithelium do 
occur in relation to hormonal status. Reports include the development of mucin, keratin and the 
appearance of microridges in response to ovarian hormones. Other studies by Davina et al. 
(1981), show cyclical changes in the epithelium ofthe human ectocervix, investigated using 
freeze fracturing techniques. Studies of the Rhesus monkey during the menstrual cycle and 
during pregnancy, demonstrated that the surface of the vagina changed considerably with 
hormonal status. During pregnancy the surface of the vagina was reported to become thinner, 
and develop microvillus projections rather than microridges (Davina et al., 1981 ). Similar 
cyclical changes may be evident in human vestibule and vaginal epithelium. However, details 
of menstrual cycle, and the use of oral contraceptives was not obtained from control patients, 
and consequently surface ultrastructure could not be correlated with hormonal status. It was 
expected that the surface ultrastructure of the vagina may vary between samples due to 
hormonal differences, however, the epithelium of the vestibule is reported to be endodermal in 
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origin, and unresponsive to ovarian hormones, and was not therefore expected to vary much in 
appearance (Wilkinson, 1992). 
Vaginal epitheliwn did exhibit short microvillous projections in some areas, generally however, 
microridges were seen to characterise the surface of the vagina. Corbeil et al. (I %5) describe 
microvilli and microrugae on the vaginal surface. In the present investigation, the surface of 
both the vestibular and vaginal epithelia were covered by microruggae rather than microvilli. 
Microrugae as described by Corbeil et al. ( 1985), appear to be similar the microridg(.'s on the 
surface of the vestibular epithelium. These structures are not the same as the microridges 
evident on the surface of keratinised perineal epithelium. Microrugae are described as long 
raised projections with no organisation, rather than evenly distributed, stubby surface 
projections (microvilli). In the vagina the length of microvilli has been correlated with the level 
of estrogenic activity. This may be linked to absorption and cell adhesiveness in uterine cells 
to promote blastocyst implantation (Lamb et al., 1978 as cited by Corbeil et al., 1985). 
The development ofmicroridges may be an expression of the estrogen status, or alternatively, 
microridges may be linked to the stability, protection or lubrication of the epithelial surface 
(Sperry & Wasersug, 1976). The vestibule does not contain true mucus secreting glands, 
therefore relying on mucus from the cervix for lubrication and protection. Microridges on the 
vestibule were anticipated, as these structures are reported to trap mucus and maintain a moist 
protective covering, to prevent dehydration and penetration of pathogenic organisms. The 
surface of the vagina was more difficult to visualise than that of the vestibule and perineum. 
The presence of large amounts of mucus did not permit the visualisation of vaginal surface 
cells. The maintenance of mucus on this surface, despite treatment to remove the mucus, may 
indicate the effectiveness of microridges. 
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Using TEM the pattern ofmicroridges in the perineum appeared more regular than in vestibular 
epithelium. Microridges were short and stubby in appearance with thickened cytoplasmic 
membranes (Plate 4a) consistent with the SEM findings in this investigation. The superficial 
cell layers of vestibular and vaginal epithelium were not as compacted as those characteristic 
of keratinised skin (Plate 7a & lla). By TEM, surface cells of the vestibule and vagina were 
electron-lucent in comparison with their counterparts in perineum, which are keratinised and 
compressed and have retained many electron dense tonofilaments (Breathnach, 1971; Toner and 
Carr, 1982; Sternberg, 1992). The cytoplasmic membrane in perineal surface cells is heavily 
thickened, a process which was not evident in vestibular surface cells (Plate 4b). Fully 
keratinised squames of true skin do not have organelles, nuclei or glycogen deposits (Odland, 
1958; Breathnach, 1971; Nakano et al., 1987; Sternberg, 1992), all of which were evident in 
vestibular and vaginal surface cells, and which have been reported in oral epithelia (Squier, 
1976; Landay and Schroeder, 1977). In vestibular and vaginal epithelium, superficial cells 
retain surface folds of the cytoplasm whereas in perineal epithelium the surfaces become 
smoother (Plate 4a and Plate 7a). This is particularly evident on the underside of surface cells 
in vestibular epithelium. The cytoplasmic membrane is thrown into folds, similar in appearance 
to cytoplasmic processes visible in other cell layers of vestibular epithelium. King (1983), 
reports changes in the vaginal epithelium during pregnancy, which result in an epithelial surface 
similar in appearance to the vestibular epithelium observed in this investigation. Vaginal tissue 
is reported by King ( 1983), to have a keratinised surface, only becoming un-keratinised during 
pregnancy. This was not observed in the present investigation, where the vaginal epithelium did 
not appear keratinised in any of the biopsies examined (Plate 11 a). None of the control patients 
were pregnant, or had recently given birth. However, the variation in appearance may be due 
to the sample site, or the hormonal status of the patients. Vaginal biopsies were removed from 
the entrance of the vagina and not near to the cervix as in Kings' investigation (1983), which 
may account for the variation in keratinisation. 
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The presence of vesicles close to the cytoplasmic membrane of surface cells was particularly 
intriguing as these structures were not evident in all of the vestibular samples. Electron lucent, 
spherical, membrane -bound vesicles, were often seen fusing with the cytoplasmic membrane, 
or seen in clusters in close contact with the cytoplasmic membrane (Plate 7a, b & d). 
Occasionally an electron-dense vesicle was present, these structures may be membrane coating 
granules (MCG) associated with keratinisation and thickening of the cytoplasmic membrane 
of surface cells. However, the vesicles visible in this study were generally electron lucent in 
appearance, inconsistent with the characteristic 'cored' appearance ofMCG in keratinised and 
non-keratinised epithelia (Breathnach, 1971; Squier, 1977; Landay & Schroeder, 1977, 1979: 
Schroeder, 1981 ). Typical MCG in non-keratinising epithelia are membrane bound with an 
electron dense core from which fine filaments radiate out towards the trilaminar membrane 
(Squier, 1977). The major difference between MCG in keratinising and non-keratinising 
epithelium is the absence of intemal1amellae in non-keratinising MCG (Squier, 1977). Landay 
and Schroeder (1978), describe numerous MCG in the upper intermediate cell layer of oral 
epithelium; these granules are non-laminated, with a dark core characteristic ofMCG found 
in non-keratinising epithelia (Hayward & Hackemann, 1973, as cited by Landay and Schroeder, 
1978). In vestibular epithelium, a small percentage of vesicles were electron dense, however, 
the majority did not exhibit electron dense cores, characteristic of true MCG. The fate of 
electron lucent vesicles in vestibular epithelium appears similar to MCG. As in keratinised 
epithelia, vesicles were frequently seen in close contact and fusing with the cytoplasmic 
membrane of surface cells, possibly releasing their contents into the intracellular space. 
However, there is no evidence that these vesicles have the same properties or contents as MCG 
found in keratinised epithelial surfaces. The function of the MCG has received much attention, 
there is evidence that they contribute to intercellular permeability , and produce an intracellular 
cement, holding superficial cells together (Squier, 1978). Contents of granules in non-
keratinising epithelia have been identified as muco-substances and glycoproteins (Hayward & 
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Hackemann, 1973, as cited by Squier, 1978) which would not provide the same permeability 
barrier as keratinised squames. It has been suggested by Squier (1978), that modification of the 
intercellular substance by the contents of MCG may take place to produce an intercellular 
permeability barrier in non-keratinising epithelia. Similar structures have been reported in the 
non-keratinising epithelium of rumen mucosa (Lavaker, 1969, Lavaker et al., 1969). The 
presence of numerous electron lucent vesicles in some of the vestibular biopsies may suggest 
that the contents have been discharged, or alternatively, that the contents have been removed 
during processing. It is possible that the use of chemical fixation may influence the visualisation 
of these structures, as they were present in all three of the samples processed using LTFS. The 
absence of vesicles in a majority of the vestibular samples may suggest a hormonal influence 
on the formation of these structures. The influence of ovarian hormones is well documented 
to affect the thickness of superficial and intermediate cell layers, and deposition of glycogen. 
The maturation of vestibular epithelium and the deposition of glycogen may be linked to the 
formation of vesicles which appear to have a similar function to MCG, which would suggest 
why these structures were only evident in a minority of the control samples. 
Vestibular epithelium processed by LTFS proved particularly interesting. The general structure 
was found to be identical to chemically fixed tissue using light microscopy. However, low 
temperature processing did not give comparable results when samples were examined using 
electron microscopy. Light chemical fixation, rapid freezing and UV polymerisation of the resin 
was expected to provide good ultrastructure and ensure antigen preservation (Robertson et al., 
1992). Despite this, results achieved using LTFS were disappointing, however, it was possible 
to detect several significant differences between tissues processed by using chemical fixatives 
or by LTFS. Using LTFS, the ultrastructural preservation was poor in the basal and lower 
intermediate cells, suggesting that during rapid freezing the full thickness of the tissue was not 
frozen rapidly. The cells of the basal layer were electron dense and shrunken in appearance, 
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with no organelles visible (Plate 13a-d). In comparison superficial and upper intermediate cells, 
which were in direct contact with the pre-cooled mirrored surface, were well preserved (Plate 
12a-c ). A larger sample number would allow variations in speed and force of slamming to be 
investigated. Increasing the speed of slamming may result in increased penetration of the 
freezing process and maintenance of ultrastructure to a greater depth in the tissue. Another 
factor which may influence the depth of freezing is the length of time which the specimen is 
left in contact with the pre-cooled surface, increasing this time from 30 to 60 seconds may 
benefit ultrastructural preservation. 
Glycogen was evident in large amounts in vulvar and vaginal epithelium, particularly in the 
surface cell layers (Plates 7 & 11 ). Other authors have reported similar amounts of glycogen in 
rabbit vaginal epithelium, oral epithelial surfaces (Squier, 1976; Landay and Schroeder, 1977), 
and in developing embryonic skin, where it is seen in large aggregates, rosettes, or as individual 
particles (Breathnach 1971 ). Unlike skin, which does not contain glycogen in its normal state, 
the mucous membranes of the oesophagus, oral cavities and vagina are rich in glycogen (Falin, 
1961 ). Deposition of glycogen in these tissues has been associated with regeneration and 
proliferation of epithelia (Vassiljeva, 1955, as cited by Falin, 1961 ); and in the vagina, glycogen 
released as surface cells degrade may help to maintain the acid pH. In this investigation surface 
cells of vaginal epithelium appeared swollen, with large aggregates of glycogen, in greater 
quantities than seen in vestibular epithelium. Not all of the vaginal samples investigated had 
this appearance, which suggests that the development of large, glycogen filled superficial cells 
is probably linked to hormonal status. 
Glycogen, usually found in large aggregates in superficial cells, was absent in vestibular 
samples processed using L TFS (Plates 12 & 13). In the place of extensive glycogen deposits, 
large empty areas were visible, possibly where glycogen had been removed during processing. 
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The use of methanol as a substitution medium may affect glycogen storage in superficial cells, 
possible leaching glycogen from these cells. These samples were not fixed with strong aldehyde 
fixatives, or secondary fixed in osmium tetroxide, which may result in the removal of glycogen 
deposits from superficial cells. Vesicles, seen in several of the vestibular samples were visible 
in superficial cells in all three of the samples processed by LTFS. This may be coincidence, 
however, chemical processing may affect the presence of these vesicles or alter their contents, 
resulting in electron-lucent vesicles in some samples, and the absence of vesicles in other 
samples. As in the chemically fixed tissue, vesicles were seen in close contact with the 
cytoplasmic membrane of the surface cells, often fusing with the membrane (Plate 12 b & c). 
One of the benefits of L TFS is that the antigenicity of the tissue is maintained during 
processing, and secondly, the true nature of these vesicles could be determined using immuno-
gold labelling techniques for MCG. (Bailly et al., 1992). 
Although little additional information was obtained using LTFS, the trial of this technique 
proved promising and may be important in the study of vestibular tissue from VVS patients, 
especially if labelling of specific antigens is required. Unfortunately, low sample numbers 
dictated that this method of processing was used on only three samples of normal vestibular 
tissue, and therefore the process was not well developed. Possible refinements of this technique 
for future studies of vestibular epithelium would include; increased sample numbers, variations 
in speed and force of slamming, and a reduction in the substitution time to prevent extraction 
of glycogen. 
The surface of both vestibular and vaginal epithelium is moist due to the presence of mucus 
from the cervix, and therefore considerable transepidermal water loss from these epithelia is 
reported when compared with skin (Lawrence, 1993). In comparison keratinised epithelia retain 
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water due to the presence of keratin which acts as an barrier to excessive water loss. The rate 
of cell removal must be matched by the mitotic activity of the basal cells. Factors affecting the 
rate of turnover of cells include adrenalin and other hormones, stress and inflammation. Buccal 
cells are usually renewed at a rate of between 5-16 days, much more rapidly than some types 
of skin which renew at rates of 12-75 days (Squier et al., 1976). Buccal mucosa is often slightly 
inflamed, the presence of a small inflammatory cell population being said to correlate with the 
mitotic rate and consequently the rate of cell renewal (Squier, 1976). Vestibular epithelium, 
which has a significant number of inflammatory cells present in its normal state and which has 
similarities in structure with oral epithelium, consequently, may have a similar rate of cell 
turnover, although there is no direct evidence to support this. 
Oral mucosa may fall into one of three categories, keratinized, para-keratinised and non-
keratinised. Keratinised areas have a distinct granular layer which is hard to recognise in para-
keratinised epithelia and completely absent in non-keratinised epithelia (Squier et al., 1976). 
It may be the case that a similar situation occurs in vestibular epithelium. Passing from the 
hymen towards Hart's Line, the degree of keratinisation gradually increases, accompanied by 
changes in tissue structure from sub-mucosal to true keratinised skin. This would agree with 
some researchers fmdings that the epithelial surface of the vulva is slightly keratinised and 
pigmented (Friedrich, 1985), contrary to the findings of this study which showed no evidence 
of keratinisation or pigmentation. Although cells of the upper intermediate layer do not have 
keratohyalin granules as in perineum and true skin, cells at a similar distance from the surface 
of the vulvar epithelium do have characteristic features which allow them to be distinguished 
from cells of the lower intermediate and supra basal layers. Differences include an 
accumulation of large amounts of glycogen, an increase in the size of individual cells which is 
not accompanied by an increase in organelle density, and scattered individual cytokeratin 
filaments not organised into large bundles. These features were also seen in vaginal epithelium, 
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and are consistent with reported changes seen in oral mucosa (Squier, 1976; Landay and 
Schroeder, 1977, 1979). 
Some darkened, possibly apoptotic cells, were present in vestibular and vaginal epithelium. 
Visible in all cell layers, these cells were seen infrequently in both vestibular and vaginal 
epithelia, in isolated cases. These epithelial cells had the appearance of apoptotic cells, being 
shrunken in appearance, often with vacuolated cytoplasm and condensed cytokeratin filaments. 
Organelles, when visible, did not appear damaged or swollen. These apoptotic-like cells were 
barely visible using light microscopy. However, cells which stained more intensely using 
methylene blue for light microscopy, correlated with the electron dense apoptotic-like cells 
obvious using electron microscopy. 
In summary, the presence, and incidence of apoptotic-like cells, although not a significant 
feature of the control tissue, proved to be extremely important in the ultrastructural study of 
pathological tissue from vestibulitis patients (see Chapter 5). The presence of apoptotic cells 
in vestibular epithelium has not previously been described. The use of L TFS proved to be a 
useful addition to the investigation, but needed refining to ensure good ultrastructural 
preservation. Vestibular epithelium was found to share many ultrastructural characteristics with 
vaginal epithelium, but several differences included flattened surface cells, more defined 
cytoplasmic processes and frequent inflammatory cells in vestibular epithelium. Vestibular 
samples processed using L TFS illustrated the presence of vesicles similar in appearance to 
MCG, which were not evident in perineal or vaginal epithelium. These structures may be 
investigated in future studies using immunocytochemistry (Bailly et al., 1992). Characteristics 
distinguishing vestibular epithelium from keratinised perineal epidermis included: the absence 
of keratohyalin granules and granular cells; the presence of pale staining cytokeratin filaments; 
large glycogen deposits in surface and intermediate cells; close cytoplasmic processes between 
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Fig.4.5 Schematic representation of perineal epidermis, illustrating the presence of 
granular cells (Gc), keratinised squames (Sq), and spiny cells (Sp). Granular 
cells have patch like keratohyalin granules (Kg} Spiny cells are characterised 
by intensely staining cytokeratin filaments (F) and numerous desmosomes (De). 
Note the undulant basement membrane (Bm), and leukocytes (Le) in the dermis. 
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Fig.4.6 Schematic representation of vestibular epithelium, illustrating the presence of 
pale staining cytokeratin filaments (F) in intermediate cells (le). Microvilli 
(Mv) are seen on non-keratinised superficial cells (Su). Glycogen (G) is seen 
in large aggregates in the intermediate and superficial cells. Desmosomes (De) 
are infrequent; and mitochondria (M) are common in basal (Be) and 
intermediate cells (le). The basement membrane (Bm) undulant, below which 
diffuse connective tissue and capillaries (Ca) are evident. 
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Plate la 
Plate I b 
Plate le 
Plate la 
LM photograph of vaginal epithelium stained with I% methylene blue, showing 
an epithelial surface of 15 -20 cells thick. Surface cells are flattened (Su), and 
have displaced nuclei. Intermediate cells form a large proportion of this 
epithelium (le) x 450 
LM photograph of surface cells of vaginal epithelium packed with glycogen (G). 
X 950 
LM photograph of vulvar epithelium stained with 1% methylene blue, 
demonstrating slightly thickened surface cells (Su). A largely homogeneous 
intermediate cell (le) population make up the majority of this epithelium. 
Leukocytes (Le) are seen penetrating this epithelial surface, and are visible in 
the dermis (Der). x 450 
LM photograph of perineal epidermis stained with I% methylene blue, 
illustrating keratinised surface cells (Sq), a thin granular cell layer (Gc), a 
prominent spiny cell layer (Sp) and basal cells. The basement membrane and 
connective tissue (Der) are also clearly visible. x 450 
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Plate 2a 
Plate 2b 
Plate 2c 
Scanning electron micrograph of perineal surface cells (Su). Cell junctions are 
prominent, thickened and raised. Surface cells (Su) are polygonal in shape. A 
pore is visible (P) which may be a mucus secreting gland or sebaceous gland 
opening. Bar =IOJ.lm 
Polygonal surface cells of perineal epidermis, characterised by a network of 
flattened microridges (Mr). The cell at the bottom of the micrograph has a 
slightly different surface appearance (*). This cell has prominently raised 
surface microridges. Bar= 10Jlm 
High power micrograph of surface ridges. In some areas the surface cells appear 
completely flat (Fl) and structure less. Some microridges are flattened and worn 
in appearance (Mr). Bar= SJ.lm 
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Plate 3a Scanning electron micrograph of normal vestibular epithelium. The surface cells 
in this micrograph appear undulant, with prominent cell junctions (Cj). 
Bar= 5J.Jm 
Plate 3b & c The surface microridges of vestibular epithelium are raised and rounded in 
appearance. Microridges (Mr) of varying lengths and dimensions form an 
interlacing network covering the surface of superficial cells. 
Plate 3d 
Plate 3e 
b) Bar= lJ.Jm 
c) Bar= 5J.Jm 
At high magnification the microridges (Mr) appeared nodular (No). Bar= 1 J..lm 
A flat area of epithelium, indicating the fine, slightly thickened cytoplasmic 
junction (Cj) and interlacing, raised microridges (Mr). The orientation of 
microridges varies on individual cells and between surface cells. Bar= SJ.Jm 
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Plate 4a 
Plate 4b 
Plate 4c 
Plate 4d 
Plate 4e 
Plate 4f 
Swface squame (Sq) of perineal epidermis; the paler squame is desquamating 
leaving the remains of cellular junctions (De) on the exposed surface of the 
underlying darker staining cell. Cytokeratin filaments (F) are still visible in 
these keratinised cells. x 8,500 
Desmosome junction (De) from an area similar to Plate 4 a, showing thickened 
cytoplasmic membranes, dark staining cytokeratin filaments (F) and the absence 
of cellular organelles in the surface cells. x 41,000 
Transition zone in perineal epidermis from granular cells (Gc) to surface 
squames (Sq) of the stratum corneum. Note the absence of organelles in both 
cell layers, and the presence of cytokeratin filaments (F) and globular and patch-
like keratohyalin granules (Kg) in the granular cells. x 5, 500 
Globular keratohyalin granules (Kg) in the transition zone from granular to 
corneal cells. x 17,000 
Low power micrograph of a flattened cell in the granular cell layer (Gc), which 
has retained its nucleus. Note the dark staining cytokeratin filaments (F) and 
patch-like keratohyalin granules (Kg). x 5,200 
High power of Plate 4e, illustrating intensely staining cytokeratin filaments (F), 
melanin granules (Me), keratohyalin granules (Kg), and desmosomes (De). 
X ]0,500 
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Plate Sa 
Plate 5b 
Spiny cells of perineal epidermis (Sp). Note the density of staining of the 
cytokeratin filaments (F) associated with desmosomes (De), and absence of 
these filaments in the perinuclear region. Desmosomes are numerous (De), 
studded at frequent intervals around the periphery of the spiny cells. Folding of 
the cytoplasmic membrane is negligible, mitochondria are common (M). 
X 5,000 
Basal cells of perineal epidermis (Be). Note the presence of: significant numbers 
of mitochondria (M) in the peri-nuclear region, particularly near the basement 
membrane (Bm) and cytoplasmic folds (Cf) at the lateral cell surfaces. x 9,000 
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Plate 7a 
Plate 7b 
Plate 7c 
Plate 7d 
Surface cells ofvulvar epithelium (Su). Note the partially thickened appearance 
of the membranes of one surface cell (Su), the presence of large deposits of 
glycogen (G), flattened nuclei (N), and a darkened, possibly apoptotic, cell (D). 
An area similar to * is shown in Plate 7c. x 9,500 
High power micrograph of a superficial epithelial cell. Vesicles (V e) are visible 
in close contact with the cytoplasmic membranes of the surface cells. Vesicles 
are commonly electron lucent, occasionally having electron dense cores. Note 
also the presence of glycogen aggregates (G). x 25,000 
Desmosome junctions (De) from a region similar to that in Plate 7a.(asterisk). 
Note the slightly thickened cytoplasmic membranes, pale staining cytokeratin 
filaments (F), thickened plaques at desmosomaljunctions (De), but particularly 
the numerous cytoplasmic folds (Cf). x 43,000 
A superficial cell ofvulvar epithelium, the nucleus of the cell has ben retained 
(Nu). Note the presence of pale-staining cytokeratin filaments (F), mitochondria 
(M), small electron lucent vesicles (Ye) and microvillous ridges (Mv). The 
remains of a desmosomal junction (De) is visible on the surface of this 
flattened cell. x 3 7,500 
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Plate 8a 
Plate 8b 
Upper intennediate cells (le) of vulvar epithelium. Note particularly: the 
presence of large deposits of glycogen (G) in the perinuclear region, fonning a 
pale halo around the nucleus in some cases; the density of cytokeratin filaments 
(F) at desmosomal junctions (De); and the presence of numerous interdigitating 
cytoplasmic folds (Cf). x 5,300 
Intennediate cells layer (Ic) of vulvar epithelium. Two leukocytes (Le) of 
unknown origin are visible between cells of the upper intennediate cell layer 
(le). The nucleus of the larger leukocyte is lobed, and the cytoplasm is rich in 
organelles. x 8,000 
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Plate 9 Low magnification electron micrograph of the vulva, illustrating the presence 
of: lymphocytes (L); an dark staining, apoptotic-like cell (D); and intermediate 
cells (le) with many mitochondria (M) and endoplasmic reticulum (Er). Note 
also, the basement membrane (Bm) in bottom right corner of the micrograph, 
cytoplasmic folds interdigitating between epidermal cells and infrequent 
desmosomal junctions (De). x 6,300 
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Plate I Oa 
Plate !Ob 
Lower intermediate cells (le) with abundant folding of the cytoplasmic 
membrane (Cf) and numerous mitochondria (M). Desmosomes (De) are not 
common in this cell layer. 
X 8, 800 
Basal cells (Be) of vulvar epithelium. Cytokeratin filan1ents are pale-staining, 
forming small bundles (F). Desmosomal junctions (De) are sparse, and 
cytoplasmic folds are numerous between basal cells. Hemi-desmosomes (H) are 
visible at the basement membrane. A centriole (Ce) can be seen in one of the 
basal cells. x 8,600 
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Plate !la 
Plate 11 b 
Plate lie 
Surface cells of vaginal epithelium. Surface microvilli are masked by the 
presence of electron dense mucus (Mu). Surface cells have large deposits of 
glycogen (G) and flattened nuclei (Nu). There are few organelles in this cell 
layer. x 6,300 
Upper intermediate cells of vaginal epithelium. Cells appear swollen with large 
amounts of glycogen (G) present in a halo around the nucleus. Cytoplasmic 
folds (Cf) are common, and desmosomes are short (De). x 5,700 
A lower intermediate cell, with glycogen deposits (G), close cytoplasmic folds 
(Cf), and few organelles. Note the leukocyte in the top right of the micrograph 
(Le). x 9,000 
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Plate 12a 
Plate 12b 
Plate 12c 
Vulvar epitheliwn processed by LTFS. Illustrating an upper intermediate cell 
(le), with large voids where glycogen has been removed (*). The nuclear 
membrane and cytoplasmic membrane are intact, however, mitochondria appear 
to be damaged (M). Membrane coating granules are visible (Mcg). x 7,800 
Surface cells of vestibular epitheliwn processed by LTFS. Microvillous 
processes are visible (Mv), as are electron lucent vesicles (Ye). Mitochondria 
appear to have lost their internal membrane structure (M). x 26,000 
A high power micrograph of the surface cell shown in Plate 12b. Cytokeratin 
filaments (F) are clearly visible, the cytoplasmic membrane appears slightly 
thickened. Electron dense, membrane coating granules appear to have an 
internal lamellae structure (Mcg). Vesicles are electron lucent, with no internal 
structure (V e). x 52,000 
183 

Plate 13 
Plate 13b 
Plate 13c 
Plate 13d 
Lower intermediate cells (le) from vestibular epithelium processed using L TFS. 
Cytokeratin filaments are visible arranged in small bundles (F). Desmosomal 
junctions are infrequent (De). There are no intact organelles in these cells. 
X 6,500 
Illustrating a leukocyte (Le) interposed between intermediate cells (le). 
Mitochondria are not present in this plane of section, however this leukocyte is 
characterised by electron dense granules and small vesicles. x 9,750 
Basal cells (Be) appear extremely shrunken with few organelles; mitochondria 
have no internal structure (M), however the nuclear membrane is still visible. 
The basement membrane appears intact (Bm). x 7,800 
High power micrograph of the dermo-epidermal junction. The basement 
membrane does not appear damaged, hemi-desmosomes are distinct (He). 
Cytokeratin filaments (F) and small vesicles (Ve) are evident in these cells. 
Collagen (C) in the dermis shows characteristic banding. x 26,000 
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CHAPTER FIVE 
The ultrastructural characteristics of vulva! periductal 
epithelium from patients with Vulvar Vestibulitis 
Syndrome 
5.0 Abstract 
The term vulvar vestibulitis syndrome (VYS) was introduced by Friedrich (1987), to describe a 
constellation of symptoms which result in idiopathic vulvar pain. Using transmission electron 
microscopy, it was concluded that the normal vestibular epithelium was ultrastructurally similar to 
mucosal-like surfaces (see Chapter 4). Examination ofvulvar, periductal epithelia from VVS patients 
using TEM, revealed several distinct differences not previously described, and which were not obvious 
using light microscopy. Intensely staining cell profiles were seen in foci, particularly along the basement 
membrane. Shrunken in appearance, with vacuolated C)1oplasm, intact organelles and condensed 
cytokeratin filaments, these cells appeared similar to cells undergoing apoptosis. Leukocy1es were 
commonly interposed between epidermal cells, particularly in contact with foci of intensely staining 
epidermal cells. Membrane bound lobules of cytoplasm, associated with the apoptotic-like cells, were 
numerous. These cytoplasmic bodies may be processes of Langerhans cells, or byproducts of the process 
of apoptosis. Vesicles, not commonly seen in control tissue were frequently visible in close contact with 
the cytoplasmic membrane of superficial cells. Using SEM, the epithelium from YVS patients showed 
a modification of the normal microridge structure. Microridges appeared shrunken and flattened in 
appearance, and pore like structures were visible. These structures varied in dimensions, distribution and 
frequency and were often localised in groups of three or four. These pore-like structures may be the 
openings of minor vestibular glands, or mucous secreting glands, the characteristics of which have not 
previously been described using SEM. The visualisation of apoptotic cells may be important in future 
studies ofWS, as the presence of these cells may affect the onset, or be a result of the syndrome. The 
presence of an inflammatory cell infiltrate in WS samples, in conjunction with apoptotic-like cells may 
suggest a cell signalling defect which is resulting in epidermal cell death. 
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5.1 Introduction 
As outlined in the general discussion, vulvar pain has been documented for over a century, and 
was first described by Skene in 1889, described a 'hyperaesthesia' of the vulva. At the 1983 
meeting of the International Society for The Study ofVulvar Disease the term 'vulvodynia' was 
introduced, and defined as chronic vulvar discomfort. Thorough diagnosis has indicated that 
there are several subsets ofvulvodynia, one of which is vulvar vestibulitis syndrome. The term 
Vulvar Vestibulitis Syndrome (VVS) was introduced by Friedrich in 1987, to expand the 
terminology associated with vulvar disease, and to replace inaccurate and ambiguous terms 
previously used to describe this constellation of symptoms. 
According to Friedrich (1983), and Woodruff & Friedrich (1985), the vestibule is that area of 
the vulva which extends laterally from the hymenal ring to a line of more keratinised skin on 
the labia minora, termed Harts' line (Hart, 1893). Anteriorly the vestibule reaches upwards to 
the frenulum of the clitoris and posteriorly downwards to the fourchette. The vestibule is 
endodermal in origin, as is the urethra and the trigone of the bladder; the remainder of the 
external female genitalia are ectodermal (Woodruff & Friedrich, 1985). The epithelial surface 
of the vestibule has not been studied in detail, but has often been described as a mucosal-like 
surface with similarities to both skin and true mucosal surfaces. It can be surmised that the 
epithelium of the vestibule has all of the sensitivity of a mucosal surface with little of the 
resistance offered by keratinised skin. There are no mucous secreting glands in the vulva as in 
other mucosal surfaces, however, the surface of the vestibule is bathed in mucus from the 
cervix, and the vestibular glands are reported to provide some lubrication of the vestibular 
surface (see Chapter 2). The glands present in the vulva, which open onto the surface of the 
vestibule, appear to be the sites of inflammation in this syndrome. There are two main types of 
glands in the vestibule; the major vestibular glands (Bartholins' and Skenes' glands); and the 
minor vestibular glands, which may be found all over the vestibular surface and which vary 
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considerably in number (Robboy et al., 1978). 
It has been proposed by many workers, that the aetiology ofVulvar Vestibulitis Syndrome is 
multifactorial, however, an association with a particular aetiological agent is yet to be 
conclusively proven. Human papilloma virus (HPV) and recurrent Candida infections have been 
shown to be important in some cases, as have therapeutic and destructive chemical agents, 
allergic reactions to cosmetic products, and psychosexual factors (Koblenzer, 1983; Lynch, 
1986; Mann et al., 1992; Schover et al., 1992; Abramov et al., 1994; Kehoe & Luesley, 1995; 
Marks et al., 1995). Other authors have suggested that VVS is a 'urogenital sinus-derived 
epithelium disorder' (Fitzpatrick et al., 1993), or that is has developed as a consequence of 
interstitial cystitis (Foster et al., 1993). A considerable amount of research has concentrated 
on the incidence of HPV associated VVS. The association of HPV with VVS has been 
supported by both histological and virological data (Horowitz, 1989; Pyka et al., 1988; Turner 
& Marinoff, 1988; Kent & Wisniewski, 1990; Bergeron et al., 1994 ). However, the diagnostic 
criteria used for HPV detection in these studies have been proved umeliable. A majority of 
studies, particularly those completed prior to 1990, relied on a histological diagnosis for the 
detection ofHPV in tissue biopsies. Typically the biopsy area is selected by the application of 
acetic acid. Areas of thickened epithelia become whitened on application of dilute acetic acid, 
indicative ofHPV infection. However, aceta-whitening is not indicative of just HPV infection, 
but any condition which causes thickening of the epidermis. Histological examination of 
vestibular biopsies for the detection of HPV is also fraught with difficulties. Koilocytic cells, 
characterised as having pyknotic and displaced nuclei are notoriously difficult to distinguish 
from normal epithelial cells (Bergeron et al., 1994). This is supported by the findings of several 
VVS studies which have detected koilocytic cells in 16-71% ofVVS samples (Pyka et al., 
1988; Horowitz, 1989; Umpierre et al., 1991; Wilkinson et al., 1993). Cells infected with HPV 
have a similar appearance to normal superficial cells in the vulva. Normal cells commonly have 
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displaced nuclei as a consequence of large glycogen deposits situated in a halo around the 
nucleus (see Chapter 4.). Frequent reports ofkoilocytosis associated with VVS have led to more 
detailed investigations using PCR, Southern blotting and in situ hybridization to determine the 
true incidence ofHPV in cases ofvestibulitis. Two recent studies using PCR gave contradictory 
results, the study by Umpierre et al. ( 1991) indicating an 85% incidence of HPV in VVS cases, 
where as Wilkinson et al. ( 1993) found the incidence in their investigation to be only 10% (see 
Chapter 2). 
The pathology of VVS is non-conclusive. There is almost always a mild to moderate 
inflammatory cell infiltrate present, particularly beneath the basement membrane (Pyka, et al., 
1988; Michelwitz et al., 1989 Furlonge et al., 1991; Marinoff & Turner, 1991; Bergeron et al., 
1994; Wilkinson et al., 1993 and Prayson et al., 1995). However, on characterisation of the 
cells present, the pattern of distribution is not indicative of a particular type of immunological 
reaction (Pyka et al., 1988). Although a reasonable amount of research has been completed 
using light microscopy, investigations of this type have failed to make any progress in the 
understanding of the pathology ofVVS. The most comprehensive study was completed by Pyka 
et al. (1988); however, since this significant paper very little work has added to the literature 
on the pathology ofVVS (see Chapter 2). The lack of knowledge of the inflammatory process 
and etiological agents, has resulted in a 'hit or miss' approach to treatment. In early papers on 
VVS researchers investigated the effects of many different topical and systemic drugs for the 
treatment of VVS with very limited success (Friedrich, 1987). The use of interferon, and the 
development of surgery to remove the affected area of the vestibule, has proved more successful 
than the use of topical treatments (Woodruff & Parmley, 1983; Peckham et al., 1986; Hatch, 
1988; Horowitz, 1989; Umpierre et al., 1991; Waltzman & Wade, 1991; Mann et al., 1992; 
Bornstein et al., 1993; Larsen et al., 1993; Marinoff & Turner, 1993). Unfortunately, both of 
these pathways are expensive, require specialised techniques, and are only completely 
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successful on a carefully selected subgroup of patients. Both interferon injections and surgical 
removal of the vestibule are particularly invasive treatments for VVS, and do not have a 100% 
success rate. Non-invasive treatment of VVS is essential; however in order to establish an 
appropriate treatment, the pathology of the condition must be understood. 
Initially, it was hoped that suitable patient numbers would allow the use of low temperature 
processing for transmission electron microscopy. This technique would maintain the 
antigenicity of the tissues, enabling immunocytochemical detection of antigens possibly linked 
to VVS. However, during the early stages of the investigation it became apparent that sample 
numbers would not enable this type of study. Obtaining biopsies from other hospitals was 
pursued, however, it was not always possible to gain ethical committee approval in time to 
complete the investigation. The aim of this investigation was primarily to describe the surface 
ultrastructure of the normal vestibular epithelium in comparison with related epithelia using 
TEM and SEM (see Chapter 4). Secondly, with some understanding of the ultrastructure of this 
unique epithelial surface, an analysis of possible differences between control and VVS affected 
vestibular tissue would be completed. Bacteria and, or fungal spores on the surface of the 
epithelia would also be investigated. It was anticipated that some advance would be made in 
the understanding of the inflammatory response occurring in this syndrome, with the long term 
aim of encouraging non-invasive treatment regimes. 
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5.2 Materials and Methods 
5.21 Light microscopy 
Samples of vestibular epitheliwn were obtained from Birminghams' Dudley Road Hospital. 
Samples were removed from patients with VVS as routine during vestibulectomy. This 
operation, carried out under general anaesthetic, involves removing the part of the vestibule 
affected by VVS. Samples were fixed in I 0% formal saline, dehydrated in a graded series of 
ethanol and embedded in paraffin wax. Section of 4!-lm, were cut and collected on glass slides. 
Sections were stained using Mallorys trichrome. 
5.22 Scanning electron microscopy 
Blocks retained for SEM were fixed in the primary fixative for 2 hours, subsequently washed 
in sodiwn cacodylate buffer (0.1 M, pH 7 .2), and post fixed in I% osmiwn tetroxide for 1 hour. 
After washing in buffer, tissue blocks were dehydrated in a series of graded ethanol, (30%, 
SO%, 70%, 90%, absolute ethanol), and propylene oxide, for I 0 minutes in each mixture, and 
subsequently critical point dried for SEM. The intermediate fluid was amyl acetate and the 
transitional fluid liquid carbon dioxide. Dry samples were mounted on brass stubs and gold 
coated in a Polaron El 500 sputter coating unit and examined in a Jeol JSM 5300 scanning 
electron microscope operated at I SkV. 
5.23 Transmission electron microscopy 
Patients attending the GU Medicine clinics at Freedom Fields Hospital (Plymouth Health Trust) 
and Addenbrookes Hospital (Cambridge) were assessed for the presence of VVS using the 
criteria established by Friedrich (1987) (see Chapter 2). Patients diagnosed as having VVS, 
were asked to participate in the study. Patients were informed that they could withdraw from 
the study at any time, and that their treatment would not be affected in any way. Ethical 
committee approval was obtained for the study from Plymouth Regional Health Authority 
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Ethical Committee, in February 1994 (see Appendix 1 ). Samples from Addenbrookes GUM 
were part of biopsies taken for routine histological investigation. Informed consent was 
obtained from each patient in writing prior to a biopsy being taken. Twenty patients in total 
were diagnosed as having VVS, of which all consented to participate in the investigation. 
Biopsies of vestibular epithelium were taken under local anaesthetic. The right Skenes' gland 
was examined colposcopically and the periductal tissue infiltrated with Citanest (4% Prilocaine 
HCI). A 3mm Keyes punch biopsy sample was removed from the lateral border of the right 
Skenes' gland (Fig. 4.0, Chapter 4) and transferred immediately to a vial containing the primary 
fixative, 4% glutaraldehyde in O.lM sodium cacodylate buffer (pH 7.2) at 4°C. Bleeding was 
controlled with silver nitrate, and the lesion was then treated with an antibiotic powder. After 
30 minutes the biopsies were subdivided into tissue blocks of !mm x lmm whilst immersed 
in primary fixative. The tissue blocks were returned to fresh primary fixative for a further 90 
minutes. Blocks were subsequently washed twice in 0.1 M sodium cacodylate buffer (pH 7 .2), 
I 0 minutes each wash, and post fixed in 1% osmium tetroxide for 60 minutes ( 4°C). At this 
point several tissue blocks were retained in buffer for scanning electron microscopy. Tissue 
blocks for TEM were stained en bloc with 2% uranyl acetate in the dark, for 30 minutes, 
washed twice with distilled water, and subsequently dehydrated in a series of graded ethanol, 
(30%, 50%, 70%, 90%, absolute ethanol), and propylene oxide for 10 minutes in each mixture. 
Infiltration of resin was carried out over several days. A series of graded mixtures of propylene 
oxide and Spurr resin (Spurr, 1969) was used (3: I, I: 1, I :3, Pure x 2). Blocks were polymerised 
at 70°C for 8 hours. Ultrathin sections (0.1Jlm), cut on a Reichert ultracut ultramicrotome, were 
collected on copper grids, stained for 10 minutes and 20 minutes with uranyl acetate and lead 
citrate respectively, and subsequently viewed using a Jeol 1200 transmission electron 
microscope. Semi-thin sections, ofO.Sflm, were cut and stained with 1% methylene blue. 
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5.3 Results 
5.31 General structure of vestibular epithelium from VVS patients 
Using light microscopy, the general appearance of vestibular epithelium, from patients with 
VVS was found to be comparable to the control tissue. However, in periductal epithelia from 
VVS patients, a mild to moderate inflammatory cell infiltrate was seen in the dermis, some cells 
penetrating the upper layers of the epithelia. The predominant intrinsic cell type was the 
lymphocyte, however, there were numerous plasma cells visible beneath the basement 
membrane. Intensely stained foci of cells, just visible using light microscopy, were seen 
distributed throughout the epithelia. Clustered particularly along the basement membrane, these 
cells stained moderately with methylene blue, having a similar staining appearance to 
leukocytes (Plate 14a). Staining with Mallorys did not demonstrate these dark staining cells, 
however, using this stain, the epithelium of the vestibule was shown to vary considerable in 
terms of keratinisation. Within vestibular samples from VVS patients obtained from 
vestibulectomy operations, areas of keratinised and partially keratinised epithelia were found, 
as well as non-keratinised vestibular epithelium (Plate IS & 16). Wax sections of vestibular 
epithelium also demonstrated structures which were similar in appearance to goblet cells (Plate 
16). These structures were not seen in any of the vestibular samples processed for TEM. 
5. 32 Scanning electron microscopy of vestibular epithelia from VVS patients 
At low magnification cells appeared polygonal in shape, I 0-30~-tm in diameter. Microridges 
appeared shrunken in VVS samples. However, individual cells and the epithelium as a whole 
did not appear to be shrunken. Microridges were thin, and did not appear to be interlacing. 
Often straight ridges were evident (Plate 17). No bacteria or fungi were evident on this 
epithelial surface. Pores appeared to be common in samples from VVS patients (Plate 17). 
Frequently seen in small groups between the surface epidermal cells, pores were of varying size 
and shape and were often masked by the surface topography. 
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5.33 TEM of vestibular epithelia from VVS patients 
Schematic representations of the differences between control and VVS affected vestibular tissue 
are shown in Fig. 4.6 (Chapter 4) & Fig.S.I. Examination using TEM revealed several distinct 
differences between control and VYS affected periductal epithelia. The intensely staining cells 
just visible using light microscopy, were found to correspond with epidermal cells which 
appeared electron dense when examined using electron microscopy (Plates 19, 20a & b, 23a & 
b). These cells were characterised by having shrunken vacuolated cytoplasm, and cytokeratin 
filaments condensed into bundles; organelles when present, did not appear particularly 
damaged. Some mitochondria appeared to have lost their cristae. Electron dense cells were 
numerous, and frequently observed in small foci of 3-4 cells throughout the epithelium, and 
were also evident along the basement membrane (Plates 19, 20a & b).These cells were visible 
at various stages of deterioration, which was indicated by an increase in electron density, 
condensation of cytokeratin filaments, and shrinkage and vacuolisation of the cytoplasm (Plate 
20a & b). The nucleus of these dark cells was often shrunken in appearance and intensely 
staining. Occasionally the nucleus appeared to be arc shaped, the euchromatin remained in 
clumps around the edge of the nucleus (Plate 20c & d). The nuclear membrane remained intact. 
No swelling of cells or organelles was visible (Plate 19). Desmosomal junctions between 
intensely staining cells and normal epidermal cells were maintained, but appeared to be reduced 
in number (Plate 20a & b). Interdigitating cytoplasmic processes were seen less frequently 
surrounding the electron dense cells in VVS samples (Plates 19, 20a & b). 
Electron dense cells were seen associated with leukocytes, the majority of which were 
lymphocytes (Plate 19a). Lymphocyte profiles were generally small with sparse cytoplasm and 
few organelles, and were interposed between epidermal cells of all layers. Also present, close 
to intensely staining cells, were leukocytes with lobed nuclei, which were possibly 
macrophages, neutrophils or NK cells (Plate 21a-c). Some leukocytes contained dark staining, 
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spherical granules which were membrane-bound (Plate 21 a); others were characterised by the 
presence of numerous vesicles and organelles (Plate 21 c). Leuk.ocytes appeared to be activated, 
the cytoplasmic membranes were folded to form projections which were seen to make close 
contact with the cytoplasmic membrane of dark staining cells. Beneath the basement membrane 
(BM), a moderate inflammatory cell infiltrate was repeatedly observed (Plate 22a-c). One VVS 
biopsy did not have a significant inflammatory cell infiltrate, and had a similar appearance to 
control samples. Plasma cells, at various stages of development were frequently seen below 
the BM, although numerous lymphocytes and an occasional mast cell were also present (Plate 
22b & c).Capillaries appeared numerous below the BM in a majority of the VVS samples. 
Frequently the capillary wall was seen in close contact with the BM, leukocytes which were 
often packed into the capillaries were seen penetrating the dermo-epidermal junction, squeezing 
between the basal cells. The basement membrane (BM) was not seen to be disrupted by the 
passage of lymphocytes, also there was no splitting of the basal laminae suggestive of other 
disease processes such as blistering. The basal cells appeared to have been displaced to allow 
leukocytes to pass through the basement membrane (Plate 19, 23a). It was not evident whether 
the integrity of the BM was affected in the long term by the passage of leukocytes. 
Lobules of cytoplasm with no apparent origin were numerous in VVS samples, and were 
commonly seen in association with intensely staining cells (Plates 19, 20b & c, 23a & b). 
Round or oval in section, lobules of cytoplasm were pale staining, of varying size, with a well 
defined cytoplasmic membrane (Plate 24a-c).lntensely staining epidermal cells were frequently 
seen associated with several cytoplasmic lobules (Plate 19 & Plate 21 ). Frequently contained 
within these lobules were vesicles, polyribosomes, mitochondria and fine cytoplasmic filaments 
(Plate 24 a-c). There were neither characteristic granules nor nuclei evident in these lobules on 
serial sectioning. Occasionally an electron dense body, similar in appearance to a nucleus, was 
visible, but without a surrounding nuclear membrane (Plate 20c & d). Cellular junctions and 
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cytoplasmic projections were not evident. Frequently, the cytoplasmic membranes surrounding 
the Iobules were seen in close contact with intensely staining cells and leukocytes (Plates 21 
& 23). Frequently epidermal cells contained membrane bound lobules of cytoplasm (Plate 25), 
thus, cytoplasmic lobules appeared to be phagocytosed by epidermal cells. 
Using TEM, the nuclei of superficial cells were frequently displaced giving the appearance of 
koilocytosis (Plate 26a). There was no evidence of viral infection in koilocyte-like cells. No 
bacteria or fungi were found attached to the surface cells. Surface cells were characterised by 
the presence of numerous microvillus projections of varying dimensions, but were generally 
0.2-0.3~m in height, spaced at intervals of approximately 0.1-0.15 ~m (Plate 26b). The plasma 
membrane of the surface cells was partially thickened, but not to such an extent as in 
keratinised cells. Intensely staining cells were uncommon in this cell layer; if present these 
electron dense cells were isolated. Leukocytes, particularly lymphocytes, were occasionally seen 
in this cell layer. As in the control material, the superficial cells of this epithelium are 
characterised by the presence of large deposits of glycogen, often seen in a halo around the 
nucleus, or replacing the nucleus (Plate 26c). Vesicles were in close contact with the 
cytoplasmic membrane of superficial cells. Some of the vesicles were characterised by electron-
dense cores, however, the vesicles were usually electron-lucent. Frequently vesicles were seen 
fusing with the cytoplasmic membrane. Vesicles of this type were found in a majority of the 
VVS samples (Plate 26c & d). 
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5.4 Discussion 
The study of normal periductal tissue from women without vulvar pain was considered essential 
to the study of pathological tissue from women with VVS. As no work had been completed on 
the EM of the vulva, a base line of the tissue structure was required, and therefore, this 
constituted the first stage of the investigation. The general structure of normal epithelium, from 
the vestibule of the vulva, has been sho\\'Il to resemble mucosal surfaces rather than keratinised 
epidermis (Sargeant et al., 1996). Using light microscopy, differentiation of the epithelium 
into distinct cell layers was difficult. However, moving upwards, towards the surface, variations 
in morphology were visible. Epithelial cells increased in volume, became slightly flattened, and 
were less intensely staining. Surface cells were pale staining in comparison with basal cells, and 
in many cases had retained their nuclei. Leukocytes, visible as intensely staining cell profiles 
were visible in all cell layers, but were seen commonly along the dermal I epidermal junction 
(see Chapter 4.) Wax sections stained with Mallorys, illustrated that part of the vestibule which 
is removed during a vestibulectomy operation as treatment of VVS, contains areas of 
epithelium which are keratinised, or partially keratinised (Plate 15 & 16). However, samples 
obtained from VVS patients in Plymouth, which were removed from the lateral border of the 
right Skenes' gland, did not show any keratinisation of the surface cells. 
Ultrastructurally, vestibular epithelia from control patients showed no conclusive evidence of 
keratinisation, although some thickening of the superficial cell walls was observed. The 
characteristic keratinised squames, and granular cells found in skin were absent. This was 
expected, as past reports on the anatomy and histology of the vulva have suggested that a 
portion of the vulva may be non-keratinised (Woodruff & Friedrich, 1985). The prominent cell 
type was the glycogenated intermediate cell, which formed a large, structurally homogenous 
population of cells. These cells lacked the characteristic spiny appearance of cells in keratinised 
epithelia; cytokeratin filaments were pale staining and loosely organised into bundles, and 
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occasionally filaments were seen to converge at electron dense plaques. Other cell types present 
were: superficial flattened cells, many having large glycogen deposits, nuclei and traces of 
organelles; supra basal cells; and basal cells both of which exhibited numerous mitochondria 
and rough endoplasmic reticulum. Some leukocytes were seen beneath the basement membrane 
and interposed between epidermal cells of the epidermis, however, these were relatively few 
in number. The predominant inflammatory cell was the lymphocyte with the occasional 
macrophage and plasma cell visible in the dermis (see Chapter 4). 
The choice of electron microscopy for the study ofVVS, has resulted in a detailed evaluation 
of the ultrastructural characteristics of the syndrome, contributing information not previously 
available using light microscopy. Scanning electron microscopy was an important addition to 
the investigation of normal, and pathological vestibular tissue. Normal vestibular tissue was 
found to be characterised by a pavement like surface of polygonal epithelial cells, with a 
complex network of microridges. Cell boundaries were prominent and raised, and microridges 
were rounded in appearance (see Chapter 4). These cells were similar in appearance when 
compared to surface cells of the vagina, cervix and bladder (Hackeman et al., 1968; Odor et al., 
1989). 
In addition to well defined microvilli, exfoliated cells of the cervix show cell boundaries, which 
have been described as 'crests' and also as 'furrows I grooves'(Ludwig & Metzger, 1976 as 
cited by Davina et al., 1981 ). Furrows and grooves were seen on the surface of both control and 
VVS affected epithelia, where cell junctions from overlying cells had caused slight 
indentations. Davina et al. ( 1981) described changes in orientation of microridges into circles 
during pregnancy. In post-menopausal women the pattern of ridges changes again, the number 
decreases and the structures become less prominent, the cell borders are reported to become 
coarse instead of fine (Ludwig & Metzger, 1976 as cited by Davina et al., 1981). This is 
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consistent with VVS samples, which when compared with nonnal (control) vestibular samples, 
appeared to be less densely populated with microridges, which are seen to be disorganised in 
overall structure, and shrunken in appearance. However, in the present study no change in 
appearance of the cell boundaries was observed. Davina et al. ( 1981) summarised past protocols 
for the processing of ecto-cervical cells for SEM, and concluded that these cells are particularly 
robust, and no alterations in surface characteristics were observed when processed by different 
methods. The lack of ultrastructural change using various methods was reported, to be due in 
part, to the partially keratinised state of the surface cells which are stable during processing. 
TEM ofboth vaginal and vestibular epithelium did not reveal keratinisation of the surface cells 
or the presence of an involucrin envelope. However, surface cells of vestibular and vaginal 
epithelium did show some thickening of the cytoplasmic membrane. 
Using SEM, pores were visible distributed over the surface of perineal, vaginal and vestibular 
epithelia. These structures were more commonly seen in vestibular tissue and particularly in 
tissue samples from women with VVS. Samples from VVS patients were removed using a 
colposcope to ensure that the biopsy was taken from beside the Skenes' gland. It has been 
reported that in this area there may be numerous minor vestibular glands (Woodruff & 
Friedrich, 1985). In 1978, Rob boy et al. described the origin and structure of these glands using 
light microscopy, and commented on their incidence at autopsy. It is possible that the pores 
visible in the vestibular samples are in fact minor vestibular glands, which have a similar 
appearance to mucus secreting glands and goblet cells evident in other epithelia. This would 
account for the increase in the incidence of these structures in VVS samples, as it is unlikely 
that an increase in these ducts I glandular structures would result in, or be a result ofVVS. 
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Transmission electron microscopy (TEM), has indicated several factors of interest which may 
be important in future studies of VVS. These observations centre around the presence of 
intensely staining cells present in the epidermal cell layers of vestibular epitheliwn: 
• Electron dense, shrunken cell profiles. 
• Lobules of cytoplasm with no detectable origin. 
• An inflammatory cell infiltrate below the basement membrane and visible in epidermal 
cell layers. 
Intensely staining cells, which were not evident in large nwnbers in the control samples, have 
not previously been described in association with VVS using light microscopy. The fact that 
these cells have remained undetected is not surprising as they are often indistinguishable from 
other epidermal cells when examined using light microscopy. The use of methylene blue 
staining has resulted in the visualisation of these unusual cells at the light microscopy level. 
However, these cells would probably not have been detected unless ultrastructural examination 
of vestibular tissue had indicated their abundance in VVS samples. In some VVS samples 
approximately l 0-20% of the basal and intermediate cell population appeared to be intensely 
staining and shrunken in appearance. Using light microscopy, these intensely staining cells have 
a similar staining intensity when compared with the nuclei of lymphocytes and normal basal 
cells, and are, therefore, hard to detect. Consequently, these cells appear more prominent in the 
supra-basal and superficial cell layers when using light microscopy. Ultrastructural 
investigation of normal vestibular tissue identified some similar intensely staining cells, but 
these cells were isolated, rarely occurring in groups. 
When examined using TEM, several distinct changes were noted when comparing normal and 
intensely staining epidermal cells. As reported, the cytoplasm of these conspicuous cells 
appeared electron dense, possibly due to the condensation and clwnping of cytokeratin 
filaments. In comparison, cytokeratin filaments in control samples and in normal areas of the 
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VVS samples, were pale staining, and not arranged in clearly defined bundles (see Chapter 4). 
In intensely staining cells, organelles were intact with little evidence of shrinkage, whereas the 
cell as a whole appears shrunken and the cytoplasm vacuolated. The nuclear membrane 
appeared undamaged. When grouped in clusters, these cells appear to be at various stages of 
change, denoted by the degree of condensation of cytokeratin filaments and vacuolation of the 
cytoplasm (Plate 19). The appearance of these cells initially suggested that the fixation schedule 
was not suitable for this tissue, however, when ultrastructural detail was compared with control 
samples fixed using the same method, the incidence of intensely staining cells was obviously 
greater. When the fixation protocol was varied there was no change in the appearance, 
distribution, or frequency of the intensely staining cells in VVS biopsies. The variation in 
electron density of these epidermal cells may be due to a natural phenomenon, such as 
metabolic differences between cells, however, it is suspected that these cells may be undergoing 
a form of cell death due to necrosis, apoptosis or a related process. 
Necrosis, which is characterised by cell swelling and inflammation had for a long time been 
considered to be the only means of cell death. Necrotic cells are normally pale in appearance 
with disintegrating cytoplasm. (Kerr et al., 1972; Wyllie, 1980; Wyllie et al., 1984). Previous 
observations which did not fit the pattern of necrosis have been disregarded as anomalous. 
However, reported anomalies of necrosis are now believed to be due to apoptosis, a process 
which has been, and often still is, masked by the process of necrosis. In the last 20 years, a 
considerable amount has been learnt about this alternative form of cell death. The term 
apoptosis, proposed by Kerr, Wyllie and Curie in 1972, describes a process which results in cell 
deletion by shrinkage of the cell, fragmentation of the cellular DNA, and the formation of 
apoptotic bodies. Kerr et al. (1972), suggested a two-stage process involving the formation of 
apoptotic bodies and subsequently the phagocytosis and degradation of these bodies by other 
cells. Due to the continued confusion of the two processes a majority of reviews have focus sed 
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on the similarities and differences of the two processes (Searle et al., 1982; Bursch et al., 1992; 
Gerschenson & Rotello, 1992; Buja et al., 1993; Cohen, 1993a & b; Collins & Rivas, 1993; 
Budtz, 1994). Necrosis is determined by environmental, often traumatic factors, and not by 
factors intrinsic to the cell itself as in apoptosis. In addition, necrosis is not involved in 
developmental processes, and does not require the expression of new mRN A or proteins, both 
of which are characteristic of apoptosis (Arends & Wyllie, 1991; Buja et al., 1993; Cohen, 
1993a & b; Schwartz & Osboume, 1993; Martin et al., 1994 ). Apoptosis in skin has been 
reported on several occasions, however, its role and regulation are still obscure. Links with 
terminal differentiation have confused the issue of apoptosis in skin (Hashimoto, 1976; Lovas, 
1986; Arends & Wyllie, 1991; Haake & Polakowska, 1993; Budtz, 1994). Experiments with 
granular cells showed endonuclease activity and DNA fragmentation, suggesting that apoptosis 
may occur in line with terminal differentiation of keratinocytes (Rosenbach et al., 1993). In 
addition, Dispasquale & Youle ( 1992), have reported the transfer of apoptosis between the 
nuclei of heterokaryons. Terms such as dyskeratosis or colloid bodies, which are frequent 
observations in skin pathology, are often used to describe shrinkage of cells similar to that 
occurring during apoptosis. Conditions such as Bowenoid papulosis, steroid induced skin 
atrophy and lichen striatus may therefore all involve apoptosis (Hashimoto, 1976; Rosenbach 
et al., 1993). 
Whether the intensely stained cells commonly seen in VVS are affected by necrosis, or 
programmed cell death, was not determined during this investigation, however, these cells were 
patently being damaged by some mechanism. This appears be related to the symptoms ofVVS 
as these cells were visible in significant numbers in the VVS samples. Image analysis of control 
and VVS affected epithelia was completed to determine the incidence of intensely staining cells 
in the epithelium (see Chapter 7). 
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Many of the characteristic cell developments associated with apoptosis, such as; cell shrinkage, 
intact organelles, membrane 'blebbing' and vacuolation of the cytoplasm, were apparent in 
samples from women with VVS. However, several of the diagnostic factors associated with 
apoptosis do not apply to VVS (Table 5.1 ). Condensation of nuclear chromatin was evident, 
however, margination and the formation of crescent shaped caps of chromatin, as well as 
apoptotic bodies containing nuclear fragments were not common in the VVS samples (Fig. 5.0). 
A similar appearance was evident however. Crescent shaped nuclei were seen commonly in 
epidermal cells, however, these were not due to margination of chromatin. The nuclei of these 
cells appeared arc shaped, and displaced in order to phagocytose cytoplasmic bodies. When 
present in epidermal cells, cytoplasmic bodies were visible almost surrounded by the nucleus. 
Despite the fact that all of the characteristics of apoptosis were not present in VVS samples, an 
alternative diagnosis of necrosis is less convincing. Necrosis was not evident when examining 
patients with VVS, and biopsies exhibiting the characteristics of necrosis have not previously 
been reported in the literature. Necrosis is a degenerative phenomenon which results in 
exudative and often chronic inflammation. Although a mild to moderate inflammatory cell 
infiltrate was present in VVS samples, the degree of inflammation was not suggestive of 
necrosis. In comparison, during cell death by apoptosis, dying cells and cell debris are rapidly 
packaged into apoptotic bodies to prevent the initiation of a potentially damaging inflammatory 
reaction (Savil et al., 1993). The presence of a moderate number of inflammatory cells in VVS 
samples may suggest a protracted form of apoptosis, where the dying cells are not cleared 
quickly, and therefore a degree of inflammation occurs. Research has indicated that there are 
possibly several subsets of apoptosis which may have less well defined characteristics 
(Rosenbach et a/,.1993). The use of immunological markers is essential to determine the 
mechanism of cell death in VVS. Rosenbach et al. ( 1993 ), highlight two main types of 
apoptosis, one which is a receptor mediated and genetically controlled process, and another less 
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well defined form. The latter form of apoptosis, may occur due to a general, cellular response 
to injury, a similar process to that seen in cell mediated cytotoxicity, and which may be 
occurring during VVS. 
In support of this, Schwartz and Osboume (1993), report experiments which show various types 
of apoptosis. Apoptosis is only one aspect of programmed cell death (PCD), not all dying cells 
display the changes associated with apoptosis. During PCD in the intercostal muscles ofthe 
tobacco hawk moth, Manduca sexta, ultrastructural examination reveals that membrane 
blebbing, chromatin margination and DNA fragmentation do not occur. The classical nuclear 
changes associated with apoptosis are replaced by pyknosis and rounding of the nucleus. The 
appearance of these cells is similar to the intensely staining cells present in VVS biopsies. The 
nuclei in these samples retained their shape and nuclear membrane, however, the chromatin 
appeared more dense, possibly pyknotic (Chu-wang and Oppenheim, 1978, as cited by 
Schwartz and Osbourne, 1993). 
Potten ( 1987) describes a form of cell death where the cells appear darkened. Enhanced staining 
of the cytoplasm and, or, the nucleus resulting in a 'dark' cell appearance, has been described 
in the tissues of sheep, rodents and man. A majority of reports using TEM have involved 
glutaraldehyde and osmium fixation, and embedding in a plastic resin for examination by TEM. 
lt has been suggested that these processing steps are linked to the visualisation of 'dark' cells 
by TEM. In one study tv.~ce as many ;dark' cells were visible after fixation with glutaraldehyde 
and osmium and embedding in Epon, than tissue embedded in wax (Klein-Szanto et al., 1982a 
& b). Murakami et al. (1985), described the appearance of similar dark keratinocytes following 
intracutaneous injection of Cholera toxin in mouse skin. Chiba et al., (1984) described two 
types of 'dark' cells. The first had many features characteristic of actively synthesising cells, 
and resembled immature keratinocytes, having few filaments and mitochondria. The second 
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type had condensed nuclei and clumped chromatin, dilated vesicles, cytoplasmic vacuolation 
and swollen mitochondria. This type of 'dark' cell had numerous organelles and prominent 
cytokeratin filaments organized into bundles. Chiba et al., (1984), suggests that these cells are 
degenerating or undergoing involution. 
Parsons et al., (1983) classified 'dark' cells into four groups, dependant on the degree 
cytoplasmic and nuclear condensation. This study suggested that these cells may be undergoing 
a type of apoptosis, although nuclear condensation was even, there was no marginal clumping 
of chromatin, and there was no evidence of phagocytosed material in surrounding cells and 
leukocytes. Nuclear changes and the overall appearance of cells are consistent with the present 
study of VVS affected tissue, where nuclear condensation was evident, but was not 
accompanied by margination, or the formation of arcs of chromatin. The visualisation of 
darkened cells using electron microscopy may in fact be linked to the use of aldehyde fixatives, 
as these cells have not previously been described in VVS biopsies processed for light 
microscopy. 
Tumour promoters have been shown to induce the formation of 'dark' cells. The action of these 
chemicals is varied, however they are capable of causing acute tissue damage. Studies using rat 
respiratory epithelium have sho\\'TI a direct relationship between the number of 'dark' cells and 
the degree of epithelial atypia. This has also been demonstrated in human oral leukoplakia 
(Klein-Szanto et al., 1982a & b). Cytoplasmic condensation per se is not indicative of apoptosis. 
Cells with moderately condensed cytoplasm but normal ultrastructure in general can be found 
in most tissues (Potten, 1987). Condensed cells with swollen mitochondria are almost certainly 
dying, however, these cells have a different appearance from cells affected by apoptosis. This 
type of cell death is not characterised by the formation ofblebs or the segregation of chromatin. 
Instead the dying cell is 'squeezed out' amongst other epithelial cells 
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Figure 5.0 Diagrammatic representation ofthe processes ofapoptosis and necrosis 
Necrosis 
Table 5. 1. Documented differences between the processes of apoptosis and necrosis 
APOPTOSIS NECROSIS 
• Individual cells or populations of cells are • A non selective degenerative phenomenon 
deleted 
• Significant cell shrinkage, mitochondria • Cell swelling, mitochondria and other 
remain intact. Characteristic cytosol and cytoplasmic compartments swell, resulting 
chromatin condensation. in rupture of membranes. 
• Apoptosis based on fragmentation of • Biochemical factors are linked to membrane 
nuclear DNA by endonucleases - fragments breakdown and alterations in ion 
of200-300 bp, irreversible homeostasis. 
• No evidence of micro-environmental • Strong inflammatory reaction observed 
inflammatory reaction around dying cells 
• Membrane ' blebbing' or zeiosis, resulting in • Rupture of cell membranes releases noxious 
fragmentation of the cell into apoptotic factors resulting in macrophage activation. 
bodies prevents release of noxious factors 
which trigger inflammation. 
• Rapid phagocytosis of whole apoptotic cells • Inflammatory cells attracted to damaged 
or apoptotic bodies by neighbouring cells or cells phagocytose dying cells 
macrophage 
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This process, which is similar to apoptosis, has been described in pathological and non-
pathological conditions. Abnormalities in mitochondria during this process suggest that it may 
be a variant of necrosis (Johannison, 1968, and Cooper et al., 1975, as cited by Potten, 1987). 
Changes in mitochondria were not obvious in VVS, some mitochondria appeared damaged, but 
the degree of damage was consistent with that of control tissue and was probably due to 
processmg. 
Epidermal cells in the control samples were characterised by the presence of numerous 
cytoplasmic projections which formed interdigitating junctions between the cells. These 
projections were evident in the epithelia of VVS samples, but were less pronounced and less 
frequent around the intensely staining cells. Wyllie ( 1980) described a similar change which 
occurred concomitant with nuclear changes during apoptosis, 'microvilli if present disappeared 
and blunt protuberances of the cell membrane form, desmosomaljunctions if present may break 
down at this stage'(Wyllie, 1980; Searle et al., 1982). ln VVS samples there was no evidence 
of desmosomal breakdown. However, desmosomes appeared to be less frequent, and 
cytoplasmic projections were less prominent around intensely staining cells common in VVS 
samples, when compared with controls. 
The most perplexing observation was the presence of membrane bound lobules of cytoplasm, 
visible interposed between epidermal cells, which appear to have no origin. On serial sectioning 
no nucleus was evident in the cytoplasmic lobules. As these bodies were devoid of cytoplasmic 
junctions and projections, it may be concluded that they may be either-projections of migratory 
cells, or alternatively, membrane bound by-products of cells. These structures may be 
interpreted as projections of leukocytes, or possibly the arms of Langerhans cells. Although 
Langerhans granules were observed on several occasions in the cytoplasm of non-epidermal 
cells, neither complete granules, nor components of Langerhans granules were evident in the 
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cytoplasmic lobules. There was an increased number of non-epidermal cells present in VVS 
samples compared with the control samples. Many of these cells had large lobed nuclei and 
granular cytoplasm. The nature of these cells is unknown as immunological marking was not 
possible on the glutaraldehyde fixed tissue. However, it is possible that a percentage of these 
cells were Langerhans cells, which may account for the presence of such lobules interposed 
between epidermal cells in the VVS samples. Marshal! & Steven (1969), described membrane 
bound structures in rumen epithelium using TEM. These structures had a similar appearance 
to cytoplasmic lobules described in this investigation. These authors attributed these structures 
to cytoplasmic processes of dendritic cells. Langerhans cells are an important component of 
the skin immune system, and are particularly vital antigen presenting cells, involved in the 
development of the immune response (Sting! et al., 1980; Edwards & Morris, 1985). The 
presence of an extensive network of dendritic process of Langerhans cells, may account for the 
increase in the inflammatory cell infiltrate evident in cases ofVVS. However, this does not 
account for the presence of large numbers of apoptotic-like cells, or the presence of 
cytoplasmic lobules contained within epidermal cells. 
An alternative origin of these membrane bound lobules may be that they are the hi-products of 
apoptosis, termed 'blebs' or 'apoptotic bodies'. Apoptotic bodies have previously been 
confused with autophagic vacuoles, as identification rests on the recognition of nuclear 
fragments or the presence of organelles not usually found in the ingesting cell. Terms such as 
zeiosis, popcorn-like cytolysis, necrobiosis and extrusion subdivision are all terms which have 
been used to describe the phenomena now termed apoptosis (Wyllie, 1980; Wyllie et al., 1984; 
Cohen, 1993a & b). Lobules of this type were visible in the epidermis of control samples, 
however, they were discrete and few in number. The lobules were seen in similar situations in 
the control and VVS affected vestibular tissues, usually associated with leukocytes and 
intensely staining apoptotic-like cells. During the process of apoptosis membrane bound blebs 
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of cytoplasm and nuclear contents are formed as the dying cells are removed. These 
extracellular bodies never show evidence of degradation and may be capable of metabolic 
activity even though they are programmed to die (Zychilinsky, 1993). This is consistent with 
the findings of the present study which indicated that membrane bound lobules of cytoplasm 
showed no evidence of cell death. 
The lobules of cytoplasm seen in the VVS samples are consistent with the descriptions of 
apoptotic bodies (Olson, 1975; Wyllie, 1980; 1984; White et al., 1993 ), being of varying sizes 
and shapes, and containing organelles and nuclear fragments. On several occasions nuclear 
remnants were visible contained within the lobules, however this was not a conunon 
observation. Other authors have described phagocytosis of apoptotic bodies by macro phages 
and by neighbouring epidermal cells. Although lobules of cytoplasm were seen in close contact 
with macrophage-like cells in the epithelium, there was no evidence of phagocytosed apoptotic 
bodies in these cells. Frequently, neighbouring epidermal cells were seen to extend cytoplasmic 
projections, which were seen to make close contact with lobules of cytoplasm. On many 
occasions similar cytoplasmic bodies were seen contained within epidermal cells, and may have 
been phagocytosed. Often the nucleus of the cell containing the cytoplasmic body was 
displaced, and arc shaped. In classical apoptosis it is essential that macrophages and phagocytes 
quickly clear cells undergoing apoptosis, and apoptotic bodies. If these structures rupture they 
will evoke a potentially harmful immune response. ln order to attract phagocytes and 
macrophages to the apoptotic cells, it has been proposed that several changes in the cytoplasmic 
membrane occur to increase the 'eat me' status (Savill et al., 1993). 
There is evidence that lymphocyte attachment to epithelial cells is often followed by apoptosis. 
which may rule out increased membrane permeability as the primary event in targeted cell 
death. In cases where cell death is believed to be induced by cell mediated immunity in vivo. 
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numerous apoptotic bodies have been found to occur in close proximity to the infiltrating 
lymphoid cells (Potten, 1987). This is consistent with observations of membrane bound lobules 
in this investigation, where leukocytes were seen to make close contact with darkened 
epidermal cells, and with surrounding lobules of cytoplasm. This type of cell mediated 
apoptosis is not restricted to lymphocytes, macrophage hai•e also been shown to trigger 
apoptosis. Cell mediated apoptosis has also been identified in chronic active hepatitis, lichen 
planus, liver allograft rejections and graft vs. host disease (Hashimoto, 1976; Potten, 1987). 
The death of cells by apoptosis has become particularly important in pathology, as the process 
may be identified as a significant factor in many diseases. This process of cell deletion has 
already been shown to occur in areas of embryogenesis, T cell development, tissue remodelling, 
homeostasis, and tissue involution (Wyllie, 1980; Wyllie et al., 1984; Jenkinson et al., 1989). 
If the ability to harness and use the power of programmed cell death becomes reality this may 
be used in the treatment of cancers. Anti-apoptotic drugs would also be useful, particularly in 
areas such as dermatology where hyper-proliferative diseases such as psoriasis are common. 
It has been proposed that there are a large number of receptors for apoptosis, as well as many 
noxious agents which may induce this process. It is probable that apoptosis is an extremely 
complex process, and that many subsets of the process occur. It has been shown that cell death 
can occur without DNA fragmentation, however, the mechanism of DNA destruction which is 
usually present is not clear (White et al., 1993). Two main theories have been suggested; firstly, 
that DNA endonuclease activity is induced or, secondly, the cellular DNA is made available for 
fragmentation by an endogenous endonuclease. Other factors such as calcium-dependant 
unfolding of the chromatin, and the effect of low pH may also be important in the process of 
apoptosis. 
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The link between apoptosis and VVS needs to be pursued further as this investigation has only 
uncovered part of a complicated chain of events, which may be attributed to apoptosis. 
Immunocytochemistry to detect proteins such as Bcl2 or Bax linked to the regulation of 
apoptosis should form the next stage of the investigation. It is essential to determine whether 
cells are affected by a type of apoptosis, by which a degree of cell mediated immunity occurs, 
and the classical nuclear changes are absent, which would account for the mixed, mild to 
moderate inflammatory cell infiltrate reported by many authors (Pyka et al., 1988; Prayson et 
al., 1995). It has been reported that apoptosis may occur in response to an autoimmune 
reaction (Tan, 1994). It is conceivable, that VVS may be ·due to a cell signalling defect, which 
results in the damage of epidermal cells in the apparent absence of an etiological agent. The 
presence of auto-antibodies on some epidermal cells in VVS samples could be investigated in 
future studies if tissue samples were processed in wax, or by L IFS for TEM. In addition, the 
presence of dendritic process of Langerhans cells, may be examined using light and electron 
microscopy, and associated immunological marking techniques to identify the numerous 
cytoplasmic bodies present in VVS samples (Hanau et al., 1986). 
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Figure 5.1 Schematic presentation of the ultrastructural characteristics of vestibular tissue 
from VVS patients. Illustrating the presence of glycogenated (G) superficial 
(Su) and intermediate cells (le), darkened, apoptotic-like cells (D), lobules of 
cytoplasm (Lb), and the infiltration ofleukocytes (Le), characteristics which are 
not so prominent in normal vestibular tissue. Note also the presence of a small 
lymphocyte (L) in the basal cell layer (Be), and a plasma cell (PI) and mast cell 
(Me) in the dermis. 
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Plate 14 a 
Plate 14b 
Plate 14c 
LM of VVS affected epithelium. Resin sections were stained with I% 
methylene blue. Dark staining cells are visible at this magnification (D). 
Leukocytes are seen penetrating the epidermis (Le), and a capillary (Ca) 
is visible in close contact with the basement membrane (Bm). x 450 
Plasma cells (PI) and other Jeukocytes in the dermis of a VVS sample, 
immediately below the basement membrane. A polymorphonuclear 
leukocyte (Pmn) is visible in the epidermis. x 570 
The dermis of a VVS sample, illustrating a moderate inflammatory cell 
infiltrate, composed of mainly lymphocytes, and plasma cells. x 450 
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x450 
Plate !Sa 
Plate ISh 
LM photograph of vestibular epithelium from a patient with VVS. Wax 
sections were stained with Mallorys. Illustrating the presence of a 
glandular structure which is similar in appearance to a sebaceous gland 
(Sg). Leukocytes are seen to be concentrated around this structure, but 
are not seen in the lumen of this gland. x 230 
Vestibular epithelium from a VVS patient, illustrating a mild 
inflammatory cell infiltrate in the dermis (Le). Surface cells are 
nucleated and slightly flattened (Su). x 600 
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Plate 16 a 
Plate 16b 
Plate 16c 
LM photograph of vestibular epithelium from a patient with VVS, stained with 
Mallorys. Illustrating a non-keratinised area of vestibular epithelium, removed 
during vestibulectomy as treatment of VVS. Surface cells are flattened (Su), 
and a leukocytes are seen in the dermis below the basement membrane (Le). 
X 460 
LM of a partially keratinised area of vestibular epithelium stained with 
Mallorys. Surface cells are thickened and do not have nuclei (Sq), spiny cells 
(Sp) and basal cells (Be) are also illustrated. x 460 
LM area of keratinised vestibular epithelium, which appears to have been 
removed from an area close to Harts' line, which indicates the transition from 
non-keratinised to keratinised epithelium. Surface squames are seen to be 
desquamating (Sq), some clear cells are seen along the basement membrane. 
X 460 
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Plate 17a 
Plate 17b 
Plate 17c 
Low power scanning electron micrograph illustrating the surface topography of 
vestibular epithelium affected by VVS. Surface cells are similar in appearance 
to normal epithelium at this magnification. Cell junctions are prominent and 
raised (Cj). These surface cells are polygonal in shape. Bar= 1 OJ.lm 
At a higher magnification, microridges (Mr) on the surface cells of VVS 
samples appear to be shrunken. Microridges are straight in appearance and not 
raised as in control samples. Cytoplasmic junctions (Cj) are intact and are fine 
in appearance. Bar= 5J.lm 
Illustrating a surface cell with shrunken microridges (Mr). Cell marked * has a 
different surface topography, being almost flat in appearance with no 
microridges. Bar= 5J.lm 
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Plate 18a 
Plate 18b 
Plate 18c 
Plate 18d 
VVS samples were characterised by the presence of pores (P) in small groups. 
These openings were more common in VVS samples than in controls. Situated 
at the junctions (Cj) between surface cells, these pores may be minor vestibular 
glands. Mucus is common, often masking the surface ultrastructure (Mu). 
Bar= IOJ.im 
Higher power micrograph of a typical surface pore (P). Debris similar to mucus 
(Mu) is visible around the pore opening. Bar= 5Jlm 
Surface cells (Su) of VVS affected epithelium. Illustrating an area where a 
surface cell appears to have been exfoliated. An intermediate cell (le) is visible, 
with more prominent surface rnicroridges. Another desquamating cell is visible 
marked *. Bar = 1 OJ.im 
Illustrating the depth of surface pores (P) seen between superficial cells (Su), 
and the microvillus appearance inside a typical pore (Mv). Mucus {Mu) is 
visible within the pore opening. Bar= 2J.1m 
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Plate 19 Low power transmission electron micrograph of vestibular epithelium, 
illustrating the presence of dark staining cells (D) in VVS samples. The 
darkened cell appears shrunken, and the cytoplasm vacuolated (V). Several 
mitochondria (M) are visible, situated close to the basement membrane (Bm). 
Note the lobules of cytoplasm (Lb) and the presence of a smalllymphocyte 
(L).The basal cells (Be) surrounding the darkened cell also appear to have 
condensed or shrunken nuclei. In these cells the cytokeratin filaments (F) appear 
to be moderately staining, however in normal intermediate cells (Ic) the 
cytokeratin filaments were pale staining in appearance. x 8,850 
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Plate 20a & b Basal cells of VVS affected epithelium. The basal cell marked (Be) is 
apparently normal. However, the darkened cell profile (D), is shrunken in 
appearance with vacuolated cytoplasm. Desmosomal junction are maintained 
(De), mitochondria (M) appear to be slightly damaged, the cytoplasm is dark in 
appearance, and cytokeratin filaments are condensed. Cytoplasmic folds (Cp) 
which were common on adjacent basal cells are absent. 
Plate 12ax 17,000 
Plate 12b x 21,500 
Plate 20c & d Intermediate cells (le) of vestibular epithelium. These cells appear to be 
engulfmg lobules of cytoplasm found in intercellular spaces in VVS samples. 
Several membrane (Me) bound cytoplasmic lobules (Lb ), of varying appearance 
are seen in this intermediate cell. One electron dense body (N), has a similar 
staining intensity as chromatin, however, a nuclear membrane was not detected. 
Another membrane bound cytoplasmic lobule is characterised by having 
vacuoles (V). 
Plate 12c, x 22,500 
Plate 12d x 11,700 
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Plate 2la Leukocytes (Le) in the intermediate cell (le) layer of VVS affected vestibular 
epithelium. Leukocytes are surrounded by several intensely staining 
intermediate cells (D) which are slightly vacuolated. Leukocytes are seen to 
make close cytoplasmic contacts with the epidermal cells. One of the leukocytes 
appears to be a Langerhans cell (Le), however, complete Birbeck granules, 
characteristic of Langerhans cells, were not identified. The other Ieukocyte has 
a slightly lobed nucleus and may be a NK cell, neutrophil or a large granular 
lymphocyte. x 11,000 
Plate 2lb & c Leukocytes (Le) in the lower (Plate 21b) superficial cells (Su) and upper 
intermediate (Plate 21 c) cell layers (le). Note the presence of cytoplasm lobules 
(Lb) close to the leukocytes and near a lymphocyte (L). Leukocytes have 
cytoplasmic projections suggesting that they are activated. The leukocyte in 
Plate 21 b. appears to be phagocytosing a membrane bound lobule of cytoplasm 
(Lb). The two leukocytes in Plate 21c have dark granules. 
Plate 21 b x 9,200 
Plate 21c x 12,000. 
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Plate 22a Leukocytes in the dermis of a VVS sample, close to the basement membrane. 
Illustrating an inflammatory infiltrate characterised by a possible neutrophil 
(Ne), polymorphonuclear cells (Pmn), and Iymphocytes (L). x 5,700 
Plate 22b & c Illustrating a mature plasma cell (Pc) and a mast cell (Me) close to a capillary 
(Ca) (Plate 22b & c). Plasma cells characteristically have a clock face clumping 
of chromatin, however, two plasma cells in 22b and 22c appear to be apoptotic 
(Ap). The chromatin of these two plasma cells is marginated characteristic of 
cells undergoing apoptosis. All plasma cells had extensive endoplasmic 
reticulum (Er) and numerous mitochondria (M). 
Plate 2la x 7,500 
Plate 21 c x 6,500 
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Plate 23a & b Illustrating the presence of membrane bound lobules (Lb), a lymphocyte (L) 
and a darkened cell (D) in the close proximity of basal cells (Be). Lobules of 
cytoplasm (Lb) are making close contacts with the darkened basal cell (D). The 
darkened cell (D) has very little cytoplasm and a condensed, intensely staining 
nucleus. Several mitochondria (M) are visible close to the basement membrane 
(Bm). 
Plate 23a x 13,500 
Plate 23b x 9,850 
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Plate 24a-c Illustrating cytoplasmic lobules which were frequently seen interposed between 
epidermal cells of all cell layers in VVS samples. Lobules (Lb) are seen to make 
close cytoplasmic contacts with neighbouring epidermal cells (le), which in 
some cases appear intensely staining. Commonly membrane bound lobules are 
seen to be phagocytosed by epidermal cells (Plate 24c) or in the process of being 
engulfed (Plate 24a). Note the presence of a leukocyte process (Le) close to 
cytoplasmic lobules. No nucleus is evident on serial sectioning. Lobules of 
cytoplasm were usually characterised by the presence of ribosomes (R) and fme 
cytoplasmic filaments (F). Occasionally vesicles (Ve) were evident in these 
cytoplasmic lobules. 
Plate 24a x 15,000 
Plate 24b x 45,000 
Plate 24c x 13,500 
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Pilne.25~ 
11 •• 
1l!,ower ;Intermediate .ceils,of'YVS affected vestibular epithelium' Intermed.ia:te 
cells (IC) are visible engulfing lobules of cy.toplasm (Lb). T1he nuC!ei,o:t: several 
·intermediate ,cells appears arc: shape& IJilie Jobules of! cytoplasm appear to 1be 
!broken. do.wn within ,the epidermal' cells:. This area of, the epithelium appears 
disorganised\ and many ofthe eplthelial;cells:are;.electron dense:andl some:.have 
developed vacuoles, ~~y),, :Mitothoncfria (Ni) are Intact, as are desmosomal 
Jtinctlons:(De), x ii;50b 
223 
Plate 26a 
Plate 26b 
Plate 26c 
Plate 26d 
Superficial cell (Su) of VVS affected epithelium. Cytoplasm of this cell is 
deteriorating as the cell is exfoliated. The nucleus is intact but slightly flattened 
in appearance. Vesicles (V e) are visible along the cytoplasmic membrane of the 
surface cell, commonly fusing with the membrane. Short desmosomaljunctions 
are evident (De). x 9,000 
Superficial cells (Su) are characterised by microvillous-like projections (Mv) of 
the cytoplasmic membrane. These projections vary in shape, length and 
distribution along the surface of these cells. The plasma membrane of the 
surface cells is slightly thickened but not keratinised. There are no keratohyalin 
granules present. Large deposits of glycogen (G) are common in these cells. 
X 30,000 
Superficial cells indicating the presence of large aggregates of glycogen (G), 
and vesicles (V e) in close contact with the cytoplasmic membrane. Folding of 
the cytoplasmic (Cf) membrane is not as pronounced when compared with the 
lower cell layers. Desmosomes are short (De). x 7,000 
High power micrograph of vesicles (V e) commonly seen in the surface cells of 
VVS affected epithelium. This cell has retained its nucleus (Nu). Vesicles (V e) 
were generally electron lucent, but occasionally vesicles with electron dense 
cores were evident, which were similar in appearance to membrane coating 
granules found in keratinised skin. x 25,000 
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CHAPTER SIX 
The Effect of Ketoconazole on the Ultrastructural 
Characteristics of VVS 
6.0 Abstract 
Ketoconazole is a topical antifungal preparation, which had been anticipated to be of use in the treatment 
ofVVS, due to the mild inhibitory effects of this drug on the production of leukotriene B4.The etiology 
of VVS remains elusive, however, pathologically VVS presents as a chronic inflammatory condition 
affecting the vestibule of the vulva. Investigation of the inflammatory response has revealed very little 
information pertaining to the cause of the syndrome (Pyka et al., 1988, Prayson et al., 1995). Post-
treatment biopsies, revealed an ultrastructural appearance similar to that seen in pre-treatment samples. 
Apoptotic-like cells were present in similar numbers when compared with the pre-treatment samples, 
however, these dark cells were more heavily vacuolised and shrunken in appearance. Despite the number 
ofleukocytes being similar in the majority of cases (see Chapter 7), the nature of the inflammatory cells 
present appeared different. Lobed nuclei, characteristic of macrophage-like cells were common in post-
treatment samples, particularly in the dermis. As in the pre-treatment samples, plasma cells and 
lymphocytes were also present. Lobules of cytoplasm were numerous, and as in pre-treatment samples, 
these bodies were found contained within macrophages, and also within neighbouring epidermal cells. 
A majority of the post-treatment samples showed increased numbers of cytoplasmic lobules in the dermis, 
often close to capillaries. Despite a documented decrease in vulvar sensitivity after treatment with 
ketoconazole (Chapter 3), this was not accompanied by significant ultrastructural changes. In conclusion, 
ketoconazole may be manipulating the inflammatory response by reducing the production of LTB4 ; 
however, the cause of the inflammation is probably not being affected. Therefore, when treatment with 
ketoconazole is discontinued, increased sensitivity of the vestibule often recurs. 
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6.1 Introduction 
Treatment of patients with inexplicable vulvar pain is particularly difficult. Many clinicians 
have attempted to treat the vulvar pain associated with VVS, but the majority have had little 
success. Patients with VVS are particularly complex to treat, as there is often no obvious 
etiological agent present. Pathological clues to the cause of the syndrome are scarce, and 
patients are often distressed, and commonly difficult to examine. Treatment regimes for VVS 
have included: calcium citrate (Solomons et al., 1991 ); carbon dioxide laser treatment (Davis, 
1989); alcohol injection; topical steroids (Friedrich, 1988); pelvic floor assessment and 
treatment (Glazer et al., 1995); and surgical removal of the vestibule (Woodruff & Parmley, 
1983; Bomstein et al., 1989, 1995). The pathology of the condition is not distinctive, however, 
there have been repeated reports ofkoilocytic cells in the superficial cell layer of the vestibular 
epithelium, which is considered indicative of HPV. The association of HPV and VVS, has 
resulted in a large number of investigations utilising the anti-viral properties of interferon (see 
Chapter 2). Interferon is currently the most widely used treatment regime for VVS, however, 
the results pertaining from these investigations are not wholly conclusive (Wilkinson et al., 
1993; Bergeron et al., 1994). More recently, studies have indicated that the methodology used 
for detecting HPV in tissue samples, has influenced the number of 'positive' cases obtained. 
The use of basic histological observation for the detection ofHPV has been heavily scrutinised, 
and this means of detecting HPV has frequently been found to be inaccurate (Bergeron et al., 
1994 ). Generally, it is accepted that interferon therapy is successful in a small number of 
carefully selected VVS cases, where HPV has been equivocally shown to be present using PCR. 
Vulvar Vestibulitis Syndrome is characterised by a non specific inflammatory cell infiltrate in 
the tissue surrounding the vestibular glands; the inflammation does not affect the gland walls 
or lumens (Pyka et a/.,1988). The inflammatory response has been investigated on several 
occasions, however, all studies report mild to moderate, mixed inflammatory response, which 
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is not characteristic of a particular disease process (Pyka et al., 1988) (see Chapter 2). In the 
present investigation, periductal vestibular tissue from VVS patients, was found to have several 
distinct characteristics which were not apparent in tissue from control patients. Prior to 
treatment with ketoconazole, the vestibular epithelium was infiltrated by a moderate number 
of leukocytes which were present in all cell layers, consistent with the findings of Pyka et al. 
(1988), Wilkinson et al. (1993) and Prayson et al. (1995). However, the most interesting 
observation was the presence of dark-staining, possibly apoptotic cells seen in small groups 
throughout the epithelium. Dark cells were characterised by the presence of shrunken, often 
vacuolated cytoplasm, and the cytoplasmic membranes of the dark cells were characteristically 
intact. Membrane bound, cytoplasmic lobules, were seen in close contact with dark cells, and 
were also found engulfed by neighbouring epidermal cells and leukocytes (see Chapter 5). These 
unusual and distinctive findings have not previously been described in association with VVS. 
It was interesting that these features were seen in biopsies taken both at Cambridge and 
Plymouth G.U.M. clinics, and that the overall ultrastructural appearance of these samples was 
similar. 
Ketoconazole, a topical antifungal preparation, was considered by the manufacturer to have 
beneficial effects which may be useful in the treatment of Vulvar Vestibulitis Syndrome. 
Ketoconazole is a member of the imidazole family of therapeutic chemicals, used mainly for 
the treatment of fungal infections (Fig. 6.0). Since the introduction of these drugs in 1969, 
imidazoles have become one of the most widely used group of antifungals in human and 
vetinary medicine, and are also used for the protection of fruit and vegetables from fungal 
infections (Dooms-Goosens et al., 1995). Other members of this widely used group of drugs 
include: clotrimazole, bifonazole, miconazole, triconazole, fluconazole and croconazole. These 
drugs can be administered orally as well as topically, and have an effect on both superficial and 
deep mycoses (Feldman, 1986). Dooms-Goosens et al. (1995), reviewed the past literature with 
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reference to the incidence of contact sensitivity to this group of drugs. Their results indicated 
that reactions to imidazoles are quite common, however, often the reaction is in response to the 
base cream, and not to the drugper se. It has also been reported that reactions to ketoconazole 
were uncommon, compared with reactions to other imidazoles. 
Fig.6.0 The chemical structure ofketoconazole 
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(Adapted from Di Pietra er al., 1992) 
Imidazoles act by inhibiting ergersterol production which is an important component of fungal 
cell membranes, an effect which may result in direct cellular damage to the fungus (Feldman, 
1986). The antifungal properties of this drug originate from its ability to bind to yeast and 
fungal cytochrome P450. In response to the binding of this enzyme, the fungal cells become 
depleted of ergersterol, and contain increased levels of 14o: methysterols which disturb 
membrane properties and the activity of membrane bound enzymes, therefore affecting growth 
(Furr & Wakeling, 1986). The affinity ofketoconazole for fungal, as opposed to mammalian 
sterol synthesis enzymes, is consistent with few reports of adverse side effects. However, side 
effects do become apparent when the maximum dose is exceeded. In man, hepatic dysfunction 
seems to be a unique, non-dose dependent reaction (Willard et al., 1986). Other side effects of 
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ketoconazole include reports of hypoadrenocorticism (Addisons disease), decreased libido, 
gynecomastia, impotence, oligospermia, and is particularly problematic in patients with 
previous liver complaints (Willard, 1986; Eil, 1992). 
Ketoconazole and other imidazole derivatives are known to inhibit steroidogenesis. Other drugs 
such as metronidazole and orthiobendazone, which contain imidazole or azote structures may 
also have some effect on hormone synthesis. The effects of oral ketoconazole administration 
include a reduction in the levels of plasma testosterone, androstenedone, dehydroepiandosterol, 
cortisol and corticosterone. The inhibition of steroidogenesis by ketoconazole in both the 
adrenal gland and the testis, may become important in the treatment of conditions when a 
reduction in the steroidogenesis would be a benefit, such as in prostatic cancers or Cushings' 
syndrome ( Furr & Wakeling, 1986; Willard et al., 1986; Amado et al., 1990; Forgue-Latiffe, 
1992). Beetens et al. (1986), examined the activity ofketoconazole compared with other known 
lipoxygenase inhibitors, and found the action of this drug to involve the selective inhibition of 
leukotriene biosynthesis. Ketoconazole has an inhibitory effect on the production of 5-hydroxy-
eicosatetraenoic acid (HETE) and LIB 4 in rat peritoneal polymorphonuclear leukocytes, but 
has no effect on the cyclooxygenase pathway, or on the IS and 12lipoxygenase system (Beetens 
et al., 1986; Hillber, 1990). For all LIB 4 inhibitors, inhibition takes place at the level of the 5-
lipoxygenase enzyme (Figure 6.1 ). Hillber ( 1990) has demonstrated that the most selective and 
strongest 5-lipoxygenase inhibitor was itraconazole. 
Although a fungal etiology has not been considered a major candidate of the cause ofVVS, one 
proposed action of ketoconazole includes the inhibiticn ofleukotriene synthesis. The use of a 
L TB4 inhibitor for the treatment of VVS, may reduce the degree of inflammation, resulting in 
a decrease in the sensitivity of the vestibule. The process of inflammation involves the 
production of leukotrienes (LTs), so called, because they were first isolated from leukocytes 
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(Borgeat & Naccache, 1990). Leukotrienes are a group of biochemically active molecules, 
which are products of the 5-lipoxygenation of arachadonic acid. 
Figure 6. I The production of leukotrienes via the arachadonic acid pathway 
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The fonnation ofLTs is completed by arachadonic 5-lipoxygenase, an enzyme which is present 
in phagocytes, mast cells and basophils. Two groups of these chemicals are produced during 
an inflammatory response; LT A 4 and L TB 4, and L TC 4, L TO 4, L TE 4 and L TF 4 (Fig. 6.1 ). 
Inflammatory stimuli such as chemotactic peptides, phagocytosed particles and immunological 
stimuli which activate phagocytes and mast cells, are all capable of stimulating LT synthesis 
(Soter et al., 1983; Borgeat & Naccache, 1990). Work involving these chemicals, has 
concentrated mainly on their role in asthma and inflammation, due to the discovery that 
peptido-leukotrienes fonn part of the slow reacting substance of anaphylaxis, and are also 
involved in smooth muscle contraction during bronchio-constriction (Bray, 1986). 
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Leukotriene B 4 has a relatively weak smooth muscle contracting ability, but is a strong 
mediator of leukocyte chemotaxis (Piambland el al., 1981; Bray, 1986; Borgeat & Naccache, 
1990; Zimmerman et al., 1990; Fret! and et al., 1993; Iwamoto et al., 1993). The presence of 
an inflammatory mediator is often signified by vasodilation, enhanced vascular permeability, 
pain and the symptoms of tissue destruction; for example increased numbers ofphagocytes and 
the release of degradative enzymes. During an acute and, or chronic inflammatory reaction, the 
cells which are found to generate the most leukotrienes, are macrophages, neutrophils and 
eosinophils. Several inflammatory mediators are able to stimulate LT formation by 
inflammatory cells such as macrophages and neutrophils. Leukotriene B4 is capable of 
enhancing the random movement of neutrophils, eosinophils, lymphocytes and macro phages 
from both experimental animals and from man. In addition, resident tissue cells are also able 
to respond to an inflammatory stimulus by releasing LT, and therefore enhancing the local 
inflammatory response. Keratinocytes, which are similar structurally to vestibular epithelial 
cells, have the ability to produce cytokines in response to antigen (Bray, 1986). 
The local effects of an inflammatory response include redness and heat, due to vasodilation and 
increased blood flow, accompanied by pain, due to the stimulation of local thermal, mechanical 
and chemo-receptors. A process which is accompanied by swelling, due to increased vascular 
permeability and extravascular plasma leakage and cell migration. All of these symptoms are 
common in cases ofVVS, where patients complain of sensitivity to pressure on the vestibule, 
a burning pain, and physical findings limited to erythema and slight oedema. Generally L TB 4 
is a weak inducer of plasma leakage, however, when injected with prostaglandin E2 (PGE 2) 
the LTB 4 response is markedly enhanced. Soter et al., (1983), found that local injection of 
L TB 4 elicited a wheal and flare reaction, which was followed by an inflammatory reaction and 
a cell infiltrate predominated by neutrophils. The combination of PGD 2 and L TB 4 , elicited 
focal tenderness and a more intense infiltration ofneutrophils. Leukotriene B 4 has been shown 
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to affect the secretory function of leukocytes and may affect the tissue degradative phase of the 
inflammatory response. It has been suggested that LTB4 may play a role in the development and 
maintenance of chronic inflammatory lesions, a situation analogous with that of VVS (Bray, 
1986). 
The main aim of this part of the investigation was to investigate the effect of the topical, anti-
inflammatory cream, 2% ketoconazole (Nizoral, Janssen Pharmaceuticals, Belgium) on VVS. 
It was proposed that this treatment would assist in the improvement of VVS, by inhibiting the 
production of L TB4 via the arachadonic acid pathway, and thus reducing the degree of 
inflammation. Existing VVS patients attending Plymouth G.U.M. clinic, had been treated with 
ketoconazole for between one and six months duration, with encouraging results (Chapter 3). 
A majority of patients showed some improvement over several months, suggesting that changes 
in the epithelium may be occurring due to treatment. Originally it was anticipated that a placebo 
controlled investigation of a stronger leukotriene inhibitor would be completed. However, 
problems with the formulation of this topical preparation prevented its use in the present 
investigation. The affect of ketoconazole, on the sensitivity of the vestibule in VVS patients 
was assessed over a four month period. Two biopsies of vestibular tissue were taken, one prior 
to treatment with ketoconazole, and another after four months of treatment. It was anticipated 
that any beneficial affect of the drug may become evident in the ultrastructural characteristics 
of the tissue when compared to pre-treatment biopsies. 
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6.2 Methods 
Patients presenting at the G.U.M. clinic at Plymouth (Freedom Fields), with idiopathic vulvar 
pain were assessed using Friedrichs' (1987), diagnostic criteria (see Chapter 2), and 
subsequently were assessed for the degree ofvulvar sensitivity using the 'Vulvar Algesiometer' 
(see Chapter 3). Patients with typically low scores on all four ducts, who also met Friedrichs' 
diagnostic criteria, were asked to participate in the investigation. Ethical committee approval 
was required for the inclusion of patients in the trial, and for the removal ofvulvar biopsies; 
this was obtained in February 1994 (Appendix 1 ). The exclusion criteria fur the investigation 
were: 
(a) Post- menopausal women, or women under 16 years of age 
(b) Patients who presented with any gross pathology, e.g., warts, or VIN. 
(c) Patients with acute vulvitis due to the presence of an etiological agent, e.g., 
Candida. 
The pharmacological information provided by Janssen Pharmaceuticals (Belgium) is included 
in Appendix 3. The cream used for the treatment of VVS was 2% ketoconazole (Nizoral, 
Janssen). Informed consent was obtained from each patient before the initial biopsy was taken. 
Patients were informed that they could withdraw from the investigation at any time, and their 
treatment would not be affected. A biopsy of periductal vestibular epithelium was removed 
from the lateral border of the right Skenes' gland, prior to treatment, under local anaesthetic 
(see Chapter 4, Fig. 4.0). Patients were instructed to apply the cream liberally, twice a day for 
one month, after which they were required to attend the G.U.M. clinic to be assessed. After four 
months of treatment with ketoconazole, a second biopsy was removed under local anaesthetic 
from the lateral border of the left Skenes' gland. Biopsies of vestibular epithelium were 
processed for TEM. 
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A 3mm Keyes punch biopsy sample was removed from the lateral border of the left Skene's 
gland and immediately transferred to a vial containing the primary fixative, 4% glutaraldehyde 
in 0.1 M sodium cacodylate buffer (pH 7.2) at 4°C, for two hours. After 30 minutes the 
biopsies were subdivided into tissue blocks of approximately I mm x I mm whilst immersed in 
fixative (4°C). The tissue blocks were returned to fresh primary fixative for a further 90 
minutes. Blocks were subsequently washed twice in 0.1 M sodium cacodylate buffer (pH 7.2), 
post fixed in 1% osmium tetroxide for 60 minutes ( 4°C) and finally washed twice in 0.1 M 
sodium cacodylate buffer (pH 7.2). Tissue blocks were block stained in 2% uranyl acetate for 
20 minutes in the dark, washed in distilled water and dehydrated in a series of graded ethanol, 
30%, 50%, 70%, 90% and absolute alcohol, for 10 minutes in each mixture. Dehydration was 
completed by two 10 minute washes in propylene oxide. Infiltration of resin was carried out 
over several days to ensure full penetration of the resin into the tissue. A series of graded 
mixtures of propylene oxide and Spurr resin (Spurr, 1969) were used (3: 1, 1:1, 1:3, Pure x 2). 
Blocks were polymerised at 70°C for 8 hours. Ultrathin sections, cut on a Reichert Ultracut 
ultramicrotome, were collected on copper grids, stained for 10 minutes in uranyl acetate and 
20 minutes in lead citrate, and subsequently viewed using a Jeol 1200 transmission electron 
microscope. Semi-thin sections, of 0.51J.m were cut and stained with 1% methylene blue for 
routine light microscopy. 
In total, fifteen patients participated in the trial of ketoconazole and its effect on the 
ultrastructural characteristics ofVVS. These patients had not received any other treatment for 
VVS prior to the initial biopsy being taken. 
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6.3 Results 
6.31 Light microscopical observations of post-treatment vestibular epithelium. 
Semi-thin sections stained with methylene blue showed an epithelium approximately 20 cells 
thick. Basal cells were dark staining in appearance; the basement membrane was undulant, 
forming wide, shallow projections into the dermis (Plate 27a). Inter-cellular junctions were 
visible surrounding cells of the intermediate cell layer (Plate 27b ). Surface cells often retained 
their nucleus, which was frequently laterally displaced. These cells were pale staining in 
comparison with intermediate and basal cells. Some intensely staining cells were visible often 
situated in groups, distributed throughout the epithelium. Some large intermediate cells 
appeared vacuolated, with pyknotic nuclei (Plate 27b). Leukocytes were common in all cell 
layers of all post-treatment vestibular samples; plasma cells and macrophage-like cells were 
present in the dermis, positioned immediately below the basement membrane (Plate 27). 
Capillaries were situated close to the basement membrane, and were often packed with 
leukocytes, particularly lymphocytes. Eosinophils and mast cells were uncommon in the dermis 
of post -treatment samples. 
6.32 Transmission electron microscopy of post-treatment vestibular epithelium 
A schematic representation of the general ultrastructural characteristics of post-treatment 
samples from VVS patients is shown in Figure 6.2. The overall ultrastructural appearance, was 
similar to that of the pre-treatment vestibular biopsies from VVS patients. Surface cells were 
flattened in appearance, and commonly contained large deposits of glycogen. Microvillous 
projections were numerous on the surface of the superficial cells. Vesicles were visible in close 
contact with the cytoplasmic membrane of upper intermediate and superficial cells. The 
epithelium was loosely organised into different cell layers, and was dominated by the presence 
of a large population of intermediate cells. These cells were not spiny in appearance, but were 
characterised by the presence of interdigitating cytoplasmic processes. Dark staining cells were 
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common in the post-treatment samples, and were found to correspond with the intensely 
staining cells visualised in semi-thin sections stained with methylene blue. It was estimated that 
these cells probably formed 20-30% of the basal and intermediate cell population. However, 
an accurate quantification of the number of dark staining cells was not possible using TEM. The 
cytoplasm of these cells was generally extensively vacuolated. Commonly, dark cells were seen 
in close contact with cytoplasmic lobules and lymphocytes (Plates 28 & 29). Intensely staining 
cells maintained intercellular junctions with neighbouring epidermal cells despite being 
shrunken in appearance. Desmosomes were structurally intact, however, these structures were 
less common surrounding dark staining cells. The nuclear, and organelle membranes of these 
cells remained intact. Intensely stained cells were seen as foci throughout the epithelium, but 
were particularly common in the basal and intermediate cell layers. Occasionally an intensely 
staining cell profile was visible in the superficial cell layer. Membrane bound lobules of 
cytoplasm, similar in appearance to apoptotic bodies, were seen in all layers of the epithelium, 
but were more common in the basal and intermediate cell layers (Plate 29a & b). These 
structures were frequently seen in groups in close contact with intensely staining cells. 
Cytoplasmic lobules frequently contained mitochondria, polyribosomes and fine cytoplasmic 
filaments, and appeared to be of epidermal origin (Plate 30a & b). Occasionally nuclear material 
was evident, contained within membrane bound cytoplasmic body (Plate 30c). Of various 
dimensions, these lobules of cytoplasm, were often found engulfed by epidermal cells, and 
commonly seen surrounded by cytoplasmic projections of macrophage-like cells or NK-like 
cells (Plate 31 ). These cytoplasmic bodies were not, however, seen contained within 
macrophages. In the dermis, identical membrane bound lobules of cytoplasm were seen close 
to capillaries (Plate 31 ). 
In several post-treatment biopsies, electron dense, angular shaped inclusions were found in 
macrophage-like cells (Plate 32). Macrophages were common in the dermis of a majority of the 
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post-treatment biopsies, these leukocytes were characterised by the presence of a large lobed 
nucleus, numerous vacuoles and many mitochondria. Natural killer-type cells were also visible 
in the epidermis and dermis, these cells were characterised by a lobed nucleus, developed Golgi 
apparatus and numerous mitochondria (Plate 31). Lymphocytes of varying sizes were the 
predominant cell type in the epidermis. Some large leukocytes were visible which had abundant 
cytoplasm and numerous organelles, these were possibly large granular lymphocytes or NK 
cells. Lymphocytes were common in all cell layers, frequently these cells were seen in close 
contact with normal and intensely staining epidermal cells (Plate 30). At the point of contact 
between the lymphocytes and the epidermal cells, vesicles were frequently visible (Plate 33b). 
These vesicles often appeared to dispel their contents into the inter-cellular space. 
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6.4 Discussion 
The ultrastructural features of post-treatment vestibular epithelium were very similar to that of 
the pre-treatment biopsies. Using light microscopy, the epithelium was found to be infiltrated 
with numerous leukocytes, which were seen in all cell layers, but appeared to be more common 
interposed between basal and intermediate cells. The characteristic nuclei of plasma cells and 
macrophages were evident in the dennis, particularly below the basement membrane, and were 
found to be distributed in a similar pattern to that observed in the pre-treatment biopsies. 
Plasma cells were generally mature, with well developed endoplasmic reticulum; in pre-
treatment samples plasma cells were more common, but were at various stages of maturity. 
Examination of post-treatment biopsies using TEM, revealed ultrastructural characteristics 
which were similar to those apparent in pre-treatment samples. As in the pre-treatment samples 
the ultrastructural observations were found to centre around the presence of dark staining, 
possibly apoptotic cells. In post-treatment samples the frequency of apoptotic-like cells in the 
epithelium appeared to be greater than in the pre-treatment samples. Quantification of the 
ultrastructural differences between the two groups was impossible using TEM. The number 
of apoptotic-like cells, was one of the factors which was investigated using image analysis, in 
order to quantify any differences between the two groups of biopsies (Chapter 7). Apoptotic-
like cells were found at different stages of change, ranging from being darkened in appearance 
to heavily vacuolated, and shrunken. In pre-treatment samples, the apoptotic-like cells did 
appear vacuolated, but not to such a degree as in the post-treatment samples. 
The presence of membrane bound cytoplasmic bodies was a common finding in the pre and 
post-treatment biopsies. These unusual structures, were again found in close contact with the 
dark staining cells, but were even more prolific in the post-treatment samples. Variable in size 
and appearance, these cytoplasmic bodies, were of the same appearance as those found in the 
238 
pre-treatment biopsies, and were believed to be apoptotic bodies. The increase in the number 
of these structures in the post-treatment samples was perplexing, as it was expected that the 
majority of these cytoplasmic bodies would be cleared by surrounding epidermal cells and 
infiltrating macrophages. Despite the presence of macrophages in both the pre- and post-
treatment samples, engulfed apoptotic bodies were not frequently visible. 
In the post-treatment samples, large lymphocytes and macrophages were seen making 
cytoplasmic contacts with dark staining cells, and with cytoplasmic bodies. As in pre-treatment 
samples, lymphocytes were the predominant cell type seen in contact with apoptotic-like cells, 
however, macrophages were seen in the epithelium in a small number of cases. Generally in the 
pre-treatment samples lobed nuclei of macrophages were not seen infiltrating the epidermis. 
The increase in the presence of macrophages in the epidermis of post -treatment samples may 
be due to the narural progress of the condition, and is unlikely to be due only to the effect of 
ketoconazole. It could be postulated that macrophages are present in the epidermis and dermis 
to clear the apoptotic cell debris and to remove any cytoplasmic bodies. In pre-treatment 
samples cytoplasmic bodies were seen in neighbouring epidermal cells, and contained within 
macrophage-like cells. In the post-treatment samples, very few macrophages were seen to 
contain the remains of epidermal cells. It was difficult to comment on the significance of this 
finding, as the plane of the sections examined may have prevented the visualisation of 
phagocytosed cytoplasmic bodies. 
The presence of a significant number of inflammatory cells, is not consistent with the classical 
process of apoptosis, where an immune response is avoided by the processing of cellular 
components into apoptotic bodies (Wyllie, 1980; Arends & Wyllie, 1991; White, 1993). 
However, there were numerous cytoplasmic bodies in the post-treatment samples which have 
not been phagocytosed. It may be the case that these cytoplasmic bodies, are in fact due to the 
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process of apoptosis, as anticipated, and that the inflammatory cells present are due to another 
factor linked to the syndrome. Streilein (1978, as cited by Bos & Kapsenberg, 1986), coined the 
term skin associated lymphoid tissues (SALT), to describe the cells present in the skin which 
have immunological properties, and are important in the initiation and development of an 
immune reaction (Table 6.0). 
Reactive oxygen species (ROS) mediated skin damage has been implicated in many 
inflammatory skin conditions (Trenman et al., 1992). The production ofROS in the skin may 
be due to the infiltration ofPI\.1Ns, UV radiation under aerobic conditions, drug toxicity, ageing 
and autoimmune disease. These processes essentially produce 0 2; the reaction and subsequently 
the toxicity of 0 2 ·therefore depends on its conversion to more cytotoxic species such as 
HP2 and .OH.H P 2• In immune mediated skin diseases such as allergic and contact dermatitis, 
it has been postulated that monocytes from patients with skin diseases produce more 0 2. than 
controls, creating an attenuated immune reaction. There is also evidence that ROS may 
contribute to other skin disorders. In patients with psoriasis, the number ofphagocytes, and the 
locomotion and adherence of these cells are increased. Psoriatic neutrophils have also been 
shown to release other mediators of inflammation, such as myeloperoxidase (MPO) and 
catalase (Trenam et al., 1992). 
Table 6.0 Skin associated lymphoid tissue (SALT) 
Skin Immune System (SIS) 
Keratinocytes 
Langerhans cells 
Intennediate cells 
Veiled cells 
Neutrophillic granulocytes 
Mast cells - connective tissue type 
Mast cells- mucosal type 
Vascular endothelial cells 
Lymphatic endothelial cells 
'Homing' T cells 
(Adapted from Bos & Kapsenberg, 1986) 
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Despite ketoconazole having an effect on the degree of sensitivity of the vestibule (see Chapter 
3), the ultrastructure of the vestibular epithelium did not appear to have altered considerably, 
and was not showing any evidence of returning to normal. Although dark staining cells, and 
leukocytes were present in the control samples, these cells were few in number and generally 
isolated. Perhaps, if treatment was continued for a further four months, the ultrastructural 
characteristics of the tissue may begin to resemble that of the control samples. Alternatively, 
women with VVS may have a greater proportion of apoptotic-like cells in the vestibular 
epithelia. This may be an inherent factor in the development of the vulvar discomfort, or a 
result of this syndrome. 
Patients treated with ketoconazole generally responded very well to this method of treatment, 
however, this may be in part, due to a form of the placebo effect. The trial ofketoconazole did 
not involve the inclusion of a placebo, as this was a pilot investigation and sample numbers 
were not sufficient to permit the inclusion of a placebo. The influence of the placebo effect, 
may give rise to similar results as those obtained in this investigation. Patients with VVS have 
frequently consulted several GP's and, or gynaecologists, who rarely diagnose VVS. 
Subsequently, when women are told that they have a recognisable condition, they immediately 
feel more positive, even though the treatment of VVS is difficult and often unsuccessful. A 
diagnosis ofVVS, may be sufficient to increase the well being of the patient, and consequently, 
reduce the amount of pain the woman reports on her next visit. However, this may also be due 
in part, to the bodies reaction to stress, which at increased levels is reported to result in an 
enhanced inflammatory response. Therefore, it must be considered that the effect of 
ketoconazole on the reported degree of sensitivity, may be due, in part, to a placebo effect. This 
is supported further, by the findings of the present investigation, that after completing a course 
of treatment, which may take up to 6 months, some women report that their symptoms return. 
These findings are also consistent with the results of this study, which did not show any 
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evidence of the tissue ultrastructure returning to normal. 
An alternative theory, is that the inhibitory effect of ketoconazole on the production of LTB 4, 
may reduce the inflammatory response sufficiently to reduce the degree ofvulvar sensitivity, 
however, wi1en treatment is ceased, LTB4 synthesis is resumed, and the pain returns. 
Ketoconazole is probably not targeting the cause of the problem in a majority of patients, 
however, a significant group of patients do show a complete recovery and remain in remission 
indefinitely. Successful treatment of this small group of patients, suggests that there may be yet 
another subgroup of patients with idiopathic vulvar pain who respond well to LTB 4 inhibitors. 
Alternatively, this may indicate that a subgroup of patients with VVS do in fact have a fungal 
infection which responds to treatment with ketoconazole. This is not however, consistent with 
the findings of other authors, who have reported, that very few VVS patients have Candida 
infections when they present with the symptoms ofVVS (Goetsch, 1991; Marinoff &Turner, 
1991, 1992; Bazin et al., 1994). If a stronger LTB 4 inhibitor was used, this may be sufficient 
to successfully treat all VVS patients, alternatively a longer course of treatment could be 
encouraged if side effects do not become apparent. 
A small percentage of VVS patients who did not respond favourably to treatment with 
ketoconazole, were subsequently treated with topical metronidazole gel. Several of the patients 
who received this treatment responded well, suggesting that this azole derivative, may also be 
of use for the treatment ofVVS in certain cases. The number of patients receiving this treatment 
were small and the results not consistent, therefore, a pilot study would be required to 
investigate the effects of metronidazole on VVS before a full trial could be supported. 
However, the fact that both metronidazole and ketoconazole have a similar effect on the 
symptoms of VVS, may suggest an analogous action of these drugs. It may be the case, that the 
anti-inflammatory property of these compounds, is not as important in the treatment of VVS 
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as the effect on androgen synthesis, which may be a complicating factor in the development of 
vvs. 
It has been reported by Stanisz et al. ( 1994 ), that women are more susceptible to auto immune 
disorders such as rheumatoid arthritis, systemic lupus erythematous, Sjogren' syndrome, and 
other diseases involving mucosal surfaces. These authors also reported that during pregnancy 
many aspects, including the symptoms of auto immune disease, are frequently found to show 
improvement. Estrogen has been shown to have a dose dependent, dual effect on the immune 
system, and may influence the functional activity ofT cells. Estrogen has been demonstrated 
to enhance (1 0 -10M) or inhibit (I o-7 M) IL6 induced IgM production by B cells. Estrogen 
receptors have been located in T suppressor cells , but not on T helper cells or on B cells. 
Receptors for estrogen are also found on monocytes, which produce ILl and IL6 in response 
to this hormone, and therefore may indirectly affect both T helper and B cells. Estrogen has 
been reported to elevate antibody (IgM) production in response to T dependent antigens, 
enhance T dependent B cell proliferation, and the expression of surface Ig on plasma cells 
(Stanisz et a/,. 1994). Macro phages function in terms of phagocytosis, lysosomal activity and 
ILl!IL6 production, has been shown to be increased in the presence of a physiological dose of 
estrogen, as is neutrophil chemotaxis and migration (Stanisz et al., 1994). 
Chemotaxis is a major mechanism by which polymorphonuclear leukocytes (PMNL), and other 
phagocytic cells move to the site of infection. The pain associated with VVS may be due 
indirectly, to chemotaxis, which does not necessitate the presence of an etiological agent or 
disease process. NK cells are able to d~grade and phagocytose dead cells and antigens. 
However, these cells differ from other phagocytic cells, as they may target cells in the absence 
of antibody or antigenic stimulation, and may be non-specifically activated by agents such as 
mitogens and interferon. Therefore NK cells may be recruited by any antigen activated T cell 
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which releases interferon. Recognition of antigen is a highly specific process which is mediated 
by T lymphocytes, which produce and release effector molecules resulting in an amplification 
of the inflammatory response. Disruption of this complicated chain of events could take place 
at any step, resulting in an abnormal, and possibly deleterious reaction. The way in which 
cytotoxic T lymphocytes (CTL) recognise and kill target cells is still undetermined to a certain 
degree. Several proposals have been suggested, however, a majority of authors agree that the 
mechanism of cell lysis by NK and CTL probably requires the presence of perforin and 
granzyrne and the formation of pores in target cells. Attack by CTL and NK cells, commonly 
results in apoptosis of the target cells, which involves fragmentation of the cellular DNA. This 
process may occur by cross linking of apoptosis-inducing cell surface molecules on the target 
cells. These molecules may include Fas which is part of the tumour necrosis factor (TNF) 
family and is a lytic effector molecule of CTLs (Berke, 1995). 
Polymorphonuclear (PMN) neutrophil granulocytes exhibit increased adherence, chemotaxis, 
degranulation and bacterial killing after stimulation with substances formed within an inflamed 
site (Rossi et al., 1993). These substances are essential for host defence but also result in tissue 
damage due to the extrusion ofPMNL lysosomal enzymes and the production oftoxic oxygen 
radicals (Plamblad et al., 1981 ). These authors showed that LTB4 stimulates neutrophil 
migration, aggregation and degranulation. In comparison L TC4 and 5 HETE were not found to 
stimulate PMN functions; suggesting a definite role of L TB4 in the inflammatory response. It 
was suggested by Plamblad et al. (1981 ), that LTB4 was formed in order to attract more 
neutrophils to an inflamed site. Fretland et al. (1993) illustrated that LTB4 elicits a dose 
dependent migration of PMNs when injected intradermally into guinea pig, and rabbit skin. 
These findings were also demonstrated in human skin, in addition, LTB4 was also shown to 
stimulate the proliferation of keratinocytes in culture. 
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The degree of chemotaxis and therefore the production of L TB 4 may be assessed by the 
production of myeloperoxidase, a neutrophil marker enzyme. This means of measuring L TB4 
has been used as a qualitative index for tissue inflammation in the gastrointestinal tract 
(Fretland et al., 1993). The production of L TB 4 could also be assessed in VVS samples with 
the use of a competitive radioimmunoassay, performed on tissue sections. This technique was 
described by Zimmerman et al. ( 1990), who demonstrated variations in the levels of L TB 4 
using two lipoxygenase inhibitors. These authors found that L TB 4 accumulation was a cause, 
rather than an effect of granulocyte infiltration. Another possible means of assessing the an1ount 
of L TB 4 present in tissues from women with VVS would be to use an immunological marker, 
and quantify the intensity of the reaction obtained. 
In summary, the effect of ketoconazole on the vestibular epithelium from VVS patients is 
unclear. Although there is a decrease in vulvar sensitivity, as assessed using the 'Vulvar 
Algesiometer' (Chapter 3), the ultrastructural characteristics of the tissue are unlike the control 
tissue, and more similar to the pre-treatment biopsies. The presence of a significant number of 
macrophage and NK-like cells in a majority of the biopsies, suggests that apoptotic-like cells 
and associated cytoplasmic bodies may be being cleared. However, there were numerous 
membrane bound, cytoplasmic bodies in both the epidermis and dermis in the post treatment 
samples, indicating that apoptosis may still be prevalent. 
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Schematic representation .of; vestibular epithelium from a ,patient wl.th VVS, 
posHreatmerit with ketoconazoie!Surface celis are flattened! (Su), with IJluge 
depostis of; glycogen; (G)_. Note particularly,, the presence o:t:iiarge numbers of 
membrane ~bound cytoplasmic ilobules (Ub); dark staining; shrunken, and. 
·vacuolated (V) epidermal cells (D) in the intermediate cell iayer (le), and the· 
,presence of leukocytes (Le} in: close 1contact with ,the dark celk A 
,polymorphonuclear leukocyte1(iPmn) is i1lustratedinear1to;a ptasma .cell ;QPl) in, 
the';dermisJbeneatii tiie I basement membrane ;(Bm), 
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Plate 27a 
Plate 27b 
LM photograph of vestibular epithelium (stained with methylene blue), 
four months post-treatment with ketoconazole. Dark staining cells are 
visible throughout the epithelium (D), individually, or in small foci 
particularly in the intermediate cell layer (le). Leukocytes are common 
in all cell layers (Le). A polymorphonuclear cell (Prnn) is visible in the 
lower part of the epithelium. x 500 
Semi-thin sections stained with methylene blue. Note the presence of 
dark cell (D) situated in foci along the basement membrane. x 800 
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x81!>0 
Plate 28a 
Plate 28b 
A darkened, vacuolated cell in the intermediate cell layer (le) of 
vestibular epithelium (D). Cytoplasmic lobules are seen in close contact 
with this cell (Lb ). x I 0,200 
Illustrating the highly vacuolated (V) cytoplasm of an apoptotic-like 
cell (D). Cytoplasmic lobules (Lb) are commonly associated with these 
dark staining cells; intact mitochondria are also present (M). x 10,000 
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Pl1itei29a 
Plate:29b 
. .. : . 
•,, I 
--· 
nlu~trating upper :intermediate cells which· have tbegun.to' flatten, Cytopiasrriic 
lobules are!common,~b),;desmosomal Junctions,~Be) are ma:ill.tainedJbetween 
apoptotic~iike cells (D),and normal appearmg epideriilall cells (le). ·X: 8,000 
!Intermediate cells Oc) in• close contact with•a group;of:cytoplasrriic lobules-(Lb) 
and a•smalllymphocyte (L). Surrounding.eplctermaltcelis:are slightly -vacuolated 
and,dark,stalriing (ID )tin appearance when·c6rripared.with the interri1ediate. c:ell 
:in.,thetop right ofthe;niicrographi~lc): x- 8J0do 
. -

Plate 30a 
Plate 30b 
Plate 30c 
Cytoplasmic lobules (Lb) containing polyribosomes, fme cytoplasmic filaments 
in the epidermis of a post-treatment sample. An unusual whorled structure is 
present in one of these lobules (* Plate 30b ), which has the appearance of a 
degenerating mast cell granule. This darker staining lobule, may in fact be a 
process of a nearby leukocyte I mast cell. x 22,000 
A high magnification micrograph of the above cytoplasmic lobule (Lb), 
illustrating the whorled structure present (*), and a neighbouring mitochondria 
(M). x 42,500 
Cytoplasmic lobules (Lb) situated in the dermis of a post-treatment sample. 
Nuclear material (N) is seen to be contained within one cytoplasmic lobule (Lb), 
no membrane is visible surrounding the electron dense nuclear material. A 
leukocyte (Le), which has the appearance of a NK cells makes close contact 
with several cytoplasmic lobules (Lb). x 34,000 
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Plate 31 Low power electron micrograph of the dermis, illustrating an area of loose 
connective tissue (C) close to a capillary, which is packed with cytoplasmic 
lobules (Lb). Nuclear material (N) is contained within one cytoplasmic lobule 
(Lb); the leukocyte (Le) present in this micrograph is large with a lobed nucleus 
and numerous mitochondria (M). 
X 12,500 
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Plate 32a & b Macrophage (Ma) in the dermis of a post-treatment sample. Seen in close 
contact with the basement membrane, these cells were more common in the 
dermis then in the epidermis. Frequently these cells were found to contain 
angular, electron dense material in numerous vacuoles (V). 
Plate 32 c 
Plate 32 a x 6,800 
Plate 32 b x 10,800 
Angular inclusions visible in the vacuoles (V) of a macrophage seen in loose 
connective tissue (C) close to the basement membrane. The nucleus of this 
macrophage is laterally displaced (Nu). x 15,000 
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Plate 33a & b High power electron micrograph of leukocytes (Le) in the epidermis of a post 
treatment biopsy. Leukocytes (Le) are seen to make close cytoplasmic contacts 
with epidermal cells (le). Often, small vesicles (V) are visible fusing with the 
outer membrane of the leukocyte, dispelling their contents into the inter-cellular 
space. Cytoplasmic folds (Cf) and desmosomal junctions (De) do not appear to 
be damaged by the movement of leukocytes. 
Plate 33 a x 40,000 
Plate 33 b x 50,000 
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CHAPTER SEVEN 
Quantification of histological parameters using image 
analysis 
7.0 Abstract 
TEM indicated three significant changes in the vestibular epithelium from VVS sufferers; a significant 
number of inflammatory cells, numerous apoptotic-like cells in all layers of the epithelium and 
undetermined membrane bound cytoplasmic bodies. Although these changes were quite pronounced in 
both the VVS and post-treatment biopsies, quantification using TEM was not able to be completed 
during this investigation. Therefore, light microscopy followed by image analysis, of control, VVS and 
post-treatment sections was undertaken using variations in the grey scale ofthe epithelium detected using 
a box transect. The analysis for the three groups indicated more dark staining cells in the VVS sections 
than in either the control or post-treatment samples. This was demonstrated by plotting the average grey 
scale values for each point along a transect line; areas of the epithelium containing densely stained cells 
resulted in a marked variation in vertical profile (i.e."spiky"), accompanied by a characteristic reduction 
in grey scale across the epithelium. This type of pattern was seen in all of the VVS samples, and to a 
lesser extent in the post-treatment biopsies. The control samples however, showed a smoother profile 
indicating a lack of densely stained cells. 
Leukocyte profile densitywas estimated using a Weibiel stereological graticule to quantify differences 
in inflammatory cell numbers in each of the three sample groups. Normal vestibular epithelium, 
characteristically showed only a small number of leukocytes in the dermis and epidermis, but in the VVS 
and post-treatment biopsies there were many more leukocytes present, also, there was a distinct difference 
in the leukocyte counts in the control and VVS biopsies. However there was no significant difference 
in the counts for the pre and post-treatment samples, suggesting that the number of leukocytes may 
remain similar despite a reduction in vulvar sensitivity. 
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7.1 Introduction 
Biopsies of vestibular epithelium, taken from VVS patients, were found to have distinct 
ultrastructural characteristics which were not evident in the control samples. These differences 
centred around the presence of a large number of dark staining, apoptotic-like epidennal cells. 
Associated with these cells were numerous lobules of cytoplasm which did not appear to have 
any cellular origin when serial sections were examined. Cytoplasmic lobules were found in 
close contact with apoptotic-like cells and with leukocytes. In post-treatment samples the 
number of apoptotic cells appeared to be very similar to the pre-treatment biopsies, however, 
these cells were more highly vacuolated than in the pre-treatment samples. This may be due to 
the natural progression of the process of apoptosis, or, alternatively, may be due to the effect 
of ketoconazole (see Chapter 6). The number of cytoplasmic bodies was greater in the post-
treatment samples than in the pre-treatment samples, suggesting a continuation of apoptosis. 
The number of inflammatory cells appeared to be similar in both groups. In the pre-treatment 
samples, the inflammatory cells present were predominantly lymphocytes and plasma cells, 
which was consistent with the findings of Pyka et al. (1988) and Prayson et al. (1995). 
Pathological reports on VVS have described a mild to moderate, mixed inflammatory infiltrate, 
which is not indicative of a particular disease process. This is consistent with the observations 
of the present investigation where a moderate inflammatory response was a common finding. 
It was not possible to estimate the number of intensely staining, apoptotic-like cells using TEM, 
as cells at various stages of change were present. However, it was obvious using TEM that there 
was a greater proportion of dark staining, apoptotic-like cells in the VVS samples when 
compared with the controls. Problems in quantification arose during the examination of post-
treatment samples, which appeared very ultrastructurally similar, to the pre-treatment samples. 
It was important that any changes in the number of dark staining epidermal cells be quantified 
in some way, as the effect of ketoconazole may manifest itself as a change in the proportion of 
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intensely staining cells in the epithelium. The number of leukocytes in the tissue sections, also 
needed quantification, as this may indicate the intensity of the cellular immune response. 
Quantification of the individualleukocyte types was not undertaken, as this had already been 
attempted by Pyka et al. (1988) and Prayson et al., (1995). 
In summary, the principal aim of this part of the investigation, was to quantifY any difference 
in staining intensity evident between control, VVS and post-treatment biopsies, which may 
indicate the frequency of apoptotic-like cells present. Additionally, in order to demonstrate any 
differences in the inflammatory response in the three groups, the leukocytes profile density of 
the tissue sections was also quantified. 
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7.2 Methods 
Semi-thin (0.4 - 0.5pm) sections taken from TEM blocks were used for the quantification 
process. Sections were collected on slides, and stained with I% methylene blue, for exactly I 
minute. Three groups of slides were examined using a Quantimet 570 image analyser; controls, 
VVS, and post-treatment VVS samples. A programme was written (see Appendix 4) to measure 
the grey scale through the epithelium (Fig. 7.0). Images were acquired by attaching a Fujitsu 
General CCD, black and white camera to a Zeiss photo-microscope 11, at an objective 
magnification ofx20 and a photo eyepiece ofx3.3. The images were digitised as a 256 grey 
scale, 512 x 512 pixel image using the Quantimet 570, and analysed using a macro (Appendix 
4). This allowed a box transect to be positioned over the section. Using the box transect, a 
horizontal profile of lines was created and used as a mask to detect grey levels (Fig. 7 .I) 
Figure 7.0 Schematic diagram of the quantification procedure 
Cambridge • 
VVS 
Controls vvs 
Leukocyte Profile 
Density 
11 slides I group 
2 readings I slide 
Measurement of 
Grey Scale 
5 slides/ group 
5 readings I slide 
Post treatment 
vvs 
(* Cambridge samples were not included in the measurement of grey scale) 
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7. 21 Leucocyte counts 
An estimation of the leukocyte profile density of a section (N J was calculated using a Weibiel 
stereo logical graticule (Williams, 1977). The number of leukocytes was estimated for control, 
Cambridge (VVS), Plymouth (VVS), and post-treatment (Plymouth) samples. Patients from 
Cambridge had been diagnosed using the same criteria for VVS as established by Friedrich 
(1987). These samples were also examined by a pathologist to ensure no other pathological 
problems were evident. Using a light microscope, a Weibiel stereological graticule was 
superi~posed over the section, positioned randomly to cover approximately an equal area of 
the epidermis and the dermis (Fig. 7.1) (Appendix 5).Two counts were completed for each 
slide, and the mean of these readings was recorded. A positive count was recorded only if the 
point sample intersect of the graticule bar was positioned over a leukocyte. If the graticule was 
positioned so that part of it was not covering the section, the number of intersections was 
reduced accordingly (see Appendix 5). 
Figure 7.1 Schematic diagram of grey scale estimation using a box transect. and leukocyte 
counts using a Weibiel stereological graticule. 
Box transect 
Epidermis 
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7.22 Grey scale estimation 
Analysis of grey scale was completed to determine the frequency of intensely staining, 
apoptotic-like cells. The image analysis programme, involved the measurement of grey scale 
along a 13.92t.J.m wide line of 30 pixels to produce an average value. This measurement was 
repeated in I pixel steps of0.464t.J.m, giving a set of324 readings for each box transect. Three 
groups of slides were used, VVS, post-treatment and controls (Fig. 7.0). Seventy five box 
transects were completed, twenty five for each of the three groups (five I slide) (Fig. 7.2). The 
data sets for each slide were imported onto a Quattro Pro spreadsheet and the mean calculated 
for each grey scale point. The mean values for each of the five slides in a group were plotted 
on a stacked line graph, and the cumulative average of these calculated (Fig. 7.2). Statistical 
analysis was completed using Excel 5.0 and Statsgraphics for Windows. 
Figure 7.2 Grey scale analysis using the image analyser 
l Control I I vvs I I Post-trea tm en t l 
~ / 
(A) Intra-slide variation 
5 readings I slide - representative 
graphs show the grey scale plot for 
the 5 individual readings+ an 
average reading for each slide 
(B) Intra-group variation 
5 slides I group - representative 
graphs show the grey scale plot for 
five slides in each group. Average 
slide readings were plotted to give a 
cumulative group average. 
(C) General overview of grey scale 
Line plot of the cumulative average for 
the three groups calculated from (B) 
averages 
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7.3 Results 
7.31 Leukocyte profile density 
One-way analysis of variance, illustrated highly significant differences between the numbers 
of leukocytes in the four groups (p>0.0001 ). There was a significant difference between the 
control slides, and all three groups ofVVS slides, however, there was no difference in the pre 
and post-treatment leukocyte profile density (Table 7.0, Fig. 7.3). The control samples gave an 
average profile density of2.4 leukocytes I graticule ± 1.4, compared to 8.4±3.18 for Cambridge 
(VVS), 5.22±2.09 for Plymouth (VVS), and 4.77±2.48 for the post-treatment samples (Table 
7.0). Control data was greatly influenced by one profile density of7leukocytes I graticule (Fig. 
7.3). Apart from this outlying result, control biopsies demonstrated counts of between 0-4 
Ieukocytes I graticule, the majority of samples demonstrated counts clustered around 2 and 3 
leukocytes I graticule (Fig. 7.3). The standard deviation from the mean was lower in the control 
samples than in the other groups (Table 7 .I). 
In comparison to the controls, the VVS and post-treatment groups showed more variation, 
particularly variation within the groups. The samples from Cambridge demonstrated the highest 
average count (8.4 leukocytes I graticule), however, the standard deviation from the mean was 
also the highest in this group. The pre and post-treatment samples showed similar average 
values, and no statistical difference was seen between these two groups. The post-treatment 
samples showed a wide range of readings from 1-1 0 Ieukocytes I graticule, which was very 
similar to the range of counts obtained from VVS samples (2-1 0). The range of counts from 
Cambridge VVS patients was different, 4-16 leukocytes I graticule. The coefficient variation 
(CV), i.e., the relationship of the mean and standard deviation demonstrated that the post-
treatment group and the control group were similar in respect to leukocyte profile density. In 
comparison the VVS samples from Plymouth and Cambridge illustrated similar coefficient 
variation, which was lower than the post treatment and control groups (Table 7.1). 
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Table 7.0 Table of mean values for leukocyte counts (leukocytes I graticule) 
Identification Mean Lower Limit Upper Limit Group 
(Leukocytes I graticule) 
Control 2.40 1.69 3.12 
Cambridge 8.40 7.69 9.12 2 
vvs 5.22 4.51 5.94 3 
Post -treatment 4.77 4.05 5.48 3 
Table 7.1 Standard deviation of leukocyte count illustrating maximum and minimum values 
Identification Standard deviation Coefficient Minimum Maximum 
(Group) from the mean Variation Leukocytes/ Leukocytes/Graticule 
(CV) Graticule 
Control 1.40 58.3 0.0 7.0 
VVS Cambridge 3.18 37.8 4.0 16.0 
VVS Plymouth 2.09 40.0 2.0 10.0 
Post-treatment 2.48 51.9 1.0 10.0 
7.32 Grey scale 
The type of grey scale plot obtained using this technique is illustrated in Figure 7.4. The 
position of the epithelial surface and the basement membrane are indicated. The depth of the 
area plot is an indication of the grey scale (i.e., the average recorded across a 30 pixelline), and 
therefore the staining intensity of the epithelium along the horizontal transect. The y-axis 
represents the grey scale, 200 and above, being pale staining (i.e., background resin), and values 
below 200 being a shade of grey (i.e., part of the tissue section). The x axis is distance along 
the line of analysis (0- 1 SOj.im). The plots for each of the readings are stacked and the average 
is shown as the bottom plot of the graph in contact with the x-axis (black).The differences in 
grey scale for the three groups of samples, which were calculated using the image analyser, are 
demonstrated in Figures 7.5- 7.7. 
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(A) Intra-slide variation - Individual readings. 
The grey scale plots obtained from the five readings I slide were very similar in all three groups 
of slides. Individual readings from VVS slides demonstrated a marked variation in vertical 
profile, producing a 'spiky' grey scale plot (Fig. 7.5). The average grey scale plot for this 
representative VVS slide is illustrated at the bottom of the area graph. The 'spiky' appearance 
of this representative plot is characteristic of all of the VVS samples measured. The appearance 
of the average plot, illustrates a change in staining intensity, which is quite considerable from 
the surface of the epithelium to the basement membrane. There are areas in this average plot, 
where many dark staining cells were encountered during the measurement of grey scale, 
however, this is more clearly demonstrated in the individual plots (Fig.7.5). 
The representative post-treatment sample also demonstrated an uneven profile, and some intra-
slide variation, which was a common observation in this group of samples (Fig. 7.6). The 
average plot for this slide is quite uneven, however the profile of the plot is uniform, and does 
not appear to taper significantly. 
The control sample illustrated a relatively uniform staining intensity throughout the epithelium, 
illustrated by the smooth plot profile (Fig. 7.7). There was a slight increase in overall staining 
intensity from the surface to the basal cells, illustrated by a slight taper towards the middle of 
the grey scale plot. Towards the left hand side of this plot, the pattern becomes slightly uneven, 
this represented an area of dermis in the control sample (Fig. 7. 7). 
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(8) Intra-group variation- Average plots /slide 
The uneven, 'spiky' appearance of VVS data plotted from individual slides (A), was evident 
in all five of the VVS slide averages, but was not as pronounced as the profiles of the individual 
plots (Fig. 7.8). Some of the average slide readings when plotted, showed a very tapered 
profile, indicating the presence of a dark staining area of epithelium. The most tapertd areas, 
of the VVS plots, seen in the middle part of the graph, were quite smooth in appearance in a 
majority of the VVS slides. Towards the left hand side, the plots became slightly uneven, this 
was followed by a decrease in grey scale and flattening of the vertical profile. The cumulative 
average plot of the five slides is seen at the bottom of the graph. Despite being an average plot, 
variations in the grey scale representative of staining intensity are evident. The average plot of 
the VVS slides, illustrates an uneven, and slightly tapered plot towards the basement 
membrane, after which there is an increase in grey scale (decreased staining), representing the 
dermis and the surrounding resin. 
The post-treatment samples clearly demonstrated some intra-group variation (Fig. 7.9). Some 
of the slides illustrated an uneven plot, with a jagged profile, whereas others, demonstrated an 
even plot, and had a smooth appearance. The area profile of the cumulative average plot, from 
post-treatment samples is illustrated at the bottom of the graph. Although being slightly uneven 
where dark cells were encountered, this plot was very uniform, and did not appear to be tapered. 
Control slides demonstrated only minimal variation within the group. The pattern of the plot 
was similar in all cases, however, some slides demonstrated a more jagged plot than others. 
The cumulative average plot from the control slides, is smooth in appearance and slightly 
tapered towards the middle of the plot followed by an increase in grey scale towards the right 
side of the plot ( Fig. 7.1 0) 
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(C) General overview of grey scale plots from VVS. post-treatment and control biopsies. 
The area cumulative average plots (C) for VVS, post-treatment, and control samples are 
illustrated in Figs. 7.11 - 7.13. It can be seen from the line plots, that the post-treatment average 
plot, illustrates minimal change in grey scale through the epithelium. However, the tapering 
pattern, from surface to basal cells is evident in all three of the line plots to various extents, and 
is seen most clearly in the control plot. The tapering of this plot illustrates the change in 
staining intensity in a normal epithelium, which involves an increase in staining intensity 
moving from surface cells towards basal cells. In ~ontrast the VVS line plot shows 
considerable variation in the grey scale, and the profile of this line plot is extremely uneven. 
A correlation was completed for the average, and cumulative average data from control, VVS 
and post-treatment samples. The correlation coefficient between samples was calculated: 
P x, y = Cov (X,Y) 
ox. oY 
(From Excel 5.0) 
Relationship of x & y = Covariance of the two data sets 
Product of their standard deviation 
It was demonstrated that the cumulative average readings for VVS and post-treatment samples 
were quite closely correlated (correl. 0.893), whereas, the control and VVS did not show much 
similarity (correl. 0.36). The post-treatment and control data was not closely correlated (correl. 
0.499). However, there was a variation in the correlation within each of the three groups of 
samples examined. The control group demonstrated two samples, C and E which produced 
readings which were not closely correlated with the other samples in the group (Table 7.2). 
These two samples were however, quite similar to each other (correl. 0.672). Samples in the 
VVS group were quite closely correlated, correlation coefficients of0.7 and 0.8 were common 
(Table 7.3). In the post-treatment group the correlation between the samples showed 
considerable variation, generally a correlation coefficient of 0.5-0. 7 was obtained. However, 
sample B was found to show very little correlation with the other samples in this group (Table 
7.4). 
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(C) General overview of grey scale plots from VVS. post-treatment and control biopsies. 
The area cumulative average plots (C) for VVS, post-treatment, and control samples are 
illustrated in Figs. 7.11 - 7.1 3. It can be seen from the line plots, that the post-treatment average 
plot, illustrates minimal change in grey scale through the epithelium. However, the tapering 
pattern, from surface to basal cells is evident in all three of the line plots to various extents, and 
is seen most clearly in the control plot. The tapering of this plot illustrates the change in 
staining intensity in a normal epithelium, which involves an increase in staining intensity 
moving from surface cells towards basal cells. In contrast the VVS line plot shows 
considerable variation in the grey scale, and the profile of this line plot is extremely uneven. 
A correlation was completed for the average, and cumulative average data from control, VVS 
and post-treatment samples. The correlation coefficient between samples was calculated: 
P x, y = Cov (X,Y) 
where -l..,;pxy~l 
Cov (X,Y) = _1 L (x1 -.uxHYI -,Uy) 
n 
It was demonstrated that the cumulative average readings for VVS and post-treatment samples 
were quite closely correlated (carrel. 0.893), whereas, the control and VVS did not show much 
similarity (correl. 0.36). The post-treatment and control data was not closely correlated (carrel. 
0.499). However, there was a variation in the correlation within each of the three groups of 
samples examined. The control group demonstrated two samples, C and E which produced 
readings which were not closely correlated with the other samples in the group (Table 7.2). 
These two samples were however, quite similar to each other (correl. 0.672). Samples in the 
VVS group were quite closely correlated, correlation coefficients of 0.7 and 0.8 were common 
(Table 7.3). In the post-treatment group the correlation between the samples showed 
considerable variation, generally a correlation coefficient of 0.5-0.7 was obtained. However, 
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A correlation was completed between each individual slide in a group, the data used for this 
correlation is an average of 5 grey scale plots I slide. Each table represents a group of samples 
either VVS control or post-treatment. In each group there are 5 slides (n=5) A - E, F is the 
average of all of the 5 slides in the group. 
Table 7.2 The correlation coefficients for control samples. 
CONTROL A B c D E F 
A - 0.943 -0.212 0.959 0.277 0.908 
B - - -0.339 0.928 0.194 0.835 
c - - - -0.209 0.672 0.183 
D - - - - 0.195 0.902 
E - - - - - 0.556 
Table 7.3 The correlation coefficients for VVS samples 
vvs A B c D E F 
A - 0.550 0.749 0.611 0.551 0.880 
B - - 0.393 0.849 0.746 0.829 
c - - - 0.654 0.589 0.774 
D - - - - 0.851 0.906 
E - - - - - 0.886 
Table 7.4 The correlation coefficients for post-treatment samples 
POST A B c D E F 
TREAT 
A - 0.560 0.151 0.723 0.630 0.755 
B - - -0.266 0.168 0.240 0.316 
c - - - 0.456 0.587 0.706 
D - - - - 0.778 0.840 
E - - - - - 0.910 
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'I3ox & Whisker.' ,plot of leucocyte counts fromVVS (Plymouth &:'Cambii<;!ge), 
control ,iand' post ~treatment samples: •Illustrating: the ~ange,; and mean l~Ukoc~e 
icounts .Refer to Appendix 6;for,an;explanation,ofthe:8o)( & Whisker:Plbt. 
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Figure 7.5 
Figure 7.6 
Representative grey scale plot of a VVS sample. Five individual readings were 
taken for each slide, and an average of these readings was calculated. The six 
resulting plots are shown stacked on top of each other, with the average at the 
bottom along the x-axis (black). They-axis relates to gray scale, the range for 
each plot is 0-200 approximately. 
Representative grey scale plot of a post-treatment sample from a VVS patient. 
Five readings were taken, and the average calculated, the five plots are shown 
stacked on top of each other in order to compare the profiles. The average plot 
is shown at the bottom of the graph in contact with the x-axis (black). 
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Figure 7.7 Representative grey scale plot from a control sample. The five individual 
readings were averaged to produce the plot which is situated at the bottom of the 
graph, in contact with the x-axis. The five plots are shown stacked together, to 
demonstrate differences in the profiles. 
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Figure 7.11 Line plot, illustrating the profile pattern obtained when the grey scale was 
measured across the epithelium. Representing the cumulative average reading 
for the VVS group. 
Figure 7.12 Line plot of grey scale, illustrating the cumulative average reading for the post-
treatment group. 
Figure 7.13 Line plot of grey scale, illustrating the cumulative average reading for the 
control group of samples. 
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7.4 Discussion 
The changes in vestibular epithelium due to VVS, which have been reported in the present 
investigation (Chapters 4 & S),were unable to be quantified using TEM. As these were novel 
findings, not previously described in association with VVS, it was important to attempt some 
quantification of these results. It was anticipated, that the intensely staining cells seen using 
TEM, were apoptotic-like, and that these cells and associated structures were linked to the 
development or maintenance of vulvar pain associated with VVS. Investigations of the 
pathology of VVS are sparse; however, past investigations have found that VVS is 
characterised only by having a mild to moderate inflammatory cell infiltrate close to the 
basement membrane and surrounding the minor vestibular glands. Some authors have attempted 
to type the inflammatory cells present, but have found no evidence to link this condition to a 
particular disease process (Pyka et al., 1988; Prayson e1 al., 1995). The visualisation of 
apoptotic-like cells in this epithelium is, therefore, an important observation, and may be a key 
link to the pathology of the syndrome. It was necessary to demonstrate that these cells were in 
fact extremely common in the VVS and post-treatment samples, but were rarely visible in the 
control samples. 
Leukocyte counts from control, VVS and post-treatment samples, demonstrated a significant 
difference between the groups (p<0.0001). It was confirmed that VVS samples had a 
significantly greater number of leukocytes in the epithelium than was evident in control 
samples. It was interesting to note that there was no difference in the number of leukocytes in 
the VVS and post-treatment samples. This may indicate, that there was no change in the 
inflammatory response due to treatment with ketoconazole (see Chapter 6). However, 
examination using TEM, demonstrated that the type of inflammatory cells present prior to 
treatment were different from those seen in the post-treatment samples (see Chapter 6). The 
use of immunological markers for various 8 and T cell types, and for Langerhans cells, may be 
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useful in elucidating change in the inflammatory response over time in this condition. 
The pattern of the grey scale plots varied between the three groups, and also within the groups. 
The control plots were smoother in appearance than the VVS and post-treatment plots, and were 
generally tapered in appearance, becoming thinner through the transect. All of the control slides 
demonstrated a tapering of the plot consistent with a gradual increase in staining intensity 
towards the basement membrane. Some of the control samples did show areas where the plot 
was uneven, and where dark cells were expected to be found. However, this was not as 
pronounced as in the VVS samples where the plot had an extremely 'spiky' and uneven 
appearance (Fig. 7.5 - 7.7). The post-treatment samples showed similar grey scale plots to 
those obtained from the VVS samples. However, these plots demonstrated less variation in the 
vertical profile, i.e., were less 'spiky', and the change in staining intensity not so pronounced 
as in the VVS samples. 
Samples from VVS patients produced an uneven plot, indicative of an epithelium with many 
dark cells. The average plot of the five slides in the VVS group demonstrates this extremely 
uneven 'spiky' appearance (Fig. 7.8). However, the variation in profile of the plot, indicative 
of change in grey scale and staining intensity, is seen more clearly in the individual slide plots, 
and in the line plot (Figs. 7.5 & 7.11). From these plots it can be seen, that there are areas in all 
of the VVS slides where dark cells are concentrated, this is illustrated by a decrease in the 
profile of the plot, which indicates a decrease in grey scale. In the VVS samples, the majority 
of the plots demonstrated a decrease in the profile, in the middle of the plot. This was also 
evident in the post-treatment and in the control samples (Figs. 7.6 & 7.12). However, the 
degree of change in the grey scale was the greatest in the VVS samples. All of the line plots 
were tapered in appearance, this was particularly clear in the control plot (Fig. 7.13), where a 
gradual decrease in staining intensity was observed moving from superficial cells to basal cells, 
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i.e., moving from the left, to the middle of the plot. This confirms the fmdings of light 
microscopy, where slides stained with 1% methylene blue, demonstrated a gradual increase in 
staining intensity from the surface towards the basement membrane. This change in staining 
was only affected by the presence of leukocytes in the epidermis, which stained intensely with 
methylene blue. 
The variation in staining within a slide did not appear to be significant, however a statistical 
analysis would be required to confirm this observation. A one-way analysis of variance could 
be completed on the individual readings for each slide, to determine whether the variation 
\Vi thin each slide is greater than the variation between slides. A statistical analysis would also 
be useful to determine whether the differences observed in the control and VVS samples were 
significant or due to chance. 
The presence of leukocytes may also affect the grey scale and, therefore, the pattern of the area 
plot. The presence of a significant number of leukocytes in both the epidermis and the dermis 
in VVS and post-treatment samples, may result in an increase in the grey scale. Leukocytes 
were particularly evident in the dermis, immediately below the basement membrane, and in the 
basal and lower intermediate cell layers of the epidermis. This may account for the large 
increase in staining intensity illustrated in the cumulative line plot for VVS. The cumulative 
line plot for the post-treatment samples, was not however, consistent with this theory. The 
average post-treatment plot showed very little variation in staining intensity, and produced a 
more uniform plot than the control samples. It is possible that the intra-group variation in the 
post -treatment group was so great, that the cumulative average is a false representation of this 
group of samples. It was anticipated that the slides from the post-treatment group may produce 
a confused picture, as some of the response to treatment with ketoconazole was not uniform. 
Some patients responded quickly, and made a complete recovery over several months. 
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However, there were several patients in this investigation who did not see any decrease in 
vulvar sensitivity over four months. It may be the case, that samples from patients who 
responded well to treatment with ketoconazole, result in plots similar in profile to those 
obtained from control patients. In comparison patients showing a poor response to treatment 
may demonstrate a plot similar to that obtained from VVS samples. This is in part, consistent 
with the findings of the ultrastructural investigation, which indicated that there was a similar 
number of apoptotic-like cells present in the pre and post-treatment samples. However, it is 
obvious from the results of the ultrastructural investigation of the effects of ketoconazole, and 
the results of the image analysis, that post-treatment samples may be more variable than first 
anticipated. This finding is also consistent with the correlation data, which demonstrated that 
there was only moderate correlation within the post-treatment group when compared with the 
VVS and control groups (Tables 7.2- 7.4). 
Image analysis has proved useful for both the quantification of leukocytes in the tissue sections, 
and for the determination of grey scale indicative of dark cells. There are however, several 
drawbacks to the use of image analysis in this context. The resin sections, although stained for 
the san1e amount of time and viewed using the same level of illumination, demonstrated 
variations in the staining intensity of the resin. This may be due to the vagaries of resin 
polymerisation, and it was anticipated that this would affect the results obtained. Consequently 
a large sample number would be required in order to sufficiently diminish variations due to 
variable resin staining. The measurement of grey scale to detect dark cells, will also detect 
leukocytes in the epidermis and dermis. These were more common in VVS and post-treatment 
samples than in the control samples, and consequently the presence of these leukocytes may 
accentuate the differences between these groups. 
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The use of the image analyser to quantify differences between control, VVS and post-treatment 
samples, may be improved by the use of wax embedded sections. Although sections from each 
group would need to be stained side by side, the use of stains for light microscopy, such as 
Giemsa or Mallorys trichrome would be more specific and easier to control. This may reduce 
the degree of staining variation, and prevent background staining which was observed in many 
of the resin sections in the present investigation. Alternatively methacrylate, LR white or 
Lowicryl resins could be used, which would provide excellent staining and contrast for image 
analysis. The use of histological staining techniques may also allow other parameters to be 
investigated, such as the nwnber of Langerhans cells, the number and distribution of leukocytes, 
and also a more accurate analysis of the nwnber of apoptotic-like cells. Fluorescence 
microscopy, or immuno-gold labelling may also be used in conjunction with image analysis, 
to quantify the amount of a particular protein or antigen in the tissue. 
Another use of image analysis which may be viable in future investigations of VVS, included 
the estimation of the volwne fraction (Vv) of the epithelia taken up by dark staining, possibly 
apoptotic cells. In order to do this, tissues could be embedded in methacrylate resin to enhance 
section staining. The area of the section occupied by the dark staining cells, could be 
investigated using a threshold, or detect setting after image processing. A high pass filter which 
exaggerates differences, and sharpens and accentuates the image would be useful for this 
technique, and would indicate the number and position of the dark staining cells in the 
epithelium. This would not have been of use for the measurement of grey scale, as high pass 
filter accentuates differences which were not really apparent, therefore, producing false data by 
increasing noise. 
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Image analysis may also be utilised for the measurement of other features visualised using 
TEM. One characteristic feature ofVVS samples which may be quantified using image analysis 
is the number of cytoplasmic lobules present, as these structures appear to be related to the 
presence of dark staining, apoptotic-like cells. These membrane bound cytoplasmic lobules 
may be by-products of apoptosis, however, they may also be dendritic processes of Langerhans 
cells. Image analysis may permit the quantification of these structures in TEM negatives from 
VVS samples, and allow a correlation to be made between the presence of dark staining cells 
and the number of cytoplasmic bodies. If no correlation is evident, and the cytoplasmic bodies 
are not positive for immunological markers for apoptosis, staining for Langerhans cells may 
elucidate their origin. This could be performed using fluorescence microscopy, which provides 
excellent contrast for image analysis. Alternatively, this analysis could be performed by direct 
image analysis on the Jeol 2000FX TEM, using the facility on the X-ray analysis package. This 
could also be completed by collecting digitised images on the TEM, and analysing them using 
the Quantimet 570. 
In conclusion, the use of image analysis has permitted the quantification of the inflammatory 
response in terms of leukocyte numbers, and has demonstrated differences in the grey scale in 
control and VVS samples which may be due to the presence of apoptotic-like cells in the VVS 
samples. The presence of apoptotic-Iike cells should be investigated further with the use of 
immuno-cytochemistry, and should involve an larger study group in order to minimise the 
variation within this group of patients. Markers for apoptosis, such as Bcl2 or Bax could be 
used in order to detect cells which are prone to programmed cell death, or cells that are in the 
process of dying. As outlined above, image analysis will be important in further investigations 
ofVVS, where it may be used for the quantification of cytoplasmic bodies, leukocyte types, 
and for the quantification of immunochemistry of apoptotic cells. 
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CHAPTER EIGHT 
General Discussion 
A revie"v of the current literature on VVS illustrated that a majority of the work on VVS has 
emanated from the USA, and that a high percentage of these studies were treatment orientated. 
A majority of past investigations, have focused on the detection of HPV in VVS biopsies, and 
subsequent treatment with interferon (Friedrich, 1988; Horowitz, 1989; Hatch, 1991; 
Bornstein e1 al., 1991, 1993; Waltzman & Wade, 1991). Very few of these investigations 
intended to examine the vestibular tissue in detail, which has resulted in a paucity of reports 
describing the inflammatory response associated with this condition. Pyka et al. ( 1988), and 
Prayson et al. ( 1995), have completed the most extensive studies of the pathology of VVS, 
but have found very little to indicate the involvement of a particular infectious agent or 
allergen. Past reports of the inflammatory response are consistent, and indicate that VVS is 
characterised by a mild to moderate inflammatory cell infiltrate, which is dominated by 
lymphocytes and plasma cells. The degree of inflammation, the type of inflammatory cells 
present, and the distribution of these cells has not been attributed to a particular disease 
process, or immunological reaction (Pyka et al., 1988). 
One of the initial aims of the investigation was to ensure that the study cohort ofVVS patients 
described similar symptoms, and gynaecological histories when compared with VVS patients 
described in previous investigations (Goetsch, 1991; Marinoff & Turner, 1991, 1992; Bazin 
e1 al., 1994). The epidemiological characteristics of the VVS patients in this study were 
described in detail in Chapter 3, this chapter also demonstrated the value of assessing vulvar 
sensitivity using the 'Vulvar Algesiometer '. 
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Past investigations have concentrated mainly on the epidemiological characteristics of their 
VVS patients, and only one of these studies has included a control group for comparison of 
data (Goetsch, 1991 ). Despite being a small pilot study, the present investigation included a 
control population of women, and explored several new areas which have not previously been 
examined. New approaches have included an examination of the use of self treatment, the 
perception of pain, and treatment by clinicians. The VVS patients were found to be similar 
biographically to patients described in other studies; all were white, an average age of27.7 
years, and commonly in stable monogamous relationships. The VVS population in the present 
study did not commonly develop VVS postpartum, and 68.2% of the VVS patients were 
nulliparous. This investigation demonstrated several differences between the control and VVS 
group, particularly in relation to the history and location of past irritations, the description of 
the pain experienced, and inconsistencies regarding the diagnosis by GPs. It was concluded, 
that many of the questions included in this pilot investigation. may be omitted in a larger 
investigation, as the questionnaire covered too broad an area. Areas of particular interest, 
which could be expanded in a full scale investigation, included: the type and use of oral 
contraceptives, the incidence of cystitis and urogenital syndromes, a detailed history of past 
infections and irritations, and the treatments prescribed. Vestibulitis patients would be asked 
more detailed questions regarding their perception of pain. and would be provided with charts 
and pain scales, to map cyclic variations and pain intensity over several months. 
The utilisation of a pain assessing instrument, the 'Vulvar Algesiometer', in accordance with 
the questionnaire, and anatomical investigation, formed a novel and balanced approach to the 
study of VVS. Although the measurement of vulvar pain is extremely subjective, there is no 
alternative means available as yet, for assessing the severity of VVS, or the improvement in 
vulvar sensitivity in response to treatment. Despite variations in pain perception between 
patients, and in individual patients over time, this means of assessment provided excellent 
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results. The initial, cumulative readings from control and VYS patients were significantly 
different, the mean cumulative score for control patients was 26.5 ± 4.85, whereas VVS 
patients demonstrated an average score of 6.9 ± 5.89. Yestibulitis patients were assessed over 
a four month period, during which time they were treated topically with 2% ketoconazole 
cream (Nizoral, Janssen Pharmaceuticals, l:klgium). The cumulative readings over three 
months were significantly different, and vulvar sensitivity was seen to improve steadily over 
this time. However, after three months treatment with ketoconazole, there was no further 
significant decrease in vulvar sensitivity. There was also no significant difference in the 
readings of patients who received treatment with imipramine in addition to ketoconazole, 
when compared with patients who received just ketoconazole. This was surprising, as it was 
anticipated that even a small dose of imipramine may be sufficient to alter the patients 
perception of pain, or the degree of stress, both of which may alter the reported level of pain. 
Algesiometer readings from the Skenes' and Bartholins' glands also showed variation. 
Commonly readings were significantly lower on the Bartholins' glands than on the Skenes' 
glands (p=0.0034). This is consistent with past investigations, which have often described 
'membraneous hypertrophy' or 'acute sensitivity' of the Bartholins' glands in cases ofVVS 
(Michelwitz et al., 1989; Barbero et al., 1994). The information obtained from the assessment 
of patients using the algesiometer was valued by both the clinician and the patient. 
Consequently, the assessment ofVVS patients is continuing in several G.U.M. clinics in the 
S.W. region, where some patients have been assessed for eight months or more. 
This study has indicated many of the potential difficulties involved in the study of a 
gynaecological condition, particularly one with an unspecified cause. Despite this, several 
interesting pathological characteristics of VVS have been described, which have not 
previously been reported. These findings centre around the presence of apoptotic-like cells, 
which were visualised using electron microscopy. The description of these cells and 
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associated ultrastructural characteristics, may provide a platform for future studies ofVVS. 
The ultrastructure of the normal vulva had not been described previously, and as this 
investigation required a detailed knowledge of normal vestibular epithelium, this became a 
primary aim of the investigation. The ultrastructural of the normal human vulva, and the 
differences in appearance due to the effect ofVVS formed the main focus of this investigation 
the results of which are illustrated in Chapters 4 & 5. As detailed in Chapter 4, the vestibular 
epithelium from control patients was similar in appearance to mucosal-like epithelia (Burgos 
& Roig de Vargas-Linares, 1978; Squier, et a/, 1976; Landay & Shroeder, 1977, 1979; 
Squier, 1977; Shroeder, 1981; King, 1983; Corbeil et al., 1985). There was no keratinisation 
of the surface cells, and no granular cell layer or spiny cell layer as in true skin (Breathnach, 
1971, Ghadially, 1988). The epithelium of the vestibule was found to be composed chiefly, 
of a large population of intermediate cells, which had sparse desmosomal junctions, and pale 
staining cytokeratin filaments. Surface cells were flattened, and the cy1oplasmic membranes 
of these cells slightly thickened. Large glycogen aggregates were found in upper intermediate 
and superficial cells of this epithelium, which were characteristically seen in a halo around 
the nucleus. This was an unusual finding, as glycogen is rarely stored in skin, except in fetal 
tissue or in response to a disease process (Falin, 1961 ). Leukocytes, which were seen in all 
cell layers were isolated cases; the predominant inflammatory cell present in a majority of 
vestibular biopsies was the lymphocyte. Scanning electron microscopy illustrated surface cells 
which were polygonal in shape, with fine, raised intercellular junctions. The epithelial surface 
was covered with a complex interdigitating network of rounded rnicroridges, of varying 
length, orientation and distribution. 
When examined using TEM, vestibular epithelium from VVS patients demonstrated several 
striking attributes which were not evident in vestibular tissue from control women; the 
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characteristic features ofVVS affected epithelium were described in detail in Chapter 5. The 
presence of dark staining, shrunken epithelial cells, visible throughout the epithelium were 
particularly distinctive; these cells were found to correspond to dark staining cells evident in 
semi-thin sections stained with methylene blue. Using TEM, these cells appeared individually, 
and in foci, and were commonly associated with leukocytes. In close proximity, membrane 
bound, cytoplasmic lobules were evident, which were not commonly seen in the control 
biopsies. It was initially anticipated, that these cytoplasmic bodies may be dendritic processes 
of Langerhans cells. However, on further examination ofVVS samples, these structures were 
numerous, and when serial sections were examined these lobules did not appear to have a 
cellular origin. 
An alternative, and exciting hypothesis for the presence of these intensely staining cells in 
VVS biopsies, involves the process of apoptosis (Wyllie et al., 1984; Arends & \Vyllie, 1991; 
Cohen, 1993a, 1993b; Collins & Rivas, 1993). Dark staining epidermal cells, demonstrated 
many of the features characteristic of apoptotic cells. Numerous epidermal cells in the VVS 
biopsies appeared shrunken, \Vith condensed nuclear material, but with intact organelles and 
cytoplasmic membranes. Cytoplasmic lobules could also be accounted for within the theory 
of apoptosis, as during this process, dying cells are packaged into membrane bound bodies to 
prevent the initiation of an immune response. Despite several features in common with 
apoptosis, the nuclear changes characteristic of programmed cell death were not evident in the 
majority of the dark staining epithelial cells found in VVS biopsies. However, consistent with 
apoptosis, cytoplasmic membranes remained intact; and membrane bound cytoplasmic bodies 
were commonly found engulfed by epidermal cells, and in the process of being phagocytosed 
by leukocytes. 
283 
The main factor contradictory to the demonstration of apoptosis, was the presence of a mild 
to moderate inflammatory cell infiltrate, which was significantly more pronounced in the VVS 
samples than in the controls (Chapter 7). The initiation of an immune reaction is not a 
characteristic feature of apoptosis, a process which does not cause any adverse, or long term 
damage to the tissue. Therefore, the presence of a significant number of inflammatory cells 
may suggest an alternative or adapted form of apoptosis which permits a mild inflammatory 
reaction. Alternatively, the presence of apoptotic-like cells, and numerous leukocytes, may 
suggest two different processes operating independently in response to the same, or different 
stimuli. These processes may be associated, as in some VVS samples with a mild infiltrate, 
the number of apoptotic cells was not as great as in biopsies with a large inflammatory cell 
population. No attempt was made to establish a correlation between the intensity of the 
inflammatory response, and the number of apoptotic-like cells present, however this may be 
attempted in future investigations. 
Scanning EM of VVS samples illustrated a similar pattern of microridges as seen in the 
control samples. However, the vestibular biopsies demonstrated slightly shrunken 
microridges, and areas where these structures were absent. In addition, small pore-like 
structures were seen, which resembled the openings of goblet cells. Using light microscopy, 
these structures were seen to be glandular in appearance. It was concluded that these structures 
were probably small minor vestibular gland openings, which were not evident in control 
samples. Biopsies taken from VVS patients were removed very accurately from beside the 
Skenes' glands with the aid of a colposcope. This may account for the increased number of 
these structures in VVS samples. This was a particularly interesting observation, as there have 
been few reports on the frequency of minor vestibular glands in the vestibule, or the 
appearance of these structures using SEM. Low temperature SEM, although not successful 
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in this study, may be useful in future investigations to clarify any changes in the microridge 
appearance in response to VVS. 
Past pathological investigations ofVVS have involved the assessment of vestibular biopsies 
only when patit:nts initially present with idiopathic vulvar pain. There are no reports 
commenting on the change in the inflammatory response over time, or in response to 
treatment. In this investigation, patients were treated with a topical antifungal preparation, 
ketoconazole, which was reported to be a mild L TB 4 inhibitor (Beetens et al., 1986). 
Treatment with ketoconazole appeared to have very little effect on the ultrastructural 
characteristics of VVS, however, some subtle changes were detected (Chapter 6). Dark 
staining cells were seen in similar numbers when compared with the pre-treatment samples, 
however, these cells were extremely vacuolated and were commonly surrounded by abundant 
cytoplasmic bodies. Lymphocytes and NK-like cells were frequent in the epidermis, in close 
contact with both cytoplasmic bodies, and with apoptotic-like epithelial cells. NK-like cells 
had a slightly lobed nucleus, abundant mitochondria and a well developed Golgi body, 
occasionally dark staining granules were seen in these cells. Alternatively, these leukocytes 
may have been large granular lymphocytes. In the dermis, plasma cells were less frequent, and 
macrophages were more common when compared with the pre-treatment samples. Frequently, 
macrophages were seen in the dermis, with pseudopodia extended, and in contact with groups 
of cytoplasmic bodies. The inflammatory response may be the result of a cell signalling error, 
resulting in the initiation of an inflammatory response out of context, as no etiological agent 
was evident in a majority of cases. Alternatively, an etiological agent or antigen may be 
present which has not yet been detected. 
The frequency of dark staining cells and the number of leukocytes in the control and VVS 
samples were examined in Chapter 7. It was demonstrated, that there was a highly significant 
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difference in the numbers ofleukocytes in the VVS and control samples. However, there was 
no difference in leukocyte nwnbers in the biopsies from VVS patients removed pre and post-
treatment. This was anticipated, as the inflammatory cell infiltrate was seen to be of a similar 
intensity in a majority of VVS biopsies before and after treatment. However, the type of 
inflammatory cells present appeared to be different. This substantiates past reports which 
reported an inflammatory cell infiltrate in VVS biopsies, and refutes claims that VVS is 
predominantly a psychosexual problem (Schover et al., 1992). 
The assessment of the staining intensity of vestibular epithelium was problematic. Once the 
presence of apoptotic-like cells was established, the main intention of this experiment was to 
quantify the number of dark cells in the epidermis using image analysis. It was anticipated that 
an increased number of dark staining cells in the VVS samples would alter the staining 
intensity, and subsequently the pattern of the grey scale plot obtained. Although the sections 
were stained for an equal time, and at a preset level illumination, there were variations in resin 
staining which were unavoidable. If larger tissue samples were available, wax sections of 
vestibular tissue from control and VVS patients would be examined using alternative staining 
techniques, allowing various parameters to be measured more accurately, such as leukocyte 
types, numbers of Langerhans cells, and glycogen content of the epithelium. Image analysis 
has good scope for the assessment ofVVS biopsies using TEM. Other approaches using this 
technique, may include an assessment of the density of cytoplasmic lobules present in the 
VVS samples. Additionally, the microridge structure and distribution could be investigated 
using the quantification facility available on the Jeol 2000 FX transmission electron 
microscope. 
The use ofTEM has proved invaluable in the study ofVVS, and has illustrated significant 
changes in the ultrastructural characteristics of this epithelium, which appear to be due to 
286 
VVS. However, with the information resulting from this investigation, it is now essential to 
develop histological techniques to investigate these characteristic findings in more detail. 
Immuno-cytochemistry may be of particular use in future investigations ofVVS. In particular, 
the presence of markers linked to apoptosis should be examined, such as Bcl2 and Bax, to 
determine whether the dark staining cells are actually undergoing apoptosis. The application 
of L TFS for TEM, once perfected, has the benefit of maintaining the antigenicity and natural 
structure of the tissues. This technique will permit the use of immuno-gold labelling for TEM 
in order to accurately locate markers of apoptosis. The nature of the cored and electron lucent 
vesicles seen in VVS samples could also be investigated using this teclmique (Bailly et al., 
1992). The change in the inflammatory response should also be characterised, as this may 
provide clues to the progress of the syndrome, and the action of the treatments used. As in 
the studies completed by Pyka et al.( 1988), and Prayson e1 al. (I 995), the characteristic cells 
of the immune response could be detected using a range ofT and B cell markers, however, 
these studies have indicated this approach to be of little value. The presence ofNK cells and 
macrophages in post-treannent samples could also be quantified to demonstrate any trends 
present. The origin of the membrane bound lobules should also be investigated to ensure that 
they are of epidermal cell origin. If they do not prove to be renmants of epidermal cells, the 
possibility of dendritic or Langerhans cell processes should be investigated further using LM 
or immuno-gold labelling at the TEM level (Hanau et al., 1986). 
Another interesting observation ensuing from this investigation, has involved the initiation 
of symptoms associated with a 'urogenital sinus' syndrome, in patients who have been treated 
successfully for VVS. Patients with VVS were found to suffer with cystitis at a higher 
frequency than control patients (see Chapter 3). The correlation between interstitial cystitis, 
urogenital syndrome and VVS has been investigated by several authors, however, the results 
were inconclusive (McCormack, 1990; Fitzpatrick et al., 1993; Foster et al., 1993). Several 
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samples of trigone epithelium were obtained during the course of this investigation which 
were processed for TEM. The trigone of the bladder is derived from the same embryonic 
origin as the vestibule of the vulva, and consequently may show similar changes in response 
to VVS. These biopsies demonstrated some unusual findings, however, no control biopsies 
were available for comparison. Future investigation of patients with VVS would include the 
assessment of patients for urogenital problems; patients who did demonstrate urethral 
discomfort with no obvious etiological cause should be biopsied, and the tissue investigated 
using LM and TEM. 
This study has resulted in a step towards the understanding of the pathological process 
involved in VVS. However, as in a majority of investigations, many more questions have been 
raised than have been answered. It is probably true that the initiating factor in the development 
of VVS is multifactorial. However, the maintenance of the immune reaction, resulting in 
vulvar pain associated with VVS may be due to a common factor. The possibility of an 
autoimmune type reaction, such as in bullous skin conditions affecting the vulva, should not 
be ignored (Marren, 1993 ). It may be the case that apoptosis is occurring in response to an 
autoimmune stimulus, and is affecting large numbers of epidermal cells which express a 
particular antigen (Tan 1994). The presence of a moderate inflammatory cell infiltrate, may 
not be linked to the process of apoptosis. If apoptosis is operating on a large scale as 
anticipated, why are inflammatory cells more common in VVS than in control samples? Is the 
cellular damage a result of the inflammatory response, and if so, why does the tissue show no 
effects of disease on a macroscopic scale0 
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APPENDIX,ONE 
Ethica19tJm11Jittee approval 
3.01 
Telephon<:: Plymouth: (0752) 7nJII 
Extensions: HMSC Chairman 
HMSC Hon. Secretary 
HMSC Committee Ocrk 
: 2640 
: 52045 
: 2641 
Your Ref: Our Re/-' MTI/kw/LREC 
Please address all co"espondence w the above-named Department 
Dr G D Morrison 
Consultant in Genito-Urinary Medicine 
Freedom Fields Hospital 
Plymouth 
DnRRII'ORD HOSPITAL 
OERRI'FORD ROAD 
PLY~OUTH 
PIJi ~OH 
8 February 1994-
Re: Investigation of Vulvar Vestibulitis Syndrome for llltram.icroscopy 
pre and post treatment with Ketoconazole. 
Plymouth Study No 446 
DearGeorge 
Thank you for your letter of 31 January 1994 enclosing copy of the DDX certificate for the 
above-named study and for confinning that the University of Plymouth will meet the 
histopathology costs. 
I am pleased to take Chairman's action to give approval for this study to commence in 
Plymouth. 
The Committee would be pleased to have a report on progress and outcome in due course. 
Best wishes. 
Yours sincerely 
~~~~ 
M Tlnman 
Chairman 
Plymouth Local Research Ethics CommitWe 
~-~for the attention of Clinical Trials Officer) 
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APPLICATION TO THE PLYMOUTH LOCAL RESEARCH ETHICS COMMITTEE FOR APPROVAL OF 
A STUDY INVOLVING HUMAN SUBJECTS 
APRIL 1992 
INSTRUCTIONS 
Investigators are advised to check that this is the current version of this 
application form. 
(a) Please complete in TYPESCRIPT. 
(b) Send 11 COPIES (collated) to: The Chairman 
(c) 
Local Research Ethics Committee 
HMSC Office 
Level 7 
Derriford Hospital 
Plymouth PL6 8DH 
The Plymouth Local Research Ethics Committee meets 
Tuesday of each month, except August. Applications 
the Chairman at least two weeks before that date. 
If there is insufficient space on the form ·to answer 
please attach your answer(s) on separate sheet(s). 
questions should be answered; it is not sufficient 
Protocol." Please use the symbol "N/A" where a 
applicable. 
on the 
should 
second 
be with 
any question(s), 
All applicable 
just to say "see 
question is not 
1. TITLE OF PROJECT 
A pilot study of ~ulvar vestibulitis (vvs) its prevalence, social 
sequelae and associated conditions. 
2. (a) Applicant - names and addresses, position, qualifications and 
functions of all involved. 
Or E J Chandler, Principal Lecturer in Sociology, University of 
Plymouth, Department of Applied Social Science, Drake Circus-, Plymouth, 
PL4 BAA. Ph.D. Director of research project. 
(b) ALL other workers' names and addresses etc. 
Ms. Carole Sutton, Lecturer in Computing, University of Plymouth, 
Department of Applied Social Science, Drake Circus, Plymouth, PL4 8AA. 
Ms P Sargent, Postgraduate Research Student, Department of Biological 
Sciences, 410 Davy Building, University of Plymouth, Drake Circus, 
Plymouth, PL4 8AA. 
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(c) State the personal experience of the applicant (and, if 
different, that of team members involved) in the field of 
investigation concerned. 
Extensive experience in conducting and managing social science 
research projects. 
(d) Which of the above is co-ordinating ttie study? 
(e) If the applicant is not a Consultant (or equivalent) give the 
name and status of the person taking responsibility for the 
study. 
Dr. George Morrison, Consultant in Genito-Urinary Medicine, Freedom 
Fields Hospital, Plymouth, PL4 7JJ. 
3. Where will the research be done? 
The GU Clinic, Freedom Fields Hospital & 2 family Planning Clinics 
in GP Practices. 
4. Purpose of the research: 
(a) To which of the following does it relate: Diagnosis, therapy, 
prevention or understanding of disease or function? 
The understanding of the disease and the effectiveness of treatment. 
(b) Is it a pilot study or a definitive one? Single centre or 
multi-centre? 
Pilot study in a single centre. 
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(c) Approximately how long will the study take to complete? 
g months 
(d) ·Please state the precise aims of the'study (what questions are 
to be answered and what is the value of answering them). 
i) to gain more information about the prevalence of VVS in the 
general population. 
ii) to establish the r~lationship between VVS, obstetric history, 
sexual behaviour, hygiene regimes and associated conditions of 
Candida infections & papilloma warts. 
iii) to test/develop an interview schedule to be used in a 
larger scale study. 
5. Design of the study - what will be done, what results are expected, 
and how the results will be analysed or evaluated. Include 11 
copies of the full Protocol, including any questionnaires to be 
administered. (Please note Draft Pro to cols are not acceptable). 
6. 
Copies of protocol and questionnaire enclosed. 
Give the inclusion and 
patients/subjects. 
exclusion criteria for choosing 
As there will be a census of women attending the GU clinic, all 
subjects will be included. The sample of women aged 20-35 in 
the Family Planning Clinics will be randomly· selected. No criteria 
other than. age gender will be used for selecting the sample. 
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How many patients/subjects do you expect to enrol locally? 
Total number of subjects = 75. 
How was the number of patients/subjects decided on? 
There are currently 25 patients registered with this disorder at 
the GU clinic. These are to be matched with 2 groups of 25 
subjects, w~th each group drawn from family planQing clinics 
located in different socio-economic areas. This ~hould permit 
an analysis of sufficient statistical significance to support 
a larger study. 
9. How will the patients/subjects be recruited: 
(a) What sources of patients/subjects will be used? 
The GU Clinic and 2 Family ·Planning Clinics. 
(b) How will they be approached? 
They will be written to, informed ahout the research and invited 
to participate. 
(c) Do they have a special relationship with the investigator? 
e.g. student or subordinate staff. 
No 
(d) Is written information to be given to them? (Please attach). 
Yes- Enclosed in protocol. 
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Please attach the consent form to be used. Consent should 
normally be WRITTEN. If consent is to be verbal, please give 
a justification. 
The consent form will be incorporated in the information given 
to subjects and this is enclosed in the protocol. 
(b) Please give a justification if, in any circumstances, consent is 
to be given by someone OTHER than the patient/subject. 
'\ 
11. If the subjects are in an especially vulnerable group (e.g. Children 
under 16, mentally handicapped etc.) please complete the following 
sections: 
(a) In what way, if any, can the proposed study be expected to 
benefit the individual patient/subject on whom it is to be 
performed? 
not applicable 
(b) In the case of a study which cannot be expected to benefit the 
individual patient/subject -
(i) What are the potential risks, if any, to the persons 
taking part in the study? 
not applicable 
(ii) Is parental or guardian agreement to be obtained, and 
if so, in what form? 
not applicable 
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(iii) 
6 
Is the patient/subject capable of giving assent? 
("ASSENT" is used here to imply a willingness that does 
not necessarily carry the greater understanding and 
legal implications that are generally understood by 
'consent' ) . 
not applicab-le 
If the study 
applies to each 
for which it is 
Not applicable 
involves a drug or drugs, what stage 
drug? Does it have a produ2t licence 
to be used?* 
of evaluation 
for the purpose 
13. Is any drug being supplied by a company with a clinical trial 
exemption certificate or in response to an investigator with a 
clinical trial exemption?* 
14. 
Not applicable 
Product 
supplier 
nature of 
resulting 
liability and consumer protection legislation make the 
and producer (manufacturer, or any person changing the 
a substance, e.g. by dilution) strictly liable for any harm 
from a consumer's (subject or patient) use of a product. 
(a) What arrangements have been made for indemnity for unforeseen 
adverse reactions? If applicable, the arrangements involving a 
drug supplied by a company should conform to the ABPI code of 
practice. (Copies of the ABPI Indemnity Form are available 
from the Research Ethics Committee Office). 
not applicable 
*See Appendix I at the back of the form. 
309 
15 0 
7 
(b) What arrangements will exist to indemnify investigators and the 
Health Authority against claims made against them? Medically 
qualified investigators are advised against entering indemnity 
agreements in which the indemnifying body takes control of 
claims arising out of alleged negligence by the investigators; 
defence of these claims should always remain in the hands of 
the defence organisations. 
not applicable 
"·· 
What will be done to the patients/subjects? If arterial 
blood samples are to be taken, please specify how, where, 
and amount. 
Not applicable 
or venous 
frequency 
16. If the study is on patients: 
(a) What differences are there from the usual management of such 
cases? 
.None 
(b) If additional imaging procedures are being undertaken for the 
purpose of this Trial, please confirm that the Director of 
Imaging is satisfied that the risks are acceptable. 
r.ot applicable 
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11. What information is to be given to the patient's GP (especially if a 
drug is to be given or an invasive procedure is undertaken) and will 
the passage of such information be a condition of the subject's 
participation? 
Not applicable 
18. Multi-centre studies: 
(a) Who takes overall responsibility for the study? 
(b) Who has the control of the data generated? 
(c) Are there other research ethical committees to whom this study 
is being referred? Indicate those who have already given 
approval. 
19. The declaration of details relating to financial arrangements for 
research work is now a GMC requirement. Give FULL details of 
payments to be received and payments to be made to researchers, 
individuals or departments e.g. Pharmacy, chemistry etc. Details of 
payments to be made to subjects/patients should also be included. 
The proposed research involves no payments/receipts. 
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20. (a) State any ethical problems or considerations that the 
investigators consider to be important or difficult with the 
propos~d study. 
The personal and sensitive nature uf the infomation to be 
gdthered in the interviews. All those involved in the research 
have been· tr~ined in interviewing skills. If personal help 
is requested by subjects in the course of the interview, they 
will be given information about confidential counselling service 
for women and a contact number for a nurse at the GU clinic. 
(b) Are there any potential hazards to su&~ects/patients. If so 
what is their estimated probability and what precautions are 
being taken to meet them? 
(c) Are the procedures being used in this study likely 
discomfort or distress to subjects/patients? 
estimate the degree and frequency of discomfort or 
entailed. 
to cause 
If yes, 
distress 
21 . Principal investigator's signature ................................. . 
22. Signature of Consultant (or equivalent) taking responsibility if 
different from Principal Investigator. 
Date 
N.B. The Plymouth Local Research Ethics Committee requires a progress 
report on all studies given approval. 
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AlPiplEN1D1JX. TW01 
QU,estiQnnaineformat 
University of Plymouth 
Genllo-Urinary Clinic 
Biographical de1alls 
au 1. Whal is your age? c=J 
au 2. What is your presem martial Slalus ? (TICk one) 
1.Single n 
2.Married0 
3. Separaled r::J 
4. Divorced D 
5. Widowed. D 
Ou3. How many children do you have ? c=J H none. go IO Qu. 5 
au 4. How old are your children ? 
Firs! child 
Second child 
lllird child 
Fourlhchild 
Filth child 
Ou5. What is your elhnic origin? (TICk one) 
1.Whi!e § 
2. Black Caribbean 
3. Black olher" 
4.-lndian § 
5. Pakislani 
6. C•unese 
Ou6. Whal is your occupalion ? Ou7. 
ObSietric HISiory 
Qu 8. Details of preonaOOes 
7.01her" 0 
• Please specily 
What is your parlnefs occupation ? 
(ff appriCable) 
Please complete lhe following lable licking alllhose applicable for each pregnancy SJaning wilh your 
firSI pregnancy. 
SHOWCARD1 
1. Forceps 2. Sl~ches 3. Caesarean 4. Miseaniage 5. Termination 6. Normal 
Page 1 
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0u 9. In the six months lollowing pregnancy did you have any diflicuhies with the following ? 
Ou 10. 
Ou 11. 
Ou 12. 
Ou 13. 
1. Using 
Tampons 
2. Sexual 
Intercourse 
First 
Second 
Third 1-------t----i 
Focnh 1-----+------1 
Frf1h 
Are you having regular sexual intercourse wfth a man ? (TICk one) 
1. Yes E3 
2. No Why not ? 
If no go to Ou 18, 
page 3. 
How long have you been in your current relationship ? 
Years Months 
Do you currently use any form of contraception ? (TICk one) 
I. Yes E1 
2. No H no go to Ou 15, 
page3. 
TICk any of the following contraceptives that you are ~using. 
SHOWCARD2 
1. Condoms 
2. Pill 
3.Cap 
4. Coil 
5. Contraceptive cream 
6. Femidom 
8. Contraceptive loam I 
Pessary 
---- Brand name 
----What cream cio you use ? ------
---- Brand name 
---- Brand name 
Ou 14. · How long have you been using this method of contraception? (Tick one) 
t. Less than 6 months§ 
2. 6-12 months 
3. More than 1 year 
Page2 
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Qu15. 
au 16. 
au 11. 
Qu18. 
au 19. 
Whal was your lasl method of contraception ? (Tod< one) 
SHOWCARD2 
Wtrf <foci you change ? 
1. Condoms 
2. Pill 
3.cap 
4. Coil 
5. Contraceptive cream 
6. FemidOm 
8. Contraceptive foam I 
Pessary 
-----------------------------
In the last month how often have you had sexual interoourse ? (Tick one) 
SHOWCARD3 
1.Notatan 
2. Once 
3. Two to Three times 
4. Once a week 
5. Several times a week 
6. Daily 
7. More often than above 
AI what age did you slan menstruating (periods) ? c::::::=J 
AI what age <foci you first have sexual inlercourse ? c::::::=J 
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Qu20. When you have a menstrual period do you use {Tick one) 
1. San~IIJ}I lowels only § 
2. TaiT4>0flS only Go lo Ou 24. 
3. Bo1h lampOns & Sanilary 1owels J 
Ou21. 
Ou22. 
Ou23. 
H San~ary lowel only . Have you used tampons in lhe past ? 
1.Yes D 
2.No D Hnogoto0u24. 
When did you last use 1ampons ? (Tick one) 
1. Up lo 6 monlhs ago 
2. 6 momhs 10 1 year 
3. 1-2 years 
4. 2-5 years 
5. Greater than 5 years 
Why did you slop using lampons ? 
The folloWtng are a series of questions relating to the types of toiletries and washing 
products that you may use. 
Ou24. 
Ou25. 
Ou26. 
Do you wash your underclothes- underpants. bras. tights etc. - in: (TICk all appfiC.:~:o, 
1. Biological washing powder § 
2. Non biological washing powder 
3. Fabric Sottners 
When you have a bath do you use bubble balh or a similar product? (TICk one) 
1. Yes 
2.No 
3. Do not bath 
When you have a shower do you use a shower gel or similar product ? {TICk one) 
1. Yes 
2.No 
3. Do not shower 
317 
Page 4 
Qu27. 
Ou28. 
Ou29. 
QuJO_ 
Qu31. 
Ou31. 
Ou32. 
Qu33. 
Do you wash your hair in the :(TICk one) 
1. Bath 
2. Shower 
3. Wash basin I 
using a shower head 
Do you wash your vaginal area apart trom when you are in the bath 1 shower? 
1. Yes E3 
2. No 11 no, go to au 29. 
Do you use !-'Jap ? 
r-------------------1.Yes 
2.No E3 Brand name --- -- ------ -H no, go to Ou 31. 
If yes, have you experienced any irritation after washing ? 
1. Yes 
2.No E3 
Do you use any special cleansing products tor the vaginal area eg. Fem1resh, moist 
tissues, talcum powder ? 
,----------1. Yes 
. 2. No 
H yes, wllat are you using ? 
E3u no. go to Ou 32. 
How often do you use ~ ? (TICk one) 
1.0noeaday ~ 
2. Twice a day 
3. Every 2-3 days 
4. Less than the above 
Now go to Qu 33. 
11 no, have you used such products in the past ? 
t. Yes 
2. No E3 What were they?-------
Did you find that the special cleansing products caused you any irritation ? 
1. Yes 
2.No E3 
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Qu34. 
Qu35. 
Qu 36. 
Qu 37. 
Qu 38. 
Qu39. 
Ou40. 
Have you ever suffered any disoomfon 1 irritation or other symptoms in the folloWing areas ? 
SHOWCARD4 1. pubic area 
2. cmorts 
3. vulva (outside lips) 
4. urethra (bladder opening) 
5. labia (inside fips) 
6.vagina 
?.perineum 
09. None, go to au 39. 
In your own words please describe the symptoms. 
Did you treat affernpt to treat the symptoms yourseH ? 
1. Yes 
2.No B H yes. What did you do?=========== 
Did you consuft any otthe loltowing ? 
What was the diagnosis ? 
Was your laS1 smear normal ? 
t.Yes 
2.No 
3. Do not know 
1.GP § 
2. Chemist 
3. Gen~o-Urinary Clinic 
4. Other (please state) 
When was your last smear taken ? 
_ _ _ _ months ago 
Have you ever suffered lrom any of the tollowing cond~ions ? (Tick all applicable) 
SHOW CARDS 
1. Thrush/Yeast infections Please answer the questions on the GREEN sheet 
2. Cyst~is 
3. Herpes 
4. Genital Warts /Papilloma virus Please answer the questions on the BLUE sheet 
5. Vagi11itis - a 1ish smelling vaginal discharge 
6. Vulvar Vestibulitis Please answer the questions on the PINK sheet 
Pages 
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GREEN 
University of Plymouth 
Gmito-Urinary Oinic The following questions shOuld be answered only by Individuals who 
have suffere<llrom thrush, candida and other yeast Infections 
Ou41. 
Ou42. 
Ou43. 
Ou44. 
Ou45. 
Ou46. 
Ou 47. 
When you firs1 had the symp1oms <fld you try lo lreat yoursen ? 
.------------ 1. Yes 
2.No 
What did you use ? 
Did you oonsutt your GP ? 
.-------- 1. Yes 
2.No 
B If no, go to Ou 43 . 
Did~ wor1<? 1. Yes 
2.No 
B Uno,golo0u46. 
Did your GP examine you ? 
1. Yes § 
2.No 
3. Can not remember 
Did your GP lake a swab (sample) lhat was sent to the laboratory for diagnosis? 
Did you go la I he chemiSI ? 
t.Yes 
2.No 
3. Do nol know 
1. Yes 
2.No 
What were you given ? 
Did you go lo lhe Gen~o-Urinary Clinic? 
r--1.Yes 
1 
2. No 
Wha' were you given ? 
B 
B 
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Qu48. 
Qu49. 
QuSO. 
Qu51. 
How long did the treatmen1taS1tor? (TICk one) 
t.Oneday § 
2. 2-6days 
:-~:e::~ weeks 
Did the symptoms reoccur ? 
r-----------------------t.Yes 
2.No El Hno,goto0u51. 
How many times have the symJtoms reoccured in the last year ? 
1 . One to four times D 
2. More than four times D 
Have you taken any of the following in the last year? 
1. Antibiotics 
2. Steroids B 
Thank you for completing this section of the questionnaire. H you haVe suffered 1tom : 
Papilloma 1 genttal wan virus please complete the questions on the Blue sheet (page 9) 
Vutvar VestlbuiHis please complete the questions on the Pink slleet (page t 1) 
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University of Plymouth 
Genito-Urinary Qinic llle lollowing quesllons should be an......en!d only by Individuals who have 
suffered With the papilloma I genHal wan virus 
Qu52. Have you auef11lled to lreat the warts yourseH ? 
r------------------------- 1.Y~ 
2..No B H no.golo0u54. 
Qu 53. . What did you do ? 
Qu54. 
Qu55. 
Qu56. 
OU57. 
Qu58. 
On suspecling your cond~ion did you fiiSI go to the 
1.YourGP ~ 
2.. Gen~o-Urinary Cfl . ] Go 10 Qu 5?. 
3. Olher, please state 
Did your GP say I hey would go away on lheir own ? 
'·Yes 
2. No 
Did your GP refer you 10 lhe GU clinic ? 
Did you receive any lrealmenl ? 
1.Y~ 
2. No 
B 
B 
r---------------------------1.Yes 
;:,No B H no,gotoOu 59, page 10 
If y~. what 1reatmen1 did you receive ? 
SHOWCARD6 
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1. Laser trealmenl ~ 
2. Eledrical Cauterisalion 
3. Topicallrealmenl 
4. Freezing 
5. lnter1eron Injections 
6. Other. please state 
Page 9 
Qu59. 
Qu60. 
OU61. 
How long were you treated tor? 
Did the warts reoccur ? 
1. Yes 
2.No 
Have you been lor a ched< up in the last 6 months ? 
1. Yes 
2.No 
months 
B 
El 
Thank you for completing this section of the questionnaire. If you haVe suffered from : 
ThNSh I Yeast Infection please complete the questions on the Green sheet (page 7) 
Vulvar VestlbuiHis please complete the questions on the Pink sheet (page 11) 
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University of Plymouth 
Genito-Urinary Clinic The following questions should be answered only by individuals who 
have suffered with vutvar vestibulitis. 
Qu62. 
OU63. 
Qu64. 
OU65. 
OuS<>. 
Ou 67. 
Ou 66. 
Ou 69. 
Did you aUempt to seH treat your symptoms ? 
r------------------------------t.Yes 
2.No B n no,gofo0u64. 
If Yes, what cfld you do ? 
When you first experienced vulvar vestibulilis did you first go to : 
1.YourGP § 
2. Gentte>-Urnary Clinic ] DO NOT answer 
3. Other, please state any of the remain-
------- ing questions on 
the pink sheets 
Did your GP examine you ? 
1. Yes 
2.No 
3. can not remember 
Did your GP immediately diagnose vutvar vestibulitis ? 
1. Yes 
r----------------------------2.No 
11 no. was the initial diagnosis any of the following ? 
SHOWCARD7 
B If yes go to Ou 68 
1. Thrush !Yeast infections ~ 
2. Cyst1tis 
3. Herpes 
4. Genrtal Wans /Paptlloma v1rus 
5 Vagin~•s ·a fish smelling vaginal diScharge 
6. Vulvar Vestibulijis 
Did your GP initially offer you any treatment ? 
1. Yes 
2.No B If no, go to Ou 70 (page 12) 
What was the treatment ? Did the treatment work ? 
1. Yes 
2.No 
3. Only tor a shon period 
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Qu70. 
Qu71. 
Qu72. 
Did you reiUm to your GP for further help? 
1.Yes 
2.No B 
~yes, what were the ouloomes of your subsequem visits to your GP ? 
SHOW CARDS 
Did you try going to cfdferent GPs ? 
1. Further treatment that worked § 
2. Further treatment thal did not woll<ed 
3. Lack of help & gave up going 
4. Seeing a counsellorllherapist 
5. Refered to GU clinic 
1. Yes 
2.No B 
PINK 
lhe following statements relate to whal you thought of your GP on presehting yourseH with thiS c:onclhlon. 
H you saw more than one GP please answer for the first GP that you saw. Tick the box for the answer that 
Is the ~rest to whal you think. licking neutral means that you do not having any feelings either way to 
the question. 
Qu73. 
Qu74. 
Qu75. 
I was totally satislied with my initial ~isit to the GP. 
SHOW CARDS 
!.Strongly Agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Strongly disagree 
Some aspects of my consuttation could have been beher. 
SHOW CARDS 
!.Strongly Agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Strongly disagree 
The Doaor was interested in now the symptoms were ahecting me. 
SHOW CARDS 
1.Sirongly Agree 
2. Agree 
3. Neutral 
4. Disagree 
5. Strongly disagree 
ln>ank you for completing this section of the questionnaire. If you have sulfered from : 
Papilloma I genital wan virus please complete the questions on the Blue sheet (pageS) 
!rhrus I Yeast Infections please complete the questions on the Green sheets (page 7) 
L-------------------------------------------------------~Paget2 
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Genito" Urinary Clinic Section two: To be completed by vutvar vestibuiHis sufferers attend-
Ing the GenHo-Urlnary Clinic only. 
Ou1. 
Ou2. 
Were you refered by a GP to the GU Clinic ? (TICk one) 
1. Yes 
2.No 
How many times have you been to the clinic to date ? 
B 
Ou 3. On preser.ting yourseH at :he Clinic did you already know that you were 
1. Yes 
~--------------------------2.No 
suffering with vulvar vestibu[dis ? all yes, go to Qu 5. 
Ou 4. H no, what did you think was a ma«er with you, in your own words? 
Ou5. On hearing the diagnosis .which of the following best desaibeo olOW you ten ? 
1. Relieved 
2. Anger 
3. No spec~ic feelings 
Ou 6. In your own words describe the symptoms that you are experiencing 
Ou 7. What bothers you most about this cond~ion ? 
Qu 8. How long have you had these symptoms? (Tick one) 
1. Less than six months 
2. Six months to one year 
3. One to three years 
4. Five to ten years 
5. More than ten years 
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Ou 9. Have you been tree trom the symptoms at any time ? 
Ou 10. 
Ou 11. 
Ou 12. 
Ou 13. 
Ou 14. 
Ou 15. 
1. Yes 
2.No B ttno,gotoOu11. 
H yes, wllen ? 
What seems to make the symptoms worse ? 
What can you do to get reliet ? 
How are the symp1oms you have NOW related to your INITIAL symptoms ? 
(rock all applicable) SHOW CARD 10 
1. Same 
2. Less intense discomton 
3. More intense discomton 
4. Less trequern 
5. More trequern 
Which ot the loltowing statements best describes the disoomton that you experience most ohen ? 
SHOW CARD 11 
1. Slight, I only notice ~when I think about n § 
2. Sfighl, I can ignore n by not thinking about n 
3. Moderate, t always know it is there but 1 can still pertorm most tasks 
4. Severe, I can only pertorm a nuntler ot tasks which require little concentratio 
5. Severe, I find it imposibte to do anything 
Do you find that your discomton resuns in any ot the tot towing ? 
SHOWCAAD12 
1. No interference with daily routine 
2. Some interference with daily routine 
3. lnterleres wnh daily routine 
4. Confinement to bed 
5. needs immediate mecfcal attention 
Page 14 
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Ou 16. 
Ou 17. 
Ou 18. 
Ou 19. 
Ou 20. 
Do your symptoms have any otthe following affects ? 
SHOW CARD 13 
1. Does not affect sexual intercourse 
2. Sometimes prevents you from having sexual intercourse 
3. Cof11lletely prevents sexual intercourse 
4. Causes diS<X>ntfort but does not prevent sexual intercourse 
5. Do not know -not sexuany active. 
n you try to have sexual intercourse in<fiC31e any ol the following that are applicable 
SHOWCARD14 
1. llisoJntfort is worse w~h certain pos~ions 
2. Discomfort is roostly at the opening of the vagina 
3. Painful on entry but then intercourse is tolerable 
4. Discomforl/ initatkm after intercourse 
Have you seen a counsellor since you have been anendng the GU clinic ? 
1. Yes 
2. No B 
Have you been given any advice on how to manage the symp1oms and discomfort ? 
r----------------------------1.Yes 
2. No 
What was the advice ? 
B 
--------------------------------
--------------------------------------------------------------------------
--------------------------------
Have you had any treatment since attending lhe GU clinic ? 
r----------------------------t.Yes 
2. No 
What was the treatment ? 
B 
--------------------------------
--------------------------------
--------------------------------
Thank you for completing this questionnaire. 
Page 15 
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Drug information - Ketoconazole 
1 
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1. rNTRODUCTrON 
Vulvar vestibulitis syndrome is a complex condition with symptoms and 
findings involving and limited to the vulvar vestibule. It consists of 
severe pain on vestibular touch to attempted vaginal entry, tenderness 
to pressure localised within the vulvar vestibule and vulvar erythema of 
varying degrees. Histopathological findings are consistent with a 
chronic, non-specific inflammatory response that is occasionally 
associated with metaplasia of the minor vestibular glands. To date the 
syndrome has been seen in association with sub-clinical human 
papillomavirus, chronic recurrent vaginal candidosis, chronic recurrent 
bacterial vaginosis, chronic alteration in the vaginal pH and the use of 
chemical and destructive therapeutic agents. 
1.1 Treatment 
The treatment for acute vulvar vestibulitis syndrome requires the 
eradication of any infection and all therapeutic modalities, local or 
systemic, that may continue to the problem should be discontinued. 
Topical steroids are applied as soon as all infection has been treated. 
The treatment for chronic vulvar vestibulitis is much more complicated. 
Some success has been obtained when a specific etiologic condition can 
be identified and treated but even in these cases, such an approach will 
not yield a cure in many cases. When all treatment modalities have 
failed, surgery is then considered. 
Recently a pilot study was completed looking at the efficacy of 
ketoconazole 2% cream in chronic vulvar vestibulitis. The intention was 
to utilise the weak 5-lipoxygenase activity of ketoconazole in 
controlling this condition. Response was defined as at least a SO% 
improvement in presenting symptoms. A total of 14 patients were treated 
with ketoconazole 2% cream applied twice daily to the vulva for one 
month. Of those treated 9 responded, 4 had no benefit from therapy and 
one patient failed to return for follow-up. This response rate was 
considered adequate to justify further research into chronic vulvar 
vestibulitis with much more potent and specific 5-lipoxygenase 
inhibitors. 
1. 2. R85355. 
At submicromolar concentrations, R85355 suppresses the FMLP-induced 
leukotriene biosynthesis by intact human polymorphonuclear leukocytes 
with an ICSO value of 0.30mM. It inhibits the conversion of arachidonic ~acid to S_:__~'!'Jl_!?y_RBL 5_-_l:i_p_ox;ygenase. This inhibitory effect is · · sUbstantially reduced in the presence of 13-HpQDE suggesting the ability of R85355 to interfere with the oxidative activation of this enzyme. 
en tested at a concentration of SmM, R85355 had no inhibitory effects 
on cycle-oxygenase, phospholipase A2 and xanthine oxidase. A partial 
inhibition, (<35%), of platelet 12-lipoxygenase and soybean 15-
lipoxygenase was observed. 
3 
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R85355 has been investigated for inhibition of radioligand binding in 
vitro to neurotransmitter receptor sites, drug receptor binding sites, 
ion channel ligand binding sites, peptide receptor binding sites, 
thromboxane A2, PAF, leukotriene D4 receptor binding sites and 
terbenazine sensitive release sites. It was also examined for inhibition 
of neurotransmitter uptake in rat brain synaptosome preparations. At the 
highest tested concentration, 10mM, RSS355 was inactive in all these 
systems. 
At 10-5 molar RSS355 has no or little effect on alpha-1, alpha-2, beta-1 
and beta-2 adrenergic responses, 5HT2, H1 and H2 histaminic responses, 
contractions induced by adrenergic nerve stimulation, calcium induced 
contractions, endothelium dependent relaxations or singlet oxygen-
induced contractions. At high concentrations a slight decrease in 
cardiac output was observed in isolated working rabbit hearts. No 
protection against deterioration of heart function after isct~emia and 
reperfusion was observed. 
These experiments indicate that RSS355 is at present thought to be 
devoid of major effects other than the documented inhibition of 5-
lipoxygenase enzymatic activity. 
Leukotrienes formed from arachidonic acid by the 5-lipoxygenase enzyme 
are presumed to be involved in allergic and inflammatory processes. 
RSS355 inhibits in vitro and ex vivo the 5-lipoxygenase activity in 
blood. In vitro RS5355 inhibits the production of LTB4 in A23187 or 
zymosan-stimulated human blood. Similar results are obtained in canine 
and rat blood. At higher concentrations inhibition of the cycle-
oxygenase enzyme is observed. 
Oral administration of R85355 to beagle dogs, (0.31 to 2.5mg/kg), 
produces a rapid and sustained inhibition of ex vivo LTB4 biosynthesis. 
At 2.Smg/kg this inhibition is almost complete, (~90%), for more than 8 
hours. At this dose th~s no effect on the cycle-oxygenase activity 
confirming the selectivity of R85355 for 5-lipoxygenase. 
R85355 has been studied in a large series of general in vivo 
pharmacological tests in mice rats and dogs at a dose of 40mg/kg. It was 
devoid of significant interaction with muscarine, nicotine, dopamine, Dl 
and D2), adrenaline (alpha 1 and 2), histamine (h1 and 2), serotonin, 
opoid and PAF receptors, monoamine oxydase inhibition and monoamine 
uptake. It was also devoid of toxic effects, aspecific effects on body 
temperature, muscle tone or respiration. No activity chtacteristic of 
~~ stimulants, sedatives, hypnotics, anticonvulsants, benzodiazipines, 
antihypnotic compounds, anti-diarrhoeals, laxatives, gastrointestinal 
motor stimulating compounds, antisecretory compounds, diuretics, 
antiemetics,emetics, narcotics, aspirin-like compounds or anti-
inflammatory compounds was observed. R85355 was also devoid of 
interaction with liver microsomal enzymes. 
In the rat one month toxicity study it was concluded that R85355 was 
well tolerated and did not result in overt signs of toxicity up to 
BOmg/kg/day. Laboratory examination revealed no target organ for 
overdosing. When administered for one month to dogs, R85355 was well 
tolerated up to 10mg/kg/day. At 40mg/kg/day toxicity was mainly 
evidenced by decreased body weight gain and changes in laboratory 
parameters that identified the urinary tract as the main target organ 
for overdosing. A similar tendecy was present at 10mg/kg/day with" 
2.5mg/kg/day non-toxic. 
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In the reverse gene mutation test it was concluded that R85355 had no 
mutagenic properties. 
The specific inhibition of the 5-lipoxygenase enzymes suggests that 
R85355 would be a suitable agent to treat vulval vestibulitis. 
2 . OBJECTIVES 
The prime objective is to determine the efficacy of the 5-lipoxygenase 
inhibitor R 85355 in the treatment of vulvar vestibulitis and the speed 
di onset of action. Once this has been established a placebo controlled 
s~udy will be considered. 
Secondary objective is 
To assess a new pressure application device and it's value in providing 
quantitative variables rather than the subjective one's used to date. 
Assessment of vulvar vestibulitis has been extremely difficult in the 
past as only subjective criteria have been available. The standard 
methodology involved a swab test in which a water moistened cotton 
tipped swab is applied gently over the skin at 6 pre-determined sites. 
These 6 sites are 3 posterior to the vagina, 2 either site of the 
urethra and 1 posterior to the clitoris. 
Response is graded as follows; 
o = normal sensation 
1 =·unpleasant scratchy sensation 
2 painful sharp sensation 
3 patient acknowledged pain and was 
noted to flinch 
4 patient noted significant pain and 
was recoiled 
A specific piece of apparatus has been developed at The University of 
Plymouth in which a small disposable probe produces variable pressures 
on a 5 point scale. The pressures available are measured in mille Newton 
and range from 0 to 0.63 with the first grade of pressure being variable 
between 0 and 0.14mN and the other 4 fixed pressures. It is therefore 
possible to provide quantitative and reproducible pressure stimulation. 
3. PAT:rENTS 
10 patients with Vulvar vestibulitis will be recruited. 
To be eligible for the study patients must fulfil the following 
criteria. 
3.1. Inclusion Criteria. 
1. Bartholin's and Skene's ductal erythema 
2. Bartholin's and Skene's ductal tenderness 
3. Hymenal ring tenderness 
4. Entry dyspareunia e.g. intercourse, insertion of tampon/speculum 
5 
5. 
5. Sensitivity to pressure with a variable pressure applicator on at 
least two of 6 predetermined vulval sites 
3.2 Exclusion criteria 
1. Pregnant patient or patients intending to become pregnant. 
2. Women of child-bearing potential not receiving an adequate form of 
contraception. 
3. Patients with microbiologically proven anaerobic vaginosis. 
4. Patients with mycologically proven vaginal candidosis. 
5. Patients unavailable for a 6 month follow-up period. 
6. Apparently free from anaerobic vaginosis or vaginal candidosis 
for the past 3 months. 
4. STUDY DESIGN. 
An open non-controlled study. Two centres will be involved in the 
study.; PLymouth General Hospital and the Royal Devon and Exeter 
Hospital. 
5 . TREATMENT 
Formulation : 0.5% R85355 cream 
3 x 30g will be provided per patient 
Route : Topical 
Administration Cream to be applied twice daily to the vulvar 
area 
Treatment duration 8 weeks 
Medication 
Medication will be supplied by Janssen Pharmaceutical Ltd.The pharmacist 
will be responsible for dispensing and accounting for the clinical trial 
supplies. A record of the drugs dispensed must be maintained and 
recorded on the patients drug sheets and in the study case record form. 
Both sh:'•·:j be available to the monitor for inspection. 
Under no circumstances will the investigator allow the trial 
supplies to be used for a purpose other than as directed by this 
protocol. 
Clinical trial supplies assigned to a patient participating in 
the trial and returned by that patient must be entered on the 
Drug Accountability form. These supplies must not be dispensed 
again, even to the same patient. 
All unused clinical trial drugs will be counted by the 
investigator or pharmacist and monitor for assessment of 
compliance. Reasons for non-compliance should be ascertained by 
the investigator. An account of returned medication will .be kept 
on the Drug Accountability form provided to the pharmacy. 
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Storage at room temperature. 
LABELLING 
R85355-GBR-001 
Patient Initials 
Randomisation No ____ _ 
Apply twice daily to the affected area 
VARIABLES TO BE :MEASURED. 
On entry to the study then weekly for 4 weeks then monthly for a further 
3 months. 
The following will be assessed as 
0 
1 
2 
3 
absent 
mild 
moderate 
severe 
1. Entry dyspareunia during intercourse, tampon insertion or speculum 
insertion. 
2. Bartholin's ductal erythema 
3. Skeen's ductal erythema 
4. Hymenal ring tenderness 
5. Pressure response for Bartholin's ductal tenderness and Skeen•s 
ductal tenderness. This will be assessed on a 1 to 5 scale where 
1 = 0 to 0.14mN and 5 = 0.63mN 
On entry then at the end of the 8 week treatment period. 
A biopsy will be taken from periductal tissue for electron microscopy. 
7 
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ADVERSE EVENTS 
All adverse events experienced by patients treated will be recorded on 
the adverse event report forms. Information collected will include date 
and time of onset and cessation, frequency, and severity, action taken. 
A judgement by the treating physician on causality will also be 
obtained. Any serious adverse events (where 'serious' is defined as 
fatal, life threatening, disabling, incapacitating or resulting in 
hospitalisation or the prolongation of hospitalisation) should be 
reported immediately to the Adverse Reaction Monitoring Unit at Janssen 
Pharmaceutical Ltd, even if not considered to be related to the trial 
medication. These will be immediately notified by the unit to the DoH 
under the CTX scheme. All other adverse events will be notified to the 
DoH at the end of the trial. 
10. MONITORING OF TBE TRIAL 
The study will be monitored according to the current JRF standard 
operating procedure for the Monitoring of Clinical Trials. This will 
involve an initial set up visit followed by monthly telephone contact 
and visits every 6-8 weeks as appropriate to patient recruitment rate. 
The trial monitor will meet with the investigator and all staff involved 
in the study prior to the study start to review the procedures to be 
followed in conducting the study and recordicg the findings in the Case 
Report Forms. During the trial, the investigator will permit the trial 
monitor to control the progress of the trial on site as frequently as 
necessary. The investigator will make available the Case Report Forms, 
provide missing or corrected data, and sign the Case Report Forms. Key 
items of data transcribed onto the Case Report Forms, such as the 
patient's sex, date of birth, assessment dates and bleed oestrone 
concentrations will be reviewed again source documents in the presence 
of the investigator without compromising patient confidentiality. Any 
inconsistencies found at this review will be resolved and the Case 
Report Form amended. 
Monitors will sign an undertaking to be bound by the confidentiality 
requirements of The Venereal Diseases act 1918. 
CRITERIA FOR MODIFICATION OR TERMINATION OF TBE STUDY 
There are no criteria for modifying or terminating this study. 
REYIEW & CONSENT PROCEDURES 
CTX approval will be obtained. Approval will be obtained from the 
Plymouth Area Health Authority and The Royal Devon and Exeter Ethics 
Committees, from the Janssen Pharmaceutical Ltd. protocol approval 
committee and the international product co-ordinator in Janssen Beerse. 
8 
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Written informed consent will be obtained from the patients before 
commencement of the study. 
Patients will be supplied with an information leaflet prior to obtaining 
that consent, and an information leaflet will be also sent to the 
patients' general practitioner. 
The patient is free to withdraw from the study at any time without 
prejudice to her/his welfare or future treatment. 
INDEMNITY COVER 
Jaossen Pharmaceutical Limited has endorsed· the A.B.P.I. guidelines on 
compensation for medicine induced injury in clinical trials which were 
published in the British Medical Journal on 3rd September 1983. The 
Company carries liability insurance to cover such claims but this 
coverage is not extended to damages which the investigators or third 
parties may suffer by reason of acts of commission or omission on the 
part of such investigators and which are not in accordance with accepted 
common medical practices (state of the art). 
INDEMNITY AGREEMENT 
See Appendix 2 
PUBLICATION POLICY 
Investigators are free to publish the data generated from this study in 
any form, provided that Janssen Pharmaceutical Ltd., will first be given 
the opportunity to comment on the content. Publication of results will 
be initiated by the trial investigator. The data generated on the 
original clinical trial record forms will be the property of Janssen. 
These are required as some regulatory authorities, notably the FDA, 
require original data sets for examination. Copies of the originals 
will be provided by Janssen for the investigators to retain. 
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APPE'NTDiiX f.Oi(JR 
Image' analysis programme· 
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5 dim g(325) 
10 camera 1 
11 scanner 30.45 51.16 
12 setlamps 43.74 0 
20 qmenu 'image_setup' 
30 calibrate 3, 't' 
40 mframe 175 122 30 325 
41 iframe 0 0 512 512 
50 multiacquire 5 0 4 
60 delin 0 1 256 3 
85 qmenu 'measure _grey' 
86 vprofl 175 122 30 325 g(l) 
90 input 'name of file? 'n$ 
100 open #1 'b:'+n$+'.pm' 
110 x=1:g=1 
120 print#! :g, g(x) 
130 g=g+ 1 :x=x+ 1 
140 if g=325 then 200 
150 goto 120 
200 close#! 
210 wtoph 1 2 256 3 
220 anamorph 2 3 6 9 
230 greydetect 3 3 86 1 1 0 
240 binmode 1 2 
242 binsegment 2 3 256 1 5 
250 setftrpar "8,28,15,1,2,3,29" 
251 ftrgrey 1 : measfeat 3 1 4 300000 : clraccept 
252 acceptxfer 3 4 
260 qmenu 'feature _results' 
300 end 
339 
A1?PEND[X FIVE 
Bsiirnqtion .of Leukoc;yte Profile Bensi~' 
Estimation of Leukocyte Profile Denisity using a W eibiel 
Steriological Graticule 
Epidermis 
• 
W eibiel graticule 
Dermis 
• Negative count 
• Positive count 
Positive counts were recorded only if a leukocyte was positioned on a point 
sample intersection. The leukocyte profile density for this example would be 4. 
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APPENDIX Sl:X 
Explanai:ioi11 ofthe Box and Whisker Plot 
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Explanation of a Box and Whisker Plot, illustrating the 
maximum, minimum, mean, median and outlying values. 
\1e<11at 
A -
r- Outlier 
c cp 1- + f- fB 
....___ N ean 
I + I 0 [p l p 
Minimum MaxiiJ?Um 
I + V 
0 4 8 12 
No. Leukocytes I count 
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CJ 0 
Schematic representation ,6fyestibu\ar·epithelium, illustrating the .presence\of 
pale staining cytoken1tin filaments (F) :i]} intermediate cells, (le) .. Microvilli 
(Mv~: are seen .ori .fioncK:etatillised sUper[lcial cells (Su), Glycogen!((])• is seen 
:in I large aggregates: mJthe interfu.egi(lte and .superficial' cells. 11Desmosomes (De) 
are Infrequent;• ,and ·fuito"hohciria i(tvf) are common in: basal {Be) and 
.intermediate c·eus (le). The 1bas(!il1ent membrane (Bm} undulant, below which 
:diffuse\conriettive .tiss(ie ®d _c(lpillariesi(Ca)!are evident. 
, I 
Mv 
Be 
' 
$u 
M 
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Plate la 
Plate I b 
Plate le 
Plate I a 
LM photograph of vaginal epithelium stained with I% methylene blue, showing 
an epithelial surface of IS -20 cells thick. Surface cells are flattened (Su), and 
have displaced nuclei. Intermediate cells form a large proportion of this 
epithelium (le) x 450 
LM photograph of surface cells of vaginal epithelium packed with glycogen (G). 
X 950 
LM photograph of vulvar epithelium stained with 1% methylene blue, 
demonstrating slightly thickened surface cells (Su). A largely homogeneous 
intermediate cell (le) population make up the majority of this epithelium. 
Leukocytes (Le) are seen penetrating this epithelial surface, and are visible in 
the dermis (Der). x 450 
LM photograph of perineal epidermis stained with 1% methylene blue, 
illustrating keratinised surface cells (Sq), a thin granular cell layer (Gc), a 
prominent spiny cell layer (Sp) and basal cells. The basement membrane and 
connective tissue (Der) are also clearly visible. x 450 
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Plate 2a 
Plate 2b 
Plate 2c 
Scanning electron micrograph of perineal surface cells (Su). Cell junctions are 
prominent, thickened and raised. Surface cells (Su) are polygonal in shape. A 
pore is visible (P) which may be a mucus secreting gland or sebaceous gland 
opening. Bar =l011m 
Polygonal surface cells of perineal epidermis, characterised by a network of 
flattened microridges (Mr). The cell at the bottom of the micrograph has a 
slightly different surface appearance (*). This cell has prominently raised 
surface microridges. Bar = 1 011m 
High power micrograph of surface ridges. In some areas the surface cells appear 
completely flat (Fl) and structure less. Some microridges are flattened and worn 
in appearance (Mr). Bar= S11m 
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Plate 3a Scanning electron micrograph of normal vestibular epithelium. The surface cells 
in this micrograph appear undulant, with prominent cell junctions (Cj). 
Bar= 5~m 
Plate 3b & c The surface microridges of vestibular epithelium are raised and rounded in 
appearance. Microridges (Mr) of varying lengths and dimensions form an 
interlacing network covering the surface of superficial cells. 
Plate 3d 
Plate 3e 
b) Bar= l~m 
c) Bar= 5~m 
At high magnification the microridges (Mr) appeared nodular (No). Bar= 1 ~m 
A flat area of epithelium, indicating the fine, slightly thickened cytoplasmic 
junction (Cj) and interlacing, raised microridges (Mr). The orientation of 
microridges varies on individual cells and between surface cells. Bar= 5~m 
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Plate 4a 
Plate 4b 
Plate 4c 
Plate 4d 
Plate 4e 
Plate 4f 
Surface squame (Sq) of perineal epidermis; the paler squame is desquamating 
leaving the remains of cellular junctions (De) on the exposed surface of the 
underlying darker staining cell. Cytokeratin filaments (F) are still visible in 
these keratinised cells. x 8,500 
Desmosome junction (De) from an area similar to Plate 4 a, showing thickened 
cytoplasmic membranes, dark staining cytokeratin filaments (F) and the absence 
of cellular organelles in the surface cells. x 41,000 
Transition zone in perineal epidermis from granular cells (Gc) to surface 
squames (Sq) of the stratum corneum. Note the absence of organelles in both 
cell layers, and the presence of cytokeratin filaments (F) and globular and patch-
like keratohyalin granules (Kg) in the granular cells. x 5, 500 
Globular keratohyalin granules (Kg) in the transition zone from granular to 
corneal cells. x 17,000 
Low power micrograph of a flattened cell in the granular cell layer (Gc ), which 
has retained its nucleus. Note the dark staining cytokeratin filaments (F) and 
patch-like keratohyalin granules (Kg). x 5,200 
High power of Plate 4e, illustrating intensely staining cytokeratin filaments (F), 
melanin granules (Me), keratohyalin granules (Kg), and desmosomes (De). 
X 10,500 
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Plate Sa 
Plate Sb 
Spiny cells of perineal epidermis (Sp). Note the density of staining of the 
cytokeratin filaments (F) associated with desmosomes (De), and absence of 
these filaments in the perinuclear region. Desmosomes are numerous (De), 
studded at frequent intervals around the periphery of the spiny cells. Folding of 
the cytoplasmic membrane is negligible, mitochondria are common (M). 
X 5,000 
Basal cells of perineal epidermis (Be). Note the presence of: significant numbers 
of mitochondria (M) in the peri-nuclear region, particularly near the basement 
membrane (Bm) and cytoplasmic folds (Cf) at the lateral cell surfaces. x 9,000 
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r[Low rpower electronimicrograph:ot: pefineaJ·epidermls; showing· the differences 
:in staining ofcytokeratin filaments inrbasali (Bc)iand:spiny cellsi(Sp), rNote aiso 
•numerous• desmosomes'(IDe); and theyresence Of'a ieuko·cyte (Le} \Vhicll)l~ 
just ,penetrated the 'basement :membrane .. A mitotic \Jasalrcelli :is also· visible 
r~Mi). 
x6;300 
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Plate 7a 
Plate 7b 
Plate 7c 
Plate 7d 
Surface cells of vulvar epithelium (Su). Note the partially thickened appearance 
of the membranes of one surface cell (Su), the presence of large deposits of 
glycogen (G), flattened nuclei (N), and a darkened, possibly apoptotic, cell (D). 
An area similar to * is shown in Plate 7c. x 9,500 
High power micrograph of a superficial epithelial cell. Vesicles (V e) are visible 
in close contact with the cytoplasmic membranes of the surface cells. Vesicles 
are commonly electron lucent, occasionally having electron dense cores. Note 
also the presence of glycogen aggregates (G). x 25,000 
Desmosome junctions (De) from a region similar to that in Plate 7a.(asterisk). 
Note the slightly thickened cytoplasmic membranes, pale staining cytokeratin 
filaments (F), thickened plaques at desmosomaljunctions (De), but particularly 
the numerous cytoplasmic folds (Cf). x 43,000 
A superficial cell of vulvar epithelium, the nucleus of the cell has ben retained 
(Nu). Note the presence of pale-staining cytokeratin filaments (F), mitochondria 
(M), small electron lucent vesicles (Ye) and microvillous ridges (Mv). The 
remains of a desmosomal junction (De) is visible on the surface of this 
flattened cell. x 37,500 
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Plate 8a 
Plate 8b 
Upper intermediate cells (Ic) of ~lvar epithelium .. Note: particularly: the 
presence!of large depositS of glycogen: (6) in the lperinu&ar region; fomiing a 
_pale halo'around the nucleus tn some cases; the densitY ofcytokeratin filaments 
~~)!at desmosomali junctions (E>e }; and the presence .ol':nwnerous interdigitating 
cytoplasmic folds (Cf). x 5,300! 
Intermediate :cells layer (IC) of vuivar epithdlwn•. Two leukocytes (Le) of: 
·unknown. origin are visible between· cells of tl\.e :upper intermediate cell layer 
(le). llhe nucleus ofthe larger leukocyte ·is lobed, and the:cytoplasm Is rich .in 
organelles. x•8;000 1 
·, . 

-' 
f>late 9~ .Low,magnificatiomelectron1 micrograph of1ihe vulva, illustrating; the presence 
()f: :lymphocytes (L);:an dark staining,:apoptotic-like cell:@O); and intermediate 
:cells (le) with;many mitochondria' (M) and 1endoplasmic reticuhrm (Er): Note, 
:also, the basemenfmembrane (Bm~:in bottom right corner of the micrograph, 
icytoplasmic folds interdigitatil'!g between, epidennali cell's and: ·infrequent 
·desmosomal'junctions (De): X•6,300. 
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Plate 1 Oa 
Plate lOb 
Lower intermediate cells (le) with abundant folding of the cytoplasmic 
membrane (Cf) and numerous mitochondria (M). Desmosomes (De) are not 
common in this cell layer. 
X 8, 800 
Basal cells (Be) of vulvar epithelium. Cytokeratin filaments are pale-staining, 
forming small bundles (F). Desmosomal junctions (De) are sparse, and 
cytoplasmic folds are numerous between basal cells. Hemi-desmosomes (H) are 
visible at the basement membrane. A centriole (Ce) can be seen in one of the 
basal cells. x 8,600 
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Plate !la 
Plate Jib 
Plate 11 c 
Surface cells of vaginal epithelium. Surface microvilli are masked by the 
presence of electron dense mucus (Mu). Surface cells have large deposits of 
glycogen (G) and flattened nuclei (Nu). There are few organelles in this cell 
layer. x 6,300 
Upper intermediate cells of vaginal epithelium. Cells appear swollen with large 
amounts of glycogen (G) present in a halo around the nucleus. Cytoplasmic 
folds (Cf) are common, and desmosomes are short (De). x 5,700 
A lower intermediate cell, with glycogen deposits (G), close cytoplasmic folds 
(Cf), and few organelles. Note the leukocyte in the top right of the micrograph 
(Le). x 9,000 
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Plate 12a 
Plate 12b 
Plate 12c 
Vulvar epithelium processed by LTFS. Illustrating an upper intermediate cell 
(le), with large voids where glycogen has been removed (*). The nuclear 
membrane and cytoplasmic membrane are intact, however, mitochondria appear 
to be damaged (M). Membrane coating granules are visible (Mcg). x 7,800 
Surface cells of vestibular epithelium processed by LTFS. Microvillous 
processes are visible (Mv), as are electron lucent vesicles (V e). Mitochondria 
appear to have lost their internal membrane structure (M). x 26,000 
A high power micrograph of the surface cell shown in Plate 12b. Cytokeratin 
filaments (F) are clearly visible, the cytoplasmic membrane appears slightly 
thickened. Electron dense, membrane coating granules appear to have an 
internal lamellae structure (Mcg). Vesicles are electron lucent, with no internal 
structure (V e). x 52,000 
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Plate 13 
Plate 13b 
Plate 13c 
Plate 13d 
Lower intennediate cells (le) from vestibular epithelium processed using LTFS. 
Cytokeratin filaments are visible arranged in small bundles (F). Desmosomal 
junctions are infrequent (De). There are no intact organelles in these cells. 
X 6,500 
Illustrating a leukocyte (Le) interposed between intennediate cells (le). 
Mitochondria are not present in this plane of section, however this leukocyte is 
characterised by electron dense granules and small vesicles. x 9,750 
Basal cells (Be) appear extremely shrunken with few organelles; mitochondria 
have no internal structure (M), however the nuclear membrane is still visible. 
The basement membrane appears intact (Bm). x 7,800 
High power micrograph of the denno-epidennal junction. The basement 
membrane does not appear damaged, herni-desmosomes are distinct (He). 
Cytokeratin filaments (F) and small vesicles (Ve) are evident in these cells. 
Collagen (C) in the dennis shows characteristic banding. x 26,000 
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CHAPTER FIVE 
The ultrastructural characteristics of vulva! periductal 
epithelium from patients with Vulvar Vestibulitis 
Syndrome 
5.0 Abstract 
The term vulvar vestibulitis syndrome (VVS) was introduced by Friedrich (1987), to describe a 
constellation of symptoms which result in idiopathic vulvar pain. Using transmission electron 
microscopy, it was concluded that the normal vestibular epithelium was ultrastructurally similar to 
mucosal-like surfaces (see Chapter 4). Examination ofvulvar, periductal epithelia from VVS patients 
using TEM, revealed several distinct differences not previously described, and which were not obvious 
using light microscopy. Intensely staining cell profiles were seen in foci, particularly along the basement 
membrane. Shrunken in appearance, with vacuolated cytoplasm, intact organelles and condensed 
cytokeratin filaments, these cells appeared similar to cells undergoing apoptosis. Leukocytes were 
commonly interposed between epidermal cells, particularly in contact with foci of intensely staining 
epidermal cells. Membrane bound lobules of cytoplasm, associated with the apoptotic-lik:e cells, were 
numerous. These cytoplasmic bodies may be processes of Langerhans cells, or byproducts of the process 
of apoptosis. Vesicles, not commonly seen in control tissue were frequently visible in close contact with 
the cytoplasmic membrane of superficial cells. Using SEM, the epithelium from VVS patients showed 
a modification of the normal microridge structure. Microridges appeared shrunken and flattened in 
appearance, and pore like structures were visible. These structures varied in dimensions, distribution and 
frequency and were often localised in groups of three or four. These pore-like structures may be the 
openings of minor vestibular glands, or mucous secreting glands, the characteristics of which have not 
previously been described using SEM. The visualisation of apoptotic cells may be important in future 
studies ofVVS, as the presence of these cells may affect the onset, or be a result of the syndrome. The 
presence of an inflammatory cell infiltrate in VVS samples, in conjunction with apoptotic-like cells may 
suggest a cell signalling defect which is resulting in epidermal cell death. 
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5.1 Introduction 
As outlined in the general discussion, vulvar pain has been documented for over a century, and 
was first described by Skene in 1889, described a 'hyperaesthesia' of the vulva. At the 1983 
meeting of the International Society for The Study ofVu1var Disease the term 'vulvodynia' was 
introduced, and defined as chronic vulvar discomfort. Thorough diagnosis has indicated that 
there are several subsets ofvulvodynia, one of which is vulvar vestibulitis syndrome. The tenn 
Vulvar Vestibulitis Syndrome (VVS) was introduced by Friedrich in 1987, to expand the 
terminology associated with vulvar disease, and to replace inaccurate and ambiguous tenns 
previously used to describe this constellation of symptoms. 
According to Friedrich (1983), and Woodruff & Friedrich (1985), the vestibule is that area of 
the vulva which extends laterally from the hymenal ring to a line of more keratinised skin on 
the labia minora , tenned Harts' line (Hart, 1893). Anteriorly the vestibule reaches upwards to 
the frenulum of the clitoris and posteriorly downwards to the fourchette. The vestibule is 
endodennal in origin, as is the urethra and the trigone of the bladder; the remainder of the 
external female genitalia are ectodennal (Woodruff & Friedrich, 1985). The epithelial surface 
of the vestibule has not been studied in detail, but has often been described as a mucosal-like 
surface with similarities to both skin and true mucosal surfaces. It can be surmised that the 
epithelium of the vestibule has all of the sensitivity of a mucosal surface with little of the 
resistance offered by keratinised skin. There are no mucous secreting glands in the vulva as in 
other mucosal surfaces, however, the surface of the vestibule is bathed in mucus from the 
cervix, and the vestibular glands are reported to provide some lubrication of the vestibular 
surface (see Chapter 2). The glands present in the vulva, which open onto the surface of the 
vestibule, appear to be the sites of inflammation in this syndrome. There are two main types of 
glands in the vestibule; the major vestibular glands (Bartholins' and Skenes' glands); and the 
minor vestibular glands, which may be found all over the vestibular surface and which vary 
186 
